data_2ls0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ls0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.523 HG23 ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -72.5 154.53 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.838 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.6 m-85 -108.42 169.34 8.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.675 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.6 OUTLIER -116.93 110.75 18.7 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.596 ' CG1' ' HA ' ' 1' ' 77' ' ' LYS . 0.1 OUTLIER -80.55 81.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.977 0.894 . . . . 0.0 110.018 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.854 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 2.6 m-20 -82.48 -25.91 33.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 112.935 -1.939 . . . . 0.0 111.955 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.1 t70 -174.18 114.63 0.19 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.273 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.866 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.77 136.0 48.31 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.006 177.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.866 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -128.9 160.82 31.44 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.919 -177.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.532 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -72.01 103.35 3.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.839 HD13 ' NE2' ' 1' ' 37' ' ' GLN . 0.9 OUTLIER -123.8 119.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.839 -171.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' 1' ' 51' ' ' VAL . 43.6 m-20 61.66 36.65 16.47 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.355 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.56 2.93 65.17 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.307 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.532 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 94.2 m95 -60.24 131.04 49.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.921 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.62 146.69 42.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.721 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.721 ' O ' HG22 ' 1' ' 55' ' ' ILE . 21.1 t -115.14 151.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.903 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 30.5 mtp180 -144.3 142.94 30.75 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.126 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.854 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.86 150.07 52.26 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.619 HD21 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -59.69 -18.18 40.29 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.595 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.558 ' H ' HD13 ' 1' ' 42' ' ' ILE . 3.7 mp -83.23 -50.5 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.64 0.733 . . . . 0.0 110.906 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.02 -11.21 20.78 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.249 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.763 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -148.84 71.33 10.41 Favored Pre-proline 0 CA--C 1.505 -0.781 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.996 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.536 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 76.3 Cg_exo -48.96 -32.32 22.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.573 2.182 . . . . 0.0 109.231 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 11.1 t 169.47 155.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.978 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 72.33 56.96 0.15 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.903 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -84.19 111.45 19.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.647 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.75 91.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.54 0.686 . . . . 0.0 110.583 -178.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.818 ' HB3' HG21 ' 1' ' 32' ' ' ILE . 33.1 m0 -44.31 -28.58 0.55 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.506 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.647 ' CG1' HG22 ' 1' ' 49' ' ' THR . 5.9 p -52.96 -56.2 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.64 ' H ' HG13 ' 1' ' 51' ' ' VAL . 51.2 t0 -153.68 -13.05 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.259 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.099 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -86.31 -13.01 47.85 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.461 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.921 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.53 142.29 22.7 Favored Glycine 1 N--CA 1.388 -4.525 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 175.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.934 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.42 119.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.729 -178.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.53 87.72 0.66 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.571 ' O ' HG23 ' 1' ' 60' ' ' VAL . . . -35.3 -35.16 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.767 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -54.46 -35.74 63.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.252 0.549 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.0 OUTLIER -66.19 -29.08 69.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.685 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.621 HG11 HD13 ' 1' ' 55' ' ' ILE . 26.5 m -100.17 -173.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.267 0.556 . . . . 0.0 112.407 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.805 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -142.66 112.34 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.817 -177.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -62.8 121.33 13.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.015 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.633 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 1.8 m -105.22 153.71 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.896 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.444 ' O ' HD12 ' 1' ' 23' ' ' ILE . 1.6 p -83.97 161.3 20.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.468 0.452 0 O-C-N 123.882 0.739 . . . . 0.0 112.593 -178.528 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.724 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -74.83 151.54 39.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 114.42 18.33 6.69 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.189 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . 0.478 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -151.71 -109.54 0.43 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.766 -1.683 . . . . 0.0 114.675 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.564 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 0.1 OUTLIER -151.94 160.37 43.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.912 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.765 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.9 OUTLIER -154.98 173.25 16.83 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 122.013 0.911 . . . . 0.0 111.121 177.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.805 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.09 125.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.682 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.572 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -74.62 111.65 10.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.302 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.848 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.2 t-20 -54.03 115.05 7.42 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.703 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 95.0 Cg_endo -68.94 -28.21 29.58 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.133 2.555 . . . . 0.0 110.925 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -28.85 61.78 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.065 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.848 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.43 -3.56 55.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 39.2 t -96.53 132.77 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.362 0 CA-C-O 123.085 1.421 . . . . 0.0 112.134 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.839 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.97 -44.78 12.79 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 111.615 -2.539 . . . . 0.0 107.979 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.556 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.09 173.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.599 -1.637 . . . . 0.0 112.766 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.657 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -107.09 117.06 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.73 179.64 44.47 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-O 122.518 1.065 . . . . 0.0 115.028 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . 0.419 ' CG2' ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.97 138.96 95.8 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.609 -1.796 . . . . 0.0 111.934 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 25.1 Cg_endo -81.18 158.3 20.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.477 3.451 . . . . 0.0 113.925 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.2 mtt -149.22 135.84 19.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 15.0 mttt -86.36 123.68 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.346 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.41 -52.64 0.04 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.915 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.878 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.99 69.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.009 0.405 . . . . 0.0 110.585 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.27 -49.58 0.85 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.149 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.02 -16.15 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.999 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.708 ' H ' HD13 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.08 -153.53 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.769 0.795 . . . . 0.0 112.038 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' HB3' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.59 118.28 32.19 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.737 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.878 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.7 m95 -120.77 117.22 26.88 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.653 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.33 147.4 27.13 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.7 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 26.8 tt0 -80.86 102.62 10.16 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.611 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.867 HG11 ' CE1' ' 1' ' 108' ' ' PHE . 43.8 t -100.92 135.79 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.839 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 m120 -89.85 101.94 14.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.389 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.867 ' CE1' HG11 ' 1' ' 106' ' ' VAL . 1.9 m-85 -99.23 168.21 10.18 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-O 122.92 1.343 . . . . 0.0 111.927 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.658 HG22 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.13 -65.48 0.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.624 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.658 ' H ' HG22 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.31 -56.01 3.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.32 -7.4 67.79 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.974 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.45 -91.63 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.67 130.11 34.75 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.009 -0.701 . . . . 0.0 109.298 176.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.934 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.5 t -145.63 117.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.099 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.4 m95 -92.96 155.36 17.61 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.887 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.574 HD21 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.36 144.43 22.94 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.975 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.729 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -65.14 101.92 0.58 Allowed 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 124.64 2.162 . . . . 0.0 107.362 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.643 ' C ' ' H ' ' 1' ' 120' ' ' SER . 4.2 t -78.03 15.76 0.85 Allowed 'General case' 0 C--N 1.277 -2.56 1 CA-C-N 108.246 -4.07 . . . . 0.0 113.245 -174.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . . . . . . . . . 6.8 t -63.34 21.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.845 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.951 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.5 m -175.13 125.26 0.25 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.673 ' O ' HD21 ' 1' ' 124' ' ' LEU . 4.9 ttmt -74.09 -40.63 62.6 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.991 0.901 . . . . 0.0 108.745 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.791 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 85.8 m-20 -65.69 -4.64 6.68 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.951 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.52 -58.73 6.53 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.77 0.795 . . . . 0.0 110.509 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.838 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.94 -55.62 18.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 122.021 0.915 . . . . 0.0 109.452 178.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.586 HD12 ' O ' ' 1' ' 121' ' ' LYS . 6.6 mp -59.24 -45.81 90.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.147 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.3 m-85 -113.97 -31.74 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.735 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.0 26.21 8.02 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.389 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.791 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 80.0 mttt . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.005 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttm . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.553 HG23 ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -72.17 156.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.803 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 5.4 m-85 -109.76 169.71 8.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.395 -1.729 . . . . 0.0 106.798 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.666 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 5.0 mmtt -116.4 108.99 16.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.089 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.65 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.1 OUTLIER -80.0 80.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.138 0.97 . . . . 0.0 109.634 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.836 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 5.5 m-20 -80.45 -26.9 38.07 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.645 -2.071 . . . . 0.0 111.966 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . 0.425 ' HA ' ' CD ' ' 1' ' 77' ' ' LYS . 5.3 t0 -175.04 114.98 0.15 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.931 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -131.09 138.48 49.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.214 177.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.931 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -132.92 161.63 33.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.212 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.0 103.01 2.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 174.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.927 HD11 ' NE2' ' 1' ' 37' ' ' GLN . 1.1 mt -124.2 120.84 60.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.72 35.24 19.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.71 4.6 76.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.443 HD13 ' HB1' ' 1' ' 56' ' ' ALA . 0.0 OUTLIER -135.76 136.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.52 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 97.1 m95 -60.22 128.41 36.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.927 ' NE2' HD11 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.85 143.87 45.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.423 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.714 ' O ' HG23 ' 1' ' 55' ' ' ILE . 22.8 t -112.38 151.25 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.882 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 28.7 mtp180 -144.19 143.98 31.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.047 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.836 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.77 152.56 51.74 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -62.21 -15.4 46.43 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.374 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' 1' ' 40' ' ' ASN . 3.9 mp -85.43 -50.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.498 0.666 . . . . 0.0 110.673 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.558 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.4 OUTLIER -99.71 -11.43 20.88 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.212 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.731 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.2 t -147.86 71.0 11.38 Favored Pre-proline 0 CA--C 1.505 -0.787 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.228 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.51 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.3 Cg_exo -49.5 -32.22 26.47 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.574 2.182 . . . . 0.0 109.078 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 13.3 t 170.1 154.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.045 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 72.47 56.35 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.882 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.1 112.03 19.44 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.663 HG21 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.95 92.31 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.643 0.735 . . . . 0.0 110.532 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.866 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 30.5 m0 -45.22 -28.6 0.81 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.594 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.663 ' CG1' HG21 ' 1' ' 49' ' ' THR . 9.9 p -54.06 -57.48 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.713 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.64 ' H ' HG13 ' 1' ' 51' ' ' VAL . 50.9 t0 -152.72 -11.91 0.17 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.631 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.085 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.9 m120 -87.4 -14.36 40.81 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.876 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.907 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.11 145.97 27.47 Favored Glycine 1 N--CA 1.388 -4.56 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 175.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.16 120.19 33.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.949 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' 1' ' 35' ' ' ILE . . . -70.62 88.14 0.69 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.542 ' O ' HG23 ' 1' ' 60' ' ' VAL . . . -35.65 -34.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.005 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.66 -36.57 64.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.357 0.598 . . . . 0.0 110.572 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.4 m-20 -65.57 -29.07 69.63 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.552 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.592 HG12 HD11 ' 1' ' 55' ' ' ILE . 25.9 m -99.37 -176.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.412 0.625 . . . . 0.0 112.626 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.795 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -140.27 107.82 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.668 -178.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' 1' ' 62' ' ' GLU . 0.0 OUTLIER -65.92 125.25 24.82 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.195 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.599 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 6.9 m -112.02 161.19 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.345 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.465 ' O ' HD12 ' 1' ' 23' ' ' ILE . 3.3 p -83.76 162.79 20.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.48 0 O-C-N 123.953 0.783 . . . . 0.0 112.988 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.098 0.475 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -80.02 152.27 29.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.65 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.16 19.99 4.55 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.754 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . 0.46 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -151.39 -108.32 0.39 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.155 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.572 ' N ' HG21 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -152.06 160.83 43.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.777 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.5 OUTLIER -153.67 172.67 16.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.145 0.974 . . . . 0.0 110.807 177.168 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.795 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.76 124.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.588 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -74.35 114.13 13.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.468 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.893 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.7 t-20 -55.33 114.93 8.03 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.707 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.6 Cg_endo -72.3 -27.24 16.6 Favored 'Trans proline' 0 CA--C 1.502 -1.088 0 C-N-CA 123.059 2.506 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -27.45 60.31 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.069 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.893 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -83.43 -3.51 57.63 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.707 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 25.1 t -96.54 133.17 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.484 0 CA-C-O 123.002 1.382 . . . . 0.0 111.821 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.804 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.91 -48.69 10.44 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.333 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.477 ' O ' HG11 ' 1' ' 106' ' ' VAL . 0.5 OUTLIER 172.3 172.68 0.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.518 179.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.488 HG11 HG22 ' 1' ' 106' ' ' VAL . 89.5 t -92.15 165.87 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -137.05 179.66 17.77 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.244 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.18 133.71 87.81 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 113.991 -1.105 . . . . 0.0 111.184 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 23.1 Cg_endo -80.88 158.55 21.13 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.284 3.322 . . . . 0.0 113.557 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 25.9 mtt -149.3 134.67 18.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.9 pttt -85.12 124.12 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.508 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.11 -53.11 0.05 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.862 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.78 69.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.862 0.331 . . . . 0.0 110.683 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.53 -49.4 0.87 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.105 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.23 -14.25 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.036 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.701 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -77.86 -153.32 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.688 0.756 . . . . 0.0 111.777 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.515 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.2 m -116.9 118.82 33.5 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.911 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.862 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.1 m95 -119.57 117.39 28.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.41 149.75 24.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.665 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.9 tt0 -82.96 102.76 11.92 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.163 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.628 HG12 ' CE1' ' 1' ' 108' ' ' PHE . 69.2 t -101.28 133.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.804 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -87.65 102.56 14.75 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.13 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.628 ' CE1' HG12 ' 1' ' 106' ' ' VAL . 5.5 m-85 -100.64 168.6 9.59 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.91 1.338 . . . . 0.0 111.98 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.667 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.6 t -52.21 -65.63 0.52 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.716 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.667 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.29 -55.93 3.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.07 -7.49 66.98 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.111 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 61.12 -90.44 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.18 132.09 34.34 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.74 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 9.3 t -145.18 113.99 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.085 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -91.96 152.42 20.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.896 0.855 . . . . 0.0 112.848 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.483 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.66 145.38 23.4 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.73 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.24 99.26 0.37 Allowed 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 124.765 2.222 . . . . 0.0 107.68 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.634 ' C ' ' H ' ' 1' ' 120' ' ' SER . 1.6 t -76.11 14.66 0.67 Allowed 'General case' 0 C--N 1.28 -2.434 1 CA-C-N 108.047 -4.161 . . . . 0.0 113.399 -174.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . . . . . . . . . 9.0 t -63.71 24.4 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.029 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.98 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.63 120.39 0.14 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.686 ' O ' HD21 ' 1' ' 124' ' ' LEU . 5.1 ttmm -68.77 -38.33 79.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.916 0.865 . . . . 0.0 108.893 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.78 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 13.1 m-20 -66.91 -5.0 10.82 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.98 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.24 -58.6 6.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.598 0.713 . . . . 0.0 110.309 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.803 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -63.94 -57.4 9.87 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.816 0.817 . . . . 0.0 109.662 178.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.597 HD13 ' O ' ' 1' ' 121' ' ' LYS . 6.4 mp -60.14 -46.23 90.37 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.528 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.0 OUTLIER -109.32 -31.04 7.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 98.39 26.09 9.62 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.336 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.78 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 58.6 mttt . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.963 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.278 0.561 . . . . 0.0 112.089 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.483 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.48 154.85 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -177.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.986 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.9 m-85 -110.68 170.17 8.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.956 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 0.0 OUTLIER -117.12 109.63 17.18 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.501 178.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.648 ' CG1' ' HA ' ' 1' ' 77' ' ' LYS . 0.1 OUTLIER -79.28 80.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.951 0.882 . . . . 0.0 109.782 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.841 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.4 m-20 -81.84 -25.96 34.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.881 -1.963 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -174.87 116.54 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.977 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.93 137.14 49.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.948 177.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.977 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -133.32 161.26 34.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.845 -1.071 . . . . 0.0 113.167 -177.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.462 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.2 OUTLIER -70.91 102.7 2.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.855 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 0.8 OUTLIER -124.84 129.35 73.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' 1' ' 32' ' ' ILE . 6.5 p30 52.55 35.16 17.19 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.207 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.26 90.38 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.925 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -140.23 145.08 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' 1' ' 57' ' ' ALA . 94.7 m95 -60.96 131.22 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.889 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.7 146.63 42.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.279 -178.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.71 ' O ' ' CG2' ' 1' ' 55' ' ' ILE . 22.0 t -114.6 150.62 16.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.859 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 22.1 mtp180 -144.64 144.08 31.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.278 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.841 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.45 152.9 51.33 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.536 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -62.0 -16.05 48.62 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.373 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.546 ' H ' HD11 ' 1' ' 42' ' ' ILE . 3.8 mp -85.66 -50.91 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.535 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -99.86 -10.72 21.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.211 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.722 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.2 t -148.59 71.31 10.66 Favored Pre-proline 0 CA--C 1.505 -0.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.988 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.537 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.8 Cg_exo -49.37 -32.33 25.84 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.555 2.17 . . . . 0.0 109.307 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 9.6 t 169.69 153.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.152 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 72.41 56.33 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.859 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -81.45 113.05 19.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.576 HG21 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.18 91.88 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.679 0.752 . . . . 0.0 110.335 -178.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.855 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 33.6 m0 -46.16 -27.38 0.97 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.591 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.641 ' CG1' ' N ' ' 1' ' 52' ' ' ASP . 4.0 p -53.63 -55.57 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.851 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.641 ' N ' ' CG1' ' 1' ' 51' ' ' VAL . 48.3 t0 -154.89 -11.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.358 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.068 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -88.28 -14.72 37.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.936 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.889 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.04 144.26 28.42 Favored Glycine 1 N--CA 1.387 -4.604 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 175.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.9 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.07 119.27 32.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.819 -178.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.78 87.62 0.52 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.533 ' O ' HG23 ' 1' ' 60' ' ' VAL . . . -33.35 -35.77 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.484 -1.234 . . . . 0.0 114.007 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -54.52 -35.89 63.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.116 0.484 . . . . 0.0 110.522 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.435 ' CB ' ' CD2' ' 1' ' 108' ' ' PHE . 0.4 OUTLIER -66.76 -27.16 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.522 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.665 HG13 HD12 ' 1' ' 55' ' ' ILE . 25.6 m -99.48 -171.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.779 HG12 ' HB2' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -146.05 109.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.148 -176.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.23 125.12 24.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.884 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.568 HG12 ' HB ' ' 1' ' 82' ' ' VAL . 6.9 m -107.85 167.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.483 ' O ' HD11 ' 1' ' 23' ' ' ILE . 2.4 p -85.36 160.16 19.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.678 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.768 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.2 OUTLIER -78.43 151.85 32.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.636 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.87 20.36 4.95 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.822 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . 0.485 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -153.81 -107.93 0.32 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.515 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.51 ' N ' HG21 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.99 160.6 43.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.936 -178.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.776 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.09 173.46 16.02 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.107 0.956 . . . . 0.0 110.888 177.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.716 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.94 124.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.562 HG23 ' CZ ' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -74.13 113.58 12.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.943 -178.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.779 ' HB2' HG12 ' 1' ' 61' ' ' ILE . 1.3 t-20 -55.4 115.85 10.3 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.009 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.729 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 82.5 Cg_endo -67.49 -27.09 39.86 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 123.106 2.537 . . . . 0.0 110.106 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.11 -25.14 60.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.4 t-20 -82.9 -2.16 54.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.821 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 57.2 t -101.26 129.82 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.323 0 CA-C-O 123.245 1.498 . . . . 0.0 113.092 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.898 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.25 -39.53 10.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 111.518 -2.583 . . . . 0.0 108.415 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.544 ' O ' HG12 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.2 173.26 0.36 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.174 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.635 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.18 128.74 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -101.43 179.86 28.24 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 122.173 0.874 . . . . 0.0 114.181 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . 0.404 ' CG2' ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.27 138.9 94.66 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.162 -1.519 . . . . 0.0 111.249 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.58 ' HB3' ' CG2' ' 1' ' 118' ' ' THR . 24.0 Cg_endo -81.03 158.04 20.56 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.201 3.267 . . . . 0.0 113.328 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mtt -149.58 136.12 19.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 12.3 mttt -85.47 126.06 33.52 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.497 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.56 -54.27 0.05 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.726 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.869 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -64.47 69.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.858 0.329 . . . . 0.0 110.471 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.42 -49.44 0.86 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.135 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.7 -14.62 0.52 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.155 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.706 ' H ' HD13 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.92 -153.07 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.952 0.882 . . . . 0.0 111.997 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.524 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.3 m -116.56 117.31 29.5 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.567 -1.652 . . . . 0.0 109.795 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.869 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -120.18 117.78 28.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -104.76 147.32 27.83 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.72 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 29.0 tt0 -79.57 103.04 9.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.708 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' 1' ' 91' ' ' VAL . 17.8 t -99.01 138.34 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.898 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.1 OUTLIER -89.1 101.46 14.11 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.098 -177.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.625 ' HB2' HG21 ' 1' ' 114' ' ' VAL . 37.0 m-85 -100.31 157.89 16.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 122.025 0.917 . . . . 0.0 109.384 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.996 HG22 ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.62 -62.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.039 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.996 ' N ' HG22 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.08 10.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.929 0.871 . . . . 0.0 109.725 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.9 -1.99 56.55 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.03 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.45 -95.13 0.01 OUTLIER Glycine 0 C--O 1.212 -1.26 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.9 129.02 38.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.9 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 6.5 t -144.83 120.02 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.068 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.6 m95 -93.89 155.49 17.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.909 0.861 . . . . 0.0 112.784 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.48 HD21 ' HH ' ' 1' ' 24' ' ' TYR . 0.2 OUTLIER -153.93 146.19 23.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.126 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.4 OUTLIER -65.31 101.55 0.57 Allowed 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 124.847 2.261 . . . . 0.0 107.212 178.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.632 ' C ' ' H ' ' 1' ' 120' ' ' SER . 4.1 t -77.99 14.79 1.03 Allowed 'General case' 0 C--N 1.279 -2.494 1 CA-C-N 107.894 -4.23 . . . . 0.0 113.285 -174.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . 0.407 ' CG2' ' OD1' ' 1' ' 117' ' ' ASN . 8.1 t -62.96 22.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.849 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.976 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.3 m -175.81 125.18 0.22 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.715 ' O ' HD21 ' 1' ' 124' ' ' LEU . 7.3 tptm -73.8 -41.03 62.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.129 0.966 . . . . 0.0 108.699 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.791 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 11.8 m-20 -65.01 -4.41 4.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.976 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.05 -58.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.766 0.793 . . . . 0.0 110.239 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.986 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -63.16 -56.57 15.66 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 121.88 0.848 . . . . 0.0 109.581 178.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.571 HD13 ' O ' ' 1' ' 121' ' ' LYS . 6.4 mp -59.73 -43.62 94.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.185 -1.37 . . . . 0.0 112.736 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.632 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -119.96 -30.65 4.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' 1' ' 123' ' ' ASN . . . 100.21 27.96 7.48 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.732 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.791 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.435 -1.213 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.973 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . 0.445 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.6 mmtm . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.71 0.291 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.478 HG23 ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -72.53 154.6 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -177.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.978 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.8 m-85 -111.65 171.53 7.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.867 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.64 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 14.5 mptt -116.91 109.67 17.35 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.279 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -79.85 80.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.9 0.857 . . . . 0.0 109.447 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.894 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 1.0 OUTLIER -81.59 -25.87 35.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.891 -178.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.59 116.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.149 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.907 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.27 136.92 49.69 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.112 0.482 . . . . 0.0 110.264 177.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.907 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -130.35 160.86 32.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.065 -177.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.485 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.99 102.49 2.97 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.815 HD11 ' CG ' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -124.9 122.22 62.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -171.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 60.96 35.51 19.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.253 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.13 4.27 72.3 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -136.19 139.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.485 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 87.4 m95 -60.42 129.85 43.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.875 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.76 145.14 43.69 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.34 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.73 ' O ' ' CG2' ' 1' ' 55' ' ' ILE . 22.0 t -113.1 151.24 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.834 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 33.3 mtp180 -144.56 141.46 29.48 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.185 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.894 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -129.74 152.62 49.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.569 HD21 ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.9 -15.98 47.14 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.608 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' 1' ' 40' ' ' ASN . 3.7 mp -84.34 -50.54 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.715 0.769 . . . . 0.0 110.76 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.542 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -101.72 -10.08 20.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.386 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.734 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.1 t -148.12 70.26 10.94 Favored Pre-proline 0 CA--C 1.505 -0.77 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.048 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 94.3 Cg_exo -50.86 -30.7 30.96 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.505 2.137 . . . . 0.0 109.323 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.0 t 169.22 151.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.259 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 56.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.834 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.64 112.39 18.79 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.645 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.11 91.84 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.662 0.744 . . . . 0.0 110.35 -178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.815 ' CG ' HD11 ' 1' ' 32' ' ' ILE . 35.8 m0 -44.92 -28.19 0.63 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.653 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.655 HG13 ' H ' ' 1' ' 52' ' ' ASP . 7.3 p -53.5 -57.07 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.369 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.655 ' H ' HG13 ' 1' ' 51' ' ' VAL . 52.1 t0 -151.94 -11.79 0.19 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.498 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.039 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.8 m120 -87.23 -10.97 51.12 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.886 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.875 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.98 142.32 22.33 Favored Glycine 1 N--CA 1.388 -4.563 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 175.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.851 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.39 117.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.417 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.46 87.51 0.46 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.522 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -34.88 -34.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.707 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -53.99 -33.97 58.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.07 0.462 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.5 m-20 -70.16 -27.6 64.67 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.852 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.668 HG11 HD11 ' 1' ' 55' ' ' ILE . 32.0 m -98.78 -173.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.424 0.63 . . . . 0.0 112.126 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.756 HG12 ' HB2' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -142.72 105.33 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.538 -177.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -65.81 126.46 28.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.744 -178.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.616 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 15.8 m -116.48 161.76 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.746 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . . . . . . . . . 1.6 p -83.7 163.92 19.96 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.433 0 O-C-N 123.901 0.75 . . . . 0.0 112.926 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.088 0.47 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.56 151.57 37.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.579 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 117.82 18.15 5.27 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -150.81 -109.47 0.46 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 118.655 -1.736 . . . . 0.0 114.579 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.538 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -151.86 160.19 43.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.927 -0.637 . . . . 0.0 109.523 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.751 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.9 OUTLIER -153.19 173.11 15.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.057 0.932 . . . . 0.0 110.946 177.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.734 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.28 124.54 35.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.562 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -74.19 112.22 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.439 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.888 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.4 t-20 -52.39 114.0 5.04 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.707 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 87.4 Cg_endo -70.61 -27.23 22.67 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.065 2.51 . . . . 0.0 110.532 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' 1' ' 85' ' ' PRO . 6.7 m-80 -74.53 -28.62 61.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.999 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.888 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.71 -2.09 53.2 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.707 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 37.9 t -96.54 130.25 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.425 0 CA-C-O 123.002 1.382 . . . . 0.0 111.84 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.841 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.3 -46.28 13.85 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 111.782 -2.463 . . . . 0.0 107.856 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.584 ' O ' HG11 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 173.99 172.72 0.18 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.815 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.606 ' HA ' HG21 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.96 145.93 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -118.19 179.44 17.06 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-O 122.072 0.818 . . . . 0.0 113.676 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.05 137.85 91.03 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.48 -1.36 . . . . 0.0 111.443 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.633 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 25.4 Cg_endo -81.54 158.31 19.3 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.274 3.316 . . . . 0.0 113.574 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtm -149.53 130.89 14.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.509 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.4 mttp -85.17 124.97 32.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.857 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.77 -48.63 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.584 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.883 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -66.63 69.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.396 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.96 -49.39 0.86 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.152 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.81 -17.07 0.39 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.039 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.703 HD12 ' H ' ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -75.73 -153.45 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.849 0.833 . . . . 0.0 112.394 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.573 ' HB3' HG23 ' 1' ' 118' ' ' THR . 1.1 m -116.72 118.29 32.13 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.773 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.883 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.5 m95 -120.44 117.12 26.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.36 149.68 24.54 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.723 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.0 tt0 -83.52 103.07 12.57 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 112.576 -2.102 . . . . 0.0 111.897 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.73 HG12 ' CE1' ' 1' ' 108' ' ' PHE . 44.1 t -102.88 138.69 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.841 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.9 OUTLIER -89.99 101.51 14.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.73 ' CE1' HG12 ' 1' ' 106' ' ' VAL . 3.4 m-85 -98.35 167.27 10.95 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.953 1.359 . . . . 0.0 111.287 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.661 HG22 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -50.84 -65.88 0.48 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.299 -2.228 . . . . 0.0 116.55 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.661 ' H ' HG22 ' 1' ' 109' ' ' THR . 0.5 OUTLIER -86.46 -56.6 3.36 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.76 -7.32 61.41 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.587 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.73 -92.11 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' 1' ' 52' ' ' ASP . 0.4 OUTLIER -83.61 129.51 34.97 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.901 -0.764 . . . . 0.0 109.129 176.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.851 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 2.8 t -145.09 120.07 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.039 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.3 m95 -94.7 154.85 17.12 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.103 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.506 HD21 ' OD1' ' 1' ' 123' ' ' ASN . 0.1 OUTLIER -153.23 143.63 22.48 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.077 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.27 100.0 0.43 Allowed 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 124.704 2.193 . . . . 0.0 107.329 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.647 ' C ' ' H ' ' 1' ' 120' ' ' SER . 2.5 t -76.84 14.88 0.74 Allowed 'General case' 0 C--N 1.279 -2.47 1 CA-C-N 107.957 -4.201 . . . . 0.0 114.041 -174.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . 0.482 ' OG1' ' OD1' ' 1' ' 117' ' ' ASN . 1.1 p -64.0 25.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.928 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.958 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.0 OUTLIER -175.15 126.01 0.26 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.666 ' O ' HD22 ' 1' ' 124' ' ' LEU . 21.3 tttm -74.26 -41.16 61.73 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.923 0.868 . . . . 0.0 108.676 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.87 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 6.4 m-20 -65.8 -4.54 6.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.958 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.76 -58.7 6.53 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.73 0.776 . . . . 0.0 110.526 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.978 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.81 -56.1 15.58 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.887 0.851 . . . . 0.0 109.353 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.622 HD13 ' O ' ' 1' ' 121' ' ' LYS . 6.5 mp -58.99 -45.17 91.26 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.355 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -115.35 -31.69 5.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.173 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.724 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.14 27.71 7.2 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.569 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.87 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 38.5 mttp . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.019 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . 0.448 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.8 mmtt . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.651 HD12 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.43 153.21 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -177.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.89 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.9 m-85 -109.11 170.28 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 2.5 mttt -117.2 109.44 16.9 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.853 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.61 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.0 OUTLIER -79.62 81.66 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.074 0.94 . . . . 0.0 109.756 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.846 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 4.0 m-20 -81.31 -27.23 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.898 -1.955 . . . . 0.0 111.983 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.3 t0 -175.72 118.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.831 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -132.06 137.87 47.95 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.277 0.56 . . . . 0.0 110.108 177.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.831 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.01 160.83 31.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.581 -177.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.537 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.4 OUTLIER -71.45 102.64 2.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.871 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 0.9 OUTLIER -120.69 120.72 63.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -171.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . 0.494 ' OD1' HG23 ' 1' ' 32' ' ' ILE . 2.9 p-10 49.55 47.47 22.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 3.2 59.28 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.294 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 1.6 mm -138.2 135.94 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.645 0.26 . . . . 0.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.537 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 87.5 m95 -59.75 131.55 51.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.871 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.7 146.48 42.74 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.806 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.708 ' O ' ' CG2' ' 1' ' 55' ' ' ILE . 19.9 t -113.33 150.96 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.886 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.61 141.97 29.8 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.412 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.846 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.24 150.32 52.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.693 HD21 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -59.74 -17.46 35.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.326 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.539 ' H ' HD11 ' 1' ' 42' ' ' ILE . 3.7 mp -82.85 -50.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 121.54 0.686 . . . . 0.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.604 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.6 -11.93 19.64 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.162 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.78 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.49 71.82 9.87 Favored Pre-proline 0 CA--C 1.504 -0.822 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.274 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.5 Cg_exo -49.3 -32.3 25.25 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.548 2.165 . . . . 0.0 109.306 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 12.8 t 169.56 155.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.47 -1.696 . . . . 0.0 110.879 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 72.1 56.45 0.16 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.886 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.87 113.11 20.72 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.676 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.33 91.7 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.677 0.751 . . . . 0.0 110.082 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.788 ' HB3' HG22 ' 1' ' 32' ' ' ILE . 42.1 m0 -46.05 -28.47 1.19 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.887 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.676 ' CG1' HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.46 -56.86 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.794 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.629 ' H ' HG12 ' 1' ' 51' ' ' VAL . 48.2 t0 -149.33 -14.34 0.29 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.956 -1.475 . . . . 0.0 113.502 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.071 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 0.9 OUTLIER -87.02 -12.86 46.13 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.53 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.795 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.31 140.42 22.06 Favored Glycine 1 N--CA 1.387 -4.572 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.873 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.05 119.07 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.304 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.53 87.57 0.47 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.514 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -35.25 -35.3 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.859 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -54.58 -35.87 63.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.419 0.628 . . . . 0.0 110.216 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.464 ' OD2' ' HA3' ' 1' ' 111' ' ' GLY . 0.5 OUTLIER -66.89 -27.64 67.67 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.722 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.704 HG12 HD12 ' 1' ' 55' ' ' ILE . 25.1 m -99.05 -173.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.864 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -144.98 112.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.11 -176.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.9 mt-10 -63.83 128.28 35.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.56 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.569 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 0.9 OUTLIER -109.07 161.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.876 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.651 ' O ' HD12 ' 1' ' 23' ' ' ILE . 1.4 p -85.41 159.08 20.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.728 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.04 151.8 38.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.61 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.1 18.05 5.19 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.293 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . 0.419 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -152.78 -107.96 0.34 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 118.833 -1.651 . . . . 0.0 114.277 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.559 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 1.4 m-85 -151.7 160.38 43.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.764 ' O ' ' HB2' ' 1' ' 24' ' ' TYR . 0.7 OUTLIER -154.5 173.57 16.11 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.128 0.966 . . . . 0.0 110.728 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.864 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.37 125.7 33.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.532 HD11 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.1 113.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.994 -178.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.724 ' HB2' HG12 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -55.67 114.65 7.75 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.709 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 70.0 Cg_endo -64.2 -26.69 64.56 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 122.95 2.434 . . . . 0.0 109.717 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.79 -27.52 62.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.953 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.8 t-20 -82.82 -1.75 52.69 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.821 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 53.8 t -102.6 129.77 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.319 0 CA-C-O 122.94 1.352 . . . . 0.0 112.786 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.857 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.83 -37.73 11.6 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 111.78 -2.464 . . . . 0.0 108.194 178.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.603 ' O ' HG13 ' 1' ' 106' ' ' VAL . 6.0 p 177.21 172.84 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.37 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.676 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -110.35 122.16 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -93.28 179.67 39.28 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-O 122.45 1.028 . . . . 0.0 114.873 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.91 139.66 97.86 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 112.723 -1.738 . . . . 0.0 111.182 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.646 ' HB3' ' CG2' ' 1' ' 118' ' ' THR . 23.7 Cg_endo -81.67 157.68 18.83 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.476 3.451 . . . . 0.0 113.869 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -149.68 137.6 20.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.49 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 1.7 mttt -84.53 124.26 31.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.617 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.56 -60.21 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.5 -1.334 . . . . 0.0 114.012 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.891 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -59.57 72.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.893 0.346 . . . . 0.0 111.108 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 105.08 -49.52 0.89 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.393 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.88 -16.0 0.45 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.71 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.42 -153.33 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.68 0.752 . . . . 0.0 112.107 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.537 ' HB3' HG22 ' 1' ' 118' ' ' THR . 0.7 OUTLIER -116.54 119.21 34.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.593 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.891 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -121.44 119.31 31.69 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -106.84 147.02 30.24 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.1 tt0 -78.91 102.86 8.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.78 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' 1' ' 91' ' ' VAL . 19.7 t -97.7 137.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.857 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -86.79 102.09 13.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.951 -177.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.644 ' C ' ' HD3' ' 1' ' 89' ' ' LYS . 35.8 m-85 -103.21 157.15 17.21 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.244 1.021 . . . . 0.0 110.062 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.998 HG23 ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.61 -62.25 1.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.416 -1.72 . . . . 0.0 114.238 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.998 ' N ' HG23 ' 1' ' 109' ' ' THR . 0.1 OUTLIER -85.91 -42.69 13.86 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.941 -177.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -78.55 -0.34 79.05 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.147 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.13 -91.49 0.01 OUTLIER Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -93.15 130.67 38.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.873 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.9 t -145.52 115.93 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.071 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.9 m95 -91.84 155.9 17.88 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.065 0.936 . . . . 0.0 113.152 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.673 HD21 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.85 144.56 22.53 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.094 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.725 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.19 100.81 0.48 Allowed 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 124.68 2.181 . . . . 0.0 107.126 178.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.664 ' C ' ' H ' ' 1' ' 120' ' ' SER . 5.7 t -75.94 15.4 0.54 Allowed 'General case' 0 C--N 1.279 -2.484 1 CA-C-N 108.273 -4.058 . . . . 0.0 113.401 -174.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . . . . . . . . . 9.6 t -62.62 22.08 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.669 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.962 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.5 OUTLIER -175.68 125.86 0.23 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.674 ' O ' HD23 ' 1' ' 124' ' ' LEU . 0.8 OUTLIER -74.24 -39.83 62.79 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.246 1.022 . . . . 0.0 108.354 -179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.828 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 75.2 m-20 -65.91 -5.04 8.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.962 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.86 -58.38 7.61 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.642 0.734 . . . . 0.0 110.299 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.89 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.3 -57.01 10.63 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 122.014 0.911 . . . . 0.0 109.605 178.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.56 ' H ' HD11 ' 1' ' 125' ' ' LEU . 6.6 mp -59.08 -45.62 90.35 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.612 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.7 m-85 -112.58 -31.61 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.132 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.725 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.79 25.88 8.86 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 119.364 -1.398 . . . . 0.0 111.273 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.828 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.201 0.524 . . . . 0.0 111.414 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.571 HD13 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.45 154.18 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -176.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.862 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -107.65 170.42 7.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.676 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.4 OUTLIER -117.31 111.36 19.27 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.027 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.571 ' CG1' ' HA ' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -80.83 80.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 122.132 0.968 . . . . 0.0 109.676 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.857 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.8 m-20 -80.35 -26.37 38.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.946 -1.934 . . . . 0.0 111.686 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' 1' ' 39' ' ' ARG . 4.2 t0 -174.94 119.01 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.341 -0.543 . . . . 0.0 112.285 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.894 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.43 136.41 45.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.185 0.517 . . . . 0.0 110.255 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.894 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.86 160.95 31.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.093 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.534 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -70.87 102.42 2.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 174.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.944 HD12 ' NE2' ' 1' ' 37' ' ' GLN . 1.1 mt -124.35 121.53 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.09 35.16 18.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.148 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.08 4.49 72.77 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.075 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.73 137.79 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.572 ' HB3' HD12 ' 1' ' 29' ' ' LEU . 92.0 m95 -59.7 129.43 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.944 ' NE2' HD12 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.87 145.53 43.51 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.489 -177.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.746 ' O ' HG22 ' 1' ' 55' ' ' ILE . 22.6 t -114.07 151.39 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.898 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 4.3 mtp180 -144.36 144.25 31.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.986 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.857 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.72 151.54 51.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.577 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.88 -16.13 48.11 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.703 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' 1' ' 40' ' ' ASN . 3.8 mp -83.93 -50.24 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-O 121.771 0.796 . . . . 0.0 110.581 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.618 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.5 -11.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.235 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.759 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.6 t -148.01 70.22 11.05 Favored Pre-proline 0 CA--C 1.504 -0.797 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.083 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.531 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.1 Cg_exo -49.88 -31.98 28.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.477 2.118 . . . . 0.0 109.265 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.1 t 169.87 154.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.255 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.18 55.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.898 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.86 112.21 19.46 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.683 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.07 92.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.646 0.736 . . . . 0.0 110.743 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.854 ' HB3' HG21 ' 1' ' 32' ' ' ILE . 31.2 m0 -44.33 -29.43 0.67 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.814 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.683 ' CG1' HG22 ' 1' ' 49' ' ' THR . 6.5 p -53.78 -56.44 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.809 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.652 ' O ' ' HD1' ' 1' ' 115' ' ' TRP . 52.6 t0 -152.79 -13.1 0.16 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.405 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.089 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.0 OUTLIER -85.71 -14.92 43.89 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.394 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.93 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.96 144.32 26.14 Favored Glycine 1 N--CA 1.386 -4.689 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.899 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.25 119.75 33.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.488 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.48 87.87 0.66 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.563 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -35.58 -35.76 0.06 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.67 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -55.31 -32.87 62.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.305 0.574 . . . . 0.0 110.432 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 0.7 OUTLIER -69.42 -28.92 66.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.429 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.576 HG11 HG13 ' 1' ' 83' ' ' ILE . 31.7 m -100.49 -175.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.885 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.1 OUTLIER -141.53 113.63 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.127 -177.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' 1' ' 80' ' ' TYR . 1.8 mt-10 -64.89 128.98 38.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.115 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.579 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 1.9 m -113.05 157.89 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.792 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.571 ' O ' HD13 ' 1' ' 23' ' ' ILE . 1.7 p -85.36 159.8 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 0.0 112.889 -178.312 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.791 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -73.48 151.71 40.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.553 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.2 17.26 5.4 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.35 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -152.57 -109.29 0.4 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 118.68 -1.724 . . . . 0.0 114.439 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.593 ' O ' ' HG2' ' 1' ' 62' ' ' GLU . 0.8 OUTLIER -152.01 160.4 43.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.372 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.776 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.8 OUTLIER -153.52 173.25 15.97 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.056 0.931 . . . . 0.0 110.582 177.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.885 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.04 125.41 39.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.339 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.576 HG13 HG11 ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -74.46 114.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.941 0.4 . . . . 0.0 110.597 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.898 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.9 t-20 -56.79 114.82 8.65 Favored Pre-proline 0 N--CA 1.436 -1.167 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.679 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 84.4 Cg_endo -70.47 -26.95 23.67 Favored 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 123.088 2.526 . . . . 0.0 110.58 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.69 -29.42 61.21 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.039 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.898 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.99 -2.43 55.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.679 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 37.2 t -96.92 130.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.924 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.896 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 112.122 -2.308 . . . . 0.0 107.985 178.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.626 ' O ' HG12 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.4 172.7 0.4 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.777 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.61 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -106.55 124.01 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -97.05 179.54 33.88 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-O 122.528 1.071 . . . . 0.0 114.735 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . 0.408 HG21 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -62.82 137.91 96.9 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.74 -1.73 . . . . 0.0 111.666 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 23.3 Cg_endo -81.29 156.88 19.64 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.248 3.299 . . . . 0.0 113.405 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 22.4 mtt -149.75 134.68 17.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.743 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.0 OUTLIER -84.97 123.9 31.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.629 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.69 -51.61 0.04 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.733 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.882 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -65.36 69.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.98 0.39 . . . . 0.0 110.588 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.21 -49.56 0.85 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.258 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.19 -16.09 0.42 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.911 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.705 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.22 -153.63 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.768 0.795 . . . . 0.0 111.86 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.527 ' HB3' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.76 119.38 35.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.698 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.882 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 11.0 m95 -121.17 118.48 29.78 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.72 145.19 30.44 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.676 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.8 tt0 -79.64 102.32 8.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.274 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.768 HG13 ' CE1' ' 1' ' 108' ' ' PHE . 42.2 t -100.25 136.47 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.896 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 t-20 -86.73 101.38 13.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.502 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.768 ' CE1' HG13 ' 1' ' 106' ' ' VAL . 12.4 m-85 -101.44 167.6 10.05 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 123.008 1.385 . . . . 0.0 112.101 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.659 HG21 ' H ' ' 1' ' 110' ' ' THR . 3.4 t -52.17 -66.12 0.44 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 111.871 -2.422 . . . . 0.0 116.67 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.659 ' H ' HG21 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.5 -55.93 3.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.86 -7.41 61.87 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.008 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.87 -89.64 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -86.42 130.86 34.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.899 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.6 t -145.58 113.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.089 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 44.2 m95 -90.25 156.17 18.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.135 0.969 . . . . 0.0 113.465 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.573 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.57 142.95 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.731 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.736 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -64.91 100.32 0.4 Allowed 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 124.801 2.239 . . . . 0.0 107.282 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.67 ' C ' ' H ' ' 1' ' 120' ' ' SER . 4.7 t -76.32 16.3 0.48 Allowed 'General case' 0 C--N 1.28 -2.453 1 CA-C-N 107.962 -4.199 . . . . 0.0 113.45 -174.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . . . . . . . . . 7.2 t -63.51 23.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.453 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.99 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.64 122.22 0.15 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.679 ' O ' HD21 ' 1' ' 124' ' ' LEU . 1.2 ptpt -71.14 -40.38 71.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.217 1.008 . . . . 0.0 108.401 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.828 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 68.2 m-20 -66.05 -4.66 7.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.99 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.0 -58.67 6.53 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.672 0.749 . . . . 0.0 110.401 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.862 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.15 -56.69 13.03 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 122.01 0.909 . . . . 0.0 109.325 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.605 ' H ' HD13 ' 1' ' 125' ' ' LEU . 6.7 mp -58.36 -46.03 87.07 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.212 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.36 -32.1 6.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.695 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.7 26.27 7.68 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.36 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.828 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.0 mttt . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.88 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 1.1 mmtm . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.765 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.603 HD13 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.78 154.11 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.876 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.3 m-85 -107.53 169.5 8.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.682 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 9.7 mttt -116.62 108.84 16.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.745 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.602 ' CG1' ' HA ' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -78.39 81.47 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.067 0.937 . . . . 0.0 109.791 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.839 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.8 m-20 -80.92 -25.94 37.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.91 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 12.6 t0 -175.83 116.69 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.928 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.17 134.8 47.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.08 0.467 . . . . 0.0 110.226 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.928 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -130.44 160.83 32.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.805 -177.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.2 tptp -71.3 102.81 2.67 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.908 HD12 ' NE2' ' 1' ' 37' ' ' GLN . 1.2 mt -124.53 122.89 64.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.22 35.73 18.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.131 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.75 3.64 68.25 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.205 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.96 140.21 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.52 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 92.7 m95 -59.54 129.78 43.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.911 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.77 146.73 42.63 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.432 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.692 ' O ' HG21 ' 1' ' 55' ' ' ILE . 19.0 t -114.36 150.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.45 140.55 29.03 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.441 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.839 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.02 153.32 49.39 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.914 0.864 . . . . 0.0 108.761 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.556 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -62.14 -16.72 54.66 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.435 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.631 HD13 ' HB2' ' 1' ' 40' ' ' ASN . 3.7 mp -83.15 -50.55 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.758 0.79 . . . . 0.0 110.829 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.602 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.7 -11.0 19.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.376 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.732 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.5 t -146.9 71.33 12.37 Favored Pre-proline 0 CA--C 1.505 -0.786 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.988 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.544 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 73.1 Cg_exo -48.29 -32.93 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.518 2.145 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 8.0 t 169.09 154.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.662 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.24 56.06 0.16 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.885 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.55 111.77 18.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.701 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.81 91.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.655 0.74 . . . . 0.0 110.524 -178.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.857 ' HB3' HG21 ' 1' ' 32' ' ' ILE . 34.8 m0 -44.41 -28.28 0.54 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.742 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.701 ' CG1' HG22 ' 1' ' 49' ' ' THR . 7.8 p -53.27 -56.95 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.54 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.649 ' H ' HG13 ' 1' ' 51' ' ' VAL . 50.0 t0 -153.25 -11.67 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.893 -1.503 . . . . 0.0 113.063 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.006 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.6 m120 -86.43 -12.37 49.26 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.642 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.911 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -82.86 144.03 22.66 Favored Glycine 1 N--CA 1.387 -4.595 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 175.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.845 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.15 119.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.788 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.42 87.49 0.63 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.564 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -34.18 -34.49 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.01 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.24 -35.98 63.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.633 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.2 m-20 -67.57 -27.21 66.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.911 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.628 HG11 HD13 ' 1' ' 55' ' ' ILE . 28.7 m -99.51 -172.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.777 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -144.68 112.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.981 -176.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.07 123.72 19.3 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.84 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.617 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 0.8 OUTLIER -108.17 155.79 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.628 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.603 ' O ' HD13 ' 1' ' 23' ' ' ILE . 1.9 p -85.09 160.02 20.06 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.468 0.456 0 O-C-N 123.806 0.691 . . . . 0.0 112.738 -178.615 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -72.82 151.35 42.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.94 17.34 5.91 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.528 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -152.65 -109.16 0.39 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.559 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 0.2 OUTLIER -151.86 160.47 43.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.904 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.783 ' O ' ' HB2' ' 1' ' 24' ' ' TYR . 0.7 OUTLIER -155.05 172.99 17.21 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.014 0.912 . . . . 0.0 110.563 177.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.777 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -138.55 125.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.555 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -72.72 112.74 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.94 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 113.58 5.35 Favored Pre-proline 0 N--CA 1.436 -1.134 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.691 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 86.9 Cg_endo -71.84 -27.69 17.53 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.424 2.749 . . . . 0.0 110.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.64 -28.18 60.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.73 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.94 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.87 -3.34 56.74 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.691 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 27.0 t -98.77 135.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.502 0 CA-C-O 122.945 1.355 . . . . 0.0 111.51 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.88 ' HD2' ' O ' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.61 -48.43 9.52 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.871 -2.422 . . . . 0.0 107.791 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER 172.28 172.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.465 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.472 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 67.8 t -89.94 162.56 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -130.09 179.68 16.67 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.175 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.35 133.77 90.91 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.984 -1.108 . . . . 0.0 110.75 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 23.9 Cg_endo -81.35 158.18 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.347 3.364 . . . . 0.0 113.534 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtt -149.7 138.01 20.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.981 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 2.1 mtpt -85.84 125.4 33.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.561 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.96 -53.35 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.791 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.872 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -66.07 69.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.398 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.62 -49.47 0.86 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.208 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.13 -14.43 0.48 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.185 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.691 ' H ' HD13 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -76.92 -153.15 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.83 0.824 . . . . 0.0 112.108 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.585 ' HB3' HG23 ' 1' ' 118' ' ' THR . 1.1 m -116.86 116.74 28.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.988 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.872 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 9.9 m95 -118.63 117.39 28.83 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -105.0 150.18 25.14 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.661 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 23.0 tt0 -82.31 102.18 11.03 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.816 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.816 HG11 ' CE1' ' 1' ' 108' ' ' PHE . 53.2 t -98.84 135.77 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.88 ' O ' ' HD2' ' 1' ' 89' ' ' LYS . 0.2 OUTLIER -89.14 102.69 15.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.384 -177.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.816 ' CE1' HG11 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER -102.77 169.14 8.79 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.978 1.37 . . . . 0.0 111.544 178.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.671 HG23 ' H ' ' 1' ' 110' ' ' THR . 2.7 t -51.38 -66.08 0.45 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.196 -2.274 . . . . 0.0 116.913 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.671 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.55 -56.12 3.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.77 -7.15 61.07 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.593 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.01 -91.67 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.31 131.06 34.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 121.947 -0.737 . . . . 0.0 109.066 176.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.81 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 7.9 t -145.36 113.48 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.006 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -89.42 153.38 20.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.901 0.858 . . . . 0.0 113.101 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.601 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.55 144.92 23.11 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.032 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.74 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.33 100.36 0.47 Allowed 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 124.675 2.179 . . . . 0.0 107.076 178.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.607 ' C ' ' H ' ' 1' ' 120' ' ' SER . 3.1 t -75.89 14.62 0.64 Allowed 'General case' 0 C--N 1.281 -2.396 1 CA-C-N 107.981 -4.19 . . . . 0.0 113.495 -174.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . 0.404 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 14.8 t -63.79 22.73 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.047 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.995 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -175.24 123.07 0.22 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.704 ' O ' HD23 ' 1' ' 124' ' ' LEU . 18.5 tttt -72.29 -39.47 68.27 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.926 0.87 . . . . 0.0 108.666 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.871 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 78.1 m-20 -66.61 -5.14 10.46 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.995 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.73 -58.48 7.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.818 0.818 . . . . 0.0 110.27 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.876 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -63.86 -57.02 11.13 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 122.025 0.917 . . . . 0.0 109.515 178.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.594 HD12 ' O ' ' 1' ' 121' ' ' LYS . 6.6 mp -59.71 -45.04 93.36 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.739 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -113.58 -31.43 6.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.42 26.59 8.6 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.273 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.871 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 23.4 mttp . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.81 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . 0.412 ' HD2' ' CD2' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 121.186 0.517 . . . . 0.0 111.664 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.535 HG22 ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -72.49 155.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.921 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.6 m-85 -108.48 169.88 8.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.865 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 15.3 mmmt -116.64 108.52 16.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.133 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.585 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.0 OUTLIER -78.54 82.63 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.976 0.893 . . . . 0.0 109.905 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.833 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.7 m-20 -83.48 -27.38 29.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.275 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -174.64 119.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.849 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.13 138.28 46.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.233 0.54 . . . . 0.0 110.743 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.849 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.28 160.57 32.56 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.399 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.53 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.0 OUTLIER -71.93 103.18 3.11 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.864 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 1.1 mm -123.88 117.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -171.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 61.22 37.58 17.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.101 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.72 1.95 68.36 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.292 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.57 136.36 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.53 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 93.1 m95 -59.66 131.56 51.29 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.864 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.97 146.49 42.97 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.899 -179.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 1.0 HG13 ' CZ ' ' 1' ' 81' ' ' PHE . 19.4 t -114.07 150.0 16.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.818 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 6.4 mtp180 -144.11 144.08 31.43 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.042 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.833 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.26 152.94 51.11 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.28 -17.33 52.98 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.4 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.526 ' H ' HD11 ' 1' ' 42' ' ' ILE . 3.9 mp -84.27 -50.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-O 121.699 0.761 . . . . 0.0 110.673 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.54 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -100.43 -11.8 19.91 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.425 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.761 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.63 71.09 9.74 Favored Pre-proline 0 CA--C 1.505 -0.761 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.197 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.531 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.3 Cg_exo -49.76 -31.84 27.15 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.534 2.156 . . . . 0.0 109.343 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 13.7 t 169.51 155.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.052 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 72.31 56.49 0.15 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.818 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.81 113.81 20.7 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.673 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.52 91.76 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.726 0.774 . . . . 0.0 109.849 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.852 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 42.5 m0 -47.58 -27.47 1.86 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.798 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.673 ' CG1' HG22 ' 1' ' 49' ' ' THR . 9.8 p -54.03 -56.19 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.657 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.64 ' H ' HG11 ' 1' ' 51' ' ' VAL . 50.5 t0 -151.38 -14.09 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.518 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.084 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 0.8 OUTLIER -86.82 -11.6 50.45 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.377 0.608 . . . . 0.0 110.812 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.746 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.88 140.03 21.22 Favored Glycine 1 N--CA 1.391 -4.302 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.817 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.03 117.81 29.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.379 -178.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -68.97 87.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.579 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.473 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -34.38 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.585 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -37.04 64.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.434 0.635 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.5 ' OD2' ' HA3' ' 1' ' 111' ' ' GLY . 0.5 OUTLIER -68.0 -26.19 65.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.116 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.7 HG12 HD11 ' 1' ' 55' ' ' ILE . 23.5 m -98.26 -171.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.85 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -145.95 107.61 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.183 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.7 pt-20 -65.81 122.93 18.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.291 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.547 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 15.6 m -115.0 160.65 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.433 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.465 ' O ' HD12 ' 1' ' 23' ' ' ILE . 3.1 p -83.72 164.76 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.006 0.432 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.665 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -77.55 152.25 34.13 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.585 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.61 18.46 4.84 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.54 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.37 -109.38 0.44 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 118.742 -1.694 . . . . 0.0 114.309 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.5 ' N ' HG22 ' 1' ' 26' ' ' VAL . 0.4 OUTLIER -151.68 160.05 43.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.589 . . . . 0.0 109.642 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 1.0 ' CZ ' HG13 ' 1' ' 38' ' ' VAL . 0.6 OUTLIER -154.72 173.43 16.42 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.95 0.881 . . . . 0.0 110.291 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.85 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -137.58 125.32 31.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.675 HG23 ' CE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -73.39 115.65 14.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.309 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.723 ' HB2' HG12 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -56.29 114.53 7.85 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.714 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 74.1 Cg_endo -65.13 -26.85 57.25 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 C-N-CA 122.933 2.422 . . . . 0.0 109.834 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.35 -27.07 61.3 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 113.419 -1.718 . . . . 0.0 109.92 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.625 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.9 t-20 -82.29 -2.35 52.37 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.805 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 55.6 t -101.85 130.55 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 CA-C-O 123.165 1.46 . . . . 0.0 113.029 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.86 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -90.58 -42.33 10.86 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.445 -2.616 . . . . 0.0 107.876 177.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.558 ' O ' HG12 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 174.66 173.47 0.21 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.383 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.657 ' HA ' HG21 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -103.28 138.35 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.46 179.69 20.92 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-O 122.194 0.885 . . . . 0.0 114.067 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 137.79 94.82 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.178 -1.511 . . . . 0.0 111.601 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.608 ' HB3' ' CG2' ' 1' ' 118' ' ' THR . 22.1 Cg_endo -81.46 157.56 19.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 124.435 3.424 . . . . 0.0 113.625 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.6 mtm -149.5 137.81 20.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.9 mtmm -85.18 124.98 32.46 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.657 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.55 -55.88 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.206 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.873 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -63.75 69.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.901 0.351 . . . . 0.0 110.791 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.08 -49.55 0.85 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.258 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.36 -15.17 0.48 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.04 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.707 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.76 -153.21 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.754 0.788 . . . . 0.0 111.928 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.545 ' HB3' HG23 ' 1' ' 118' ' ' THR . 1.1 m -116.74 119.3 35.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.661 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.873 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.64 118.03 28.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -104.91 148.52 26.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.688 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.2 tt0 -81.22 102.94 10.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.742 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' 1' ' 91' ' ' VAL . 32.7 t -98.33 138.42 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.86 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER -88.48 102.12 14.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.835 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' 1' ' 83' ' ' ILE . 12.1 m-85 -100.22 157.93 16.23 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-O 122.104 0.954 . . . . 0.0 109.695 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 1.021 HG23 ' N ' ' 1' ' 110' ' ' THR . 0.3 OUTLIER -58.64 -62.55 1.78 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.681 -1.599 . . . . 0.0 114.228 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 1.021 ' N ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.12 10.72 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.911 0.862 . . . . 0.0 109.804 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -73.83 -2.39 61.13 Favored Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.159 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 46.88 -92.52 0.01 OUTLIER Glycine 0 C--O 1.212 -1.226 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.26 130.59 37.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.814 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.7 t -145.36 117.58 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.084 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 42.7 m95 -92.46 156.18 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.342 -0.943 . . . . 0.0 113.023 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.482 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.75 143.03 21.48 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.731 -1.577 . . . . 0.0 108.678 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.737 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -64.87 101.4 0.49 Allowed 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 124.595 2.141 . . . . 0.0 107.052 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.664 ' C ' ' H ' ' 1' ' 120' ' ' SER . 6.6 t -75.64 14.5 0.62 Allowed 'General case' 0 C--N 1.281 -2.374 1 CA-C-N 108.2 -4.091 . . . . 0.0 113.527 -174.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . 0.411 ' CG2' ' OD1' ' 1' ' 117' ' ' ASN . 12.6 t -62.37 21.51 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.715 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.956 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.6 OUTLIER -175.33 126.37 0.25 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.643 ' O ' HD22 ' 1' ' 124' ' ' LEU . 0.3 OUTLIER -74.51 -41.35 60.8 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 122.126 0.965 . . . . 0.0 108.893 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.863 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 1.3 m-20 -66.25 -4.41 7.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.956 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.23 -58.81 6.37 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.417 0.627 . . . . 0.0 110.453 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.921 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.89 -55.08 21.53 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.789 0.805 . . . . 0.0 109.601 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.585 ' H ' HD11 ' 1' ' 125' ' ' LEU . 6.6 mp -60.33 -43.73 96.14 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.037 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.595 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 2.1 m-85 -114.49 -32.14 6.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.688 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.92 26.04 7.7 Favored Glycine 0 CA--C 1.505 -0.575 0 C-N-CA 119.427 -1.368 . . . . 0.0 111.718 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.863 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 26.3 mttp . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.952 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.199 0.523 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -72.5 152.2 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.92 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -105.85 170.94 7.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.406 -1.725 . . . . 0.0 106.555 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.675 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 70.7 mttt -117.41 109.5 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.98 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.663 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.0 OUTLIER -80.19 81.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.138 0.971 . . . . 0.0 109.708 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.844 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.3 m-20 -79.04 -26.74 43.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.745 -2.025 . . . . 0.0 111.618 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 11.6 t0 -176.54 118.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.902 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.62 137.4 45.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.185 177.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.74 160.84 32.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.716 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.482 ' HG2' ' CE2' ' 1' ' 36' ' ' TRP . 0.1 OUTLIER -70.62 103.25 2.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 175.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.864 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.1 mt -124.66 123.27 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 59.41 37.67 23.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.485 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.2 3.68 70.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.267 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -138.53 138.69 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.513 ' HB3' HD13 ' 1' ' 29' ' ' LEU . 82.0 m95 -59.77 130.1 45.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.909 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.91 144.93 43.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.393 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.715 ' O ' HG23 ' 1' ' 55' ' ' ILE . 21.8 t -112.8 150.97 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.798 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 75.8 mtm180 -144.65 135.44 24.81 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.513 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.844 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -124.76 153.03 43.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.91 -17.75 57.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.057 -1.428 . . . . 0.0 112.451 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.705 HD11 ' HB2' ' 1' ' 40' ' ' ASN . 3.3 mp -81.97 -50.62 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.842 0.83 . . . . 0.0 110.968 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.12 -12.23 18.96 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.593 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.718 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.4 t -148.42 70.84 10.78 Favored Pre-proline 0 CA--C 1.503 -0.851 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.998 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.516 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.6 Cg_exo -49.32 -31.89 24.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 14.0 t 170.24 154.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.994 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 72.29 56.68 0.15 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.798 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -85.07 112.77 20.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.681 HG23 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.26 91.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.705 0.764 . . . . 0.0 110.301 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.864 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 37.2 m0 -45.37 -28.8 0.92 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.647 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.681 ' CG1' HG23 ' 1' ' 49' ' ' THR . 7.5 p -54.28 -57.09 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.797 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.637 ' H ' HG13 ' 1' ' 51' ' ' VAL . 51.0 t0 -150.94 -13.28 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.609 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.018 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -87.58 -14.33 40.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.76 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.909 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.62 145.27 27.47 Favored Glycine 1 N--CA 1.386 -4.638 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 175.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.936 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.16 118.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.757 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.35 87.58 0.62 Allowed 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.619 ' O ' HG23 ' 1' ' 60' ' ' VAL . . . -36.27 -34.77 0.06 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.694 -176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -54.67 -33.59 60.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.649 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.3 m-20 -68.62 -29.63 68.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.551 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.619 HG23 ' O ' ' 1' ' 57' ' ' ALA . 29.0 m -100.04 -175.03 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.13 0.491 . . . . 0.0 112.172 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.827 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -141.74 110.08 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.043 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.2 OUTLIER -64.98 122.98 18.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.632 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.555 ' CG2' HG13 ' 1' ' 23' ' ' ILE . 7.2 m -104.95 159.45 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.951 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.406 ' O ' HD13 ' 1' ' 23' ' ' ILE . 2.5 p -84.08 161.55 20.63 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.467 0.389 0 O-C-N 123.845 0.716 . . . . 0.0 112.749 -178.563 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.883 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -79.15 151.65 31.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.663 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.15 18.86 4.91 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.072 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.75 -106.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 118.881 -1.628 . . . . 0.0 114.244 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.674 ' HB2' HG12 ' 1' ' 23' ' ' ILE . 0.1 OUTLIER -151.87 160.64 43.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.177 -0.511 . . . . 0.0 110.134 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.7 OUTLIER -154.36 173.07 16.7 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 122.139 0.971 . . . . 0.0 111.204 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.827 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.0 OUTLIER -136.68 125.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.568 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -74.45 112.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.896 0.379 . . . . 0.0 110.457 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.861 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 114.65 6.96 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.7 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 89.5 Cg_endo -69.76 -28.12 25.63 Favored 'Trans proline' 0 CA--C 1.5 -1.197 0 C-N-CA 123.05 2.5 . . . . 0.0 110.882 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -28.53 61.44 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.012 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.861 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.55 -3.26 55.7 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.7 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 38.4 t -96.51 132.75 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-O 123.08 1.419 . . . . 0.0 112.246 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.862 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -86.08 -43.74 12.84 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 108.167 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.461 ' O ' HG12 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.55 173.36 0.29 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.953 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.651 ' HA ' HG21 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.31 117.33 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.35 179.63 45.01 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 122.408 1.004 . . . . 0.0 114.711 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.63 142.38 98.47 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 112.711 -1.745 . . . . 0.0 111.26 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 26.0 Cg_endo -81.34 157.99 19.74 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.482 3.455 . . . . 0.0 113.762 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 11.4 mtt -149.57 135.2 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.7 mttm -85.39 126.51 33.83 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.414 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.25 -52.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.794 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.871 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -64.91 69.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.637 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.07 -49.39 0.86 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.193 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.07 -16.05 0.43 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.05 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.708 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.13 -152.89 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.807 0.813 . . . . 0.0 112.136 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.519 ' HB3' HG23 ' 1' ' 118' ' ' THR . 1.3 m -116.74 118.6 32.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.737 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.871 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.84 117.52 26.72 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.25 147.38 27.12 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.687 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.3 tt0 -80.9 102.76 10.28 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.851 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.839 HG13 ' CE1' ' 1' ' 108' ' ' PHE . 41.8 t -101.62 136.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.862 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.3 m120 -90.31 101.64 14.37 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.367 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.839 ' CE1' HG13 ' 1' ' 106' ' ' VAL . 1.8 m-85 -98.89 168.36 10.16 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 123.034 1.397 . . . . 0.0 111.877 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.662 HG22 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.2 -65.32 0.58 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 111.972 -2.376 . . . . 0.0 116.569 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.662 ' H ' HG22 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.16 -55.91 3.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.82 -6.02 66.2 Favored Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.995 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.11 -91.37 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.79 129.19 34.9 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.936 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.5 t -145.4 119.0 2.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.018 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 45.4 m95 -93.55 156.07 16.94 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.006 0.907 . . . . 0.0 113.17 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.489 HD22 ' OD1' ' 1' ' 123' ' ' ASN . 0.1 OUTLIER -153.43 143.2 21.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.1 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.732 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.07 100.01 0.4 Allowed 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 124.965 2.317 . . . . 0.0 107.182 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.643 ' C ' ' H ' ' 1' ' 120' ' ' SER . 5.1 t -77.12 14.69 0.84 Allowed 'General case' 0 C--N 1.281 -2.387 1 CA-C-N 107.622 -4.354 . . . . 0.0 113.975 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . 0.474 ' OG1' ' OD1' ' 1' ' 117' ' ' ASN . 0.9 OUTLIER -63.2 22.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.991 178.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.993 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 3.6 m -175.19 121.28 0.21 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.689 ' O ' HD21 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -69.57 -40.34 76.81 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.944 0.878 . . . . 0.0 109.125 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.839 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 98.5 m-20 -65.2 -4.69 5.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.993 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.98 -58.59 6.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.703 0.763 . . . . 0.0 110.483 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.92 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.5 -56.81 11.66 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.02 0.914 . . . . 0.0 109.534 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.574 ' H ' HD13 ' 1' ' 125' ' ' LEU . 6.6 mp -59.86 -44.62 94.03 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.696 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.52 -31.51 6.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.64 26.42 7.63 Favored Glycine 0 CA--C 1.504 -0.642 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.728 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.839 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 70.8 mttt . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.957 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.195 0.522 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 23' ' ' ILE . . . . . 0.58 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -73.26 154.3 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 24' ' ' TYR . . . . . 0.909 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.0 m-85 -105.96 169.54 8.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 25' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.2 OUTLIER -116.85 108.69 16.15 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.1 177.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 26' ' ' VAL . . . . . 0.589 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.0 OUTLIER -78.42 82.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.888 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 27' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.9 m-20 -81.03 -27.34 35.83 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 112.82 -1.991 . . . . 0.0 111.81 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 28' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 2.5 t70 -175.84 118.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.227 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 29' ' ' LEU . . . . . 0.863 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -131.97 136.39 47.28 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.271 0.558 . . . . 0.0 110.344 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 30' ' ' GLN . . . . . 0.863 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.82 160.5 33.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.701 -178.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 31' ' ' LYS . . . . . 0.47 ' HG2' ' CZ2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.33 103.6 2.91 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 32' ' ' ILE . . . . . 0.88 HD12 ' NE2' ' 1' ' 37' ' ' GLN . 1.1 mt -123.94 118.93 55.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -171.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.08 39.27 16.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.534 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.15 4.85 69.41 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.6 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 35' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -137.9 136.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 36' ' ' TRP . . . . . 0.483 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 78.4 m95 -59.81 130.2 45.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 37' ' ' GLN . . . . . 0.899 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.8 146.71 42.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.411 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 38' ' ' VAL . . . . . 0.71 ' O ' HG23 ' 1' ' 55' ' ' ILE . 21.5 t -114.18 150.97 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 39' ' ' ARG . . . . . 0.892 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 7.6 mtp180 -144.45 138.52 27.72 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.368 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 40' ' ' ASN . . . . . 0.849 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -128.56 153.04 47.62 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 121.989 0.9 . . . . 0.0 108.689 175.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 41' ' ' ASN . . . . . 0.597 HD21 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -61.01 -18.46 57.81 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.47 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 42' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' 1' ' 40' ' ' ASN . 3.6 mp -82.25 -50.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.729 0.776 . . . . 0.0 110.853 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.597 ' C ' HG22 ' 1' ' 44' ' ' VAL . 0.4 OUTLIER -100.56 -11.92 19.69 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.529 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 44' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.2 t -148.43 71.6 10.83 Favored Pre-proline 0 CA--C 1.504 -0.798 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.086 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 45' ' ' PRO . . . . . 0.525 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.2 Cg_exo -49.47 -31.68 24.58 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.503 2.135 . . . . 0.0 109.113 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 46' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 14.2 t 169.87 152.79 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.005 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.7 56.91 0.13 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 48' ' ' PHE . . . . . 0.892 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.16 112.75 20.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 49' ' ' THR . . . . . 0.674 HG21 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.83 91.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.442 -178.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 50' ' ' TRP . . . . . 0.845 ' CG ' HD11 ' 1' ' 32' ' ' ILE . 33.2 m0 -45.51 -27.97 0.84 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.555 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.674 ' CG1' HG21 ' 1' ' 49' ' ' THR . 8.9 p -53.73 -57.15 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.674 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 52' ' ' ASP . . . . . 0.646 ' H ' HG11 ' 1' ' 51' ' ' VAL . 51.9 t0 -152.29 -12.61 0.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.349 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 53' ' ' ASN . . . . . 1.064 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -86.75 -13.74 44.38 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.624 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 54' ' ' GLY . . . . . 0.899 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.89 144.5 27.64 Favored Glycine 1 N--CA 1.386 -4.635 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 175.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 55' ' ' ILE . . . . . 0.831 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.41 118.76 31.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.557 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 56' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.14 87.64 0.59 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 57' ' ' ALA . . . . . 0.549 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -35.1 -35.6 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.3 -1.318 . . . . 0.0 113.895 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -54.07 -34.43 60.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.349 0.595 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 59' ' ' ASP . . . . . 0.556 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.1 m-20 -68.55 -27.54 66.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.848 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 60' ' ' VAL . . . . . 0.633 HG11 HD13 ' 1' ' 55' ' ' ILE . 30.1 m -99.75 -173.36 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 61' ' ' ILE . . . . . 0.777 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -143.48 110.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.01 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 62' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.51 124.64 21.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.987 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 63' ' ' VAL . . . . . 0.597 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 2.5 m -109.47 160.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.026 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 64' ' ' THR . . . . . 0.58 ' O ' HD11 ' 1' ' 23' ' ' ILE . 2.6 p -84.8 159.84 20.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.469 0.509 0 O-C-N 123.929 0.768 . . . . 0.0 112.859 -178.532 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' 1' 1 ' 77' ' ' LYS . . . . . 0.78 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.85 151.73 37.38 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 78' ' ' GLY . . . . . 0.589 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.03 17.31 5.46 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.357 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 79' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -153.25 -108.02 0.33 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.54 -1.79 . . . . 0.0 114.6 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 80' ' ' TYR . . . . . 0.556 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -151.92 160.36 43.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.144 -0.528 . . . . 0.0 109.89 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.755 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.19 172.83 16.97 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 121.916 0.865 . . . . 0.0 110.467 177.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 82' ' ' VAL . . . . . 0.777 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -137.27 124.8 31.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 83' ' ' ILE . . . . . 0.565 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -73.41 112.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 84' ' ' ASN . . . . . 0.896 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -52.6 114.52 5.79 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.701 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.0 Cg_endo -71.24 -27.56 19.63 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 123.164 2.576 . . . . 0.0 110.845 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -74.89 -27.92 60.43 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.842 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 87' ' ' ASN . . . . . 0.896 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.47 -4.08 56.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 88' ' ' VAL . . . . . 0.701 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 37.8 t -96.63 131.71 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-O 122.991 1.377 . . . . 0.0 111.84 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.817 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.43 -46.94 12.84 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 111.718 -2.492 . . . . 0.0 107.693 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 90' ' ' SER . . . . . 0.557 ' O ' HG11 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 173.76 172.88 0.17 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.787 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 91' ' ' VAL . . . . . 0.615 ' HA ' HG21 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.69 138.81 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 92' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.99 179.83 20.66 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 122.104 0.836 . . . . 0.0 114.021 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.6 136.18 92.38 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.286 -1.457 . . . . 0.0 111.684 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 94' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 21.7 Cg_endo -81.21 157.16 19.92 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.42 3.413 . . . . 0.0 113.563 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 95' ' ' MET . . . . . 0.493 ' HG3' ' CH2' ' 1' ' 115' ' ' TRP . 0.3 OUTLIER -148.8 137.03 20.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.427 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 96' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -86.3 126.87 34.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.546 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 97' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.29 -53.66 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.51 -1.328 . . . . 0.0 113.803 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 98' ' ' SER . . . . . 0.876 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -64.96 69.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.655 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 99' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.0 -49.4 0.86 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.213 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.55 -15.67 0.47 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.008 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 101' ' ' LEU . . . . . 0.701 ' H ' HD13 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.43 -153.68 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.797 0.808 . . . . 0.0 111.955 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 102' ' ' SER . . . . . 0.541 ' HB3' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.79 118.26 32.03 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.811 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 103' ' ' TRP . . . . . 0.876 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.2 m95 -120.11 117.2 27.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 104' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.73 148.19 26.36 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -175.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 105' ' ' GLN . . . . . 0.681 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 28.4 tt0 -82.21 102.31 11.05 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.395 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 106' ' ' VAL . . . . . 0.655 HG12 ' CE1' ' 1' ' 108' ' ' PHE . 42.6 t -101.03 137.93 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 107' ' ' ASN . . . . . 0.817 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.0 OUTLIER -89.95 101.72 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.309 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 108' ' ' PHE . . . . . 0.71 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.7 m-85 -99.52 168.58 9.88 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.046 1.403 . . . . 0.0 111.79 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 109' ' ' THR . . . . . 0.658 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -52.29 -65.6 0.53 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.057 -2.338 . . . . 0.0 116.637 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 110' ' ' THR . . . . . 0.658 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.35 -56.06 3.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 111' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -71.77 -7.37 65.41 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.938 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 112' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.99 -90.6 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 113' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -84.7 130.5 34.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 114' ' ' VAL . . . . . 0.806 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.3 t -145.33 116.28 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 115' ' ' TRP . . . . . 1.064 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 50.0 m95 -92.08 154.14 18.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.853 0.835 . . . . 0.0 112.777 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 116' ' ' LEU . . . . . 0.534 HD21 ' OD1' ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.58 143.5 22.01 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.045 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 117' ' ' ASN . . . . . 0.732 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -64.9 100.39 0.41 Allowed 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 124.856 2.265 . . . . 0.0 107.103 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 118' ' ' THR . . . . . 0.61 ' C ' ' H ' ' 1' ' 120' ' ' SER . 3.4 t -75.82 15.02 0.57 Allowed 'General case' 0 C--N 1.279 -2.467 1 CA-C-N 107.858 -4.246 . . . . 0.0 113.348 -174.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 119' ' ' THR . . . . . 0.403 HG23 ' OD1' ' 1' ' 117' ' ' ASN . 13.0 t -64.58 24.0 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.916 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 120' ' ' SER . . . . . 0.96 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -175.27 126.08 0.25 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 121' ' ' LYS . . . . . 0.672 ' O ' HD22 ' 1' ' 124' ' ' LEU . 3.2 tttt -74.38 -40.78 61.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 122' ' ' ASP . . . . . 0.839 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 77.7 m-20 -65.83 -4.61 7.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 123' ' ' ASN . . . . . 0.96 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.7 OUTLIER -62.9 -58.57 6.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.674 0.749 . . . . 0.0 110.457 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 124' ' ' LEU . . . . . 0.909 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -65.09 -55.62 17.73 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.131 0.967 . . . . 0.0 109.418 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 125' ' ' LEU . . . . . 0.583 HD12 ' O ' ' 1' ' 121' ' ' LYS . 6.7 mp -59.57 -45.15 92.7 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.261 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 126' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -115.05 -31.51 6.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 127' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 102.45 26.77 7.12 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 119.233 -1.461 . . . . 0.0 111.829 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 128' ' ' LYS . . . . . 0.839 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 39.8 mttt . . . . . 0 N--CA 1.433 -1.285 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.814 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.008 0.432 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 111.48 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.19 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.98 33.99 45.23 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.996 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 46.8 t -99.6 2.78 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.601 0.239 . . . . 0.0 111.351 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -102.42 112.01 24.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.698 0.285 . . . . 0.0 110.944 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -168.09 113.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -108.1 142.37 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.75 150.46 32.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -114.91 159.23 20.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -83.61 -172.28 4.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.282 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.16 138.69 14.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.289 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.04 10.22 38.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -128.71 69.27 79.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.949 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.49 130.0 13.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.546 2.164 . . . . 0.0 112.283 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -169.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -97.38 103.16 14.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.788 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.27 165.71 30.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.591 2.194 . . . . 0.0 112.482 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 9.2 t -109.67 -2.89 17.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 3.1 t -113.3 58.27 0.66 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.739 0.304 . . . . 0.0 111.274 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . 0.421 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 29.8 m120 -67.22 127.54 33.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.084 0.468 . . . . 0.0 111.039 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.408 HD12 ' HG3' ' 1' ' 85' ' ' PRO . 0.3 OUTLIER -67.01 94.3 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.882 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER -53.11 169.22 0.11 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.099 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.523 HG23 ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -72.5 154.53 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.838 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.6 m-85 -108.42 169.34 8.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.675 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.6 OUTLIER -116.93 110.75 18.7 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.596 ' CG1' ' HA ' ' 1' ' 77' ' ' LYS . 0.1 OUTLIER -80.55 81.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.977 0.894 . . . . 0.0 110.018 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.854 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 2.6 m-20 -82.48 -25.91 33.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 112.935 -1.939 . . . . 0.0 111.955 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.1 t70 -174.18 114.63 0.19 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.273 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.866 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.77 136.0 48.31 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.006 177.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.866 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -128.9 160.82 31.44 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.919 -177.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.532 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -72.01 103.35 3.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.839 HD13 ' NE2' ' 1' ' 37' ' ' GLN . 0.9 OUTLIER -123.8 119.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.839 -171.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . 0.404 ' ND2' ' O ' ' 1' ' 51' ' ' VAL . 43.6 m-20 61.66 36.65 16.47 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.355 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.56 2.93 65.17 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.307 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.532 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 94.2 m95 -60.24 131.04 49.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.921 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.62 146.69 42.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.721 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.721 ' O ' HG22 ' 1' ' 55' ' ' ILE . 21.1 t -115.14 151.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.903 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 30.5 mtp180 -144.3 142.94 30.75 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.126 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.854 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.86 150.07 52.26 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.056 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.619 HD21 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -59.69 -18.18 40.29 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.595 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.558 ' H ' HD13 ' 1' ' 42' ' ' ILE . 3.7 mp -83.23 -50.5 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.64 0.733 . . . . 0.0 110.906 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.568 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.02 -11.21 20.78 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.249 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.763 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -148.84 71.33 10.41 Favored Pre-proline 0 CA--C 1.505 -0.781 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.996 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.536 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 76.3 Cg_exo -48.96 -32.32 22.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.573 2.182 . . . . 0.0 109.231 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.536 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 11.1 t 169.47 155.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.978 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 72.33 56.96 0.15 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 177.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.903 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -84.19 111.45 19.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.647 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.75 91.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.54 0.686 . . . . 0.0 110.583 -178.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.818 ' HB3' HG21 ' 1' ' 32' ' ' ILE . 33.1 m0 -44.31 -28.58 0.55 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.506 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.647 ' CG1' HG22 ' 1' ' 49' ' ' THR . 5.9 p -52.96 -56.2 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.64 ' H ' HG13 ' 1' ' 51' ' ' VAL . 51.2 t0 -153.68 -13.05 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.259 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.099 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -86.31 -13.01 47.85 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.461 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.921 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.53 142.29 22.7 Favored Glycine 1 N--CA 1.388 -4.525 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 175.442 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.934 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.42 119.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.729 -178.815 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.53 87.72 0.66 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.571 ' O ' HG23 ' 1' ' 60' ' ' VAL . . . -35.3 -35.16 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.767 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -54.46 -35.74 63.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.252 0.549 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.58 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.0 OUTLIER -66.19 -29.08 69.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.685 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.621 HG11 HD13 ' 1' ' 55' ' ' ILE . 26.5 m -100.17 -173.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.267 0.556 . . . . 0.0 112.407 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.805 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -142.66 112.34 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.817 -177.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -62.8 121.33 13.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.015 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.821 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 1.8 m -105.22 153.71 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.896 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.639 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 1.6 p -83.97 161.3 20.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -37.81 -35.66 0.15 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.882 0.739 . . . . 0.0 112.593 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -7.43 55.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 111.085 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 92.05 23.33 27.76 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.734 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.821 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.8 OUTLIER -72.32 116.34 12.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.862 0.363 . . . . 0.0 110.415 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.589 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 5.5 mtt85 -72.85 137.56 45.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 1.8 t 42.05 74.15 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.94 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -86.02 -49.17 8.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' 1' ' 73' ' ' GLN . 1.0 OUTLIER -96.87 -27.11 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' 1' ' 72' ' ' ASP . 7.8 tt0 86.9 -24.72 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.057 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.53 105.99 19.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.199 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.536 ' C ' ' HG3' ' 1' ' 76' ' ' GLN . 0.2 OUTLIER -57.24 147.22 25.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.0 111.811 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.536 ' HG3' ' C ' ' 1' ' 75' ' ' LEU . 6.9 mt-30 -154.27 132.81 12.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.487 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.724 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -74.83 151.54 39.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 114.42 18.33 6.69 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.189 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . 0.478 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -151.71 -109.54 0.43 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.766 -1.683 . . . . 0.0 114.675 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.564 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 0.1 OUTLIER -151.94 160.37 43.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.912 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.765 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.9 OUTLIER -154.98 173.25 16.83 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 122.013 0.911 . . . . 0.0 111.121 177.483 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.805 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.09 125.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.682 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.572 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -74.62 111.65 10.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.302 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.848 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.2 t-20 -54.03 115.05 7.42 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.703 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 95.0 Cg_endo -68.94 -28.21 29.58 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.133 2.555 . . . . 0.0 110.925 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -28.85 61.78 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.065 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.848 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.43 -3.56 55.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 39.2 t -96.53 132.77 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.362 0 CA-C-O 123.085 1.421 . . . . 0.0 112.134 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.839 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.97 -44.78 12.79 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 111.615 -2.539 . . . . 0.0 107.979 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.556 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.09 173.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.599 -1.637 . . . . 0.0 112.766 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.657 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -107.09 117.06 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.73 179.64 44.47 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-O 122.518 1.065 . . . . 0.0 115.028 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . 0.419 ' CG2' ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.97 138.96 95.8 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.609 -1.796 . . . . 0.0 111.934 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 25.1 Cg_endo -81.18 158.3 20.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.477 3.451 . . . . 0.0 113.925 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.2 mtt -149.22 135.84 19.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 15.0 mttt -86.36 123.68 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.346 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.41 -52.64 0.04 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.915 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.878 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.99 69.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.009 0.405 . . . . 0.0 110.585 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.27 -49.58 0.85 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.149 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.02 -16.15 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.999 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.708 ' H ' HD13 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.08 -153.53 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.769 0.795 . . . . 0.0 112.038 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' HB3' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.59 118.28 32.19 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.737 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.878 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.7 m95 -120.77 117.22 26.88 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.653 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.33 147.4 27.13 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.7 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 26.8 tt0 -80.86 102.62 10.16 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.611 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.867 HG11 ' CE1' ' 1' ' 108' ' ' PHE . 43.8 t -100.92 135.79 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.839 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 m120 -89.85 101.94 14.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.389 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.867 ' CE1' HG11 ' 1' ' 106' ' ' VAL . 1.9 m-85 -99.23 168.21 10.18 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-O 122.92 1.343 . . . . 0.0 111.927 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.658 HG22 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.13 -65.48 0.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.624 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.658 ' H ' HG22 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.31 -56.01 3.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.32 -7.4 67.79 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.974 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.45 -91.63 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.67 130.11 34.75 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.009 -0.701 . . . . 0.0 109.298 176.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.934 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.5 t -145.63 117.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.099 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.4 m95 -92.96 155.36 17.61 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.887 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.574 HD21 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.36 144.43 22.94 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.975 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.729 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -65.14 101.92 0.58 Allowed 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 124.64 2.162 . . . . 0.0 107.362 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.643 ' C ' ' H ' ' 1' ' 120' ' ' SER . 4.2 t -78.03 15.76 0.85 Allowed 'General case' 0 C--N 1.277 -2.56 1 CA-C-N 108.246 -4.07 . . . . 0.0 113.245 -174.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . . . . . . . . . 6.8 t -63.34 21.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.845 178.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.951 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.5 m -175.13 125.26 0.25 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.673 ' O ' HD21 ' 1' ' 124' ' ' LEU . 4.9 ttmt -74.09 -40.63 62.6 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.991 0.901 . . . . 0.0 108.745 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.791 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 85.8 m-20 -65.69 -4.64 6.68 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.951 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.52 -58.73 6.53 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.77 0.795 . . . . 0.0 110.509 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.838 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.94 -55.62 18.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 122.021 0.915 . . . . 0.0 109.452 178.35 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.586 HD12 ' O ' ' 1' ' 121' ' ' LYS . 6.6 mp -59.24 -45.81 90.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.147 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.3 m-85 -113.97 -31.74 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.735 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.0 26.21 8.02 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.389 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.791 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 80.0 mttt . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.005 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . 0.401 ' O ' ' HB2' ' 1' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' 1' ' 1' ' ' MET . 6.6 mmt85 66.13 96.18 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.908 0.385 . . . . 0.0 110.773 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.54 150.74 8.21 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.23 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -169.39 -175.78 2.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 73.58 -76.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.104 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -122.96 132.73 54.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -139.41 127.74 22.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 111.077 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -90.01 170.02 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.151 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.87 -45.54 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -121.64 25.85 9.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.42 -158.79 50.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.55 -25.6 9.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 120.94 34.67 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.036 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.63 -167.59 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.314 2.01 . . . . 0.0 111.954 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.73 97.8 11.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.12 128.54 25.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.32 153.2 35.48 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.415 2.076 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -89.75 -2.0 58.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . 0.532 ' HB ' ' HE1' ' 1' ' 126' ' ' TYR . 44.5 p -77.74 134.65 38.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . 0.601 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 1.1 m-80 -93.05 127.82 38.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.252 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 0.9 OUTLIER -62.49 89.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 111.45 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -58.15 168.69 0.96 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.553 HG23 ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -72.17 156.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.803 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 5.4 m-85 -109.76 169.71 8.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.395 -1.729 . . . . 0.0 106.798 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.666 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 5.0 mmtt -116.4 108.99 16.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.089 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.65 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.1 OUTLIER -80.0 80.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.138 0.97 . . . . 0.0 109.634 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.836 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 5.5 m-20 -80.45 -26.9 38.07 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.645 -2.071 . . . . 0.0 111.966 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . 0.425 ' HA ' ' CD ' ' 1' ' 77' ' ' LYS . 5.3 t0 -175.04 114.98 0.15 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.931 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -131.09 138.48 49.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.214 177.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.931 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -132.92 161.63 33.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.212 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.0 103.01 2.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 174.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.927 HD11 ' NE2' ' 1' ' 37' ' ' GLN . 1.1 mt -124.2 120.84 60.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.72 35.24 19.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.71 4.6 76.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.443 HD13 ' HB1' ' 1' ' 56' ' ' ALA . 0.0 OUTLIER -135.76 136.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.52 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 97.1 m95 -60.22 128.41 36.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.927 ' NE2' HD11 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.85 143.87 45.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.423 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.714 ' O ' HG23 ' 1' ' 55' ' ' ILE . 22.8 t -112.38 151.25 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.882 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 28.7 mtp180 -144.19 143.98 31.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.047 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.836 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.77 152.56 51.74 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -62.21 -15.4 46.43 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.374 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.553 HD13 ' HB2' ' 1' ' 40' ' ' ASN . 3.9 mp -85.43 -50.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.498 0.666 . . . . 0.0 110.673 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.558 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.4 OUTLIER -99.71 -11.43 20.88 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.212 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.731 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.2 t -147.86 71.0 11.38 Favored Pre-proline 0 CA--C 1.505 -0.787 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.228 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.51 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.3 Cg_exo -49.5 -32.22 26.47 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.574 2.182 . . . . 0.0 109.078 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 13.3 t 170.1 154.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.045 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 72.47 56.35 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.882 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.1 112.03 19.44 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.774 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.663 HG21 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.95 92.31 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.643 0.735 . . . . 0.0 110.532 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.866 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 30.5 m0 -45.22 -28.6 0.81 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.594 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.663 ' CG1' HG21 ' 1' ' 49' ' ' THR . 9.9 p -54.06 -57.48 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.713 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.64 ' H ' HG13 ' 1' ' 51' ' ' VAL . 50.9 t0 -152.72 -11.91 0.17 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.631 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.085 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.9 m120 -87.4 -14.36 40.81 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.876 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.907 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.11 145.97 27.47 Favored Glycine 1 N--CA 1.388 -4.56 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 175.123 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.841 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.16 120.19 33.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.949 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.443 ' HB1' HD13 ' 1' ' 35' ' ' ILE . . . -70.62 88.14 0.69 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.542 ' O ' HG23 ' 1' ' 60' ' ' VAL . . . -35.65 -34.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.005 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.66 -36.57 64.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.357 0.598 . . . . 0.0 110.572 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.575 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.4 m-20 -65.57 -29.07 69.63 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.552 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.592 HG12 HD11 ' 1' ' 55' ' ' ILE . 25.9 m -99.37 -176.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.412 0.625 . . . . 0.0 112.626 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.795 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -140.27 107.82 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.668 -178.039 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.578 ' O ' ' HG3' ' 1' ' 62' ' ' GLU . 0.0 OUTLIER -65.92 125.25 24.82 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.195 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.696 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 6.9 m -112.02 161.19 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.345 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.618 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 3.3 p -83.76 162.79 20.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.52 -35.48 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.953 0.783 . . . . 0.0 112.988 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -79.6 -8.05 58.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.191 0.519 . . . . 0.0 111.44 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.55 23.26 21.89 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.696 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -74.69 117.88 17.03 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.994 0.426 . . . . 0.0 111.241 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.495 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 6.7 mtp180 -71.42 145.9 49.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 4.3 t -160.56 79.64 0.65 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.953 0.406 . . . . 0.0 111.168 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -85.02 -21.97 29.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -47.32 75.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.53 -172.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.49 129.95 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.407 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' 1' ' 62' ' ' GLU . 0.2 OUTLIER -53.94 149.45 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.41 0.624 . . . . 0.0 111.727 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -155.33 133.27 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.834 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.875 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -80.02 152.27 29.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.65 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.16 19.99 4.55 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.754 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . 0.46 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -151.39 -108.32 0.39 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.155 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.572 ' N ' HG21 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -152.06 160.83 43.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.777 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.5 OUTLIER -153.67 172.67 16.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.145 0.974 . . . . 0.0 110.807 177.168 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.795 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.76 124.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.588 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -74.35 114.13 13.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.468 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.893 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.7 t-20 -55.33 114.93 8.03 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.707 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.6 Cg_endo -72.3 -27.24 16.6 Favored 'Trans proline' 0 CA--C 1.502 -1.088 0 C-N-CA 123.059 2.506 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -27.45 60.31 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.069 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.893 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -83.43 -3.51 57.63 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.707 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 25.1 t -96.54 133.17 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.484 0 CA-C-O 123.002 1.382 . . . . 0.0 111.821 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.804 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.91 -48.69 10.44 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.333 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.477 ' O ' HG11 ' 1' ' 106' ' ' VAL . 0.5 OUTLIER 172.3 172.68 0.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.518 179.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.488 HG11 HG22 ' 1' ' 106' ' ' VAL . 89.5 t -92.15 165.87 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -137.05 179.66 17.77 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.244 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.18 133.71 87.81 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 113.991 -1.105 . . . . 0.0 111.184 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.631 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 23.1 Cg_endo -80.88 158.55 21.13 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.284 3.322 . . . . 0.0 113.557 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 25.9 mtt -149.3 134.67 18.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.9 pttt -85.12 124.12 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.508 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.11 -53.11 0.05 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.862 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.78 69.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.862 0.331 . . . . 0.0 110.683 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.53 -49.4 0.87 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.105 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.23 -14.25 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.036 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.701 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -77.86 -153.32 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.688 0.756 . . . . 0.0 111.777 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.515 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.2 m -116.9 118.82 33.5 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.911 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.862 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.1 m95 -119.57 117.39 28.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.631 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.41 149.75 24.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.665 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.9 tt0 -82.96 102.76 11.92 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.163 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.628 HG12 ' CE1' ' 1' ' 108' ' ' PHE . 69.2 t -101.28 133.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.804 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -87.65 102.56 14.75 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.13 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.628 ' CE1' HG12 ' 1' ' 106' ' ' VAL . 5.5 m-85 -100.64 168.6 9.59 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.91 1.338 . . . . 0.0 111.98 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.667 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.6 t -52.21 -65.63 0.52 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.716 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.667 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.29 -55.93 3.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.07 -7.49 66.98 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.111 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 61.12 -90.44 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.18 132.09 34.34 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.74 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 9.3 t -145.18 113.99 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.085 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -91.96 152.42 20.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.896 0.855 . . . . 0.0 112.848 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.483 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.66 145.38 23.4 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.73 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.24 99.26 0.37 Allowed 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 124.765 2.222 . . . . 0.0 107.68 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.634 ' C ' ' H ' ' 1' ' 120' ' ' SER . 1.6 t -76.11 14.66 0.67 Allowed 'General case' 0 C--N 1.28 -2.434 1 CA-C-N 108.047 -4.161 . . . . 0.0 113.399 -174.935 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . . . . . . . . . 9.0 t -63.71 24.4 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.029 179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.98 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.63 120.39 0.14 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.686 ' O ' HD21 ' 1' ' 124' ' ' LEU . 5.1 ttmm -68.77 -38.33 79.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.916 0.865 . . . . 0.0 108.893 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.78 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 13.1 m-20 -66.91 -5.0 10.82 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.98 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.24 -58.6 6.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.598 0.713 . . . . 0.0 110.309 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.803 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -63.94 -57.4 9.87 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.816 0.817 . . . . 0.0 109.662 178.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.597 HD13 ' O ' ' 1' ' 121' ' ' LYS . 6.4 mp -60.14 -46.23 90.37 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.528 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.0 OUTLIER -109.32 -31.04 7.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.697 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 98.39 26.09 9.62 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.336 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.78 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 58.6 mttt . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.963 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -113.55 -30.95 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.88 57.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.542 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.47 -21.7 12.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.38 112.15 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.88 99.89 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.722 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 121.96 15.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -90.69 139.89 30.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -169.81 22.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.388 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -90.91 -66.17 0.95 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.789 0.328 . . . . 0.0 111.223 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.65 -170.31 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.187 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 28.2 p -112.64 -35.49 5.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.318 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . 0.434 ' HG3' ' HD2' ' 1' ' 14' ' ' PRO . 0.4 OUTLIER -108.43 131.45 21.75 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . 0.434 ' HD2' ' HG3' ' 1' ' 13' ' ' GLU . 85.4 Cg_endo -83.01 42.79 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.643 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 91.5 m -83.8 163.69 20.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.589 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.57 141.35 32.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.829 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.0 156.74 43.02 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.566 2.177 . . . . 0.0 112.645 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.84 36.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.568 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . 0.459 ' HA ' ' OH ' ' 1' ' 126' ' ' TYR . 5.0 t -155.67 30.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.161 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.23 141.5 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.219 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.528 ' O ' HG23 ' 1' ' 82' ' ' VAL . 0.3 OUTLIER -56.48 95.32 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.925 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.2 OUTLIER -41.96 165.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.089 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.483 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.48 154.85 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -177.418 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.986 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.9 m-85 -110.68 170.17 8.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.956 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.632 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 0.0 OUTLIER -117.12 109.63 17.18 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.501 178.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.648 ' CG1' ' HA ' ' 1' ' 77' ' ' LYS . 0.1 OUTLIER -79.28 80.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.951 0.882 . . . . 0.0 109.782 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.841 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.4 m-20 -81.84 -25.96 34.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.881 -1.963 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -174.87 116.54 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.977 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.93 137.14 49.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.948 177.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.977 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -133.32 161.26 34.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.845 -1.071 . . . . 0.0 113.167 -177.312 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.462 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.2 OUTLIER -70.91 102.7 2.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.855 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 0.8 OUTLIER -124.84 129.35 73.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.824 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' 1' ' 32' ' ' ILE . 6.5 p30 52.55 35.16 17.19 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.207 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.13 2.26 90.38 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.925 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.489 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -140.23 145.08 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.5 ' O ' ' N ' ' 1' ' 57' ' ' ALA . 94.7 m95 -60.96 131.22 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.889 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.7 146.63 42.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.279 -178.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.71 ' O ' ' CG2' ' 1' ' 55' ' ' ILE . 22.0 t -114.6 150.62 16.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.859 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 22.1 mtp180 -144.64 144.08 31.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.278 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.841 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.45 152.9 51.33 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.536 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -62.0 -16.05 48.62 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.373 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.546 ' H ' HD11 ' 1' ' 42' ' ' ILE . 3.8 mp -85.66 -50.91 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.535 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -99.86 -10.72 21.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.211 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.722 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.2 t -148.59 71.31 10.66 Favored Pre-proline 0 CA--C 1.505 -0.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.988 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.537 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.8 Cg_exo -49.37 -32.33 25.84 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.555 2.17 . . . . 0.0 109.307 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.537 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 9.6 t 169.69 153.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.152 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 72.41 56.33 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.859 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -81.45 113.05 19.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.576 HG21 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.18 91.88 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.679 0.752 . . . . 0.0 110.335 -178.304 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.855 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 33.6 m0 -46.16 -27.38 0.97 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.591 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.641 ' CG1' ' N ' ' 1' ' 52' ' ' ASP . 4.0 p -53.63 -55.57 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.851 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.641 ' N ' ' CG1' ' 1' ' 51' ' ' VAL . 48.3 t0 -154.89 -11.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.358 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.068 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -88.28 -14.72 37.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.936 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.889 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.04 144.26 28.42 Favored Glycine 1 N--CA 1.387 -4.604 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 175.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.9 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.07 119.27 32.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.819 -178.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.78 87.62 0.52 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.533 ' O ' HG23 ' 1' ' 60' ' ' VAL . . . -33.35 -35.77 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.484 -1.234 . . . . 0.0 114.007 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -54.52 -35.89 63.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.116 0.484 . . . . 0.0 110.522 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.435 ' CB ' ' CD2' ' 1' ' 108' ' ' PHE . 0.4 OUTLIER -66.76 -27.16 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.522 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.665 HG13 HD12 ' 1' ' 55' ' ' ILE . 25.6 m -99.48 -171.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.779 HG12 ' HB2' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -146.05 109.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.148 -176.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.23 125.12 24.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.884 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 6.9 m -107.85 167.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.624 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 2.4 p -85.36 160.16 19.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -38.04 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.46 -7.47 59.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.158 0.504 . . . . 0.0 111.485 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.624 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 95.16 22.91 21.37 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.37 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.661 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -75.35 116.94 16.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.505 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 15.9 mtm180 -74.11 143.02 45.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.233 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -159.04 86.47 0.83 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 2.0 p -76.5 -27.41 56.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.576 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.99 -33.28 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.127 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.81 179.5 6.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.025 0.441 . . . . 0.0 111.57 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.07 129.27 64.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.652 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.509 ' HG ' ' HG3' ' 1' ' 62' ' ' GLU . 0.3 OUTLIER -58.5 148.4 28.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.504 0.669 . . . . 0.0 111.934 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.506 ' HG3' ' C ' ' 1' ' 75' ' ' LEU . 15.1 mt-30 -155.06 132.54 11.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.415 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.768 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.2 OUTLIER -78.43 151.85 32.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.636 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.87 20.36 4.95 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.822 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . 0.485 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -153.81 -107.93 0.32 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.515 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.51 ' N ' HG21 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.99 160.6 43.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.936 -178.642 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.776 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.09 173.46 16.02 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.107 0.956 . . . . 0.0 110.888 177.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.716 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.94 124.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.562 HG23 ' CZ ' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -74.13 113.58 12.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.943 -178.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.779 ' HB2' HG12 ' 1' ' 61' ' ' ILE . 1.3 t-20 -55.4 115.85 10.3 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.009 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.729 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 82.5 Cg_endo -67.49 -27.09 39.86 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 123.106 2.537 . . . . 0.0 110.106 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.11 -25.14 60.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.63 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.4 t-20 -82.9 -2.16 54.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.821 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 57.2 t -101.26 129.82 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.323 0 CA-C-O 123.245 1.498 . . . . 0.0 113.092 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.898 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.25 -39.53 10.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 111.518 -2.583 . . . . 0.0 108.415 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.544 ' O ' HG12 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.2 173.26 0.36 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.174 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.635 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.18 128.74 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.497 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -101.43 179.86 28.24 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 122.173 0.874 . . . . 0.0 114.181 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . 0.404 ' CG2' ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.27 138.9 94.66 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.162 -1.519 . . . . 0.0 111.249 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.58 ' HB3' ' CG2' ' 1' ' 118' ' ' THR . 24.0 Cg_endo -81.03 158.04 20.56 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.201 3.267 . . . . 0.0 113.328 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mtt -149.58 136.12 19.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 12.3 mttt -85.47 126.06 33.52 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.497 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.56 -54.27 0.05 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.726 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.869 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -64.47 69.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.858 0.329 . . . . 0.0 110.471 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.42 -49.44 0.86 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.135 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.7 -14.62 0.52 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.155 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.706 ' H ' HD13 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.92 -153.07 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.952 0.882 . . . . 0.0 111.997 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.524 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.3 m -116.56 117.31 29.5 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.567 -1.652 . . . . 0.0 109.795 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.869 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -120.18 117.78 28.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -104.76 147.32 27.83 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.72 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 29.0 tt0 -79.57 103.04 9.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.708 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' 1' ' 91' ' ' VAL . 17.8 t -99.01 138.34 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.898 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.1 OUTLIER -89.1 101.46 14.11 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.098 -177.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.625 ' HB2' HG21 ' 1' ' 114' ' ' VAL . 37.0 m-85 -100.31 157.89 16.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 122.025 0.917 . . . . 0.0 109.384 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.996 HG22 ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.62 -62.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.039 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.996 ' N ' HG22 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.08 10.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.929 0.871 . . . . 0.0 109.725 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.9 -1.99 56.55 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.03 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.45 -95.13 0.01 OUTLIER Glycine 0 C--O 1.212 -1.26 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.9 129.02 38.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.9 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 6.5 t -144.83 120.02 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.068 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.6 m95 -93.89 155.49 17.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.909 0.861 . . . . 0.0 112.784 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.48 HD21 ' HH ' ' 1' ' 24' ' ' TYR . 0.2 OUTLIER -153.93 146.19 23.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.126 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.708 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.4 OUTLIER -65.31 101.55 0.57 Allowed 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 124.847 2.261 . . . . 0.0 107.212 178.082 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.632 ' C ' ' H ' ' 1' ' 120' ' ' SER . 4.1 t -77.99 14.79 1.03 Allowed 'General case' 0 C--N 1.279 -2.494 1 CA-C-N 107.894 -4.23 . . . . 0.0 113.285 -174.587 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . 0.407 ' CG2' ' OD1' ' 1' ' 117' ' ' ASN . 8.1 t -62.96 22.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.849 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.976 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.3 m -175.81 125.18 0.22 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.715 ' O ' HD21 ' 1' ' 124' ' ' LEU . 7.3 tptm -73.8 -41.03 62.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.129 0.966 . . . . 0.0 108.699 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.791 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 11.8 m-20 -65.01 -4.41 4.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.976 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.05 -58.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.766 0.793 . . . . 0.0 110.239 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.986 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -63.16 -56.57 15.66 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 121.88 0.848 . . . . 0.0 109.581 178.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.571 HD13 ' O ' ' 1' ' 121' ' ' LYS . 6.4 mp -59.73 -43.62 94.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.185 -1.37 . . . . 0.0 112.736 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.632 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -119.96 -30.65 4.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' 1' ' 123' ' ' ASN . . . 100.21 27.96 7.48 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.732 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.791 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.435 -1.213 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.973 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 35.9 mtm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.815 0.34 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.54 138.69 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.55 -31.45 4.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t -74.38 129.22 37.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.747 0.308 . . . . 0.0 110.939 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -160.5 39.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -140.04 124.33 17.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -140.03 109.96 6.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -89.86 107.63 19.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -122.59 157.86 31.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.003 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 63.71 84.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.29 -28.33 0.07 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.662 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -103.66 -24.1 13.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.091 0.445 . . . . 0.0 111.868 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.99 93.71 4.14 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 111.284 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.27 83.07 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.608 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 21.5 p -81.19 -164.19 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.542 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 13.7 m -70.49 129.28 90.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.756 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.93 147.65 24.32 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.435 2.09 . . . . 0.0 112.309 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 -10.78 29.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -72.01 99.8 2.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -178.64 140.45 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 111.811 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.544 ' HG ' ' HD3' ' 1' ' 85' ' ' PRO . 4.4 mm? 25.14 73.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.445 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.6 mmtm -60.17 168.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.71 0.291 . . . . 0.0 110.343 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.522 HD11 ' HA2' ' 1' ' 67' ' ' GLY . 0.0 OUTLIER -72.53 154.6 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -177.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.978 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.8 m-85 -111.65 171.53 7.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.867 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.64 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 14.5 mptt -116.91 109.67 17.35 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.279 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -79.85 80.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.9 0.857 . . . . 0.0 109.447 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.894 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 1.0 OUTLIER -81.59 -25.87 35.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.891 -178.489 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.59 116.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.149 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.907 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.27 136.92 49.69 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.112 0.482 . . . . 0.0 110.264 177.954 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.907 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -130.35 160.86 32.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.065 -177.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.485 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.99 102.49 2.97 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.815 HD11 ' CG ' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -124.9 122.22 62.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -171.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 60.96 35.51 19.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.253 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.13 4.27 72.3 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -136.19 139.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.485 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 87.4 m95 -60.42 129.85 43.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.875 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.76 145.14 43.69 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.34 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.73 ' O ' ' CG2' ' 1' ' 55' ' ' ILE . 22.0 t -113.1 151.24 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.834 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 33.3 mtp180 -144.56 141.46 29.48 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.185 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.894 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -129.74 152.62 49.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.569 HD21 ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.9 -15.98 47.14 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.608 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' 1' ' 40' ' ' ASN . 3.7 mp -84.34 -50.54 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.715 0.769 . . . . 0.0 110.76 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.542 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -101.72 -10.08 20.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.386 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.734 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.1 t -148.12 70.26 10.94 Favored Pre-proline 0 CA--C 1.505 -0.77 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.048 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 94.3 Cg_exo -50.86 -30.7 30.96 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.505 2.137 . . . . 0.0 109.323 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.0 t 169.22 151.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.259 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 56.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.834 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.64 112.39 18.79 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.61 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.645 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.11 91.84 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.662 0.744 . . . . 0.0 110.35 -178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.815 ' CG ' HD11 ' 1' ' 32' ' ' ILE . 35.8 m0 -44.92 -28.19 0.63 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.653 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.655 HG13 ' H ' ' 1' ' 52' ' ' ASP . 7.3 p -53.5 -57.07 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.369 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.655 ' H ' HG13 ' 1' ' 51' ' ' VAL . 52.1 t0 -151.94 -11.79 0.19 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.498 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.039 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.8 m120 -87.23 -10.97 51.12 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.886 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.875 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.98 142.32 22.33 Favored Glycine 1 N--CA 1.388 -4.563 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 175.694 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.851 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.39 117.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.417 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.46 87.51 0.46 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.522 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -34.88 -34.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.707 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -53.99 -33.97 58.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.07 0.462 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.5 m-20 -70.16 -27.6 64.67 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.852 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.668 HG11 HD11 ' 1' ' 55' ' ' ILE . 32.0 m -98.78 -173.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.424 0.63 . . . . 0.0 112.126 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.756 HG12 ' HB2' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -142.72 105.33 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.538 -177.33 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -65.81 126.46 28.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.744 -178.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.64 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 15.8 m -116.48 161.76 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.746 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.637 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 1.6 p -83.7 163.92 19.96 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -37.86 -35.28 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.901 0.75 . . . . 0.0 112.926 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -80.18 -4.99 55.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.174 0.512 . . . . 0.0 111.318 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 89.91 23.33 33.13 Favored Glycine 0 CA--C 1.505 -0.583 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.212 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.8 OUTLIER -75.49 116.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.883 0.373 . . . . 0.0 111.129 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.487 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 3.4 mtp180 -68.45 115.82 8.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.568 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . 0.466 ' OG1' ' HG2' ' 1' ' 62' ' ' GLU . 68.2 p -79.95 89.29 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 30.4 m -61.31 -11.72 10.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.806 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -49.03 -26.47 2.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.67 0.271 . . . . 0.0 111.429 -179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 74.76 7.87 4.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.631 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . 0.402 ' CG1' ' O ' ' 1' ' 74' ' ' VAL . 10.3 p -109.16 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.734 0.302 . . . . 0.0 111.176 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.405 ' O ' ' HG2' ' 1' ' 76' ' ' GLN . 0.2 OUTLIER -83.8 151.12 25.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.226 0.536 . . . . 0.0 111.366 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 35.8 mt-30 -156.92 133.23 9.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.007 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.56 151.57 37.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.579 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 117.82 18.15 5.27 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -150.81 -109.47 0.46 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 118.655 -1.736 . . . . 0.0 114.579 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.538 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -151.86 160.19 43.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.927 -0.637 . . . . 0.0 109.523 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.751 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.9 OUTLIER -153.19 173.11 15.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.057 0.932 . . . . 0.0 110.946 177.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.734 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.28 124.54 35.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.562 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -74.19 112.22 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.439 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.888 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.4 t-20 -52.39 114.0 5.04 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.707 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 87.4 Cg_endo -70.61 -27.23 22.67 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.065 2.51 . . . . 0.0 110.532 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . 0.546 HD21 ' HG2' ' 1' ' 85' ' ' PRO . 6.7 m-80 -74.53 -28.62 61.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.999 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.888 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.71 -2.09 53.2 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.707 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 37.9 t -96.54 130.25 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.425 0 CA-C-O 123.002 1.382 . . . . 0.0 111.84 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.841 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.3 -46.28 13.85 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 111.782 -2.463 . . . . 0.0 107.856 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.584 ' O ' HG11 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 173.99 172.72 0.18 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.815 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.606 ' HA ' HG21 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.96 145.93 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -118.19 179.44 17.06 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-O 122.072 0.818 . . . . 0.0 113.676 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.05 137.85 91.03 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.48 -1.36 . . . . 0.0 111.443 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.633 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 25.4 Cg_endo -81.54 158.31 19.3 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.274 3.316 . . . . 0.0 113.574 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtm -149.53 130.89 14.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.509 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.4 mttp -85.17 124.97 32.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.857 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.408 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.77 -48.63 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.584 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.883 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -66.63 69.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.396 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.96 -49.39 0.86 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.152 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.81 -17.07 0.39 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.039 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.703 HD12 ' H ' ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -75.73 -153.45 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.849 0.833 . . . . 0.0 112.394 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.573 ' HB3' HG23 ' 1' ' 118' ' ' THR . 1.1 m -116.72 118.29 32.13 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.773 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.883 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.5 m95 -120.44 117.12 26.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.633 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.36 149.68 24.54 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.723 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.0 tt0 -83.52 103.07 12.57 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 112.576 -2.102 . . . . 0.0 111.897 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.73 HG12 ' CE1' ' 1' ' 108' ' ' PHE . 44.1 t -102.88 138.69 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.841 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.9 OUTLIER -89.99 101.51 14.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.73 ' CE1' HG12 ' 1' ' 106' ' ' VAL . 3.4 m-85 -98.35 167.27 10.95 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.953 1.359 . . . . 0.0 111.287 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.661 HG22 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -50.84 -65.88 0.48 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.299 -2.228 . . . . 0.0 116.55 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.661 ' H ' HG22 ' 1' ' 109' ' ' THR . 0.5 OUTLIER -86.46 -56.6 3.36 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.923 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.76 -7.32 61.41 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.587 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.73 -92.11 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' 1' ' 52' ' ' ASP . 0.4 OUTLIER -83.61 129.51 34.97 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.901 -0.764 . . . . 0.0 109.129 176.758 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.851 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 2.8 t -145.09 120.07 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.039 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.3 m95 -94.7 154.85 17.12 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.103 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.506 HD21 ' OD1' ' 1' ' 123' ' ' ASN . 0.1 OUTLIER -153.23 143.63 22.48 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.077 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.727 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.27 100.0 0.43 Allowed 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 124.704 2.193 . . . . 0.0 107.329 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.647 ' C ' ' H ' ' 1' ' 120' ' ' SER . 2.5 t -76.84 14.88 0.74 Allowed 'General case' 0 C--N 1.279 -2.47 1 CA-C-N 107.957 -4.201 . . . . 0.0 114.041 -174.39 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . 0.482 ' OG1' ' OD1' ' 1' ' 117' ' ' ASN . 1.1 p -64.0 25.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.928 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.958 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.0 OUTLIER -175.15 126.01 0.26 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.666 ' O ' HD22 ' 1' ' 124' ' ' LEU . 21.3 tttm -74.26 -41.16 61.73 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.923 0.868 . . . . 0.0 108.676 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.87 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 6.4 m-20 -65.8 -4.54 6.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.958 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.76 -58.7 6.53 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.73 0.776 . . . . 0.0 110.526 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.978 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.81 -56.1 15.58 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.887 0.851 . . . . 0.0 109.353 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.622 HD13 ' O ' ' 1' ' 121' ' ' LYS . 6.5 mp -58.99 -45.17 91.26 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.355 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.625 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -115.35 -31.69 5.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.173 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.724 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.14 27.71 7.2 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.569 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.87 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 38.5 mttp . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.019 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.76 117.06 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.798 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.32 -103.49 1.09 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 27.4 t -64.8 121.55 14.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.018 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -84.13 -28.22 27.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.023 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.22 114.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -99.73 123.89 44.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -152.25 140.95 20.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -172.37 98.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.82 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.51 130.52 35.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.32 104.5 2.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.26 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 66.3 p -103.77 11.58 35.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -107.71 127.24 28.13 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.562 0.22 . . . . 0.0 111.043 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.99 178.94 5.86 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.526 2.15 . . . . 0.0 112.268 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -99.78 2.37 44.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.468 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 106.91 59.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.552 0.215 . . . . 0.0 110.929 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.99 121.75 6.78 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.476 2.117 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.98 52.68 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 110.56 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t -152.1 23.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . 0.491 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 0.4 OUTLIER -75.07 127.36 33.03 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.987 0.422 . . . . 0.0 110.817 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 1.4 mt -66.59 84.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.448 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.8 mmtt -55.6 169.43 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.651 HD12 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.43 153.21 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -177.162 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.89 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.9 m-85 -109.11 170.28 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.683 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 2.5 mttt -117.2 109.44 16.9 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.853 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.61 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.0 OUTLIER -79.62 81.66 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.074 0.94 . . . . 0.0 109.756 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.846 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 4.0 m-20 -81.31 -27.23 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.898 -1.955 . . . . 0.0 111.983 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.3 t0 -175.72 118.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.831 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -132.06 137.87 47.95 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.277 0.56 . . . . 0.0 110.108 177.918 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.831 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.01 160.83 31.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.581 -177.255 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.537 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.4 OUTLIER -71.45 102.64 2.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.871 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 0.9 OUTLIER -120.69 120.72 63.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -171.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . 0.494 ' OD1' HG23 ' 1' ' 32' ' ' ILE . 2.9 p-10 49.55 47.47 22.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.89 3.2 59.28 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.294 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.464 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 1.6 mm -138.2 135.94 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.645 0.26 . . . . 0.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.537 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 87.5 m95 -59.75 131.55 51.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.871 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.7 146.48 42.74 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.806 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.708 ' O ' ' CG2' ' 1' ' 55' ' ' ILE . 19.9 t -113.33 150.96 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.886 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.61 141.97 29.8 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.412 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.846 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.24 150.32 52.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.192 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.693 HD21 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -59.74 -17.46 35.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.326 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.539 ' H ' HD11 ' 1' ' 42' ' ' ILE . 3.7 mp -82.85 -50.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 121.54 0.686 . . . . 0.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.604 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.6 -11.93 19.64 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.162 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.78 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.49 71.82 9.87 Favored Pre-proline 0 CA--C 1.504 -0.822 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.274 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.5 Cg_exo -49.3 -32.3 25.25 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.548 2.165 . . . . 0.0 109.306 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.538 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 12.8 t 169.56 155.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.47 -1.696 . . . . 0.0 110.879 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 72.1 56.45 0.16 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.886 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.87 113.11 20.72 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.676 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.33 91.7 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.677 0.751 . . . . 0.0 110.082 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.788 ' HB3' HG22 ' 1' ' 32' ' ' ILE . 42.1 m0 -46.05 -28.47 1.19 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.887 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.676 ' CG1' HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.46 -56.86 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.794 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.629 ' H ' HG12 ' 1' ' 51' ' ' VAL . 48.2 t0 -149.33 -14.34 0.29 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.956 -1.475 . . . . 0.0 113.502 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.071 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 0.9 OUTLIER -87.02 -12.86 46.13 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.53 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.795 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.31 140.42 22.06 Favored Glycine 1 N--CA 1.387 -4.572 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.873 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.05 119.07 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.304 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.53 87.57 0.47 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.514 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -35.25 -35.3 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.859 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -54.58 -35.87 63.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.419 0.628 . . . . 0.0 110.216 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.464 ' OD2' ' HA3' ' 1' ' 111' ' ' GLY . 0.5 OUTLIER -66.89 -27.64 67.67 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.722 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.704 HG12 HD12 ' 1' ' 55' ' ' ILE . 25.1 m -99.05 -173.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.864 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -144.98 112.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.11 -176.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.9 mt-10 -63.83 128.28 35.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.56 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.575 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 0.9 OUTLIER -109.07 161.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.876 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.651 ' O ' HD12 ' 1' ' 23' ' ' ILE . 1.4 p -85.41 159.08 20.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -37.51 -33.77 0.08 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.4 -8.1 58.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.552 . . . . 0.0 111.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.34 22.95 23.26 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.417 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.575 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.8 OUTLIER -74.27 116.54 15.05 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.044 0.45 . . . . 0.0 111.141 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.552 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 8.8 mtp180 -73.51 138.42 45.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.001 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -162.12 100.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . 0.453 ' HB2' HG21 ' 1' ' 61' ' ' ILE . 6.0 t -88.8 -26.28 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -50.45 -29.82 11.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.601 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -83.23 -179.26 7.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 111.729 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 13.1 t -109.01 124.05 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.756 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.508 ' HG ' ' HG3' ' 1' ' 62' ' ' GLU . 0.3 OUTLIER -56.98 147.4 24.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.452 0.644 . . . . 0.0 112.339 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.474 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 12.1 mt-30 -156.99 133.24 9.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.747 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.728 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.04 151.8 38.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.61 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.1 18.05 5.19 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.293 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . 0.419 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -152.78 -107.96 0.34 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 118.833 -1.651 . . . . 0.0 114.277 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.559 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 1.4 m-85 -151.7 160.38 43.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.764 ' O ' ' HB2' ' 1' ' 24' ' ' TYR . 0.7 OUTLIER -154.5 173.57 16.11 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.128 0.966 . . . . 0.0 110.728 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.864 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.37 125.7 33.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.275 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.532 HD11 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.1 113.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.994 -178.665 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.724 ' HB2' HG12 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -55.67 114.65 7.75 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.709 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 70.0 Cg_endo -64.2 -26.69 64.56 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 122.95 2.434 . . . . 0.0 109.717 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.79 -27.52 62.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.953 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.556 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.8 t-20 -82.82 -1.75 52.69 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.821 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 53.8 t -102.6 129.77 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.319 0 CA-C-O 122.94 1.352 . . . . 0.0 112.786 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.857 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.83 -37.73 11.6 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 111.78 -2.464 . . . . 0.0 108.194 178.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.603 ' O ' HG13 ' 1' ' 106' ' ' VAL . 6.0 p 177.21 172.84 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.37 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.676 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -110.35 122.16 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.6 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -93.28 179.67 39.28 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-O 122.45 1.028 . . . . 0.0 114.873 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.91 139.66 97.86 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 112.723 -1.738 . . . . 0.0 111.182 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.646 ' HB3' ' CG2' ' 1' ' 118' ' ' THR . 23.7 Cg_endo -81.67 157.68 18.83 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.476 3.451 . . . . 0.0 113.869 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -149.68 137.6 20.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.49 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 1.7 mttt -84.53 124.26 31.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.617 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.56 -60.21 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.5 -1.334 . . . . 0.0 114.012 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.891 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -59.57 72.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.893 0.346 . . . . 0.0 111.108 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 105.08 -49.52 0.89 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.393 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.88 -16.0 0.45 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.71 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.42 -153.33 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.68 0.752 . . . . 0.0 112.107 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.537 ' HB3' HG22 ' 1' ' 118' ' ' THR . 0.7 OUTLIER -116.54 119.21 34.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.593 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.891 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -121.44 119.31 31.69 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -106.84 147.02 30.24 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.1 tt0 -78.91 102.86 8.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.78 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.676 HG23 ' HA ' ' 1' ' 91' ' ' VAL . 19.7 t -97.7 137.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.857 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -86.79 102.09 13.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.951 -177.224 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.644 ' C ' ' HD3' ' 1' ' 89' ' ' LYS . 35.8 m-85 -103.21 157.15 17.21 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.244 1.021 . . . . 0.0 110.062 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.998 HG23 ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.61 -62.25 1.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.416 -1.72 . . . . 0.0 114.238 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.998 ' N ' HG23 ' 1' ' 109' ' ' THR . 0.1 OUTLIER -85.91 -42.69 13.86 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.941 -177.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -78.55 -0.34 79.05 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.147 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.13 -91.49 0.01 OUTLIER Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -93.15 130.67 38.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.873 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.9 t -145.52 115.93 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.071 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.9 m95 -91.84 155.9 17.88 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.065 0.936 . . . . 0.0 113.152 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.673 HD21 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.85 144.56 22.53 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.094 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.725 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.19 100.81 0.48 Allowed 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 124.68 2.181 . . . . 0.0 107.126 178.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.664 ' C ' ' H ' ' 1' ' 120' ' ' SER . 5.7 t -75.94 15.4 0.54 Allowed 'General case' 0 C--N 1.279 -2.484 1 CA-C-N 108.273 -4.058 . . . . 0.0 113.401 -174.743 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . . . . . . . . . 9.6 t -62.62 22.08 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.669 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.962 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.5 OUTLIER -175.68 125.86 0.23 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.674 ' O ' HD23 ' 1' ' 124' ' ' LEU . 0.8 OUTLIER -74.24 -39.83 62.79 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.246 1.022 . . . . 0.0 108.354 -179.221 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.828 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 75.2 m-20 -65.91 -5.04 8.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.962 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.86 -58.38 7.61 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.642 0.734 . . . . 0.0 110.299 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.89 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.3 -57.01 10.63 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 122.014 0.911 . . . . 0.0 109.605 178.134 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.56 ' H ' HD11 ' 1' ' 125' ' ' LEU . 6.6 mp -59.08 -45.62 90.35 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.612 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.7 m-85 -112.58 -31.61 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.132 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.725 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.79 25.88 8.86 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 119.364 -1.398 . . . . 0.0 111.273 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.828 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.773 0.32 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.26 -107.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.575 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 59.62 100.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -87.58 -176.66 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -160.56 112.17 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -137.12 114.36 10.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . 0.402 ' HD1' ' HA ' ' 1' ' 8' ' ' HIS . 0.0 OUTLIER -89.9 80.04 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.679 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 -68.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.305 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -82.42 36.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.573 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.6 4.83 62.92 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.065 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -102.01 -15.34 16.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.831 0.316 . . . . 0.0 111.292 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -168.55 95.28 0.57 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.616 0.246 . . . . 0.0 111.12 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.68 128.41 15.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.579 2.186 . . . . 0.0 112.239 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 83.5 m -95.11 54.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.659 179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.02 141.34 22.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.77 116.26 4.59 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.488 2.126 . . . . 0.0 112.539 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -124.37 -1.73 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.95 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . 0.429 ' HA ' ' OH ' ' 1' ' 126' ' ' TYR . 4.6 t -55.2 142.44 31.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . 0.464 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 0.9 OUTLIER 179.47 128.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.617 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.524 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 0.4 OUTLIER -62.39 86.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.18 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.433 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 1.0 OUTLIER -50.09 169.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.414 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.571 HD13 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.45 154.18 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -176.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.862 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -107.65 170.42 7.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.676 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.4 OUTLIER -117.31 111.36 19.27 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.027 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.571 ' CG1' ' HA ' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -80.83 80.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 122.132 0.968 . . . . 0.0 109.676 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.857 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.8 m-20 -80.35 -26.37 38.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.946 -1.934 . . . . 0.0 111.686 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' 1' ' 39' ' ' ARG . 4.2 t0 -174.94 119.01 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.341 -0.543 . . . . 0.0 112.285 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.894 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.43 136.41 45.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.185 0.517 . . . . 0.0 110.255 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.894 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.86 160.95 31.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.093 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.534 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -70.87 102.42 2.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 174.759 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.944 HD12 ' NE2' ' 1' ' 37' ' ' GLN . 1.1 mt -124.35 121.53 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.09 35.16 18.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.148 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.08 4.49 72.77 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.075 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.73 137.79 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.572 ' HB3' HD12 ' 1' ' 29' ' ' LEU . 92.0 m95 -59.7 129.43 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.944 ' NE2' HD12 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.87 145.53 43.51 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.489 -177.908 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.746 ' O ' HG22 ' 1' ' 55' ' ' ILE . 22.6 t -114.07 151.39 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.898 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 4.3 mtp180 -144.36 144.25 31.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.986 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.857 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.72 151.54 51.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.577 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.88 -16.13 48.11 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.703 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.56 HD11 ' HB2' ' 1' ' 40' ' ' ASN . 3.8 mp -83.93 -50.24 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-O 121.771 0.796 . . . . 0.0 110.581 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.618 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.5 -11.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.235 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.759 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.6 t -148.01 70.22 11.05 Favored Pre-proline 0 CA--C 1.504 -0.797 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.083 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.531 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.1 Cg_exo -49.88 -31.98 28.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.477 2.118 . . . . 0.0 109.265 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.1 t 169.87 154.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.255 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.18 55.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.898 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.86 112.21 19.46 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.007 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.683 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.07 92.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.646 0.736 . . . . 0.0 110.743 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.854 ' HB3' HG21 ' 1' ' 32' ' ' ILE . 31.2 m0 -44.33 -29.43 0.67 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.814 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.683 ' CG1' HG22 ' 1' ' 49' ' ' THR . 6.5 p -53.78 -56.44 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.809 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.652 ' O ' ' HD1' ' 1' ' 115' ' ' TRP . 52.6 t0 -152.79 -13.1 0.16 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.405 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.089 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.0 OUTLIER -85.71 -14.92 43.89 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.394 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.93 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.96 144.32 26.14 Favored Glycine 1 N--CA 1.386 -4.689 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.899 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.25 119.75 33.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.488 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.48 87.87 0.66 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.563 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -35.58 -35.76 0.06 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.67 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -55.31 -32.87 62.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.305 0.574 . . . . 0.0 110.432 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 0.7 OUTLIER -69.42 -28.92 66.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.429 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.576 HG11 HG13 ' 1' ' 83' ' ' ILE . 31.7 m -100.49 -175.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.885 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.1 OUTLIER -141.53 113.63 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.127 -177.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.593 ' HG2' ' O ' ' 1' ' 80' ' ' TYR . 1.8 mt-10 -64.89 128.98 38.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.115 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.669 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 1.9 m -113.05 157.89 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.792 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.634 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 1.7 p -85.36 159.8 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -37.29 -35.8 0.13 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 0.0 112.889 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -76.74 -9.87 58.98 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.253 0.549 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 95.16 23.12 20.79 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.711 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.669 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.8 OUTLIER -74.46 116.93 15.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.543 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 22.0 mtm-85 -74.51 137.74 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.371 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . 0.462 HG22 ' O ' ' 1' ' 69' ' ' ARG . 70.7 p -152.1 91.99 1.67 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.217 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . 0.66 ' HB3' HG23 ' 1' ' 61' ' ' ILE . 93.3 p -88.26 -29.19 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.793 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -35.66 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -77.42 -177.25 4.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.584 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.01 130.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.441 ' HG ' ' HG3' ' 1' ' 62' ' ' GLU . 0.2 OUTLIER -60.48 150.2 31.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.443 0.639 . . . . 0.0 112.21 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -156.6 133.28 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.08 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.791 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -73.48 151.71 40.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.553 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.2 17.26 5.4 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.35 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . 0.404 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -152.57 -109.29 0.4 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 118.68 -1.724 . . . . 0.0 114.439 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.593 ' O ' ' HG2' ' 1' ' 62' ' ' GLU . 0.8 OUTLIER -152.01 160.4 43.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.372 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.776 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.8 OUTLIER -153.52 173.25 15.97 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.056 0.931 . . . . 0.0 110.582 177.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.885 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.04 125.41 39.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.339 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.576 HG13 HG11 ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -74.46 114.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.941 0.4 . . . . 0.0 110.597 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.898 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.9 t-20 -56.79 114.82 8.65 Favored Pre-proline 0 N--CA 1.436 -1.167 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.679 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 84.4 Cg_endo -70.47 -26.95 23.67 Favored 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 123.088 2.526 . . . . 0.0 110.58 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.69 -29.42 61.21 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.039 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.898 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.99 -2.43 55.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.679 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 37.2 t -96.92 130.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.924 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.896 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 112.122 -2.308 . . . . 0.0 107.985 178.781 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.626 ' O ' HG12 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.4 172.7 0.4 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.777 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.61 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -106.55 124.01 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.354 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.573 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -97.05 179.54 33.88 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-O 122.528 1.071 . . . . 0.0 114.735 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . 0.408 HG21 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -62.82 137.91 96.9 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.74 -1.73 . . . . 0.0 111.666 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.647 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 23.3 Cg_endo -81.29 156.88 19.64 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.248 3.299 . . . . 0.0 113.405 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 22.4 mtt -149.75 134.68 17.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.743 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.0 OUTLIER -84.97 123.9 31.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.629 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.69 -51.61 0.04 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.733 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.882 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -65.36 69.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.98 0.39 . . . . 0.0 110.588 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.21 -49.56 0.85 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.258 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.19 -16.09 0.42 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.911 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.705 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.22 -153.63 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.768 0.795 . . . . 0.0 111.86 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.527 ' HB3' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.76 119.38 35.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.698 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.882 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 11.0 m95 -121.17 118.48 29.78 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.72 145.19 30.44 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.676 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.8 tt0 -79.64 102.32 8.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.274 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.768 HG13 ' CE1' ' 1' ' 108' ' ' PHE . 42.2 t -100.25 136.47 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.896 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 t-20 -86.73 101.38 13.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.502 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.768 ' CE1' HG13 ' 1' ' 106' ' ' VAL . 12.4 m-85 -101.44 167.6 10.05 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 123.008 1.385 . . . . 0.0 112.101 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.659 HG21 ' H ' ' 1' ' 110' ' ' THR . 3.4 t -52.17 -66.12 0.44 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 111.871 -2.422 . . . . 0.0 116.67 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.659 ' H ' HG21 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.5 -55.93 3.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.86 -7.41 61.87 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.008 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.87 -89.64 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -86.42 130.86 34.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.313 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.899 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.6 t -145.58 113.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.089 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 44.2 m95 -90.25 156.17 18.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.135 0.969 . . . . 0.0 113.465 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.573 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.57 142.95 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.731 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.736 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -64.91 100.32 0.4 Allowed 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 124.801 2.239 . . . . 0.0 107.282 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.67 ' C ' ' H ' ' 1' ' 120' ' ' SER . 4.7 t -76.32 16.3 0.48 Allowed 'General case' 0 C--N 1.28 -2.453 1 CA-C-N 107.962 -4.199 . . . . 0.0 113.45 -174.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . . . . . . . . . 7.2 t -63.51 23.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.453 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.99 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.64 122.22 0.15 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.679 ' O ' HD21 ' 1' ' 124' ' ' LEU . 1.2 ptpt -71.14 -40.38 71.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.217 1.008 . . . . 0.0 108.401 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.828 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 68.2 m-20 -66.05 -4.66 7.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.99 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.0 -58.67 6.53 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.672 0.749 . . . . 0.0 110.401 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.862 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.15 -56.69 13.03 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 122.01 0.909 . . . . 0.0 109.325 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.605 ' H ' HD13 ' 1' ' 125' ' ' LEU . 6.7 mp -58.36 -46.03 87.07 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.212 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.36 -32.1 6.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.695 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.7 26.27 7.68 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.36 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.828 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.0 mttt . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.88 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.94 132.77 47.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.6 126.29 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.706 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.84 -30.67 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.42 -35.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 103.21 15.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.3 119.52 38.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.635 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.48 77.23 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.277 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.59 18.62 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -64.96 -82.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.487 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.38 129.41 6.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.364 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.09 -29.35 9.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . 0.456 ' H ' ' HD2' ' 1' ' 14' ' ' PRO . 3.0 mp0 -110.45 -62.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . 0.456 ' HD2' ' H ' ' 1' ' 13' ' ' GLU . 74.1 Cg_endo -76.9 93.93 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.237 1.958 . . . . 0.0 112.445 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -172.72 174.99 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -111.41 121.29 40.63 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.41 -178.46 4.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.0 112.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -133.6 53.27 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.843 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 3.7 t -165.55 41.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 72.6 m-20 -82.05 127.73 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 0.6 OUTLIER -63.66 86.12 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 1.1 mmtm -52.38 168.54 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.765 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.603 HD13 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.78 154.11 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.876 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.3 m-85 -107.53 169.5 8.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.682 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 9.7 mttt -116.62 108.84 16.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.745 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.602 ' CG1' ' HA ' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -78.39 81.47 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.067 0.937 . . . . 0.0 109.791 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.839 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.8 m-20 -80.92 -25.94 37.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.91 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 12.6 t0 -175.83 116.69 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.928 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.17 134.8 47.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.08 0.467 . . . . 0.0 110.226 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.928 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -130.44 160.83 32.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.805 -177.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.2 tptp -71.3 102.81 2.67 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.908 HD12 ' NE2' ' 1' ' 37' ' ' GLN . 1.2 mt -124.53 122.89 64.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.22 35.73 18.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.131 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.75 3.64 68.25 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.205 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.96 140.21 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.52 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 92.7 m95 -59.54 129.78 43.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.911 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.77 146.73 42.63 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.432 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.692 ' O ' HG21 ' 1' ' 55' ' ' ILE . 19.0 t -114.36 150.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.885 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.45 140.55 29.03 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.441 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.839 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.02 153.32 49.39 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.914 0.864 . . . . 0.0 108.761 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.556 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -62.14 -16.72 54.66 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.435 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.631 HD13 ' HB2' ' 1' ' 40' ' ' ASN . 3.7 mp -83.15 -50.55 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.758 0.79 . . . . 0.0 110.829 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.602 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.7 -11.0 19.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.376 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.732 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.5 t -146.9 71.33 12.37 Favored Pre-proline 0 CA--C 1.505 -0.786 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.988 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.544 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 73.1 Cg_exo -48.29 -32.93 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.518 2.145 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.544 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 8.0 t 169.09 154.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.662 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.24 56.06 0.16 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.885 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.55 111.77 18.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.701 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.81 91.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.655 0.74 . . . . 0.0 110.524 -178.587 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.857 ' HB3' HG21 ' 1' ' 32' ' ' ILE . 34.8 m0 -44.41 -28.28 0.54 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.742 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.701 ' CG1' HG22 ' 1' ' 49' ' ' THR . 7.8 p -53.27 -56.95 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.54 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.649 ' H ' HG13 ' 1' ' 51' ' ' VAL . 50.0 t0 -153.25 -11.67 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.893 -1.503 . . . . 0.0 113.063 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.006 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.6 m120 -86.43 -12.37 49.26 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.642 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.911 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -82.86 144.03 22.66 Favored Glycine 1 N--CA 1.387 -4.595 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 175.296 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.845 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.15 119.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.788 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.42 87.49 0.63 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.564 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -34.18 -34.49 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.01 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.24 -35.98 63.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.633 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.2 m-20 -67.57 -27.21 66.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.911 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.628 HG11 HD13 ' 1' ' 55' ' ' ILE . 28.7 m -99.51 -172.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.777 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -144.68 112.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.981 -176.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.07 123.72 19.3 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.84 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 0.8 OUTLIER -108.17 155.79 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.628 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.634 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 1.9 p -85.09 160.02 20.06 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 80.3 p -37.87 -34.28 0.11 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.806 0.691 . . . . 0.0 112.738 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.26 -6.99 57.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 111.078 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 93.14 23.23 25.37 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.568 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.77 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -72.1 116.29 12.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.964 0.411 . . . . 0.0 110.668 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.571 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 0.0 OUTLIER -73.48 142.18 46.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 34.9 p 42.7 75.32 0.09 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.085 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -93.45 -49.12 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.34 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' 1' ' 73' ' ' GLN . 7.3 m-20 -99.36 -25.34 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.104 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' 1' ' 72' ' ' ASP . 0.0 OUTLIER 80.85 -25.65 0.17 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.223 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 8.8 p -109.52 115.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.972 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.463 ' CD1' HG21 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -66.9 147.64 52.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.639 0.733 . . . . 0.0 112.424 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -157.48 132.78 8.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.361 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.753 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -72.82 151.35 42.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.94 17.34 5.91 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.528 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . 0.421 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -152.65 -109.16 0.39 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.559 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.519 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 0.2 OUTLIER -151.86 160.47 43.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.904 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.783 ' O ' ' HB2' ' 1' ' 24' ' ' TYR . 0.7 OUTLIER -155.05 172.99 17.21 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.014 0.912 . . . . 0.0 110.563 177.33 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.777 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -138.55 125.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.555 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -72.72 112.74 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.94 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 113.58 5.35 Favored Pre-proline 0 N--CA 1.436 -1.134 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.691 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 86.9 Cg_endo -71.84 -27.69 17.53 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.424 2.749 . . . . 0.0 110.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.64 -28.18 60.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.73 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.94 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.87 -3.34 56.74 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.691 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 27.0 t -98.77 135.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.502 0 CA-C-O 122.945 1.355 . . . . 0.0 111.51 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.88 ' HD2' ' O ' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.61 -48.43 9.52 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.871 -2.422 . . . . 0.0 107.791 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER 172.28 172.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.465 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.472 ' HA ' HG23 ' 1' ' 106' ' ' VAL . 67.8 t -89.94 162.56 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.62 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -130.09 179.68 16.67 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.175 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.35 133.77 90.91 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.984 -1.108 . . . . 0.0 110.75 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.602 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 23.9 Cg_endo -81.35 158.18 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.347 3.364 . . . . 0.0 113.534 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtt -149.7 138.01 20.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.981 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 2.1 mtpt -85.84 125.4 33.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.561 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.96 -53.35 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.791 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.872 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -66.07 69.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.398 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.62 -49.47 0.86 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.208 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.13 -14.43 0.48 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.185 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.691 ' H ' HD13 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -76.92 -153.15 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.83 0.824 . . . . 0.0 112.108 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.585 ' HB3' HG23 ' 1' ' 118' ' ' THR . 1.1 m -116.86 116.74 28.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.988 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.872 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 9.9 m95 -118.63 117.39 28.83 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -105.0 150.18 25.14 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.661 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 23.0 tt0 -82.31 102.18 11.03 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.816 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.816 HG11 ' CE1' ' 1' ' 108' ' ' PHE . 53.2 t -98.84 135.77 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.88 ' O ' ' HD2' ' 1' ' 89' ' ' LYS . 0.2 OUTLIER -89.14 102.69 15.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.384 -177.509 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.816 ' CE1' HG11 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER -102.77 169.14 8.79 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.978 1.37 . . . . 0.0 111.544 178.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.671 HG23 ' H ' ' 1' ' 110' ' ' THR . 2.7 t -51.38 -66.08 0.45 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.196 -2.274 . . . . 0.0 116.913 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.671 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.55 -56.12 3.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.925 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.77 -7.15 61.07 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.593 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.01 -91.67 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.31 131.06 34.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 121.947 -0.737 . . . . 0.0 109.066 176.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.81 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 7.9 t -145.36 113.48 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.006 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -89.42 153.38 20.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.901 0.858 . . . . 0.0 113.101 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.601 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.55 144.92 23.11 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.032 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.74 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.33 100.36 0.47 Allowed 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 124.675 2.179 . . . . 0.0 107.076 178.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.607 ' C ' ' H ' ' 1' ' 120' ' ' SER . 3.1 t -75.89 14.62 0.64 Allowed 'General case' 0 C--N 1.281 -2.396 1 CA-C-N 107.981 -4.19 . . . . 0.0 113.495 -174.546 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . 0.404 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 14.8 t -63.79 22.73 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.047 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.995 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -175.24 123.07 0.22 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.704 ' O ' HD23 ' 1' ' 124' ' ' LEU . 18.5 tttt -72.29 -39.47 68.27 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.926 0.87 . . . . 0.0 108.666 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.871 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 78.1 m-20 -66.61 -5.14 10.46 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.995 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.73 -58.48 7.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.818 0.818 . . . . 0.0 110.27 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.876 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -63.86 -57.02 11.13 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 122.025 0.917 . . . . 0.0 109.515 178.086 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.594 HD12 ' O ' ' 1' ' 121' ' ' LYS . 6.6 mp -59.71 -45.04 93.36 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.739 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -113.58 -31.43 6.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.705 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.42 26.59 8.6 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.273 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.871 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 23.4 mttp . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.81 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.696 0.284 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.01 41.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.643 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.26 58.25 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.225 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -65.35 134.71 54.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.36 . . . . 0.0 111.189 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -108.42 112.37 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -103.17 87.44 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.113 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 101.45 4.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -89.79 102.97 15.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -147.45 -23.81 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.574 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -171.76 -158.29 0.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.05 132.09 10.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.144 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -15.66 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.618 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . 0.542 ' HB3' ' HD2' ' 1' ' 14' ' ' PRO . 23.4 mt-10 -80.43 164.52 51.44 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . 0.542 ' HD2' ' HB3' ' 1' ' 13' ' ' GLU . 11.9 Cg_endo -53.79 -81.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.5 2.133 . . . . 0.0 112.486 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m 53.03 30.65 9.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.77 0.319 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -59.92 126.97 84.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.95 138.99 17.01 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.603 2.202 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -139.8 24.2 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 1.7 t -72.82 112.67 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . 0.409 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 4.1 p30 -177.51 133.93 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 111.359 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.435 HD12 ' HD3' ' 1' ' 85' ' ' PRO . 0.3 OUTLIER -64.97 85.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.412 ' HD2' ' CD2' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER -47.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 111.664 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.535 HG22 ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -72.49 155.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.921 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.6 m-85 -108.48 169.88 8.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.865 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.636 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 15.3 mmmt -116.64 108.52 16.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.133 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.585 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.0 OUTLIER -78.54 82.63 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.976 0.893 . . . . 0.0 109.905 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.833 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.7 m-20 -83.48 -27.38 29.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.275 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -174.64 119.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.849 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.13 138.28 46.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.233 0.54 . . . . 0.0 110.743 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.849 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.28 160.57 32.56 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.399 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.53 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.0 OUTLIER -71.93 103.18 3.11 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.864 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 1.1 mm -123.88 117.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -171.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 61.22 37.58 17.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.101 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.72 1.95 68.36 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.292 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.57 136.36 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.53 ' CD2' ' HD3' ' 1' ' 31' ' ' LYS . 93.1 m95 -59.66 131.56 51.29 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.864 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.97 146.49 42.97 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.899 -179.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 1.0 HG13 ' CZ ' ' 1' ' 81' ' ' PHE . 19.4 t -114.07 150.0 16.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.818 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 6.4 mtp180 -144.11 144.08 31.43 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.042 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.833 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.26 152.94 51.11 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.582 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.28 -17.33 52.98 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.4 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.526 ' H ' HD11 ' 1' ' 42' ' ' ILE . 3.9 mp -84.27 -50.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-O 121.699 0.761 . . . . 0.0 110.673 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.54 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -100.43 -11.8 19.91 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.425 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.761 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.63 71.09 9.74 Favored Pre-proline 0 CA--C 1.505 -0.761 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.197 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.531 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.3 Cg_exo -49.76 -31.84 27.15 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.534 2.156 . . . . 0.0 109.343 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 13.7 t 169.51 155.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.052 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 72.31 56.49 0.15 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.818 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.81 113.81 20.7 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.673 HG22 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.52 91.76 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.726 0.774 . . . . 0.0 109.849 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.852 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 42.5 m0 -47.58 -27.47 1.86 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.798 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.673 ' CG1' HG22 ' 1' ' 49' ' ' THR . 9.8 p -54.03 -56.19 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.657 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.64 ' H ' HG11 ' 1' ' 51' ' ' VAL . 50.5 t0 -151.38 -14.09 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.518 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.084 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 0.8 OUTLIER -86.82 -11.6 50.45 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.377 0.608 . . . . 0.0 110.812 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.746 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.88 140.03 21.22 Favored Glycine 1 N--CA 1.391 -4.302 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.817 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.03 117.81 29.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.379 -178.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -68.97 87.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.579 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.473 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -34.38 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.585 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -37.04 64.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.434 0.635 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.5 ' OD2' ' HA3' ' 1' ' 111' ' ' GLY . 0.5 OUTLIER -68.0 -26.19 65.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.116 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.7 HG12 HD11 ' 1' ' 55' ' ' ILE . 23.5 m -98.26 -171.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.85 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -145.95 107.61 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.183 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.7 pt-20 -65.81 122.93 18.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.291 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.646 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 15.6 m -115.0 160.65 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.433 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.645 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 3.1 p -83.72 164.76 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.5 -35.88 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.46 -5.88 57.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.185 0.516 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.645 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 91.19 23.56 29.2 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.646 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -74.61 118.9 18.09 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.007 0.432 . . . . 0.0 111.138 -178.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.446 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 21.2 mtt180 -69.1 144.87 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.362 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 8.9 t -161.61 57.39 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . 0.579 ' HB3' HG23 ' 1' ' 61' ' ' ILE . 8.3 p -76.87 -6.93 54.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.075 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.64 -6.04 3.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -122.15 -156.97 0.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.621 0.248 . . . . 0.0 111.002 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.5 141.36 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.48 ' O ' ' HG2' ' 1' ' 76' ' ' GLN . 0.1 OUTLIER -66.63 150.81 48.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 111.643 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 6.2 mt-30 -154.55 133.04 11.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.923 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.665 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -77.55 152.25 34.13 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.585 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.61 18.46 4.84 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.54 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . . . . . . . . . . . -151.37 -109.38 0.44 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 118.742 -1.694 . . . . 0.0 114.309 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.5 ' N ' HG22 ' 1' ' 26' ' ' VAL . 0.4 OUTLIER -151.68 160.05 43.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.589 . . . . 0.0 109.642 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 1.0 ' CZ ' HG13 ' 1' ' 38' ' ' VAL . 0.6 OUTLIER -154.72 173.43 16.42 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.95 0.881 . . . . 0.0 110.291 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.85 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -137.58 125.32 31.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.675 HG23 ' CE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -73.39 115.65 14.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.309 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.723 ' HB2' HG12 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -56.29 114.53 7.85 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.714 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 74.1 Cg_endo -65.13 -26.85 57.25 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 C-N-CA 122.933 2.422 . . . . 0.0 109.834 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.35 -27.07 61.3 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 113.419 -1.718 . . . . 0.0 109.92 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.625 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.9 t-20 -82.29 -2.35 52.37 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.805 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 55.6 t -101.85 130.55 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 CA-C-O 123.165 1.46 . . . . 0.0 113.029 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.86 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -90.58 -42.33 10.86 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.445 -2.616 . . . . 0.0 107.876 177.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.558 ' O ' HG12 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 174.66 173.47 0.21 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.383 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.657 ' HA ' HG21 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -103.28 138.35 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.252 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.612 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.46 179.69 20.92 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-O 122.194 0.885 . . . . 0.0 114.067 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.5 137.79 94.82 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.178 -1.511 . . . . 0.0 111.601 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.608 ' HB3' ' CG2' ' 1' ' 118' ' ' THR . 22.1 Cg_endo -81.46 157.56 19.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 124.435 3.424 . . . . 0.0 113.625 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.6 mtm -149.5 137.81 20.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.581 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.9 mtmm -85.18 124.98 32.46 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.657 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.55 -55.88 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.206 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.873 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -63.75 69.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.901 0.351 . . . . 0.0 110.791 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.08 -49.55 0.85 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.258 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.36 -15.17 0.48 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.04 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.707 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.76 -153.21 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.754 0.788 . . . . 0.0 111.928 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.545 ' HB3' HG23 ' 1' ' 118' ' ' THR . 1.1 m -116.74 119.3 35.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.661 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.873 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.64 118.03 28.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -104.91 148.52 26.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.688 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.2 tt0 -81.22 102.94 10.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.742 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.657 HG21 ' HA ' ' 1' ' 91' ' ' VAL . 32.7 t -98.33 138.42 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.86 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER -88.48 102.12 14.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.835 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' 1' ' 83' ' ' ILE . 12.1 m-85 -100.22 157.93 16.23 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-O 122.104 0.954 . . . . 0.0 109.695 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 1.021 HG23 ' N ' ' 1' ' 110' ' ' THR . 0.3 OUTLIER -58.64 -62.55 1.78 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.681 -1.599 . . . . 0.0 114.228 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 1.021 ' N ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.12 10.72 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.911 0.862 . . . . 0.0 109.804 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -73.83 -2.39 61.13 Favored Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.159 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 46.88 -92.52 0.01 OUTLIER Glycine 0 C--O 1.212 -1.226 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.26 130.59 37.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.814 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.7 t -145.36 117.58 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.084 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 42.7 m95 -92.46 156.18 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.342 -0.943 . . . . 0.0 113.023 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.482 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.75 143.03 21.48 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.731 -1.577 . . . . 0.0 108.678 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.737 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -64.87 101.4 0.49 Allowed 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 124.595 2.141 . . . . 0.0 107.052 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.664 ' C ' ' H ' ' 1' ' 120' ' ' SER . 6.6 t -75.64 14.5 0.62 Allowed 'General case' 0 C--N 1.281 -2.374 1 CA-C-N 108.2 -4.091 . . . . 0.0 113.527 -174.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . 0.411 ' CG2' ' OD1' ' 1' ' 117' ' ' ASN . 12.6 t -62.37 21.51 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.715 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.956 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.6 OUTLIER -175.33 126.37 0.25 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.643 ' O ' HD22 ' 1' ' 124' ' ' LEU . 0.3 OUTLIER -74.51 -41.35 60.8 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 122.126 0.965 . . . . 0.0 108.893 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.863 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 1.3 m-20 -66.25 -4.41 7.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.956 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.23 -58.81 6.37 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.417 0.627 . . . . 0.0 110.453 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.921 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.89 -55.08 21.53 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.789 0.805 . . . . 0.0 109.601 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.585 ' H ' HD11 ' 1' ' 125' ' ' LEU . 6.6 mp -60.33 -43.73 96.14 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.037 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.595 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 2.1 m-85 -114.49 -32.14 6.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.688 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.92 26.04 7.7 Favored Glycine 0 CA--C 1.505 -0.575 0 C-N-CA 119.427 -1.368 . . . . 0.0 111.718 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.863 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 26.3 mttp . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.952 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 8.9 mtp180 -75.39 162.15 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.91 7.03 36.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.747 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -69.4 135.29 50.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -116.77 -31.86 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . 0.438 ' CD2' ' O ' ' 1' ' 6' ' ' HIS . 0.4 OUTLIER -83.43 100.9 11.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -133.0 129.48 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.01 72.83 7.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -122.24 177.07 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.438 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.35 176.46 7.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.23 21.84 43.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.623 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -93.51 18.69 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.712 0.291 . . . . 0.0 111.111 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.51 58.6 17.44 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.79 140.73 51.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.686 2.257 . . . . 0.0 112.369 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.17 45.35 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.802 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . 0.425 ' CG2' ' HD2' ' 1' ' 17' ' ' PRO . 0.2 OUTLIER -97.47 142.12 24.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . 0.425 ' HD2' ' CG2' ' 1' ' 16' ' ' THR . 40.2 Cg_endo -66.69 135.02 37.12 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.398 2.065 . . . . 0.0 112.297 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 17.4 m -127.2 53.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 16.3 p -115.43 41.84 2.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . 0.45 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 3.0 m120 -72.12 129.63 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.32 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 0.5 OUTLIER -63.51 87.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.952 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -50.62 166.93 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.199 0.523 . . . . 0.0 111.522 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -72.5 152.2 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.92 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -105.85 170.94 7.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.406 -1.725 . . . . 0.0 106.555 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.675 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 70.7 mttt -117.41 109.5 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.98 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.663 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.0 OUTLIER -80.19 81.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.138 0.971 . . . . 0.0 109.708 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.844 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.3 m-20 -79.04 -26.74 43.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.745 -2.025 . . . . 0.0 111.618 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 11.6 t0 -176.54 118.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.902 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.62 137.4 45.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.185 177.698 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.74 160.84 32.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.716 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.482 ' HG2' ' CE2' ' 1' ' 36' ' ' TRP . 0.1 OUTLIER -70.62 103.25 2.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 175.262 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.864 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.1 mt -124.66 123.27 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 59.41 37.67 23.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.485 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.2 3.68 70.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.267 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -138.53 138.69 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.513 ' HB3' HD13 ' 1' ' 29' ' ' LEU . 82.0 m95 -59.77 130.1 45.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.909 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.91 144.93 43.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.393 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.715 ' O ' HG23 ' 1' ' 55' ' ' ILE . 21.8 t -112.8 150.97 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.798 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 75.8 mtm180 -144.65 135.44 24.81 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.513 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.844 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -124.76 153.03 43.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.083 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.91 -17.75 57.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.057 -1.428 . . . . 0.0 112.451 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.705 HD11 ' HB2' ' 1' ' 40' ' ' ASN . 3.3 mp -81.97 -50.62 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.842 0.83 . . . . 0.0 110.968 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.61 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.12 -12.23 18.96 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.593 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.718 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.4 t -148.42 70.84 10.78 Favored Pre-proline 0 CA--C 1.503 -0.851 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.998 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.516 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.6 Cg_exo -49.32 -31.89 24.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.516 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 14.0 t 170.24 154.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.994 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 72.29 56.68 0.15 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.798 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -85.07 112.77 20.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.681 HG23 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.26 91.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.705 0.764 . . . . 0.0 110.301 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.864 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 37.2 m0 -45.37 -28.8 0.92 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.647 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.681 ' CG1' HG23 ' 1' ' 49' ' ' THR . 7.5 p -54.28 -57.09 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.797 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.637 ' H ' HG13 ' 1' ' 51' ' ' VAL . 51.0 t0 -150.94 -13.28 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.609 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.018 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -87.58 -14.33 40.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.76 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.909 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.62 145.27 27.47 Favored Glycine 1 N--CA 1.386 -4.638 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 175.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.936 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.16 118.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.757 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.35 87.58 0.62 Allowed 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.619 ' O ' HG23 ' 1' ' 60' ' ' VAL . . . -36.27 -34.77 0.06 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.694 -176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -54.67 -33.59 60.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.649 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.3 m-20 -68.62 -29.63 68.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.551 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.619 HG23 ' O ' ' 1' ' 57' ' ' ALA . 29.0 m -100.04 -175.03 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.13 0.491 . . . . 0.0 112.172 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.827 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -141.74 110.08 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.043 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.2 OUTLIER -64.98 122.98 18.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.632 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.791 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 7.2 m -104.95 159.45 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.951 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.646 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 2.5 p -84.08 161.55 20.63 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -37.85 -33.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.845 0.716 . . . . 0.0 112.749 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -79.8 -7.56 58.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 92.63 23.35 26.3 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.607 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.791 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -73.68 116.69 14.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.921 0.391 . . . . 0.0 110.788 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.553 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 6.7 mtm105 -73.23 140.01 46.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.082 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . 0.444 HG23 ' O ' ' 1' ' 69' ' ' ARG . 9.5 t 39.71 78.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.275 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . 0.423 ' HB2' HG23 ' 1' ' 68' ' ' THR . 13.7 t -92.18 -47.68 7.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.693 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 29.8 p30 -96.24 -13.94 23.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.679 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 71.66 9.77 6.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.627 0.251 . . . . 0.0 111.148 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 11.6 p -149.21 109.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.783 0.325 . . . . 0.0 110.724 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.531 ' HG ' ' HB3' ' 1' ' 62' ' ' GLU . 0.2 OUTLIER -58.82 144.06 45.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.55 0.691 . . . . 0.0 112.354 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.515 ' HG2' ' C ' ' 1' ' 75' ' ' LEU . 0.6 OUTLIER -151.95 133.16 14.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.843 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.883 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -79.15 151.65 31.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.663 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.15 18.86 4.91 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.072 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . . . . . . . . . . . -153.75 -106.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 118.881 -1.628 . . . . 0.0 114.244 -179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.674 ' HB2' HG12 ' 1' ' 23' ' ' ILE . 0.1 OUTLIER -151.87 160.64 43.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.177 -0.511 . . . . 0.0 110.134 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.746 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.7 OUTLIER -154.36 173.07 16.7 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 122.139 0.971 . . . . 0.0 111.204 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.827 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.0 OUTLIER -136.68 125.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.568 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -74.45 112.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.896 0.379 . . . . 0.0 110.457 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.861 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 114.65 6.96 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.7 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 89.5 Cg_endo -69.76 -28.12 25.63 Favored 'Trans proline' 0 CA--C 1.5 -1.197 0 C-N-CA 123.05 2.5 . . . . 0.0 110.882 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -28.53 61.44 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.012 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.861 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.55 -3.26 55.7 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.7 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 38.4 t -96.51 132.75 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-O 123.08 1.419 . . . . 0.0 112.246 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.862 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -86.08 -43.74 12.84 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 108.167 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.461 ' O ' HG12 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.55 173.36 0.29 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.953 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.651 ' HA ' HG21 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.31 117.33 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.555 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.35 179.63 45.01 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 122.408 1.004 . . . . 0.0 114.711 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.63 142.38 98.47 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 112.711 -1.745 . . . . 0.0 111.26 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.626 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 26.0 Cg_endo -81.34 157.99 19.74 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.482 3.455 . . . . 0.0 113.762 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 11.4 mtt -149.57 135.2 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.7 mttm -85.39 126.51 33.83 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.414 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.25 -52.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.794 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.871 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -64.91 69.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.637 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.07 -49.39 0.86 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.193 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.07 -16.05 0.43 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.05 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.708 ' H ' HD11 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.13 -152.89 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.807 0.813 . . . . 0.0 112.136 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.519 ' HB3' HG23 ' 1' ' 118' ' ' THR . 1.3 m -116.74 118.6 32.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.737 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.871 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.84 117.52 26.72 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.626 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.25 147.38 27.12 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.687 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.3 tt0 -80.9 102.76 10.28 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.851 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.839 HG13 ' CE1' ' 1' ' 108' ' ' PHE . 41.8 t -101.62 136.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.862 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.3 m120 -90.31 101.64 14.37 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.367 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.839 ' CE1' HG13 ' 1' ' 106' ' ' VAL . 1.8 m-85 -98.89 168.36 10.16 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 123.034 1.397 . . . . 0.0 111.877 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.662 HG22 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.2 -65.32 0.58 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 111.972 -2.376 . . . . 0.0 116.569 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.662 ' H ' HG22 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.16 -55.91 3.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.82 -6.02 66.2 Favored Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.995 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.11 -91.37 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.79 129.19 34.9 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.936 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.5 t -145.4 119.0 2.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.018 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 45.4 m95 -93.55 156.07 16.94 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.006 0.907 . . . . 0.0 113.17 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.489 HD22 ' OD1' ' 1' ' 123' ' ' ASN . 0.1 OUTLIER -153.43 143.2 21.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.1 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.732 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.07 100.01 0.4 Allowed 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 124.965 2.317 . . . . 0.0 107.182 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.643 ' C ' ' H ' ' 1' ' 120' ' ' SER . 5.1 t -77.12 14.69 0.84 Allowed 'General case' 0 C--N 1.281 -2.387 1 CA-C-N 107.622 -4.354 . . . . 0.0 113.975 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . 0.474 ' OG1' ' OD1' ' 1' ' 117' ' ' ASN . 0.9 OUTLIER -63.2 22.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.991 178.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.993 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 3.6 m -175.19 121.28 0.21 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.689 ' O ' HD21 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -69.57 -40.34 76.81 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.944 0.878 . . . . 0.0 109.125 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.839 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 98.5 m-20 -65.2 -4.69 5.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.993 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.98 -58.59 6.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.703 0.763 . . . . 0.0 110.483 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.92 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -64.5 -56.81 11.66 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.02 0.914 . . . . 0.0 109.534 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.574 ' H ' HD13 ' 1' ' 125' ' ' LEU . 6.6 mp -59.86 -44.62 94.03 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.696 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.613 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.52 -31.51 6.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.687 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.64 26.42 7.63 Favored Glycine 0 CA--C 1.504 -0.642 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.728 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.839 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 70.8 mttt . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.957 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 60.6 mtp . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.02 165.23 7.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.73 130.16 9.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.414 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.58 27.42 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 0.0 111.129 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.62 -55.69 3.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -137.56 120.25 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.206 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -100.22 135.58 41.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.484 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.16 84.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.277 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -142.91 -67.79 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.18 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.5 -14.83 59.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.465 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 44.9 3.35 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.148 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 10.5 p -113.7 -2.43 13.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 111.099 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -110.45 82.85 2.95 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.77 165.45 32.19 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.7 2.266 . . . . 0.0 112.404 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -96.83 -7.14 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.388 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -108.32 106.88 59.51 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.681 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.85 119.3 3.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.526 2.151 . . . . 0.0 112.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -146.84 30.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.829 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 8.3 t -178.28 99.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.045 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 20' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' 1' ' 21' ' ' LEU . 1.3 t-20 -166.94 127.47 1.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.438 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 21' ' ' LEU . . . . . 0.566 HD11 ' HG3' ' 1' ' 85' ' ' PRO . 1.8 mt 6.69 96.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 22' ' ' LYS . . . . . 0.479 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 0.5 OUTLIER -60.75 168.72 2.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.195 0.522 . . . . 0.0 111.068 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 23' ' ' ILE . . . . . 0.58 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -73.26 154.3 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 24' ' ' TYR . . . . . 0.909 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.0 m-85 -105.96 169.54 8.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 25' ' ' LYS . . . . . 0.667 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.2 OUTLIER -116.85 108.69 16.15 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.1 177.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 26' ' ' VAL . . . . . 0.589 ' HB ' ' H ' ' 1' ' 78' ' ' GLY . 0.0 OUTLIER -78.42 82.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.888 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 27' ' ' ASP . . . . . 0.849 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.9 m-20 -81.03 -27.34 35.83 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 112.82 -1.991 . . . . 0.0 111.81 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 28' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 2.5 t70 -175.84 118.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.227 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 29' ' ' LEU . . . . . 0.863 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -131.97 136.39 47.28 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.271 0.558 . . . . 0.0 110.344 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 30' ' ' GLN . . . . . 0.863 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.82 160.5 33.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.701 -178.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 31' ' ' LYS . . . . . 0.47 ' HG2' ' CZ2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.33 103.6 2.91 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.604 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 32' ' ' ILE . . . . . 0.88 HD12 ' NE2' ' 1' ' 37' ' ' GLN . 1.1 mt -123.94 118.93 55.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -171.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 61.08 39.27 16.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.534 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.15 4.85 69.41 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.6 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 35' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -137.9 136.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 36' ' ' TRP . . . . . 0.483 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 78.4 m95 -59.81 130.2 45.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 37' ' ' GLN . . . . . 0.899 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.8 146.71 42.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.411 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 38' ' ' VAL . . . . . 0.71 ' O ' HG23 ' 1' ' 55' ' ' ILE . 21.5 t -114.18 150.97 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 39' ' ' ARG . . . . . 0.892 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 7.6 mtp180 -144.45 138.52 27.72 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.368 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 40' ' ' ASN . . . . . 0.849 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -128.56 153.04 47.62 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 121.989 0.9 . . . . 0.0 108.689 175.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 41' ' ' ASN . . . . . 0.597 HD21 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -61.01 -18.46 57.81 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.47 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 42' ' ' ILE . . . . . 0.621 HD12 ' HB2' ' 1' ' 40' ' ' ASN . 3.6 mp -82.25 -50.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.729 0.776 . . . . 0.0 110.853 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.597 ' C ' HG22 ' 1' ' 44' ' ' VAL . 0.4 OUTLIER -100.56 -11.92 19.69 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.529 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 44' ' ' VAL . . . . . 0.738 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.2 t -148.43 71.6 10.83 Favored Pre-proline 0 CA--C 1.504 -0.798 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.086 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 45' ' ' PRO . . . . . 0.525 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.2 Cg_exo -49.47 -31.68 24.58 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.503 2.135 . . . . 0.0 109.113 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 46' ' ' THR . . . . . 0.525 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 14.2 t 169.87 152.79 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.005 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.7 56.91 0.13 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 48' ' ' PHE . . . . . 0.892 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.16 112.75 20.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 49' ' ' THR . . . . . 0.674 HG21 ' CG1' ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.83 91.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.442 -178.479 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 50' ' ' TRP . . . . . 0.845 ' CG ' HD11 ' 1' ' 32' ' ' ILE . 33.2 m0 -45.51 -27.97 0.84 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.555 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.674 ' CG1' HG21 ' 1' ' 49' ' ' THR . 8.9 p -53.73 -57.15 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.674 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 52' ' ' ASP . . . . . 0.646 ' H ' HG11 ' 1' ' 51' ' ' VAL . 51.9 t0 -152.29 -12.61 0.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.349 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 53' ' ' ASN . . . . . 1.064 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -86.75 -13.74 44.38 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.624 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 54' ' ' GLY . . . . . 0.899 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.89 144.5 27.64 Favored Glycine 1 N--CA 1.386 -4.635 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 175.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 55' ' ' ILE . . . . . 0.831 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.41 118.76 31.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.557 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 56' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.14 87.64 0.59 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 57' ' ' ALA . . . . . 0.549 ' O ' HG21 ' 1' ' 60' ' ' VAL . . . -35.1 -35.6 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.3 -1.318 . . . . 0.0 113.895 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -54.07 -34.43 60.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.349 0.595 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 59' ' ' ASP . . . . . 0.556 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.1 m-20 -68.55 -27.54 66.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.848 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 60' ' ' VAL . . . . . 0.633 HG11 HD13 ' 1' ' 55' ' ' ILE . 30.1 m -99.75 -173.36 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 61' ' ' ILE . . . . . 0.777 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -143.48 110.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.01 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 62' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.51 124.64 21.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.987 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 63' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' 1' ' 68' ' ' THR . 2.5 m -109.47 160.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.026 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 64' ' ' THR . . . . . 0.637 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 2.6 p -84.8 159.84 20.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 73.7 p -37.56 -33.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.929 0.768 . . . . 0.0 112.859 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -79.34 -8.37 59.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.267 0.556 . . . . 0.0 111.259 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 67' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.15 22.84 23.99 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.428 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 68' ' ' THR . . . . . 0.656 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -75.12 117.27 16.77 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.067 0.461 . . . . 0.0 111.287 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 69' ' ' ARG . . . . . 0.516 ' HA ' ' CG1' ' 1' ' 63' ' ' VAL . 7.8 mtp180 -71.46 141.0 50.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.93 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 70' ' ' THR . . . . . 0.466 HG21 ' O ' ' 1' ' 69' ' ' ARG . 21.2 p -154.22 93.83 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.575 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.28 -29.15 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.44 -27.54 56.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.187 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -86.15 -177.52 6.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.38 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -108.93 139.92 29.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 75' ' ' LEU . . . . . 0.537 ' O ' ' HG3' ' 1' ' 76' ' ' GLN . 0.2 OUTLIER -66.73 145.12 55.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.329 0.585 . . . . 0.0 111.724 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' 1' ' 75' ' ' LEU . 4.0 mt-30 -152.84 132.93 13.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.814 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 77' ' ' LYS . . . . . 0.78 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.85 151.73 37.38 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 78' ' ' GLY . . . . . 0.589 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.03 17.31 5.46 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.357 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 79' ' ' GLY . . . . . 0.41 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . -153.25 -108.02 0.33 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.54 -1.79 . . . . 0.0 114.6 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 80' ' ' TYR . . . . . 0.556 ' HB3' ' O ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -151.92 160.36 43.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.144 -0.528 . . . . 0.0 109.89 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.755 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.19 172.83 16.97 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 121.916 0.865 . . . . 0.0 110.467 177.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 82' ' ' VAL . . . . . 0.777 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -137.27 124.8 31.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 83' ' ' ILE . . . . . 0.565 HG13 ' CG1' ' 1' ' 60' ' ' VAL . 0.3 OUTLIER -73.41 112.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 84' ' ' ASN . . . . . 0.896 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -52.6 114.52 5.79 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.701 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.0 Cg_endo -71.24 -27.56 19.63 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 123.164 2.576 . . . . 0.0 110.845 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -74.89 -27.92 60.43 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.842 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 87' ' ' ASN . . . . . 0.896 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.47 -4.08 56.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 88' ' ' VAL . . . . . 0.701 ' HB ' ' O ' ' 1' ' 85' ' ' PRO . 37.8 t -96.63 131.71 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-O 122.991 1.377 . . . . 0.0 111.84 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.817 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.43 -46.94 12.84 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 111.718 -2.492 . . . . 0.0 107.693 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 90' ' ' SER . . . . . 0.557 ' O ' HG11 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 173.76 172.88 0.17 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.787 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 91' ' ' VAL . . . . . 0.615 ' HA ' HG21 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.69 138.81 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 92' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.99 179.83 20.66 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 122.104 0.836 . . . . 0.0 114.021 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.6 136.18 92.38 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.286 -1.457 . . . . 0.0 111.684 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 94' ' ' PRO . . . . . 0.623 ' HA ' ' HA ' ' 1' ' 104' ' ' ALA . 21.7 Cg_endo -81.21 157.16 19.92 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.42 3.413 . . . . 0.0 113.563 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 95' ' ' MET . . . . . 0.493 ' HG3' ' CH2' ' 1' ' 115' ' ' TRP . 0.3 OUTLIER -148.8 137.03 20.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.427 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 96' ' ' LYS . . . . . 0.57 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -86.3 126.87 34.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.546 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 97' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.29 -53.66 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.51 -1.328 . . . . 0.0 113.803 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 98' ' ' SER . . . . . 0.876 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -64.96 69.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.655 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 99' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.0 -49.4 0.86 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.213 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.55 -15.67 0.47 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.008 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 101' ' ' LEU . . . . . 0.701 ' H ' HD13 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.43 -153.68 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.797 0.808 . . . . 0.0 111.955 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 102' ' ' SER . . . . . 0.541 ' HB3' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.79 118.26 32.03 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.811 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 103' ' ' TRP . . . . . 0.876 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.2 m95 -120.11 117.2 27.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 104' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.73 148.19 26.36 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -175.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 105' ' ' GLN . . . . . 0.681 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 28.4 tt0 -82.21 102.31 11.05 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.395 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 106' ' ' VAL . . . . . 0.655 HG12 ' CE1' ' 1' ' 108' ' ' PHE . 42.6 t -101.03 137.93 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 107' ' ' ASN . . . . . 0.817 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.0 OUTLIER -89.95 101.72 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.309 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 108' ' ' PHE . . . . . 0.71 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.7 m-85 -99.52 168.58 9.88 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.046 1.403 . . . . 0.0 111.79 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 109' ' ' THR . . . . . 0.658 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -52.29 -65.6 0.53 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.057 -2.338 . . . . 0.0 116.637 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 110' ' ' THR . . . . . 0.658 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.35 -56.06 3.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 111' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -71.77 -7.37 65.41 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.938 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 112' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.99 -90.6 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 113' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -84.7 130.5 34.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 114' ' ' VAL . . . . . 0.806 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.3 t -145.33 116.28 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 115' ' ' TRP . . . . . 1.064 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 50.0 m95 -92.08 154.14 18.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.853 0.835 . . . . 0.0 112.777 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 116' ' ' LEU . . . . . 0.534 HD21 ' OD1' ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.58 143.5 22.01 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.045 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 117' ' ' ASN . . . . . 0.732 ' HA ' ' HA ' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -64.9 100.39 0.41 Allowed 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 124.856 2.265 . . . . 0.0 107.103 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 118' ' ' THR . . . . . 0.61 ' C ' ' H ' ' 1' ' 120' ' ' SER . 3.4 t -75.82 15.02 0.57 Allowed 'General case' 0 C--N 1.279 -2.467 1 CA-C-N 107.858 -4.246 . . . . 0.0 113.348 -174.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 119' ' ' THR . . . . . 0.403 HG23 ' OD1' ' 1' ' 117' ' ' ASN . 13.0 t -64.58 24.0 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.916 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 120' ' ' SER . . . . . 0.96 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -175.27 126.08 0.25 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 121' ' ' LYS . . . . . 0.672 ' O ' HD22 ' 1' ' 124' ' ' LEU . 3.2 tttt -74.38 -40.78 61.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 122' ' ' ASP . . . . . 0.839 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 77.7 m-20 -65.83 -4.61 7.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 123' ' ' ASN . . . . . 0.96 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.7 OUTLIER -62.9 -58.57 6.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.674 0.749 . . . . 0.0 110.457 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 124' ' ' LEU . . . . . 0.909 ' HA ' ' OH ' ' 1' ' 24' ' ' TYR . 0.0 OUTLIER -65.09 -55.62 17.73 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.131 0.967 . . . . 0.0 109.418 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 125' ' ' LEU . . . . . 0.583 HD12 ' O ' ' 1' ' 121' ' ' LYS . 6.7 mp -59.57 -45.15 92.7 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.261 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 126' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -115.05 -31.51 6.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 127' ' ' GLY . . . . . 0.691 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 102.45 26.77 7.12 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 119.233 -1.461 . . . . 0.0 111.829 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 128' ' ' LYS . . . . . 0.839 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 39.8 mttt . . . . . 0 N--CA 1.433 -1.285 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.814 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.55 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.5 154.53 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.867 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.6 m-85 -108.42 169.34 8.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.648 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.6 OUTLIER -116.93 110.75 18.7 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.823 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -80.55 81.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.977 0.894 . . . . 0.0 110.018 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 2.6 m-20 -82.48 -25.91 33.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 112.935 -1.939 . . . . 0.0 111.955 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.1 t70 -174.18 114.63 0.19 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.273 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.852 HD11 ' HB3' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -130.77 136.0 48.31 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.006 177.949 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.805 ' O ' HG13 ' 1' ' 32' ' ' ILE . 0.8 OUTLIER -128.9 160.82 31.44 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.919 -177.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.538 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -72.01 103.35 3.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 1.025 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -123.8 119.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.839 -171.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . 0.408 ' O ' HG13 ' 1' ' 35' ' ' ILE . 43.6 m-20 61.66 36.65 16.47 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.355 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.56 2.93 65.17 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.307 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.852 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 94.2 m95 -60.24 131.04 49.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.975 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.62 146.69 42.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.721 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.835 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 21.1 t -115.14 151.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.931 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 30.5 mtp180 -144.3 142.94 30.75 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.126 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.808 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.86 150.07 52.26 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.056 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.438 ' OD1' HD12 ' 1' ' 42' ' ' ILE . 4.3 p30 -59.69 -18.18 40.29 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.595 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.589 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -83.23 -50.5 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.64 0.733 . . . . 0.0 110.906 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.02 -11.21 20.78 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.249 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.771 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.3 t -148.84 71.33 10.41 Favored Pre-proline 0 CA--C 1.505 -0.781 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.996 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.593 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 76.3 Cg_exo -48.96 -32.32 22.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.573 2.182 . . . . 0.0 109.231 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.889 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 11.1 t 169.47 155.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.978 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . 0.889 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.33 56.96 0.15 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 177.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.931 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -84.19 111.45 19.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.747 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.75 91.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.54 0.686 . . . . 0.0 110.583 -178.502 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 1.025 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.1 m0 -44.31 -28.58 0.55 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.506 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.747 HG12 HG22 ' 1' ' 49' ' ' THR . 5.9 p -52.96 -56.2 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.682 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.2 t0 -153.68 -13.05 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.259 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.012 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -86.31 -13.01 47.85 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.461 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.975 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.53 142.29 22.7 Favored Glycine 1 N--CA 1.388 -4.525 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 175.442 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 0.94 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.42 119.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.729 -178.815 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.67 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.53 87.72 0.66 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.744 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.3 -35.16 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.767 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -54.46 -35.74 63.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.252 0.549 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.67 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 1.0 OUTLIER -66.19 -29.08 69.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.685 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 0.849 HG13 HD11 ' 1' ' 55' ' ' ILE . 26.5 m -100.17 -173.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.267 0.556 . . . . 0.0 112.407 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.835 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -142.66 112.34 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.817 -177.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -62.8 121.33 13.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.015 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.726 HG21 HG23 ' 1' ' 82' ' ' VAL . 1.8 m -105.22 153.71 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.896 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.55 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.6 p -83.97 161.3 20.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.468 0.452 0 O-C-N 123.882 0.739 . . . . 0.0 112.593 -178.528 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -74.83 151.54 39.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.552 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 114.42 18.33 6.69 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.189 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.74 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.71 -109.54 0.43 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.766 -1.683 . . . . 0.0 114.675 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.823 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.1 OUTLIER -151.94 160.37 43.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.912 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.835 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.9 OUTLIER -154.98 173.25 16.83 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 122.013 0.911 . . . . 0.0 111.121 177.483 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.835 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.09 125.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.682 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.622 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.62 111.65 10.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.302 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.902 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.03 115.05 7.42 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.892 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.683 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 95.0 Cg_endo -68.94 -28.21 29.58 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.133 2.555 . . . . 0.0 110.925 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -28.85 61.78 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.065 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.902 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.43 -3.56 55.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.788 HG23 ' O ' ' 1' ' 84' ' ' ASN . 39.2 t -96.53 132.77 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.362 0 CA-C-O 123.085 1.421 . . . . 0.0 112.134 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.97 -44.78 12.79 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 111.615 -2.539 . . . . 0.0 107.979 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.52 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.09 173.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.599 -1.637 . . . . 0.0 112.766 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.911 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -107.09 117.06 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.73 179.64 44.47 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-O 122.518 1.065 . . . . 0.0 115.028 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . 0.524 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.97 138.96 95.8 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.609 -1.796 . . . . 0.0 111.934 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.045 ' HB3' HG21 ' 1' ' 118' ' ' THR . 25.1 Cg_endo -81.18 158.3 20.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.477 3.451 . . . . 0.0 113.925 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.2 mtt -149.22 135.84 19.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 15.0 mttt -86.36 123.68 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.346 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.41 -52.64 0.04 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.915 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.9 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.99 69.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.009 0.405 . . . . 0.0 110.585 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.27 -49.58 0.85 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.149 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.02 -16.15 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.999 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.842 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.08 -153.53 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.769 0.795 . . . . 0.0 112.038 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.547 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.59 118.28 32.19 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.737 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.9 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.7 m95 -120.77 117.22 26.88 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.66 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.33 147.4 27.13 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.707 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 26.8 tt0 -80.86 102.62 10.16 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.611 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.911 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 43.8 t -100.92 135.79 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.878 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 m120 -89.85 101.94 14.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.389 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.746 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.9 m-85 -99.23 168.21 10.18 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-O 122.92 1.343 . . . . 0.0 111.927 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.929 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.13 -65.48 0.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.624 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.929 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.31 -56.01 3.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.768 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.32 -7.4 67.79 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.974 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.45 -91.63 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.67 130.11 34.75 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.009 -0.701 . . . . 0.0 109.298 176.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.94 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.5 t -145.63 117.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.012 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.4 m95 -92.96 155.36 17.61 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.887 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.556 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.36 144.43 22.94 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.975 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.792 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.3 OUTLIER -65.14 101.92 0.58 Allowed 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 124.64 2.162 . . . . 0.0 107.362 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.045 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.2 t -78.03 15.76 0.85 Allowed 'General case' 0 C--N 1.277 -2.56 1 CA-C-N 108.246 -4.07 . . . . 0.0 113.245 -174.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.792 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 6.8 t -63.34 21.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.845 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 0.999 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.5 m -175.13 125.26 0.25 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.559 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 4.9 ttmt -74.09 -40.63 62.6 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.991 0.901 . . . . 0.0 108.745 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.818 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 85.8 m-20 -65.69 -4.64 6.68 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 0.999 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.52 -58.73 6.53 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.77 0.795 . . . . 0.0 110.509 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.026 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.94 -55.62 18.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 122.021 0.915 . . . . 0.0 109.452 178.35 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.6 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.24 -45.81 90.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.147 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.3 m-85 -113.97 -31.74 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.739 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.0 26.21 8.02 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.389 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.818 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 80.0 mttt . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.005 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttm . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.598 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.17 156.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.803 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 5.4 m-85 -109.76 169.71 8.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.395 -1.729 . . . . 0.0 106.798 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.674 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 5.0 mmtt -116.4 108.99 16.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.089 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.854 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -80.0 80.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.138 0.97 . . . . 0.0 109.634 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 5.5 m-20 -80.45 -26.9 38.07 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.645 -2.071 . . . . 0.0 111.966 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . 0.519 ' OD1' ' NE2' ' 1' ' 30' ' ' GLN . 5.3 t0 -175.04 114.98 0.15 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -131.09 138.48 49.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.214 177.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.852 ' O ' HG13 ' 1' ' 32' ' ' ILE . 1.9 mp0 -132.92 161.63 33.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.212 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.0 103.01 2.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 174.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 0.989 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -124.2 120.84 60.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.72 35.24 19.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.71 4.6 76.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.76 136.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.663 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 97.1 m95 -60.22 128.41 36.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.955 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.85 143.87 45.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.423 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.791 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 22.8 t -112.38 151.25 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.91 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 28.7 mtp180 -144.19 143.98 31.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.047 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.777 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.77 152.56 51.74 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.067 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.587 ' ND2' ' OD1' ' 1' ' 27' ' ' ASP . 0.7 OUTLIER -62.21 -15.4 46.43 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.374 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.643 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.9 mp -85.43 -50.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.498 0.666 . . . . 0.0 110.673 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.693 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -99.71 -11.43 20.88 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.212 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.751 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.2 t -147.86 71.0 11.38 Favored Pre-proline 0 CA--C 1.505 -0.787 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.228 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.559 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.3 Cg_exo -49.5 -32.22 26.47 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.574 2.182 . . . . 0.0 109.078 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.608 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 13.3 t 170.1 154.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.045 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . 0.608 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.5 OUTLIER 72.47 56.35 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.332 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.91 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.1 112.03 19.44 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.774 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.812 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.95 92.31 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.643 0.735 . . . . 0.0 110.532 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 0.989 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 30.5 m0 -45.22 -28.6 0.81 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.594 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.812 HG12 HG22 ' 1' ' 49' ' ' THR . 9.9 p -54.06 -57.48 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.713 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.722 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.9 t0 -152.72 -11.91 0.17 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.631 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.062 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.9 m120 -87.4 -14.36 40.81 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.876 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.955 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.11 145.97 27.47 Favored Glycine 1 N--CA 1.388 -4.56 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 175.123 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 0.904 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.16 120.19 33.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.949 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.638 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.62 88.14 0.69 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.791 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.65 -34.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.005 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.66 -36.57 64.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.357 0.598 . . . . 0.0 110.572 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.638 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 1.4 m-20 -65.57 -29.07 69.63 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.552 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 0.904 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.9 m -99.37 -176.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.412 0.625 . . . . 0.0 112.626 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.826 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -140.27 107.82 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.668 -178.039 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.92 125.25 24.82 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.195 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.581 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 6.9 m -112.02 161.19 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.345 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.598 ' O ' HD11 ' 1' ' 23' ' ' ILE . 3.3 p -83.76 162.79 20.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.48 0 O-C-N 123.953 0.783 . . . . 0.0 112.988 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.098 0.475 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.913 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -80.02 152.27 29.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.631 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.16 19.99 4.55 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.754 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.751 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.39 -108.32 0.39 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.155 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.854 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -152.06 160.83 43.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.798 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.5 OUTLIER -153.67 172.67 16.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.145 0.974 . . . . 0.0 110.807 177.168 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.826 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.76 124.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.73 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.739 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.35 114.13 13.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.468 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.955 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -55.33 114.93 8.03 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.564 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.674 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.6 Cg_endo -72.3 -27.24 16.6 Favored 'Trans proline' 0 CA--C 1.502 -1.088 0 C-N-CA 123.059 2.506 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -27.45 60.31 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.069 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.955 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -83.43 -3.51 57.63 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.781 HG23 ' O ' ' 1' ' 84' ' ' ASN . 25.1 t -96.54 133.17 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.484 0 CA-C-O 123.002 1.382 . . . . 0.0 111.821 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.84 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.91 -48.69 10.44 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.333 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.5 OUTLIER 172.3 172.68 0.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.518 179.672 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.76 HG13 HG22 ' 1' ' 106' ' ' VAL . 89.5 t -92.15 165.87 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -137.05 179.66 17.77 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.244 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.18 133.71 87.81 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 113.991 -1.105 . . . . 0.0 111.184 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.066 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.1 Cg_endo -80.88 158.55 21.13 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.284 3.322 . . . . 0.0 113.557 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 25.9 mtt -149.3 134.67 18.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.9 pttt -85.12 124.12 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.508 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.11 -53.11 0.05 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.881 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.78 69.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.862 0.331 . . . . 0.0 110.683 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.53 -49.4 0.87 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.105 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.23 -14.25 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.036 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.811 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -77.86 -153.32 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.688 0.756 . . . . 0.0 111.777 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.515 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.2 m -116.9 118.82 33.5 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.911 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.881 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.1 m95 -119.57 117.39 28.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.669 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -103.41 149.75 24.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.669 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.9 tt0 -82.96 102.76 11.92 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.163 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.76 HG22 HG13 ' 1' ' 91' ' ' VAL . 69.2 t -101.28 133.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.84 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -87.65 102.56 14.75 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.13 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.633 ' CE2' HG23 ' 1' ' 83' ' ' ILE . 5.5 m-85 -100.64 168.6 9.59 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.91 1.338 . . . . 0.0 111.98 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.929 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.6 t -52.21 -65.63 0.52 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.716 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.929 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.29 -55.93 3.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.07 -7.49 66.98 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.111 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 61.12 -90.44 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.18 132.09 34.34 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.76 HG13 ' HA ' ' 1' ' 55' ' ' ILE . 9.3 t -145.18 113.99 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.062 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -91.96 152.42 20.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.896 0.855 . . . . 0.0 112.848 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.841 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.66 145.38 23.4 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.727 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -65.24 99.26 0.37 Allowed 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 124.765 2.222 . . . . 0.0 107.68 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.066 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 1.6 t -76.11 14.66 0.67 Allowed 'General case' 0 C--N 1.28 -2.434 1 CA-C-N 108.047 -4.161 . . . . 0.0 113.399 -174.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.689 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 9.0 t -63.71 24.4 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.029 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 1.024 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.63 120.39 0.14 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 5.1 ttmm -68.77 -38.33 79.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.916 0.865 . . . . 0.0 108.893 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.805 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 13.1 m-20 -66.91 -5.0 10.82 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 1.024 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 4.7 t30 -63.24 -58.6 6.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.598 0.713 . . . . 0.0 110.309 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.075 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.94 -57.4 9.87 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.816 0.817 . . . . 0.0 109.662 178.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.622 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.4 mp -60.14 -46.23 90.37 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.528 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.0 OUTLIER -109.32 -31.04 7.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 98.39 26.09 9.62 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.336 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.805 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 58.6 mttt . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.963 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.278 0.561 . . . . 0.0 112.089 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.566 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.48 154.85 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -177.418 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.998 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.9 m-85 -110.68 170.17 8.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.956 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.675 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 0.0 OUTLIER -117.12 109.63 17.18 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.501 178.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.805 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -79.28 80.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.951 0.882 . . . . 0.0 109.782 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.4 m-20 -81.84 -25.96 34.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.881 -1.963 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . 0.49 ' OD1' ' NE2' ' 1' ' 30' ' ' GLN . 5.8 t70 -174.87 116.54 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.827 ' O ' ' OE1' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.93 137.14 49.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.948 177.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.827 ' OE1' ' O ' ' 1' ' 29' ' ' LEU . 2.0 mp0 -133.32 161.26 34.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.845 -1.071 . . . . 0.0 113.167 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' 1' ' 31' ' ' LYS . 0.2 OUTLIER -70.91 102.7 2.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 0.964 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.8 OUTLIER -124.84 129.35 73.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' 1' ' 32' ' ' ILE . 6.5 p30 52.55 35.16 17.19 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.207 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . 0.708 ' C ' HD13 ' 1' ' 35' ' ' ILE . . . 81.13 2.26 90.38 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.925 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.708 HD13 ' C ' ' 1' ' 34' ' ' GLY . 0.0 OUTLIER -140.23 145.08 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.771 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 94.7 m95 -60.96 131.22 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.93 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.7 146.63 42.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.279 -178.18 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.774 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 22.0 t -114.6 150.62 16.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.877 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 22.1 mtp180 -144.64 144.08 31.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.278 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.758 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.45 152.9 51.33 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.477 ' ND2' ' OD1' ' 1' ' 27' ' ' ASP . 0.8 OUTLIER -62.0 -16.05 48.62 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.373 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.576 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.8 mp -85.66 -50.91 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.535 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -99.86 -10.72 21.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.211 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.724 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.2 t -148.59 71.31 10.66 Favored Pre-proline 0 CA--C 1.505 -0.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.988 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.595 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.8 Cg_exo -49.37 -32.33 25.84 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.555 2.17 . . . . 0.0 109.307 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.744 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 9.6 t 169.69 153.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.152 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.8 OUTLIER 72.41 56.33 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.877 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -81.45 113.05 19.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.74 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.18 91.88 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.679 0.752 . . . . 0.0 110.335 -178.304 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 0.964 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.6 m0 -46.16 -27.38 0.97 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.591 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.74 HG12 HG22 ' 1' ' 49' ' ' THR . 4.0 p -53.63 -55.57 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.851 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.655 ' N ' HG13 ' 1' ' 51' ' ' VAL . 48.3 t0 -154.89 -11.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.358 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.104 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -88.28 -14.72 37.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.936 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.93 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.04 144.26 28.42 Favored Glycine 1 N--CA 1.387 -4.604 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 175.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 0.994 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.07 119.27 32.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.819 -178.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.879 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -69.78 87.62 0.52 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.774 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -33.35 -35.77 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.484 -1.234 . . . . 0.0 114.007 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -54.52 -35.89 63.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.116 0.484 . . . . 0.0 110.522 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.879 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.4 OUTLIER -66.76 -27.16 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.522 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 0.994 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.6 m -99.48 -171.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.932 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -146.05 109.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.148 -176.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.23 125.12 24.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.884 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.702 HG13 ' HB ' ' 1' ' 82' ' ' VAL . 6.9 m -107.85 167.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.566 ' O ' HD11 ' 1' ' 23' ' ' ILE . 2.4 p -85.36 160.16 19.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.678 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.2 OUTLIER -78.43 151.85 32.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.61 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.87 20.36 4.95 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.822 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.686 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.81 -107.93 0.32 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.515 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.805 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.99 160.6 43.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.936 -178.642 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.803 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.09 173.46 16.02 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.107 0.956 . . . . 0.0 110.888 177.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.912 HG12 HD12 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.94 124.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.68 HG23 ' HE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -74.13 113.58 12.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.943 -178.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.932 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -55.4 115.85 10.3 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.009 178.283 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.698 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 82.5 Cg_endo -67.49 -27.09 39.86 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 123.106 2.537 . . . . 0.0 110.106 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.11 -25.14 60.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.68 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.4 t-20 -82.9 -2.16 54.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.817 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 57.2 t -101.26 129.82 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.323 0 CA-C-O 123.245 1.498 . . . . 0.0 113.092 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.923 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.25 -39.53 10.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 111.518 -2.583 . . . . 0.0 108.415 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.461 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.2 173.26 0.36 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.174 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.877 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.18 128.74 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -101.43 179.86 28.24 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 122.173 0.874 . . . . 0.0 114.181 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . 0.536 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.27 138.9 94.66 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.162 -1.519 . . . . 0.0 111.249 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.043 ' HB3' HG21 ' 1' ' 118' ' ' THR . 24.0 Cg_endo -81.03 158.04 20.56 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.201 3.267 . . . . 0.0 113.328 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mtt -149.58 136.12 19.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 12.3 mttt -85.47 126.06 33.52 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.497 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.56 -54.27 0.05 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.726 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.892 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -64.47 69.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.858 0.329 . . . . 0.0 110.471 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.42 -49.44 0.86 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.135 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.7 -14.62 0.52 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.155 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.822 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.92 -153.07 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.952 0.882 . . . . 0.0 111.997 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.542 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.3 m -116.56 117.31 29.5 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.567 -1.652 . . . . 0.0 109.795 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.892 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -120.18 117.78 28.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.646 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -104.76 147.32 27.83 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.727 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 29.0 tt0 -79.57 103.04 9.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.708 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.877 HG22 HG12 ' 1' ' 91' ' ' VAL . 17.8 t -99.01 138.34 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.923 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.1 OUTLIER -89.1 101.46 14.11 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.098 -177.612 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.68 ' HE2' HG23 ' 1' ' 83' ' ' ILE . 37.0 m-85 -100.31 157.89 16.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 122.025 0.917 . . . . 0.0 109.384 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.642 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.62 -62.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.039 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.642 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.08 10.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.929 0.871 . . . . 0.0 109.725 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.9 -1.99 56.55 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.03 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.45 -95.13 0.01 OUTLIER Glycine 0 C--O 1.212 -1.26 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.9 129.02 38.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.916 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 6.5 t -144.83 120.02 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.104 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.6 m95 -93.89 155.49 17.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.909 0.861 . . . . 0.0 112.784 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.543 HD21 ' HE2' ' 1' ' 24' ' ' TYR . 0.2 OUTLIER -153.93 146.19 23.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.126 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.834 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.4 OUTLIER -65.31 101.55 0.57 Allowed 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 124.847 2.261 . . . . 0.0 107.212 178.082 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.043 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.1 t -77.99 14.79 1.03 Allowed 'General case' 0 C--N 1.279 -2.494 1 CA-C-N 107.894 -4.23 . . . . 0.0 113.285 -174.587 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.834 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 8.1 t -62.96 22.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.849 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 1.018 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.3 m -175.81 125.18 0.22 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 7.3 tptm -73.8 -41.03 62.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.129 0.966 . . . . 0.0 108.699 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.801 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 11.8 m-20 -65.01 -4.41 4.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 1.018 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.05 -58.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.766 0.793 . . . . 0.0 110.239 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.02 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.16 -56.57 15.66 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 121.88 0.848 . . . . 0.0 109.581 178.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.632 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.4 mp -59.73 -43.62 94.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.185 -1.37 . . . . 0.0 112.736 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.632 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -119.96 -30.65 4.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' 1' ' 123' ' ' ASN . . . 100.21 27.96 7.48 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.732 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.801 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.435 -1.213 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.973 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . 0.444 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.6 mmtm . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.71 0.291 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.629 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.53 154.6 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -177.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.987 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.8 m-85 -111.65 171.53 7.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.867 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.662 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 14.5 mptt -116.91 109.67 17.35 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.279 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.807 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -79.85 80.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.9 0.857 . . . . 0.0 109.447 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.86 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 1.0 OUTLIER -81.59 -25.87 35.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.891 -178.489 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.59 116.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.149 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.799 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -130.27 136.92 49.69 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.112 0.482 . . . . 0.0 110.264 177.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.818 ' HB2' HD11 ' 1' ' 32' ' ' ILE . 1.6 mp0 -130.35 160.86 32.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.065 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' 1' ' 31' ' ' LYS . 0.0 OUTLIER -71.99 102.49 2.97 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 0.98 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -124.9 122.22 62.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -171.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 60.96 35.51 19.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.253 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.13 4.27 72.3 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -136.19 139.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.771 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 87.4 m95 -60.42 129.85 43.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.921 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.76 145.14 43.69 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.34 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' 1' ' 57' ' ' ALA . 22.0 t -113.1 151.24 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.845 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 33.3 mtp180 -144.56 141.46 29.48 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.185 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.86 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -129.74 152.62 49.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' 1' ' 41' ' ' ASN . 3.4 p30 -61.9 -15.98 47.14 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.608 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.571 HG22 HD13 ' 1' ' 43' ' ' LEU . 3.7 mp -84.34 -50.54 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.715 0.769 . . . . 0.0 110.76 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.841 HD12 HD21 ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.72 -10.08 20.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.386 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.734 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.1 t -148.12 70.26 10.94 Favored Pre-proline 0 CA--C 1.505 -0.77 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.048 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.597 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 94.3 Cg_exo -50.86 -30.7 30.96 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.505 2.137 . . . . 0.0 109.323 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.0 t 169.22 151.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.259 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 56.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.845 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.64 112.39 18.79 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.61 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.868 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.11 91.84 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.662 0.744 . . . . 0.0 110.35 -178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 0.98 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 35.8 m0 -44.92 -28.19 0.63 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.653 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.868 HG12 HG22 ' 1' ' 49' ' ' THR . 7.3 p -53.5 -57.07 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.369 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.732 ' N ' HG13 ' 1' ' 51' ' ' VAL . 52.1 t0 -151.94 -11.79 0.19 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.498 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.015 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.8 m120 -87.23 -10.97 51.12 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.886 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.921 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.98 142.32 22.33 Favored Glycine 1 N--CA 1.388 -4.563 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 175.694 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 0.907 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.39 117.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.417 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.46 87.51 0.46 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.801 ' HB2' HG23 ' 1' ' 38' ' ' VAL . . . -34.88 -34.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.707 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -53.99 -33.97 58.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.07 0.462 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.5 m-20 -70.16 -27.6 64.67 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.852 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 0.907 HG13 HD11 ' 1' ' 55' ' ' ILE . 32.0 m -98.78 -173.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.424 0.63 . . . . 0.0 112.126 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.95 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -142.72 105.33 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.538 -177.33 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -65.81 126.46 28.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.744 -178.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.602 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 15.8 m -116.48 161.76 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.746 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.629 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.6 p -83.7 163.92 19.96 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.433 0 O-C-N 123.901 0.75 . . . . 0.0 112.926 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.088 0.47 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.56 151.57 37.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.578 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 117.82 18.15 5.27 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.758 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -150.81 -109.47 0.46 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 118.655 -1.736 . . . . 0.0 114.579 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.807 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.86 160.19 43.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.927 -0.637 . . . . 0.0 109.523 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.772 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.9 OUTLIER -153.19 173.11 15.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.057 0.932 . . . . 0.0 110.946 177.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.802 HG12 HD12 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.28 124.54 35.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.615 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.19 112.22 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.439 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.95 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -52.39 114.0 5.04 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.669 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 87.4 Cg_endo -70.61 -27.23 22.67 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.065 2.51 . . . . 0.0 110.532 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -74.53 -28.62 61.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.999 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.946 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.71 -2.09 53.2 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.708 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.9 t -96.54 130.25 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.425 0 CA-C-O 123.002 1.382 . . . . 0.0 111.84 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.3 -46.28 13.85 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 111.782 -2.463 . . . . 0.0 107.856 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.451 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 173.99 172.72 0.18 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.815 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.932 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.96 145.93 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -118.19 179.44 17.06 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-O 122.072 0.818 . . . . 0.0 113.676 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . 0.489 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -60.05 137.85 91.03 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.48 -1.36 . . . . 0.0 111.443 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.022 ' HB3' HG21 ' 1' ' 118' ' ' THR . 25.4 Cg_endo -81.54 158.31 19.3 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.274 3.316 . . . . 0.0 113.574 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtm -149.53 130.89 14.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.509 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.4 mttp -85.17 124.97 32.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.857 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.77 -48.63 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.584 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.906 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -66.63 69.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.396 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.96 -49.39 0.86 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.152 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.81 -17.07 0.39 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.039 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.823 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -75.73 -153.45 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.849 0.833 . . . . 0.0 112.394 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.505 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.1 m -116.72 118.29 32.13 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.773 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.906 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.5 m95 -120.44 117.12 26.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.36 149.68 24.54 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.728 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.0 tt0 -83.52 103.07 12.57 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 112.576 -2.102 . . . . 0.0 111.897 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.932 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 44.1 t -102.88 138.69 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.878 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.9 OUTLIER -89.99 101.51 14.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 3.4 m-85 -98.35 167.27 10.95 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.953 1.359 . . . . 0.0 111.287 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.922 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -50.84 -65.88 0.48 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.299 -2.228 . . . . 0.0 116.55 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.922 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.5 OUTLIER -86.46 -56.6 3.36 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.923 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' 1' ' 59' ' ' ASP . . . -70.76 -7.32 61.41 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.587 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.73 -92.11 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' 1' ' 52' ' ' ASP . 0.4 OUTLIER -83.61 129.51 34.97 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.901 -0.764 . . . . 0.0 109.129 176.758 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.86 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 2.8 t -145.09 120.07 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.015 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.3 m95 -94.7 154.85 17.12 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.103 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -153.23 143.63 22.48 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.077 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.841 HD21 HD12 ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -65.27 100.0 0.43 Allowed 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 124.704 2.193 . . . . 0.0 107.329 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.022 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 2.5 t -76.84 14.88 0.74 Allowed 'General case' 0 C--N 1.279 -2.47 1 CA-C-N 107.957 -4.201 . . . . 0.0 114.041 -174.39 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.632 ' OG1' ' ND2' ' 1' ' 117' ' ' ASN . 1.1 p -64.0 25.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.928 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 0.998 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.0 OUTLIER -175.15 126.01 0.26 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.53 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 21.3 tttm -74.26 -41.16 61.73 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.923 0.868 . . . . 0.0 108.676 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.9 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 6.4 m-20 -65.8 -4.54 6.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 0.998 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.76 -58.7 6.53 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.73 0.776 . . . . 0.0 110.526 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.053 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.81 -56.1 15.58 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.887 0.851 . . . . 0.0 109.353 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.604 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.5 mp -58.99 -45.17 91.26 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.355 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -115.35 -31.69 5.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.173 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.728 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.14 27.71 7.2 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.569 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.9 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 38.5 mttp . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.019 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . 0.45 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.8 mmtt . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.652 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.43 153.21 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -177.162 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.908 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.9 m-85 -109.11 170.28 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.66 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 2.5 mttt -117.2 109.44 16.9 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.853 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.816 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -79.62 81.66 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.074 0.94 . . . . 0.0 109.756 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.768 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 4.0 m-20 -81.31 -27.23 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.898 -1.955 . . . . 0.0 111.983 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.3 t0 -175.72 118.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.852 HD11 ' HB3' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -132.06 137.87 47.95 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.277 0.56 . . . . 0.0 110.108 177.918 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.702 ' HB2' HD11 ' 1' ' 32' ' ' ILE . 0.6 OUTLIER -129.01 160.83 31.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.581 -177.255 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.544 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.4 OUTLIER -71.45 102.64 2.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 0.892 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 0.9 OUTLIER -120.69 120.72 63.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -171.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' 1' ' 32' ' ' ILE . 2.9 p-10 49.55 47.47 22.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . 0.87 ' O ' HD13 ' 1' ' 35' ' ' ILE . . . 72.89 3.2 59.28 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.294 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.87 HD13 ' O ' ' 1' ' 34' ' ' GLY . 1.6 mm -138.2 135.94 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.645 0.26 . . . . 0.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.852 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 87.5 m95 -59.75 131.55 51.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.892 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.7 146.48 42.74 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.806 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.827 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 19.9 t -113.33 150.96 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.924 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.61 141.97 29.8 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.412 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.78 ' O ' ' N ' ' 1' ' 44' ' ' VAL . 0.0 OUTLIER -131.24 150.32 52.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.192 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' 1' ' 27' ' ' ASP . 10.9 p30 -59.74 -17.46 35.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.559 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -82.85 -50.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 121.54 0.686 . . . . 0.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.77 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.5 OUTLIER -100.6 -11.93 19.64 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.162 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.78 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.49 71.82 9.87 Favored Pre-proline 0 CA--C 1.504 -0.822 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.274 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.594 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.5 Cg_exo -49.3 -32.3 25.25 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.548 2.165 . . . . 0.0 109.306 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 12.8 t 169.56 155.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.47 -1.696 . . . . 0.0 110.879 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . 0.487 ' CG ' HG23 ' 1' ' 46' ' ' THR . 0.3 OUTLIER 72.1 56.45 0.16 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.924 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.87 113.11 20.72 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.081 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.81 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.33 91.7 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.677 0.751 . . . . 0.0 110.082 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 0.839 ' HB3' HG23 ' 1' ' 32' ' ' ILE . 42.1 m0 -46.05 -28.47 1.19 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.887 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.81 HG12 HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.46 -56.86 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.794 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.724 ' N ' HG13 ' 1' ' 51' ' ' VAL . 48.2 t0 -149.33 -14.34 0.29 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.956 -1.475 . . . . 0.0 113.502 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.124 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 6.3 m-20 -87.02 -12.86 46.13 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.53 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.853 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.31 140.42 22.06 Favored Glycine 1 N--CA 1.387 -4.572 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 1.008 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.05 119.07 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.304 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.898 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -69.53 87.57 0.47 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.804 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.25 -35.3 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.859 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -54.58 -35.87 63.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.419 0.628 . . . . 0.0 110.216 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.898 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.5 OUTLIER -66.89 -27.64 67.67 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.722 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 1.008 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.1 m -99.05 -173.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.888 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -144.98 112.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.11 -176.919 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.9 mt-10 -63.83 128.28 35.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.56 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' 1' ' 82' ' ' VAL . 0.9 OUTLIER -109.07 161.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.876 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.652 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.4 p -85.41 159.08 20.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.04 151.8 38.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.613 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.1 18.05 5.19 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.293 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.752 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.78 -107.96 0.34 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 118.833 -1.651 . . . . 0.0 114.277 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.816 ' N ' HG23 ' 1' ' 26' ' ' VAL . 1.4 m-85 -151.7 160.38 43.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.827 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -154.5 173.57 16.11 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.128 0.966 . . . . 0.0 110.728 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.888 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.37 125.7 33.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.697 HG23 ' HE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -73.1 113.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.994 -178.665 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.884 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -55.67 114.65 7.75 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.663 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 70.0 Cg_endo -64.2 -26.69 64.56 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 122.95 2.434 . . . . 0.0 109.717 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.79 -27.52 62.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.953 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.8 t-20 -82.82 -1.75 52.69 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.82 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 53.8 t -102.6 129.77 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.319 0 CA-C-O 122.94 1.352 . . . . 0.0 112.786 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.879 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.83 -37.73 11.6 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 111.78 -2.464 . . . . 0.0 108.194 178.017 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.538 ' O ' HG13 ' 1' ' 106' ' ' VAL . 6.0 p 177.21 172.84 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.37 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.84 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -110.35 122.16 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.515 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -93.28 179.67 39.28 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-O 122.45 1.028 . . . . 0.0 114.873 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.91 139.66 97.86 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 112.723 -1.738 . . . . 0.0 111.182 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.027 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.7 Cg_endo -81.67 157.68 18.83 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.476 3.451 . . . . 0.0 113.869 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -149.68 137.6 20.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.49 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 1.7 mttt -84.53 124.26 31.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.617 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.56 -60.21 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.5 -1.334 . . . . 0.0 114.012 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.914 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -59.57 72.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.893 0.346 . . . . 0.0 111.108 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 105.08 -49.52 0.89 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.393 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.88 -16.0 0.45 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.828 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.42 -153.33 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.68 0.752 . . . . 0.0 112.107 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.537 ' C ' HG22 ' 1' ' 118' ' ' THR . 0.7 OUTLIER -116.54 119.21 34.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.593 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.914 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -121.44 119.31 31.69 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.561 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -106.84 147.02 30.24 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.699 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.1 tt0 -78.91 102.86 8.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.78 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.84 HG22 HG12 ' 1' ' 91' ' ' VAL . 19.7 t -97.7 137.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.879 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -86.79 102.09 13.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.951 -177.224 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.697 ' HE2' HG23 ' 1' ' 83' ' ' ILE . 35.8 m-85 -103.21 157.15 17.21 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.244 1.021 . . . . 0.0 110.062 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.65 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.61 -62.25 1.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.416 -1.72 . . . . 0.0 114.238 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.65 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.1 OUTLIER -85.91 -42.69 13.86 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.941 -177.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -78.55 -0.34 79.05 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.147 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.13 -91.49 0.01 OUTLIER Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -93.15 130.67 38.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.885 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.9 t -145.52 115.93 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.124 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.9 m95 -91.84 155.9 17.88 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.065 0.936 . . . . 0.0 113.152 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.994 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.85 144.56 22.53 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.094 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.793 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -65.19 100.81 0.48 Allowed 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 124.68 2.181 . . . . 0.0 107.126 178.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.027 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 5.7 t -75.94 15.4 0.54 Allowed 'General case' 0 C--N 1.279 -2.484 1 CA-C-N 108.273 -4.058 . . . . 0.0 113.401 -174.743 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.793 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 9.6 t -62.62 22.08 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.669 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.5 OUTLIER -175.68 125.86 0.23 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' 1' ' 122' ' ' ASP . 0.8 OUTLIER -74.24 -39.83 62.79 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.246 1.022 . . . . 0.0 108.354 -179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.851 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 75.2 m-20 -65.91 -5.04 8.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 1.001 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 5.1 t30 -62.86 -58.38 7.61 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.642 0.734 . . . . 0.0 110.299 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.04 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.3 -57.01 10.63 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 122.014 0.911 . . . . 0.0 109.605 178.134 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.614 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.08 -45.62 90.35 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.612 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.7 m-85 -112.58 -31.61 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.132 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.79 25.88 8.86 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 119.364 -1.398 . . . . 0.0 111.273 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.851 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' 1' ' 126' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.201 0.524 . . . . 0.0 111.414 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.628 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.45 154.18 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -176.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.875 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -107.65 170.42 7.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.4 OUTLIER -117.31 111.36 19.27 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.027 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.818 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -80.83 80.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 122.132 0.968 . . . . 0.0 109.676 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.788 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.8 m-20 -80.35 -26.37 38.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.946 -1.934 . . . . 0.0 111.686 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' 1' ' 39' ' ' ARG . 4.2 t0 -174.94 119.01 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.341 -0.543 . . . . 0.0 112.285 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.821 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -133.43 136.41 45.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.185 0.517 . . . . 0.0 110.255 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.827 ' O ' HG13 ' 1' ' 32' ' ' ILE . 1.8 mp0 -129.86 160.95 31.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.093 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.536 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -70.87 102.42 2.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 174.759 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 1.002 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.1 mt -124.35 121.53 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.09 35.16 18.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.148 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.08 4.49 72.77 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.075 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.73 137.79 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.792 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 92.0 m95 -59.7 129.43 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.989 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.87 145.53 43.51 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.489 -177.908 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.795 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 22.6 t -114.07 151.39 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.926 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 4.3 mtp180 -144.36 144.25 31.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.986 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.788 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.72 151.54 51.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.43 ' H ' ' CG ' ' 1' ' 27' ' ' ASP . 2.6 p30 -61.88 -16.13 48.11 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.703 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.8 mp -83.93 -50.24 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-O 121.771 0.796 . . . . 0.0 110.581 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.631 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.5 -11.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.235 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.846 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.6 t -148.01 70.22 11.05 Favored Pre-proline 0 CA--C 1.504 -0.797 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.083 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.587 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.1 Cg_exo -49.88 -31.98 28.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.477 2.118 . . . . 0.0 109.265 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.587 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.1 t 169.87 154.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.255 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.18 55.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.926 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.86 112.21 19.46 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.007 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.719 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.07 92.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.646 0.736 . . . . 0.0 110.743 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 1.002 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 31.2 m0 -44.33 -29.43 0.67 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.814 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.719 HG12 HG22 ' 1' ' 49' ' ' THR . 6.5 p -53.78 -56.44 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.809 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.694 ' N ' HG13 ' 1' ' 51' ' ' VAL . 52.6 t0 -152.79 -13.1 0.16 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.405 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.111 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 6.8 m-20 -85.71 -14.92 43.89 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.394 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.989 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.96 144.32 26.14 Favored Glycine 1 N--CA 1.386 -4.689 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 0.896 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.25 119.75 33.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.488 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.704 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.48 87.87 0.66 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.753 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.58 -35.76 0.06 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.67 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -55.31 -32.87 62.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.305 0.574 . . . . 0.0 110.432 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.704 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.7 OUTLIER -69.42 -28.92 66.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.429 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 0.866 HG13 HD11 ' 1' ' 55' ' ' ILE . 31.7 m -100.49 -175.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.919 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.1 OUTLIER -141.53 113.63 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.127 -177.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' 1' ' 80' ' ' TYR . 1.8 mt-10 -64.89 128.98 38.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.115 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.639 HG21 HG23 ' 1' ' 82' ' ' VAL . 1.9 m -113.05 157.89 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.792 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.628 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.7 p -85.36 159.8 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 0.0 112.889 -178.312 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -73.48 151.71 40.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.545 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.2 17.26 5.4 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.35 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.759 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.57 -109.29 0.4 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 118.68 -1.724 . . . . 0.0 114.439 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.818 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.8 OUTLIER -152.01 160.4 43.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.372 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.797 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.8 OUTLIER -153.52 173.25 15.97 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.056 0.931 . . . . 0.0 110.582 177.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.919 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.04 125.41 39.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.339 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.741 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.46 114.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.941 0.4 . . . . 0.0 110.597 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -56.79 114.82 8.65 Favored Pre-proline 0 N--CA 1.436 -1.167 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.657 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 84.4 Cg_endo -70.47 -26.95 23.67 Favored 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 123.088 2.526 . . . . 0.0 110.58 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.69 -29.42 61.21 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.039 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.99 -2.43 55.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.824 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.2 t -96.92 130.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.924 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.922 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 112.122 -2.308 . . . . 0.0 107.985 178.781 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.504 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.4 172.7 0.4 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.777 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.906 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -106.55 124.01 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -97.05 179.54 33.88 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-O 122.528 1.071 . . . . 0.0 114.735 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . 0.488 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -62.82 137.91 96.9 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.74 -1.73 . . . . 0.0 111.666 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.064 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.3 Cg_endo -81.29 156.88 19.64 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.248 3.299 . . . . 0.0 113.405 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 22.4 mtt -149.75 134.68 17.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.743 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.0 OUTLIER -84.97 123.9 31.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.629 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.69 -51.61 0.04 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.733 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.903 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -65.36 69.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.98 0.39 . . . . 0.0 110.588 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.21 -49.56 0.85 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.258 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.19 -16.09 0.42 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.911 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.826 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.22 -153.63 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.768 0.795 . . . . 0.0 111.86 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.535 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.76 119.38 35.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.698 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.903 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 11.0 m95 -121.17 118.48 29.78 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.653 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.72 145.19 30.44 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.681 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.8 tt0 -79.64 102.32 8.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.274 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.906 HG22 HG12 ' 1' ' 91' ' ' VAL . 42.2 t -100.25 136.47 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.922 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 t-20 -86.73 101.38 13.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.502 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.689 ' CD1' ' HB ' ' 1' ' 114' ' ' VAL . 12.4 m-85 -101.44 167.6 10.05 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 123.008 1.385 . . . . 0.0 112.101 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.931 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.4 t -52.17 -66.12 0.44 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 111.871 -2.422 . . . . 0.0 116.67 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.931 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.5 -55.93 3.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.86 -7.41 61.87 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.008 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.87 -89.64 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -86.42 130.86 34.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.313 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.896 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.6 t -145.58 113.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.111 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 44.2 m95 -90.25 156.17 18.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.135 0.969 . . . . 0.0 113.465 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.606 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.57 142.95 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.731 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.705 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -64.91 100.32 0.4 Allowed 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 124.801 2.239 . . . . 0.0 107.282 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.064 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.7 t -76.32 16.3 0.48 Allowed 'General case' 0 C--N 1.28 -2.453 1 CA-C-N 107.962 -4.199 . . . . 0.0 113.45 -174.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.688 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 7.2 t -63.51 23.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.453 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 1.028 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.64 122.22 0.15 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.553 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 1.2 ptpt -71.14 -40.38 71.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.217 1.008 . . . . 0.0 108.401 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.844 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 68.2 m-20 -66.05 -4.66 7.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 1.028 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.0 -58.67 6.53 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.672 0.749 . . . . 0.0 110.401 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.049 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.15 -56.69 13.03 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 122.01 0.909 . . . . 0.0 109.325 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.618 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.7 mp -58.36 -46.03 87.07 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.212 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.36 -32.1 6.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.701 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.7 26.27 7.68 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.36 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.844 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.0 mttt . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.88 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 1.1 mmtm . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.765 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.631 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.78 154.11 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.213 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.904 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.3 m-85 -107.53 169.5 8.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 9.7 mttt -116.62 108.84 16.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.745 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.826 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.39 81.47 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.067 0.937 . . . . 0.0 109.791 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.752 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.8 m-20 -80.92 -25.94 37.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.91 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 12.6 t0 -175.83 116.69 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -130.17 134.8 47.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.08 0.467 . . . . 0.0 110.226 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.851 ' O ' HG13 ' 1' ' 32' ' ' ILE . 1.7 mp0 -130.44 160.83 32.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.805 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.525 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.2 tptp -71.3 102.81 2.67 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 1.01 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.2 mt -124.53 122.89 64.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.22 35.73 18.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.131 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.75 3.64 68.25 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.205 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.96 140.21 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.77 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 92.7 m95 -59.54 129.78 43.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.951 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.77 146.73 42.63 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.432 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.826 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 19.0 t -114.36 150.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.907 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.45 140.55 29.03 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.441 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.752 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.02 153.32 49.39 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.914 0.864 . . . . 0.0 108.761 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' 1' ' 27' ' ' ASP . 1.7 p30 -62.14 -16.72 54.66 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.435 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.585 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -83.15 -50.55 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.758 0.79 . . . . 0.0 110.829 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.752 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -101.7 -11.0 19.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.376 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.76 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.5 t -146.9 71.33 12.37 Favored Pre-proline 0 CA--C 1.505 -0.786 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.988 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.606 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 73.1 Cg_exo -48.29 -32.93 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.518 2.145 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 8.0 t 169.09 154.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.662 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . 0.522 ' CG ' HG23 ' 1' ' 46' ' ' THR . 0.4 OUTLIER 72.24 56.06 0.16 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.907 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.55 111.77 18.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.577 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.749 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.81 91.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.655 0.74 . . . . 0.0 110.524 -178.587 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 1.01 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 34.8 m0 -44.41 -28.28 0.54 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.742 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.749 HG12 HG22 ' 1' ' 49' ' ' THR . 7.8 p -53.27 -56.95 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.54 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.698 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.0 t0 -153.25 -11.67 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.893 -1.503 . . . . 0.0 113.063 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 0.946 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.6 m120 -86.43 -12.37 49.26 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.642 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.951 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -82.86 144.03 22.66 Favored Glycine 1 N--CA 1.387 -4.595 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 175.296 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 0.859 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.15 119.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.788 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.42 87.49 0.63 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.741 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -34.18 -34.49 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.01 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.24 -35.98 63.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.633 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.2 m-20 -67.57 -27.21 66.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.911 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 0.851 HG13 HD11 ' 1' ' 55' ' ' ILE . 28.7 m -99.51 -172.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.887 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -144.68 112.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.981 -176.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.07 123.72 19.3 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.84 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.608 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 0.8 OUTLIER -108.17 155.79 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.628 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.631 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.9 p -85.09 160.02 20.06 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.468 0.456 0 O-C-N 123.806 0.691 . . . . 0.0 112.738 -178.615 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -72.82 151.35 42.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.528 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.94 17.34 5.91 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.528 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.765 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.65 -109.16 0.39 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.559 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.826 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.2 OUTLIER -151.86 160.47 43.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.904 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.826 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -155.05 172.99 17.21 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.014 0.912 . . . . 0.0 110.563 177.33 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.818 HG12 HD12 ' 1' ' 61' ' ' ILE . 1.2 t -138.55 125.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.596 HG23 ' CE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -72.72 112.74 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.997 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 113.58 5.35 Favored Pre-proline 0 N--CA 1.436 -1.134 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.662 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 86.9 Cg_endo -71.84 -27.69 17.53 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.424 2.749 . . . . 0.0 110.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.64 -28.18 60.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.73 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.997 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.87 -3.34 56.74 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.816 HG23 ' O ' ' 1' ' 84' ' ' ASN . 27.0 t -98.77 135.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.502 0 CA-C-O 122.945 1.355 . . . . 0.0 111.51 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.89 ' HD2' ' O ' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.61 -48.43 9.52 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.871 -2.422 . . . . 0.0 107.791 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER 172.28 172.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.465 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.823 HG13 HG22 ' 1' ' 106' ' ' VAL . 67.8 t -89.94 162.56 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -130.09 179.68 16.67 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.175 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.35 133.77 90.91 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.984 -1.108 . . . . 0.0 110.75 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.072 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.9 Cg_endo -81.35 158.18 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.347 3.364 . . . . 0.0 113.534 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtt -149.7 138.01 20.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.981 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 2.1 mtpt -85.84 125.4 33.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.561 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.96 -53.35 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.791 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.896 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -66.07 69.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.398 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.62 -49.47 0.86 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.208 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.13 -14.43 0.48 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.185 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.81 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -76.92 -153.15 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.83 0.824 . . . . 0.0 112.108 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.1 m -116.86 116.74 28.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.988 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.896 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 9.9 m95 -118.63 117.39 28.83 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -105.0 150.18 25.14 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.667 ' HG3' ' NE1' ' 1' ' 115' ' ' TRP . 23.0 tt0 -82.31 102.18 11.03 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.816 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.823 HG22 HG13 ' 1' ' 91' ' ' VAL . 53.2 t -98.84 135.77 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.89 ' O ' ' HD2' ' 1' ' 89' ' ' LYS . 2.4 m-20 -89.14 102.69 15.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.384 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.81 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 0.9 OUTLIER -102.77 169.14 8.79 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.978 1.37 . . . . 0.0 111.544 178.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.901 HG23 ' H ' ' 1' ' 110' ' ' THR . 2.7 t -51.38 -66.08 0.45 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.196 -2.274 . . . . 0.0 116.913 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.901 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.55 -56.12 3.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.925 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.77 -7.15 61.07 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.593 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.01 -91.67 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.31 131.06 34.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 121.947 -0.737 . . . . 0.0 109.066 176.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.814 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 7.9 t -145.36 113.48 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 0.946 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -89.42 153.38 20.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.901 0.858 . . . . 0.0 113.101 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.856 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.55 144.92 23.11 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.032 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.783 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -65.33 100.36 0.47 Allowed 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 124.675 2.179 . . . . 0.0 107.076 178.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.072 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 3.1 t -75.89 14.62 0.64 Allowed 'General case' 0 C--N 1.281 -2.396 1 CA-C-N 107.981 -4.19 . . . . 0.0 113.495 -174.546 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.783 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 14.8 t -63.79 22.73 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.047 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 1.032 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -175.24 123.07 0.22 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 18.5 tttt -72.29 -39.47 68.27 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.926 0.87 . . . . 0.0 108.666 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.901 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 78.1 m-20 -66.61 -5.14 10.46 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 1.032 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 5.4 t30 -62.73 -58.48 7.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.818 0.818 . . . . 0.0 110.27 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.048 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.86 -57.02 11.13 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 122.025 0.917 . . . . 0.0 109.515 178.086 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.613 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.71 -45.04 93.36 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.739 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -113.58 -31.43 6.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.706 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.42 26.59 8.6 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.273 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.901 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 23.4 mttp . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.81 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 121.186 0.517 . . . . 0.0 111.664 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.666 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.49 155.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.928 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.6 m-85 -108.48 169.88 8.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.865 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 15.3 mmmt -116.64 108.52 16.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.133 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.781 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.54 82.63 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.976 0.893 . . . . 0.0 109.905 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.768 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.7 m-20 -83.48 -27.38 29.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.275 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -174.64 119.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.759 HD11 ' HB3' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -133.13 138.28 46.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.233 0.54 . . . . 0.0 110.743 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.694 ' OE1' ' O ' ' 1' ' 29' ' ' LEU . 0.7 OUTLIER -129.28 160.57 32.56 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.399 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.535 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.0 OUTLIER -71.93 103.18 3.11 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 0.889 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 1.1 mm -123.88 117.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -171.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.22 37.58 17.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.101 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.72 1.95 68.36 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.292 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.57 136.36 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.759 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 93.1 m95 -59.66 131.56 51.29 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.889 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.97 146.49 42.97 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.899 -179.014 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.824 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 19.4 t -114.07 150.0 16.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.829 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 6.4 mtp180 -144.11 144.08 31.43 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.042 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.26 152.94 51.11 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' 1' ' 27' ' ' ASP . 1.2 p30 -61.28 -17.33 52.98 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.4 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.583 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.9 mp -84.27 -50.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-O 121.699 0.761 . . . . 0.0 110.673 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.79 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -100.43 -11.8 19.91 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.425 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.761 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.63 71.09 9.74 Favored Pre-proline 0 CA--C 1.505 -0.761 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.197 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.59 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.3 Cg_exo -49.76 -31.84 27.15 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.534 2.156 . . . . 0.0 109.343 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.835 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 13.7 t 169.51 155.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.052 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . 0.835 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.31 56.49 0.15 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.829 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.81 113.81 20.7 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.775 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.52 91.76 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.726 0.774 . . . . 0.0 109.849 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 0.878 ' CD1' HD12 ' 1' ' 32' ' ' ILE . 42.5 m0 -47.58 -27.47 1.86 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.798 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.775 HG12 HG22 ' 1' ' 49' ' ' THR . 9.8 p -54.03 -56.19 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.657 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.703 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.5 t0 -151.38 -14.09 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.518 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.133 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 5.3 m-20 -86.82 -11.6 50.45 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.377 0.608 . . . . 0.0 110.812 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.804 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.88 140.03 21.22 Favored Glycine 1 N--CA 1.391 -4.302 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 1.052 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.03 117.81 29.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.379 -178.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.833 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -68.97 87.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.579 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.824 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -34.38 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.585 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -37.04 64.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.434 0.635 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.833 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.5 OUTLIER -68.0 -26.19 65.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.116 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 1.052 HG13 HD11 ' 1' ' 55' ' ' ILE . 23.5 m -98.26 -171.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.916 HD12 HG12 ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -145.95 107.61 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.183 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.7 pt-20 -65.81 122.93 18.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.291 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.524 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 15.6 m -115.0 160.65 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.433 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.666 ' O ' HD11 ' 1' ' 23' ' ' ILE . 3.1 p -83.72 164.76 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.006 0.432 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.695 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -77.55 152.25 34.13 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.584 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.61 18.46 4.84 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.54 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.772 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.37 -109.38 0.44 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 118.742 -1.694 . . . . 0.0 114.309 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.781 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.4 OUTLIER -151.68 160.05 43.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.589 . . . . 0.0 109.642 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.812 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.72 173.43 16.42 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.95 0.881 . . . . 0.0 110.291 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.916 HG12 HD12 ' 1' ' 61' ' ' ILE . 1.2 t -137.58 125.32 31.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.678 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.39 115.65 14.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.309 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.915 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -56.29 114.53 7.85 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.67 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 74.1 Cg_endo -65.13 -26.85 57.25 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 C-N-CA 122.933 2.422 . . . . 0.0 109.834 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.35 -27.07 61.3 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 113.419 -1.718 . . . . 0.0 109.92 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.669 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.9 t-20 -82.29 -2.35 52.37 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.799 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 55.6 t -101.85 130.55 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 CA-C-O 123.165 1.46 . . . . 0.0 113.029 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.899 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -90.58 -42.33 10.86 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.445 -2.616 . . . . 0.0 107.876 177.71 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.51 ' O ' HG13 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 174.66 173.47 0.21 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.383 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.935 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -103.28 138.35 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.252 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.46 179.69 20.92 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-O 122.194 0.885 . . . . 0.0 114.067 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . 0.503 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.5 137.79 94.82 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.178 -1.511 . . . . 0.0 111.601 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.036 ' HB3' HG21 ' 1' ' 118' ' ' THR . 22.1 Cg_endo -81.46 157.56 19.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 124.435 3.424 . . . . 0.0 113.625 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.6 mtm -149.5 137.81 20.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.9 mtmm -85.18 124.98 32.46 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.657 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.55 -55.88 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.206 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.896 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -63.75 69.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.901 0.351 . . . . 0.0 110.791 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.08 -49.55 0.85 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.258 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.36 -15.17 0.48 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.04 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.823 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.76 -153.21 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.754 0.788 . . . . 0.0 111.928 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.563 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.74 119.3 35.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.661 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.896 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.64 118.03 28.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -104.91 148.52 26.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.2 tt0 -81.22 102.94 10.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.742 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.935 HG22 HG12 ' 1' ' 91' ' ' VAL . 32.7 t -98.33 138.42 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.899 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER -88.48 102.12 14.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.835 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.693 ' C ' ' HD3' ' 1' ' 89' ' ' LYS . 12.1 m-85 -100.22 157.93 16.23 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-O 122.104 0.954 . . . . 0.0 109.695 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.648 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.3 OUTLIER -58.64 -62.55 1.78 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.681 -1.599 . . . . 0.0 114.228 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.648 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.12 10.72 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.911 0.862 . . . . 0.0 109.804 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.514 ' HA3' ' OD2' ' 1' ' 59' ' ' ASP . . . -73.83 -2.39 61.13 Favored Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.159 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 46.88 -92.52 0.01 OUTLIER Glycine 0 C--O 1.212 -1.226 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.26 130.59 37.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.827 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.7 t -145.36 117.58 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.133 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 42.7 m95 -92.46 156.18 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.342 -0.943 . . . . 0.0 113.023 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.682 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.75 143.03 21.48 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.731 -1.577 . . . . 0.0 108.678 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.831 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -64.87 101.4 0.49 Allowed 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 124.595 2.141 . . . . 0.0 107.052 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.036 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 6.6 t -75.64 14.5 0.62 Allowed 'General case' 0 C--N 1.281 -2.374 1 CA-C-N 108.2 -4.091 . . . . 0.0 113.527 -174.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.831 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 12.6 t -62.37 21.51 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.715 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 1.012 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.6 OUTLIER -175.33 126.37 0.25 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.611 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 0.3 OUTLIER -74.51 -41.35 60.8 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 122.126 0.965 . . . . 0.0 108.893 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.888 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 1.3 m-20 -66.25 -4.41 7.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 1.012 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 4.8 t30 -62.23 -58.81 6.37 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.417 0.627 . . . . 0.0 110.453 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.058 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.89 -55.08 21.53 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.789 0.805 . . . . 0.0 109.601 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.614 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -60.33 -43.73 96.14 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.037 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.595 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 2.1 m-85 -114.49 -32.14 6.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.92 26.04 7.7 Favored Glycine 0 CA--C 1.505 -0.575 0 C-N-CA 119.427 -1.368 . . . . 0.0 111.718 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.888 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 26.3 mttp . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.952 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.199 0.523 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.7 HG12 ' HB2' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -72.5 152.2 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.935 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -105.85 170.94 7.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.406 -1.725 . . . . 0.0 106.555 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.713 ' HD2' HD11 ' 1' ' 42' ' ' ILE . 70.7 mttt -117.41 109.5 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.98 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.834 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -80.19 81.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.138 0.971 . . . . 0.0 109.708 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.3 m-20 -79.04 -26.74 43.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.745 -2.025 . . . . 0.0 111.618 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 11.6 t0 -176.54 118.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -133.62 137.4 45.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.185 177.698 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.74 160.84 32.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.716 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.497 ' HG2' ' CE2' ' 1' ' 36' ' ' TRP . 0.1 OUTLIER -70.62 103.25 2.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 175.262 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 0.97 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -124.66 123.27 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . 0.405 ' O ' HG13 ' 1' ' 35' ' ' ILE . 4.3 m120 59.41 37.67 23.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.485 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.2 3.68 70.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.267 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -138.53 138.69 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.805 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 82.0 m95 -59.77 130.1 45.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.967 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.91 144.93 43.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.393 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.8 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 21.8 t -112.8 150.97 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.831 ' HG2' HG11 ' 1' ' 44' ' ' VAL . 75.8 mtm180 -144.65 135.44 24.81 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.513 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.785 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -124.76 153.03 43.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.083 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' 1' ' 41' ' ' ASN . 1.5 p30 -61.91 -17.75 57.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.057 -1.428 . . . . 0.0 112.451 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.713 HD11 ' HD2' ' 1' ' 25' ' ' LYS . 3.3 mp -81.97 -50.62 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.842 0.83 . . . . 0.0 110.968 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.739 HD12 HD21 ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.12 -12.23 18.96 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.593 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.831 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.4 t -148.42 70.84 10.78 Favored Pre-proline 0 CA--C 1.503 -0.851 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.998 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.574 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.6 Cg_exo -49.32 -31.89 24.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.815 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 14.0 t 170.24 154.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.994 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . 0.815 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.29 56.68 0.15 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.808 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -85.07 112.77 20.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.844 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.26 91.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.705 0.764 . . . . 0.0 110.301 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 0.97 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 37.2 m0 -45.37 -28.8 0.92 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.647 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.844 HG12 HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.28 -57.09 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.797 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.729 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.0 t0 -150.94 -13.28 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.609 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.046 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -87.58 -14.33 40.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.76 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.967 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.62 145.27 27.47 Favored Glycine 1 N--CA 1.386 -4.638 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 175.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 0.944 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.16 118.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.757 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.502 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.35 87.58 0.62 Allowed 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.8 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -36.27 -34.77 0.06 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.694 -176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -54.67 -33.59 60.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.704 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.3 m-20 -68.62 -29.63 68.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.551 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 0.84 HG13 HD11 ' 1' ' 55' ' ' ILE . 29.0 m -100.04 -175.03 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.13 0.491 . . . . 0.0 112.172 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.855 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -141.74 110.08 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.043 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.2 OUTLIER -64.98 122.98 18.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.632 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' 1' ' 82' ' ' VAL . 7.2 m -104.95 159.45 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.951 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.413 ' O ' HD11 ' 1' ' 23' ' ' ILE . 2.5 p -84.08 161.55 20.63 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.467 0.389 0 O-C-N 123.845 0.716 . . . . 0.0 112.749 -178.563 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.929 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -79.15 151.65 31.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.642 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.15 18.86 4.91 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.072 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.763 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.75 -106.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 118.881 -1.628 . . . . 0.0 114.244 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.834 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.1 OUTLIER -151.87 160.64 43.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.177 -0.511 . . . . 0.0 110.134 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.794 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -154.36 173.07 16.7 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 122.139 0.971 . . . . 0.0 111.204 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.855 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.0 OUTLIER -136.68 125.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.624 HG23 HG12 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -74.45 112.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.896 0.379 . . . . 0.0 110.457 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.91 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 114.65 6.96 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.677 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 89.5 Cg_endo -69.76 -28.12 25.63 Favored 'Trans proline' 0 CA--C 1.5 -1.197 0 C-N-CA 123.05 2.5 . . . . 0.0 110.882 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -28.53 61.44 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.012 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.91 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.55 -3.26 55.7 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.79 HG23 ' O ' ' 1' ' 84' ' ' ASN . 38.4 t -96.51 132.75 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-O 123.08 1.419 . . . . 0.0 112.246 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.906 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -86.08 -43.74 12.84 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 108.167 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.552 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.55 173.36 0.29 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.953 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.905 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.31 117.33 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.35 179.63 45.01 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 122.408 1.004 . . . . 0.0 114.711 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.63 142.38 98.47 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 112.711 -1.745 . . . . 0.0 111.26 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.004 ' HB3' HG21 ' 1' ' 118' ' ' THR . 26.0 Cg_endo -81.34 157.99 19.74 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.482 3.455 . . . . 0.0 113.762 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 11.4 mtt -149.57 135.2 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.7 mttm -85.39 126.51 33.83 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.414 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.25 -52.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.794 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.893 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -64.91 69.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.637 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.07 -49.39 0.86 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.193 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.07 -16.05 0.43 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.05 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.839 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.13 -152.89 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.807 0.813 . . . . 0.0 112.136 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.553 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.3 m -116.74 118.6 32.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.737 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.893 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.84 117.52 26.72 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.25 147.38 27.12 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.692 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.3 tt0 -80.9 102.76 10.28 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.851 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.905 HG22 HG12 ' 1' ' 91' ' ' VAL . 41.8 t -101.62 136.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.906 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.3 m120 -90.31 101.64 14.37 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.367 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.769 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.8 m-85 -98.89 168.36 10.16 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 123.034 1.397 . . . . 0.0 111.877 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.925 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.2 -65.32 0.58 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 111.972 -2.376 . . . . 0.0 116.569 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.925 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.16 -55.91 3.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.82 -6.02 66.2 Favored Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.995 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.11 -91.37 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.79 129.19 34.9 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.944 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.5 t -145.4 119.0 2.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.046 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 45.4 m95 -93.55 156.07 16.94 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.006 0.907 . . . . 0.0 113.17 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.607 HD23 ' HG ' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -153.43 143.2 21.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.1 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.739 HD21 HD12 ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -65.07 100.01 0.4 Allowed 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 124.965 2.317 . . . . 0.0 107.182 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.004 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 5.1 t -77.12 14.69 0.84 Allowed 'General case' 0 C--N 1.281 -2.387 1 CA-C-N 107.622 -4.354 . . . . 0.0 113.975 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.624 ' OG1' ' ND2' ' 1' ' 117' ' ' ASN . 0.9 OUTLIER -63.2 22.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.991 178.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 1.042 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 3.6 m -175.19 121.28 0.21 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -69.57 -40.34 76.81 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.944 0.878 . . . . 0.0 109.125 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.867 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 98.5 m-20 -65.2 -4.69 5.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 1.042 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.98 -58.59 6.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.703 0.763 . . . . 0.0 110.483 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.051 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.5 -56.81 11.66 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.02 0.914 . . . . 0.0 109.534 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.608 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.86 -44.62 94.03 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.696 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.607 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.52 -31.51 6.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.64 26.42 7.63 Favored Glycine 0 CA--C 1.504 -0.642 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.728 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.867 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 70.8 mttt . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.957 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 22' ' ' LYS . . . . . 0.478 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.195 0.522 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 23' ' ' ILE . . . . . 0.608 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -73.26 154.3 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 24' ' ' TYR . . . . . 0.928 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.0 m-85 -105.96 169.54 8.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 25' ' ' LYS . . . . . 0.66 ' HG3' HD11 ' 1' ' 42' ' ' ILE . 0.2 OUTLIER -116.85 108.69 16.15 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.1 177.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 26' ' ' VAL . . . . . 0.809 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.42 82.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.888 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 27' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.9 m-20 -81.03 -27.34 35.83 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 112.82 -1.991 . . . . 0.0 111.81 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 28' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 2.5 t70 -175.84 118.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.227 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 29' ' ' LEU . . . . . 0.813 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -131.97 136.39 47.28 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.271 0.558 . . . . 0.0 110.344 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 30' ' ' GLN . . . . . 0.866 ' O ' HG13 ' 1' ' 32' ' ' ILE . 0.7 OUTLIER -129.82 160.5 33.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.701 -178.227 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' CZ2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.33 103.6 2.91 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 32' ' ' ILE . . . . . 0.988 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -123.94 118.93 55.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -171.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 33' ' ' ASN . . . . . 0.407 ' O ' HG13 ' 1' ' 35' ' ' ILE . 2.6 m120 61.08 39.27 16.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.534 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.15 4.85 69.41 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.6 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 35' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -137.9 136.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 36' ' ' TRP . . . . . 0.782 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 78.4 m95 -59.81 130.2 45.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 37' ' ' GLN . . . . . 0.945 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.8 146.71 42.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.411 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 38' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 21.5 t -114.18 150.97 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 39' ' ' ARG . . . . . 0.914 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 7.6 mtp180 -144.45 138.52 27.72 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.368 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 40' ' ' ASN . . . . . 0.773 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -128.56 153.04 47.62 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 121.989 0.9 . . . . 0.0 108.689 175.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 41' ' ' ASN . . . . . 0.553 HD22 ' CE ' ' 1' ' 25' ' ' LYS . 4.4 p30 -61.01 -18.46 57.81 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.47 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 42' ' ' ILE . . . . . 0.66 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.6 mp -82.25 -50.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.729 0.776 . . . . 0.0 110.853 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.684 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -100.56 -11.92 19.69 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.529 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 44' ' ' VAL . . . . . 0.792 HG11 ' HB2' ' 1' ' 48' ' ' PHE . 2.2 t -148.43 71.6 10.83 Favored Pre-proline 0 CA--C 1.504 -0.798 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.086 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 45' ' ' PRO . . . . . 0.592 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.2 Cg_exo -49.47 -31.68 24.58 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.503 2.135 . . . . 0.0 109.113 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 46' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 14.2 t 169.87 152.79 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.005 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.7 56.91 0.13 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 48' ' ' PHE . . . . . 0.914 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.16 112.75 20.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.703 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 49' ' ' THR . . . . . 0.773 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.83 91.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.442 -178.479 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 50' ' ' TRP . . . . . 0.988 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.2 m0 -45.51 -27.97 0.84 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.555 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.773 HG12 HG22 ' 1' ' 49' ' ' THR . 8.9 p -53.73 -57.15 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.674 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 52' ' ' ASP . . . . . 0.708 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.9 t0 -152.29 -12.61 0.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.349 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 53' ' ' ASN . . . . . 1.068 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -86.75 -13.74 44.38 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.624 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 54' ' ' GLY . . . . . 0.945 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.89 144.5 27.64 Favored Glycine 1 N--CA 1.386 -4.635 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 175.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 55' ' ' ILE . . . . . 0.869 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.41 118.76 31.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.557 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.14 87.64 0.59 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 57' ' ' ALA . . . . . 0.773 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.1 -35.6 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.3 -1.318 . . . . 0.0 113.895 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -54.07 -34.43 60.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.349 0.595 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 59' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.1 m-20 -68.55 -27.54 66.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.848 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 60' ' ' VAL . . . . . 0.869 HG13 HD11 ' 1' ' 55' ' ' ILE . 30.1 m -99.75 -173.36 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 61' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -143.48 110.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.01 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 62' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.51 124.64 21.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.987 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 63' ' ' VAL . . . . . 0.578 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 2.5 m -109.47 160.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.026 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 64' ' ' THR . . . . . 0.608 ' O ' HD11 ' 1' ' 23' ' ' ILE . 2.6 p -84.8 159.84 20.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.469 0.509 0 O-C-N 123.929 0.768 . . . . 0.0 112.859 -178.532 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' 1' 1 ' 77' ' ' LYS . . . . . 0.813 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.85 151.73 37.38 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 78' ' ' GLY . . . . . 0.582 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.03 17.31 5.46 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.357 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 79' ' ' GLY . . . . . 0.759 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.25 -108.02 0.33 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.54 -1.79 . . . . 0.0 114.6 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 80' ' ' TYR . . . . . 0.809 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.92 160.36 43.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.144 -0.528 . . . . 0.0 109.89 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.809 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.6 OUTLIER -154.19 172.83 16.97 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 121.916 0.865 . . . . 0.0 110.467 177.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 82' ' ' VAL . . . . . 0.798 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -137.27 124.8 31.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 83' ' ' ILE . . . . . 0.609 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.41 112.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 84' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -52.6 114.52 5.79 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.674 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.0 Cg_endo -71.24 -27.56 19.63 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 123.164 2.576 . . . . 0.0 110.845 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -74.89 -27.92 60.43 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.842 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 87' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.47 -4.08 56.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 88' ' ' VAL . . . . . 0.769 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.8 t -96.63 131.71 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-O 122.991 1.377 . . . . 0.0 111.84 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.864 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.43 -46.94 12.84 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 111.718 -2.492 . . . . 0.0 107.693 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 90' ' ' SER . . . . . 0.452 ' O ' HG13 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 173.76 172.88 0.17 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.787 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 91' ' ' VAL . . . . . 0.948 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.69 138.81 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 92' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.99 179.83 20.66 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 122.104 0.836 . . . . 0.0 114.021 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 93' ' ' THR . . . . . 0.411 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -60.6 136.18 92.38 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.286 -1.457 . . . . 0.0 111.684 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 94' ' ' PRO . . . . . 1.037 ' HB3' HG21 ' 1' ' 118' ' ' THR . 21.7 Cg_endo -81.21 157.16 19.92 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.42 3.413 . . . . 0.0 113.563 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 95' ' ' MET . . . . . 0.512 ' HG3' ' CH2' ' 1' ' 115' ' ' TRP . 0.3 OUTLIER -148.8 137.03 20.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.427 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 96' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -86.3 126.87 34.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.546 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 97' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.29 -53.66 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.51 -1.328 . . . . 0.0 113.803 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 98' ' ' SER . . . . . 0.899 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -64.96 69.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.655 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 99' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.0 -49.4 0.86 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.213 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.55 -15.67 0.47 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.008 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 101' ' ' LEU . . . . . 0.819 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.43 -153.68 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.797 0.808 . . . . 0.0 111.955 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.79 118.26 32.03 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.811 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 103' ' ' TRP . . . . . 0.899 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.2 m95 -120.11 117.2 27.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 104' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.73 148.19 26.36 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -175.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 105' ' ' GLN . . . . . 0.686 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 28.4 tt0 -82.21 102.31 11.05 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.395 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 106' ' ' VAL . . . . . 0.948 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 42.6 t -101.03 137.93 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 107' ' ' ASN . . . . . 0.864 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.0 OUTLIER -89.95 101.72 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.309 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 108' ' ' PHE . . . . . 0.736 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.7 m-85 -99.52 168.58 9.88 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.046 1.403 . . . . 0.0 111.79 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 109' ' ' THR . . . . . 0.917 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -52.29 -65.6 0.53 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.057 -2.338 . . . . 0.0 116.637 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 110' ' ' THR . . . . . 0.917 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.35 -56.06 3.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 111' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -71.77 -7.37 65.41 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.938 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 112' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.99 -90.6 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 113' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -84.7 130.5 34.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 114' ' ' VAL . . . . . 0.803 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.3 t -145.33 116.28 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 115' ' ' TRP . . . . . 1.068 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 50.0 m95 -92.08 154.14 18.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.853 0.835 . . . . 0.0 112.777 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 116' ' ' LEU . . . . . 0.908 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.58 143.5 22.01 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.045 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 117' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -64.9 100.39 0.41 Allowed 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 124.856 2.265 . . . . 0.0 107.103 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 118' ' ' THR . . . . . 1.037 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 3.4 t -75.82 15.02 0.57 Allowed 'General case' 0 C--N 1.279 -2.467 1 CA-C-N 107.858 -4.246 . . . . 0.0 113.348 -174.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 119' ' ' THR . . . . . 0.777 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 13.0 t -64.58 24.0 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.916 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 120' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -175.27 126.08 0.25 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 121' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 3.2 tttt -74.38 -40.78 61.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 122' ' ' ASP . . . . . 0.856 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 77.7 m-20 -65.83 -4.61 7.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 123' ' ' ASN . . . . . 1.001 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 4.5 t30 -62.9 -58.57 6.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.674 0.749 . . . . 0.0 110.457 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 124' ' ' LEU . . . . . 1.069 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -65.09 -55.62 17.73 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.131 0.967 . . . . 0.0 109.418 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 125' ' ' LEU . . . . . 0.598 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.7 mp -59.57 -45.15 92.7 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.261 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 126' ' ' TYR . . . . . 0.611 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -115.05 -31.51 6.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 127' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 102.45 26.77 7.12 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 119.233 -1.461 . . . . 0.0 111.829 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 128' ' ' LYS . . . . . 0.856 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 39.8 mttt . . . . . 0 N--CA 1.433 -1.285 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.814 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.008 0.432 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 111.48 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.19 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.98 33.99 45.23 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.996 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 46.8 t -99.6 2.78 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.601 0.239 . . . . 0.0 111.351 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -102.42 112.01 24.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.698 0.285 . . . . 0.0 110.944 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -168.09 113.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -108.1 142.37 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.75 150.46 32.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -114.91 159.23 20.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -83.61 -172.28 4.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.282 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.16 138.69 14.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.289 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.04 10.22 38.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -128.71 69.27 79.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.949 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.49 130.0 13.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.546 2.164 . . . . 0.0 112.283 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -169.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -97.38 103.16 14.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.788 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.27 165.71 30.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.591 2.194 . . . . 0.0 112.482 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 9.2 t -109.67 -2.89 17.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 3.1 t -113.3 58.27 0.66 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.739 0.304 . . . . 0.0 111.274 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . 0.421 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 81.3 m-20 -67.22 127.54 33.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.084 0.468 . . . . 0.0 111.039 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.525 HD13 ' HD3' ' 1' ' 85' ' ' PRO . 0.3 OUTLIER -67.01 94.3 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.882 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER -53.11 169.22 0.11 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.099 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.55 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.5 154.53 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.867 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.6 m-85 -108.42 169.34 8.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.648 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.6 OUTLIER -116.93 110.75 18.7 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.823 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -80.55 81.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.977 0.894 . . . . 0.0 110.018 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 2.6 m-20 -82.48 -25.91 33.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 112.935 -1.939 . . . . 0.0 111.955 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.1 t70 -174.18 114.63 0.19 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.273 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.852 HD11 ' HB3' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -130.77 136.0 48.31 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.006 177.949 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.805 ' O ' HG13 ' 1' ' 32' ' ' ILE . 0.8 OUTLIER -128.9 160.82 31.44 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.919 -177.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.538 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -72.01 103.35 3.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 1.025 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -123.8 119.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.839 -171.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . 0.408 ' O ' HG13 ' 1' ' 35' ' ' ILE . 43.6 m-20 61.66 36.65 16.47 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.355 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.56 2.93 65.17 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.307 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.852 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 94.2 m95 -60.24 131.04 49.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.975 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.62 146.69 42.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.721 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.835 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 21.1 t -115.14 151.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.931 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 30.5 mtp180 -144.3 142.94 30.75 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.126 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.808 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.86 150.07 52.26 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.056 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.438 ' OD1' HD12 ' 1' ' 42' ' ' ILE . 4.3 p30 -59.69 -18.18 40.29 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.595 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.589 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -83.23 -50.5 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.64 0.733 . . . . 0.0 110.906 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.02 -11.21 20.78 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.249 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.771 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.3 t -148.84 71.33 10.41 Favored Pre-proline 0 CA--C 1.505 -0.781 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.996 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.593 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 76.3 Cg_exo -48.96 -32.32 22.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.573 2.182 . . . . 0.0 109.231 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.889 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 11.1 t 169.47 155.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.978 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . 0.889 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.33 56.96 0.15 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 177.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.931 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -84.19 111.45 19.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.747 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.75 91.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.54 0.686 . . . . 0.0 110.583 -178.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 1.025 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.1 m0 -44.31 -28.58 0.55 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.506 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.747 HG12 HG22 ' 1' ' 49' ' ' THR . 5.9 p -52.96 -56.2 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.682 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.2 t0 -153.68 -13.05 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.259 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.012 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -86.31 -13.01 47.85 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.461 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.975 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.53 142.29 22.7 Favored Glycine 1 N--CA 1.388 -4.525 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 175.442 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 0.94 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.42 119.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.729 -178.815 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.67 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.53 87.72 0.66 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 1.048 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -35.3 -35.16 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.767 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -54.46 -35.74 63.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.252 0.549 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.67 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 1.0 OUTLIER -66.19 -29.08 69.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.685 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 0.849 HG13 HD11 ' 1' ' 55' ' ' ILE . 26.5 m -100.17 -173.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.267 0.556 . . . . 0.0 112.407 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.835 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -142.66 112.34 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.817 -177.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -62.8 121.33 13.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.015 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 1.8 m -105.22 153.71 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.896 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.653 HG23 HG22 ' 1' ' 68' ' ' THR . 1.6 p -83.97 161.3 20.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -37.81 -35.66 0.15 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.882 0.739 . . . . 0.0 112.593 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -7.43 55.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 111.085 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 92.05 23.33 27.76 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.734 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.816 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.8 OUTLIER -72.32 116.34 12.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.862 0.363 . . . . 0.0 110.415 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.85 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 5.5 mtt85 -72.85 137.56 45.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 1.8 t 42.05 74.15 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.94 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -86.02 -49.17 8.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' 1' ' 73' ' ' GLN . 1.0 OUTLIER -96.87 -27.11 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' 1' ' 72' ' ' ASP . 7.8 tt0 86.9 -24.72 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.057 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.53 105.99 19.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.199 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 1.048 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -57.24 147.22 25.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.0 111.811 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.553 ' HG3' ' C ' ' 1' ' 75' ' ' LEU . 18.9 mt-30 -154.27 132.81 12.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.487 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -74.83 151.54 39.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.552 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 114.42 18.33 6.69 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.189 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.74 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.71 -109.54 0.43 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.766 -1.683 . . . . 0.0 114.675 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.823 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.1 OUTLIER -151.94 160.37 43.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.912 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.835 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.9 OUTLIER -154.98 173.25 16.83 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 122.013 0.911 . . . . 0.0 111.121 177.483 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.835 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.09 125.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.682 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.622 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.62 111.65 10.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.302 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.902 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.03 115.05 7.42 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.683 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 95.0 Cg_endo -68.94 -28.21 29.58 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.133 2.555 . . . . 0.0 110.925 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -28.85 61.78 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.065 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.902 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.43 -3.56 55.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.788 HG23 ' O ' ' 1' ' 84' ' ' ASN . 39.2 t -96.53 132.77 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.362 0 CA-C-O 123.085 1.421 . . . . 0.0 112.134 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.97 -44.78 12.79 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 111.615 -2.539 . . . . 0.0 107.979 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.52 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.09 173.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.599 -1.637 . . . . 0.0 112.766 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.911 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -107.09 117.06 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.73 179.64 44.47 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-O 122.518 1.065 . . . . 0.0 115.028 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . 0.524 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.97 138.96 95.8 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.609 -1.796 . . . . 0.0 111.934 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.045 ' HB3' HG21 ' 1' ' 118' ' ' THR . 25.1 Cg_endo -81.18 158.3 20.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.477 3.451 . . . . 0.0 113.925 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.2 mtt -149.22 135.84 19.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 15.0 mttt -86.36 123.68 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.346 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.41 -52.64 0.04 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.915 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.9 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.99 69.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.009 0.405 . . . . 0.0 110.585 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.27 -49.58 0.85 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.149 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.02 -16.15 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.999 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.842 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.08 -153.53 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.769 0.795 . . . . 0.0 112.038 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.547 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.59 118.28 32.19 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.737 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.9 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.7 m95 -120.77 117.22 26.88 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.66 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.33 147.4 27.13 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.707 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 26.8 tt0 -80.86 102.62 10.16 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.611 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.911 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 43.8 t -100.92 135.79 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.878 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 m120 -89.85 101.94 14.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.389 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.746 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.9 m-85 -99.23 168.21 10.18 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-O 122.92 1.343 . . . . 0.0 111.927 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.929 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.13 -65.48 0.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.624 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.929 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.31 -56.01 3.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.32 -7.4 67.79 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.974 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.45 -91.63 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.67 130.11 34.75 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.009 -0.701 . . . . 0.0 109.298 176.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.94 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.5 t -145.63 117.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.012 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.4 m95 -92.96 155.36 17.61 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.887 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.556 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.36 144.43 22.94 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.975 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.792 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.3 OUTLIER -65.14 101.92 0.58 Allowed 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 124.64 2.162 . . . . 0.0 107.362 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.045 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.2 t -78.03 15.76 0.85 Allowed 'General case' 0 C--N 1.277 -2.56 1 CA-C-N 108.246 -4.07 . . . . 0.0 113.245 -174.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.792 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 6.8 t -63.34 21.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.845 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 0.999 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.5 m -175.13 125.26 0.25 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.559 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 4.9 ttmt -74.09 -40.63 62.6 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.991 0.901 . . . . 0.0 108.745 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.818 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 85.8 m-20 -65.69 -4.64 6.68 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 0.999 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.52 -58.73 6.53 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.77 0.795 . . . . 0.0 110.509 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.026 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.94 -55.62 18.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 122.021 0.915 . . . . 0.0 109.452 178.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.6 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.24 -45.81 90.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.147 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.3 m-85 -113.97 -31.74 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.739 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.0 26.21 8.02 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.389 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.818 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 80.0 mttt . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.005 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' 1' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' 1' ' 1' ' ' MET . 6.6 mmt85 66.13 96.18 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.908 0.385 . . . . 0.0 110.773 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.54 150.74 8.21 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.23 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -169.39 -175.78 2.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 73.58 -76.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.104 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -122.96 132.73 54.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -139.41 127.74 22.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 111.077 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -90.01 170.02 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.151 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.87 -45.54 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -121.64 25.85 9.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.42 -158.79 50.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.55 -25.6 9.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 120.94 34.67 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.036 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.63 -167.59 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.314 2.01 . . . . 0.0 111.954 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.73 97.8 11.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.12 128.54 25.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.32 153.2 35.48 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.415 2.076 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -89.75 -2.0 58.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . 0.579 ' HB ' ' HE1' ' 1' ' 126' ' ' TYR . 44.5 p -77.74 134.65 38.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . 0.601 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 2.4 m120 -93.05 127.82 38.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.252 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 0.9 OUTLIER -62.49 89.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 111.45 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -58.15 168.69 0.96 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.598 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.17 156.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.803 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 5.4 m-85 -109.76 169.71 8.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.395 -1.729 . . . . 0.0 106.798 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.674 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 5.0 mmtt -116.4 108.99 16.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.089 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.854 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -80.0 80.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.138 0.97 . . . . 0.0 109.634 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 5.5 m-20 -80.45 -26.9 38.07 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.645 -2.071 . . . . 0.0 111.966 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . 0.519 ' OD1' ' NE2' ' 1' ' 30' ' ' GLN . 5.3 t0 -175.04 114.98 0.15 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.913 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -131.09 138.48 49.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.214 177.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.852 ' O ' HG13 ' 1' ' 32' ' ' ILE . 1.9 mp0 -132.92 161.63 33.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.212 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.0 103.01 2.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 174.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 0.989 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -124.2 120.84 60.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.72 35.24 19.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.71 4.6 76.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.76 136.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.663 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 97.1 m95 -60.22 128.41 36.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.955 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.85 143.87 45.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.423 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.791 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 22.8 t -112.38 151.25 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.91 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 28.7 mtp180 -144.19 143.98 31.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.047 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.777 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.77 152.56 51.74 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.067 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.587 ' ND2' ' OD1' ' 1' ' 27' ' ' ASP . 0.7 OUTLIER -62.21 -15.4 46.43 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.374 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.643 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.9 mp -85.43 -50.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.498 0.666 . . . . 0.0 110.673 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.693 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -99.71 -11.43 20.88 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.212 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.751 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.2 t -147.86 71.0 11.38 Favored Pre-proline 0 CA--C 1.505 -0.787 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.228 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.559 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.3 Cg_exo -49.5 -32.22 26.47 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.574 2.182 . . . . 0.0 109.078 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.608 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 13.3 t 170.1 154.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.045 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . 0.608 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.5 OUTLIER 72.47 56.35 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.91 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.1 112.03 19.44 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.774 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.812 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.95 92.31 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.643 0.735 . . . . 0.0 110.532 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 0.989 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 30.5 m0 -45.22 -28.6 0.81 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.594 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.812 HG12 HG22 ' 1' ' 49' ' ' THR . 9.9 p -54.06 -57.48 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.713 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.722 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.9 t0 -152.72 -11.91 0.17 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.631 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.062 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.9 m120 -87.4 -14.36 40.81 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.876 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.955 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.11 145.97 27.47 Favored Glycine 1 N--CA 1.388 -4.56 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 175.123 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 0.904 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.16 120.19 33.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.949 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.638 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.62 88.14 0.69 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 0.89 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -35.65 -34.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.005 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.66 -36.57 64.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.357 0.598 . . . . 0.0 110.572 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.638 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 1.4 m-20 -65.57 -29.07 69.63 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.552 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 0.904 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.9 m -99.37 -176.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.412 0.625 . . . . 0.0 112.626 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.826 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -140.27 107.82 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.668 -178.039 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.92 125.25 24.82 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.195 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 6.9 m -112.02 161.19 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.345 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.664 HG23 HG22 ' 1' ' 68' ' ' THR . 3.3 p -83.76 162.79 20.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.52 -35.48 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.953 0.783 . . . . 0.0 112.988 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -79.6 -8.05 58.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.191 0.519 . . . . 0.0 111.44 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.55 23.26 21.89 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.696 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -74.69 117.88 17.03 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.994 0.426 . . . . 0.0 111.241 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.914 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 6.7 mtp180 -71.42 145.9 49.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . 0.509 HG22 ' O ' ' 1' ' 62' ' ' GLU . 4.3 t -160.56 79.64 0.65 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.953 0.406 . . . . 0.0 111.168 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -85.02 -21.97 29.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -47.32 75.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.53 -172.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.49 129.95 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.407 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 0.89 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -53.94 149.45 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.41 0.624 . . . . 0.0 111.727 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -155.33 133.27 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.834 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.913 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -80.02 152.27 29.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.631 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.16 19.99 4.55 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.754 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.751 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.39 -108.32 0.39 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.155 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.854 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -152.06 160.83 43.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.798 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.5 OUTLIER -153.67 172.67 16.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.145 0.974 . . . . 0.0 110.807 177.168 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.826 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.76 124.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.73 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.739 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.35 114.13 13.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.468 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.955 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -55.33 114.93 8.03 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.564 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.674 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.6 Cg_endo -72.3 -27.24 16.6 Favored 'Trans proline' 0 CA--C 1.502 -1.088 0 C-N-CA 123.059 2.506 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -27.45 60.31 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.069 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.955 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -83.43 -3.51 57.63 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.781 HG23 ' O ' ' 1' ' 84' ' ' ASN . 25.1 t -96.54 133.17 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.484 0 CA-C-O 123.002 1.382 . . . . 0.0 111.821 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.84 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.91 -48.69 10.44 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.333 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.5 OUTLIER 172.3 172.68 0.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.518 179.672 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.76 HG13 HG22 ' 1' ' 106' ' ' VAL . 89.5 t -92.15 165.87 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -137.05 179.66 17.77 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.244 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.18 133.71 87.81 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 113.991 -1.105 . . . . 0.0 111.184 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.066 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.1 Cg_endo -80.88 158.55 21.13 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.284 3.322 . . . . 0.0 113.557 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 25.9 mtt -149.3 134.67 18.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.9 pttt -85.12 124.12 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.508 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.11 -53.11 0.05 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.881 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.78 69.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.862 0.331 . . . . 0.0 110.683 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.53 -49.4 0.87 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.105 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.23 -14.25 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.036 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.811 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -77.86 -153.32 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.688 0.756 . . . . 0.0 111.777 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.515 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.2 m -116.9 118.82 33.5 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.911 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.881 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.1 m95 -119.57 117.39 28.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.669 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -103.41 149.75 24.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.669 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.9 tt0 -82.96 102.76 11.92 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.163 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.76 HG22 HG13 ' 1' ' 91' ' ' VAL . 69.2 t -101.28 133.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.84 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -87.65 102.56 14.75 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.13 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.633 ' CE2' HG23 ' 1' ' 83' ' ' ILE . 5.5 m-85 -100.64 168.6 9.59 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.91 1.338 . . . . 0.0 111.98 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.929 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.6 t -52.21 -65.63 0.52 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.716 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.929 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.29 -55.93 3.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.07 -7.49 66.98 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.111 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 61.12 -90.44 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.18 132.09 34.34 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.76 HG13 ' HA ' ' 1' ' 55' ' ' ILE . 9.3 t -145.18 113.99 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.062 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -91.96 152.42 20.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.896 0.855 . . . . 0.0 112.848 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.841 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.66 145.38 23.4 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.727 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -65.24 99.26 0.37 Allowed 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 124.765 2.222 . . . . 0.0 107.68 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.066 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 1.6 t -76.11 14.66 0.67 Allowed 'General case' 0 C--N 1.28 -2.434 1 CA-C-N 108.047 -4.161 . . . . 0.0 113.399 -174.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.689 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 9.0 t -63.71 24.4 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.029 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 1.024 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.63 120.39 0.14 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 5.1 ttmm -68.77 -38.33 79.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.916 0.865 . . . . 0.0 108.893 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.805 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 13.1 m-20 -66.91 -5.0 10.82 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 1.024 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 4.7 t30 -63.24 -58.6 6.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.598 0.713 . . . . 0.0 110.309 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.075 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.94 -57.4 9.87 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.816 0.817 . . . . 0.0 109.662 178.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.622 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.4 mp -60.14 -46.23 90.37 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.528 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.0 OUTLIER -109.32 -31.04 7.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 98.39 26.09 9.62 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.336 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.805 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 58.6 mttt . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.963 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -113.55 -30.95 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.88 57.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.542 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.47 -21.7 12.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.38 112.15 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.88 99.89 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.722 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 121.96 15.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -90.69 139.89 30.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -169.81 22.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.388 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 1.2 m80 -90.91 -66.17 0.95 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.789 0.328 . . . . 0.0 111.223 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.65 -170.31 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.187 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 28.2 p -112.64 -35.49 5.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.318 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . 0.46 ' HG3' ' HD2' ' 1' ' 14' ' ' PRO . 0.4 OUTLIER -108.43 131.45 21.75 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' 1' ' 13' ' ' GLU . 85.4 Cg_endo -83.01 42.79 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.643 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . 0.455 HG22 ' N ' ' 1' ' 16' ' ' THR . 91.5 m -83.8 163.69 20.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.589 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . 0.455 ' N ' HG22 ' 1' ' 15' ' ' THR . 0.2 OUTLIER -87.57 141.35 32.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.829 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.0 156.74 43.02 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.566 2.177 . . . . 0.0 112.645 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.84 36.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.568 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . 0.465 ' HA ' ' OH ' ' 1' ' 126' ' ' TYR . 5.0 t -155.67 30.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.161 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.23 141.5 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.219 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.581 HD13 ' HD3' ' 1' ' 85' ' ' PRO . 0.3 OUTLIER -56.48 95.32 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.925 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.2 OUTLIER -41.96 165.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.089 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.566 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.48 154.85 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -177.418 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.998 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.9 m-85 -110.68 170.17 8.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.956 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.675 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 0.0 OUTLIER -117.12 109.63 17.18 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.501 178.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.805 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -79.28 80.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.951 0.882 . . . . 0.0 109.782 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.4 m-20 -81.84 -25.96 34.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.881 -1.963 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . 0.49 ' OD1' ' NE2' ' 1' ' 30' ' ' GLN . 5.8 t70 -174.87 116.54 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.827 ' O ' ' OE1' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.93 137.14 49.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.948 177.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.827 ' OE1' ' O ' ' 1' ' 29' ' ' LEU . 2.0 mp0 -133.32 161.26 34.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.845 -1.071 . . . . 0.0 113.167 -177.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' 1' ' 31' ' ' LYS . 0.2 OUTLIER -70.91 102.7 2.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 0.964 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.8 OUTLIER -124.84 129.35 73.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' 1' ' 32' ' ' ILE . 6.5 p30 52.55 35.16 17.19 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.207 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . 0.708 ' C ' HD13 ' 1' ' 35' ' ' ILE . . . 81.13 2.26 90.38 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.925 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.708 HD13 ' C ' ' 1' ' 34' ' ' GLY . 0.0 OUTLIER -140.23 145.08 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.771 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 94.7 m95 -60.96 131.22 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.93 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.7 146.63 42.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.279 -178.18 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.774 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 22.0 t -114.6 150.62 16.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.877 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 22.1 mtp180 -144.64 144.08 31.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.278 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.758 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.45 152.9 51.33 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.477 ' ND2' ' OD1' ' 1' ' 27' ' ' ASP . 0.8 OUTLIER -62.0 -16.05 48.62 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.373 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.576 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.8 mp -85.66 -50.91 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.535 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -99.86 -10.72 21.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.211 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.724 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.2 t -148.59 71.31 10.66 Favored Pre-proline 0 CA--C 1.505 -0.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.988 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.595 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.8 Cg_exo -49.37 -32.33 25.84 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.555 2.17 . . . . 0.0 109.307 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.744 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 9.6 t 169.69 153.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.152 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.8 OUTLIER 72.41 56.33 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.877 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -81.45 113.05 19.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.74 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.18 91.88 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.679 0.752 . . . . 0.0 110.335 -178.304 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 0.964 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.6 m0 -46.16 -27.38 0.97 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.591 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.74 HG12 HG22 ' 1' ' 49' ' ' THR . 4.0 p -53.63 -55.57 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.851 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.655 ' N ' HG13 ' 1' ' 51' ' ' VAL . 48.3 t0 -154.89 -11.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.358 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.104 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -88.28 -14.72 37.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.936 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.93 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.04 144.26 28.42 Favored Glycine 1 N--CA 1.387 -4.604 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 175.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 0.994 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.07 119.27 32.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.819 -178.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.879 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -69.78 87.62 0.52 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 1.036 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -33.35 -35.77 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.484 -1.234 . . . . 0.0 114.007 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -54.52 -35.89 63.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.116 0.484 . . . . 0.0 110.522 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.879 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.4 OUTLIER -66.76 -27.16 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.522 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 0.994 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.6 m -99.48 -171.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.932 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -146.05 109.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.148 -176.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.23 125.12 24.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.884 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.949 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 6.9 m -107.85 167.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.703 HG23 HG22 ' 1' ' 68' ' ' THR . 2.4 p -85.36 160.16 19.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -38.04 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.46 -7.47 59.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.158 0.504 . . . . 0.0 111.485 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 95.16 22.91 21.37 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.37 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.703 HG22 HG23 ' 1' ' 64' ' ' THR . 0.9 OUTLIER -75.35 116.94 16.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.949 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 15.9 mtm180 -74.11 143.02 45.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.233 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -159.04 86.47 0.83 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 2.0 p -76.5 -27.41 56.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.576 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.99 -33.28 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.127 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.81 179.5 6.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.025 0.441 . . . . 0.0 111.57 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.07 129.27 64.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.652 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 1.036 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.3 OUTLIER -58.5 148.4 28.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.504 0.669 . . . . 0.0 111.934 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.525 ' HG3' ' C ' ' 1' ' 75' ' ' LEU . 15.1 mt-30 -155.06 132.54 11.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.415 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.2 OUTLIER -78.43 151.85 32.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.61 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.87 20.36 4.95 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.822 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.686 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.81 -107.93 0.32 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.515 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.805 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.99 160.6 43.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.936 -178.642 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.803 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.09 173.46 16.02 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.107 0.956 . . . . 0.0 110.888 177.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.912 HG12 HD12 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.94 124.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.68 HG23 ' HE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -74.13 113.58 12.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.943 -178.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.932 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -55.4 115.85 10.3 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.009 178.283 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.698 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 82.5 Cg_endo -67.49 -27.09 39.86 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 123.106 2.537 . . . . 0.0 110.106 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.11 -25.14 60.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.68 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.4 t-20 -82.9 -2.16 54.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.817 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 57.2 t -101.26 129.82 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.323 0 CA-C-O 123.245 1.498 . . . . 0.0 113.092 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.923 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.25 -39.53 10.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 111.518 -2.583 . . . . 0.0 108.415 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.461 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.2 173.26 0.36 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.174 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.877 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.18 128.74 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -101.43 179.86 28.24 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 122.173 0.874 . . . . 0.0 114.181 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . 0.536 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.27 138.9 94.66 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.162 -1.519 . . . . 0.0 111.249 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.043 ' HB3' HG21 ' 1' ' 118' ' ' THR . 24.0 Cg_endo -81.03 158.04 20.56 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.201 3.267 . . . . 0.0 113.328 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mtt -149.58 136.12 19.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 12.3 mttt -85.47 126.06 33.52 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.497 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.56 -54.27 0.05 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.726 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.892 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -64.47 69.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.858 0.329 . . . . 0.0 110.471 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.42 -49.44 0.86 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.135 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.7 -14.62 0.52 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.155 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.822 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.92 -153.07 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.952 0.882 . . . . 0.0 111.997 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.542 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.3 m -116.56 117.31 29.5 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.567 -1.652 . . . . 0.0 109.795 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.892 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -120.18 117.78 28.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.646 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -104.76 147.32 27.83 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.727 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 29.0 tt0 -79.57 103.04 9.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.708 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.877 HG22 HG12 ' 1' ' 91' ' ' VAL . 17.8 t -99.01 138.34 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.923 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.1 OUTLIER -89.1 101.46 14.11 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.098 -177.612 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.68 ' HE2' HG23 ' 1' ' 83' ' ' ILE . 37.0 m-85 -100.31 157.89 16.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 122.025 0.917 . . . . 0.0 109.384 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.642 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.62 -62.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.039 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.642 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.08 10.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.929 0.871 . . . . 0.0 109.725 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.9 -1.99 56.55 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.03 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.45 -95.13 0.01 OUTLIER Glycine 0 C--O 1.212 -1.26 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.9 129.02 38.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.916 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 6.5 t -144.83 120.02 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.104 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.6 m95 -93.89 155.49 17.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.909 0.861 . . . . 0.0 112.784 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.543 HD21 ' HE2' ' 1' ' 24' ' ' TYR . 0.2 OUTLIER -153.93 146.19 23.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.126 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.834 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.4 OUTLIER -65.31 101.55 0.57 Allowed 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 124.847 2.261 . . . . 0.0 107.212 178.082 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.043 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.1 t -77.99 14.79 1.03 Allowed 'General case' 0 C--N 1.279 -2.494 1 CA-C-N 107.894 -4.23 . . . . 0.0 113.285 -174.587 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.834 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 8.1 t -62.96 22.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.849 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 1.018 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.3 m -175.81 125.18 0.22 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 7.3 tptm -73.8 -41.03 62.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.129 0.966 . . . . 0.0 108.699 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.801 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 11.8 m-20 -65.01 -4.41 4.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 1.018 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.05 -58.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.766 0.793 . . . . 0.0 110.239 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.02 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.16 -56.57 15.66 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 121.88 0.848 . . . . 0.0 109.581 178.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.632 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.4 mp -59.73 -43.62 94.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.185 -1.37 . . . . 0.0 112.736 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.632 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -119.96 -30.65 4.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' 1' ' 123' ' ' ASN . . . 100.21 27.96 7.48 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.732 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.801 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.435 -1.213 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.973 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 35.9 mtm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.815 0.34 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.54 138.69 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.55 -31.45 4.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t -74.38 129.22 37.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.747 0.308 . . . . 0.0 110.939 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -160.5 39.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -140.04 124.33 17.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -140.03 109.96 6.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -89.86 107.63 19.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -122.59 157.86 31.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.003 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 63.71 84.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.29 -28.33 0.07 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.662 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -103.66 -24.1 13.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.091 0.445 . . . . 0.0 111.868 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.99 93.71 4.14 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 111.284 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.27 83.07 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.608 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' 1' ' 16' ' ' THR . 21.5 p -81.19 -164.19 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.542 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' 1' ' 15' ' ' THR . 13.7 m -70.49 129.28 90.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.756 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.93 147.65 24.32 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.435 2.09 . . . . 0.0 112.309 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 -10.78 29.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -72.01 99.8 2.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -178.64 140.45 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 111.811 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.6 HD13 ' O ' ' 1' ' 125' ' ' LEU . 4.4 mm? 25.14 73.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.444 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.6 mmtm -60.17 168.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.71 0.291 . . . . 0.0 110.343 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.629 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.53 154.6 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -177.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.987 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.8 m-85 -111.65 171.53 7.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.867 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.662 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 14.5 mptt -116.91 109.67 17.35 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.279 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.807 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -79.85 80.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.9 0.857 . . . . 0.0 109.447 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.86 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 1.0 OUTLIER -81.59 -25.87 35.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.891 -178.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.59 116.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.149 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.799 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -130.27 136.92 49.69 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.112 0.482 . . . . 0.0 110.264 177.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.818 ' HB2' HD11 ' 1' ' 32' ' ' ILE . 1.6 mp0 -130.35 160.86 32.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.065 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' 1' ' 31' ' ' LYS . 0.0 OUTLIER -71.99 102.49 2.97 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 0.98 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -124.9 122.22 62.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -171.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 60.96 35.51 19.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.253 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.13 4.27 72.3 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -136.19 139.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.771 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 87.4 m95 -60.42 129.85 43.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.921 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.76 145.14 43.69 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.34 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' 1' ' 57' ' ' ALA . 22.0 t -113.1 151.24 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.845 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 33.3 mtp180 -144.56 141.46 29.48 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.185 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.86 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -129.74 152.62 49.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' 1' ' 41' ' ' ASN . 3.4 p30 -61.9 -15.98 47.14 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.608 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.571 HG22 HD13 ' 1' ' 43' ' ' LEU . 3.7 mp -84.34 -50.54 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.715 0.769 . . . . 0.0 110.76 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.841 HD12 HD21 ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.72 -10.08 20.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.386 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.734 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.1 t -148.12 70.26 10.94 Favored Pre-proline 0 CA--C 1.505 -0.77 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.048 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.597 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 94.3 Cg_exo -50.86 -30.7 30.96 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.505 2.137 . . . . 0.0 109.323 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.0 t 169.22 151.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.259 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 56.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.845 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.64 112.39 18.79 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.61 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.868 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.11 91.84 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.662 0.744 . . . . 0.0 110.35 -178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 0.98 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 35.8 m0 -44.92 -28.19 0.63 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.653 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.868 HG12 HG22 ' 1' ' 49' ' ' THR . 7.3 p -53.5 -57.07 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.369 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.732 ' N ' HG13 ' 1' ' 51' ' ' VAL . 52.1 t0 -151.94 -11.79 0.19 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.498 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.015 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.8 m120 -87.23 -10.97 51.12 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.886 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.921 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.98 142.32 22.33 Favored Glycine 1 N--CA 1.388 -4.563 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 175.694 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 0.907 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.39 117.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.417 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.46 87.51 0.46 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 0.959 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -34.88 -34.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.707 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -53.99 -33.97 58.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.07 0.462 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.5 m-20 -70.16 -27.6 64.67 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.852 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 0.907 HG13 HD11 ' 1' ' 55' ' ' ILE . 32.0 m -98.78 -173.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.424 0.63 . . . . 0.0 112.126 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.95 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -142.72 105.33 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.538 -177.33 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -65.81 126.46 28.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.744 -178.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 15.8 m -116.48 161.76 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.746 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.714 HG23 HG22 ' 1' ' 68' ' ' THR . 1.6 p -83.7 163.92 19.96 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -37.86 -35.28 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.901 0.75 . . . . 0.0 112.926 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -80.18 -4.99 55.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.174 0.512 . . . . 0.0 111.318 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 89.91 23.33 33.13 Favored Glycine 0 CA--C 1.505 -0.583 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.212 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.714 HG22 HG23 ' 1' ' 64' ' ' THR . 0.8 OUTLIER -75.49 116.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.883 0.373 . . . . 0.0 111.129 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.954 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 3.4 mtp180 -68.45 115.82 8.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.568 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . 0.491 ' OG1' ' HG2' ' 1' ' 62' ' ' GLU . 68.2 p -79.95 89.29 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 30.4 m -61.31 -11.72 10.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.806 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . 0.604 ' HB3' HG12 ' 1' ' 74' ' ' VAL . 8.2 m-20 -49.03 -26.47 2.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.67 0.271 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 74.76 7.87 4.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.631 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . 0.629 ' O ' HG13 ' 1' ' 74' ' ' VAL . 10.3 p -109.16 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.734 0.302 . . . . 0.0 111.176 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 0.959 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -83.8 151.12 25.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.226 0.536 . . . . 0.0 111.366 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 35.8 mt-30 -156.92 133.23 9.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.007 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.56 151.57 37.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.578 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 117.82 18.15 5.27 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.758 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -150.81 -109.47 0.46 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 118.655 -1.736 . . . . 0.0 114.579 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.807 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.86 160.19 43.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.927 -0.637 . . . . 0.0 109.523 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.772 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.9 OUTLIER -153.19 173.11 15.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.057 0.932 . . . . 0.0 110.946 177.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.802 HG12 HD12 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.28 124.54 35.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.615 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.19 112.22 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.439 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.95 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -52.39 114.0 5.04 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.669 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 87.4 Cg_endo -70.61 -27.23 22.67 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.065 2.51 . . . . 0.0 110.532 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -74.53 -28.62 61.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.999 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.946 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.71 -2.09 53.2 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.708 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.9 t -96.54 130.25 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.425 0 CA-C-O 123.002 1.382 . . . . 0.0 111.84 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.3 -46.28 13.85 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 111.782 -2.463 . . . . 0.0 107.856 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.451 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 173.99 172.72 0.18 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.815 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.932 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.96 145.93 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -118.19 179.44 17.06 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-O 122.072 0.818 . . . . 0.0 113.676 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . 0.489 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -60.05 137.85 91.03 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.48 -1.36 . . . . 0.0 111.443 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.022 ' HB3' HG21 ' 1' ' 118' ' ' THR . 25.4 Cg_endo -81.54 158.31 19.3 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.274 3.316 . . . . 0.0 113.574 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtm -149.53 130.89 14.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.509 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.4 mttp -85.17 124.97 32.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.857 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.77 -48.63 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.584 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.906 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -66.63 69.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.396 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.96 -49.39 0.86 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.152 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.81 -17.07 0.39 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.039 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.823 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -75.73 -153.45 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.849 0.833 . . . . 0.0 112.394 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.505 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.1 m -116.72 118.29 32.13 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.773 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.906 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.5 m95 -120.44 117.12 26.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.36 149.68 24.54 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.728 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.0 tt0 -83.52 103.07 12.57 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 112.576 -2.102 . . . . 0.0 111.897 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.932 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 44.1 t -102.88 138.69 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.878 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.9 OUTLIER -89.99 101.51 14.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 3.4 m-85 -98.35 167.27 10.95 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.953 1.359 . . . . 0.0 111.287 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.922 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -50.84 -65.88 0.48 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.299 -2.228 . . . . 0.0 116.55 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.922 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.5 OUTLIER -86.46 -56.6 3.36 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.923 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' 1' ' 59' ' ' ASP . . . -70.76 -7.32 61.41 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.587 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.73 -92.11 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' 1' ' 52' ' ' ASP . 0.4 OUTLIER -83.61 129.51 34.97 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.901 -0.764 . . . . 0.0 109.129 176.758 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.86 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 2.8 t -145.09 120.07 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.015 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.3 m95 -94.7 154.85 17.12 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.103 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -153.23 143.63 22.48 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.077 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.841 HD21 HD12 ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -65.27 100.0 0.43 Allowed 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 124.704 2.193 . . . . 0.0 107.329 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.022 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 2.5 t -76.84 14.88 0.74 Allowed 'General case' 0 C--N 1.279 -2.47 1 CA-C-N 107.957 -4.201 . . . . 0.0 114.041 -174.39 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.632 ' OG1' ' ND2' ' 1' ' 117' ' ' ASN . 1.1 p -64.0 25.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.928 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 0.998 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.0 OUTLIER -175.15 126.01 0.26 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.53 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 21.3 tttm -74.26 -41.16 61.73 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.923 0.868 . . . . 0.0 108.676 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.9 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 6.4 m-20 -65.8 -4.54 6.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 0.998 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.76 -58.7 6.53 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.73 0.776 . . . . 0.0 110.526 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.053 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.81 -56.1 15.58 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.887 0.851 . . . . 0.0 109.353 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.604 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.5 mp -58.99 -45.17 91.26 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.355 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -115.35 -31.69 5.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.173 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.728 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.14 27.71 7.2 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.569 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.9 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 38.5 mttp . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.019 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.76 117.06 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.798 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.32 -103.49 1.09 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 27.4 t -64.8 121.55 14.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.018 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -84.13 -28.22 27.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.023 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.22 114.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -99.73 123.89 44.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -152.25 140.95 20.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -172.37 98.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.82 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.51 130.52 35.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.32 104.5 2.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.26 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 66.3 p -103.77 11.58 35.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -107.71 127.24 28.13 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.562 0.22 . . . . 0.0 111.043 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.99 178.94 5.86 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.526 2.15 . . . . 0.0 112.268 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -99.78 2.37 44.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.468 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 106.91 59.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.552 0.215 . . . . 0.0 110.929 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.99 121.75 6.78 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.476 2.117 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.98 52.68 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 110.56 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t -152.1 23.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . 0.491 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 0.4 OUTLIER -75.07 127.36 33.03 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.987 0.422 . . . . 0.0 110.817 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 1.4 mt -66.59 84.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.45 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.8 mmtt -55.6 169.43 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.652 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.43 153.21 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -177.162 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.908 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.9 m-85 -109.11 170.28 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.66 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 2.5 mttt -117.2 109.44 16.9 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.853 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.816 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -79.62 81.66 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.074 0.94 . . . . 0.0 109.756 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.768 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 4.0 m-20 -81.31 -27.23 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.898 -1.955 . . . . 0.0 111.983 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.3 t0 -175.72 118.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.852 HD11 ' HB3' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -132.06 137.87 47.95 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.277 0.56 . . . . 0.0 110.108 177.918 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.702 ' HB2' HD11 ' 1' ' 32' ' ' ILE . 0.6 OUTLIER -129.01 160.83 31.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.581 -177.255 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.544 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.4 OUTLIER -71.45 102.64 2.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 0.892 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 0.9 OUTLIER -120.69 120.72 63.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -171.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' 1' ' 32' ' ' ILE . 2.9 p-10 49.55 47.47 22.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . 0.87 ' O ' HD13 ' 1' ' 35' ' ' ILE . . . 72.89 3.2 59.28 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.294 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.87 HD13 ' O ' ' 1' ' 34' ' ' GLY . 1.6 mm -138.2 135.94 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.645 0.26 . . . . 0.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.852 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 87.5 m95 -59.75 131.55 51.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.892 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.7 146.48 42.74 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.806 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.827 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 19.9 t -113.33 150.96 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.924 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.61 141.97 29.8 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.412 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.78 ' O ' ' N ' ' 1' ' 44' ' ' VAL . 0.0 OUTLIER -131.24 150.32 52.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.192 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.469 ' H ' ' CG ' ' 1' ' 27' ' ' ASP . 10.9 p30 -59.74 -17.46 35.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.326 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.559 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -82.85 -50.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 121.54 0.686 . . . . 0.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.77 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.5 OUTLIER -100.6 -11.93 19.64 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.162 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.78 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.49 71.82 9.87 Favored Pre-proline 0 CA--C 1.504 -0.822 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.274 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.594 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.5 Cg_exo -49.3 -32.3 25.25 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.548 2.165 . . . . 0.0 109.306 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 12.8 t 169.56 155.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.47 -1.696 . . . . 0.0 110.879 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . 0.487 ' CG ' HG23 ' 1' ' 46' ' ' THR . 0.3 OUTLIER 72.1 56.45 0.16 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.924 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.87 113.11 20.72 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.081 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.81 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.33 91.7 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.677 0.751 . . . . 0.0 110.082 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 0.839 ' HB3' HG23 ' 1' ' 32' ' ' ILE . 42.1 m0 -46.05 -28.47 1.19 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.887 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.81 HG12 HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.46 -56.86 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.794 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.724 ' N ' HG13 ' 1' ' 51' ' ' VAL . 48.2 t0 -149.33 -14.34 0.29 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.956 -1.475 . . . . 0.0 113.502 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.124 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 6.3 m-20 -87.02 -12.86 46.13 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.53 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.853 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.31 140.42 22.06 Favored Glycine 1 N--CA 1.387 -4.572 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 1.008 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.05 119.07 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.304 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.898 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -69.53 87.57 0.47 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 0.909 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -35.25 -35.3 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.859 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -54.58 -35.87 63.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.419 0.628 . . . . 0.0 110.216 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.898 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.5 OUTLIER -66.89 -27.64 67.67 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.722 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 1.008 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.1 m -99.05 -173.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.888 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -144.98 112.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.11 -176.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.9 mt-10 -63.83 128.28 35.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.56 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 0.9 OUTLIER -109.07 161.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.876 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.717 HG23 HG22 ' 1' ' 68' ' ' THR . 1.4 p -85.41 159.08 20.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -37.51 -33.77 0.08 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.4 -8.1 58.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.552 . . . . 0.0 111.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.34 22.95 23.26 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.417 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.717 HG22 HG23 ' 1' ' 64' ' ' THR . 0.8 OUTLIER -74.27 116.54 15.05 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.044 0.45 . . . . 0.0 111.141 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.855 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 8.8 mtp180 -73.51 138.42 45.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.001 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -162.12 100.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 6.0 t -88.8 -26.28 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -50.45 -29.82 11.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.601 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.23 -179.26 7.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 111.729 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 13.1 t -109.01 124.05 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.756 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 0.909 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.3 OUTLIER -56.98 147.4 24.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.452 0.644 . . . . 0.0 112.339 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 12.1 mt-30 -156.99 133.24 9.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.747 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.04 151.8 38.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.613 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.1 18.05 5.19 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.293 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.752 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.78 -107.96 0.34 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 118.833 -1.651 . . . . 0.0 114.277 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.816 ' N ' HG23 ' 1' ' 26' ' ' VAL . 1.4 m-85 -151.7 160.38 43.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.827 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -154.5 173.57 16.11 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.128 0.966 . . . . 0.0 110.728 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.888 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.37 125.7 33.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.275 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.697 HG23 ' HE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -73.1 113.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.994 -178.665 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.884 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -55.67 114.65 7.75 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.663 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 70.0 Cg_endo -64.2 -26.69 64.56 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 122.95 2.434 . . . . 0.0 109.717 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.79 -27.52 62.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.953 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.8 t-20 -82.82 -1.75 52.69 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.82 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 53.8 t -102.6 129.77 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.319 0 CA-C-O 122.94 1.352 . . . . 0.0 112.786 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.879 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.83 -37.73 11.6 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 111.78 -2.464 . . . . 0.0 108.194 178.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.538 ' O ' HG13 ' 1' ' 106' ' ' VAL . 6.0 p 177.21 172.84 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.37 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.84 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -110.35 122.16 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -93.28 179.67 39.28 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-O 122.45 1.028 . . . . 0.0 114.873 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.91 139.66 97.86 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 112.723 -1.738 . . . . 0.0 111.182 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.027 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.7 Cg_endo -81.67 157.68 18.83 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.476 3.451 . . . . 0.0 113.869 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -149.68 137.6 20.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.49 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 1.7 mttt -84.53 124.26 31.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.617 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.56 -60.21 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.5 -1.334 . . . . 0.0 114.012 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.914 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -59.57 72.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.893 0.346 . . . . 0.0 111.108 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 105.08 -49.52 0.89 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.393 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.88 -16.0 0.45 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.828 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.42 -153.33 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.68 0.752 . . . . 0.0 112.107 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.537 ' C ' HG22 ' 1' ' 118' ' ' THR . 0.7 OUTLIER -116.54 119.21 34.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.593 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.914 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -121.44 119.31 31.69 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.561 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -106.84 147.02 30.24 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.699 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.1 tt0 -78.91 102.86 8.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.78 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.84 HG22 HG12 ' 1' ' 91' ' ' VAL . 19.7 t -97.7 137.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.879 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -86.79 102.09 13.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.951 -177.224 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.697 ' HE2' HG23 ' 1' ' 83' ' ' ILE . 35.8 m-85 -103.21 157.15 17.21 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.244 1.021 . . . . 0.0 110.062 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.65 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.61 -62.25 1.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.416 -1.72 . . . . 0.0 114.238 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.65 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.1 OUTLIER -85.91 -42.69 13.86 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.941 -177.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -78.55 -0.34 79.05 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.147 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.13 -91.49 0.01 OUTLIER Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -93.15 130.67 38.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.885 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.9 t -145.52 115.93 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.124 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.9 m95 -91.84 155.9 17.88 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.065 0.936 . . . . 0.0 113.152 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.994 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.85 144.56 22.53 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.094 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.793 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -65.19 100.81 0.48 Allowed 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 124.68 2.181 . . . . 0.0 107.126 178.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.027 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 5.7 t -75.94 15.4 0.54 Allowed 'General case' 0 C--N 1.279 -2.484 1 CA-C-N 108.273 -4.058 . . . . 0.0 113.401 -174.743 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.793 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 9.6 t -62.62 22.08 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.669 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.5 OUTLIER -175.68 125.86 0.23 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' 1' ' 122' ' ' ASP . 0.8 OUTLIER -74.24 -39.83 62.79 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.246 1.022 . . . . 0.0 108.354 -179.221 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.851 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 75.2 m-20 -65.91 -5.04 8.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 1.001 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 5.1 t30 -62.86 -58.38 7.61 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.642 0.734 . . . . 0.0 110.299 -179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.04 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.3 -57.01 10.63 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 122.014 0.911 . . . . 0.0 109.605 178.134 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.614 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.08 -45.62 90.35 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.612 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.7 m-85 -112.58 -31.61 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.132 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.79 25.88 8.86 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 119.364 -1.398 . . . . 0.0 111.273 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.851 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.773 0.32 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.26 -107.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.575 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 59.62 100.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -87.58 -176.66 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -160.56 112.17 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -137.12 114.36 10.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 80.04 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 -68.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.305 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -82.42 36.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.573 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.6 4.83 62.92 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.065 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -102.01 -15.34 16.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.831 0.316 . . . . 0.0 111.292 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -168.55 95.28 0.57 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.616 0.246 . . . . 0.0 111.12 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.68 128.41 15.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.579 2.186 . . . . 0.0 112.239 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . 0.525 HG22 ' O ' ' 1' ' 15' ' ' THR . 83.5 m -95.11 54.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.659 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . 0.58 HG22 ' HD2' ' 1' ' 17' ' ' PRO . 0.2 OUTLIER -98.02 141.34 22.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.806 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . 0.58 ' HD2' HG22 ' 1' ' 16' ' ' THR . 57.2 Cg_endo -70.77 116.26 4.59 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.488 2.126 . . . . 0.0 112.539 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -124.37 -1.73 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.95 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . 0.446 ' HA ' ' OH ' ' 1' ' 126' ' ' TYR . 4.6 t -55.2 142.44 31.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . 0.464 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 0.9 OUTLIER 179.47 128.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.617 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.54 HD13 ' HD3' ' 1' ' 85' ' ' PRO . 0.4 OUTLIER -62.39 86.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.18 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' 1' ' 126' ' ' TYR . 1.0 OUTLIER -50.09 169.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.414 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.628 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.45 154.18 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -176.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.875 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -107.65 170.42 7.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.4 OUTLIER -117.31 111.36 19.27 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.027 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.818 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -80.83 80.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 122.132 0.968 . . . . 0.0 109.676 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.788 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.8 m-20 -80.35 -26.37 38.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.946 -1.934 . . . . 0.0 111.686 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' 1' ' 39' ' ' ARG . 4.2 t0 -174.94 119.01 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.341 -0.543 . . . . 0.0 112.285 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.821 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -133.43 136.41 45.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.185 0.517 . . . . 0.0 110.255 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.827 ' O ' HG13 ' 1' ' 32' ' ' ILE . 1.8 mp0 -129.86 160.95 31.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.093 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.536 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -70.87 102.42 2.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 174.759 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 1.002 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.1 mt -124.35 121.53 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 m120 61.09 35.16 18.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.148 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.08 4.49 72.77 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.075 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.73 137.79 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.792 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 92.0 m95 -59.7 129.43 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.989 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.87 145.53 43.51 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.489 -177.908 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.795 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 22.6 t -114.07 151.39 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.926 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 4.3 mtp180 -144.36 144.25 31.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.986 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.788 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.72 151.54 51.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.43 ' H ' ' CG ' ' 1' ' 27' ' ' ASP . 2.6 p30 -61.88 -16.13 48.11 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.703 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.8 mp -83.93 -50.24 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-O 121.771 0.796 . . . . 0.0 110.581 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.631 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.5 -11.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.235 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.846 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.6 t -148.01 70.22 11.05 Favored Pre-proline 0 CA--C 1.504 -0.797 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.083 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.587 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.1 Cg_exo -49.88 -31.98 28.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.477 2.118 . . . . 0.0 109.265 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.587 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.1 t 169.87 154.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.255 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.18 55.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.926 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.86 112.21 19.46 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.007 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.719 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.07 92.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.646 0.736 . . . . 0.0 110.743 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 1.002 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 31.2 m0 -44.33 -29.43 0.67 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.814 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.719 HG12 HG22 ' 1' ' 49' ' ' THR . 6.5 p -53.78 -56.44 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.809 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.694 ' N ' HG13 ' 1' ' 51' ' ' VAL . 52.6 t0 -152.79 -13.1 0.16 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.405 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.111 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 6.8 m-20 -85.71 -14.92 43.89 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.394 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.989 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.96 144.32 26.14 Favored Glycine 1 N--CA 1.386 -4.689 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 0.896 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.25 119.75 33.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.488 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.704 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.48 87.87 0.66 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 0.753 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.58 -35.76 0.06 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.67 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -55.31 -32.87 62.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.305 0.574 . . . . 0.0 110.432 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.704 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.7 OUTLIER -69.42 -28.92 66.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.429 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 0.866 HG13 HD11 ' 1' ' 55' ' ' ILE . 31.7 m -100.49 -175.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.919 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.1 OUTLIER -141.53 113.63 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.127 -177.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' 1' ' 80' ' ' TYR . 1.8 mt-10 -64.89 128.98 38.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.115 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.817 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 1.9 m -113.05 157.89 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.792 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.634 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 1.7 p -85.36 159.8 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -37.29 -35.8 0.13 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 0.0 112.889 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -76.74 -9.87 58.98 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.253 0.549 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 95.16 23.12 20.79 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.711 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.8 OUTLIER -74.46 116.93 15.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.817 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 22.0 mtm-85 -74.51 137.74 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.371 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -152.1 91.99 1.67 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.217 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . 0.505 ' HB3' HG21 ' 1' ' 61' ' ' ILE . 93.3 p -88.26 -29.19 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.793 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -35.66 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -77.42 -177.25 4.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.584 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.01 130.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 0.739 HD11 HG23 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -60.48 150.2 31.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.443 0.639 . . . . 0.0 112.21 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -156.6 133.28 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.08 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -73.48 151.71 40.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.545 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.2 17.26 5.4 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.35 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.759 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.57 -109.29 0.4 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 118.68 -1.724 . . . . 0.0 114.439 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.818 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.8 OUTLIER -152.01 160.4 43.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.372 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.797 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.8 OUTLIER -153.52 173.25 15.97 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.056 0.931 . . . . 0.0 110.582 177.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.919 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.04 125.41 39.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.339 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.741 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.46 114.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.941 0.4 . . . . 0.0 110.597 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -56.79 114.82 8.65 Favored Pre-proline 0 N--CA 1.436 -1.167 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.657 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 84.4 Cg_endo -70.47 -26.95 23.67 Favored 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 123.088 2.526 . . . . 0.0 110.58 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.69 -29.42 61.21 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.039 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.99 -2.43 55.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.824 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.2 t -96.92 130.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.924 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.922 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 112.122 -2.308 . . . . 0.0 107.985 178.781 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.504 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.4 172.7 0.4 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.777 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.906 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -106.55 124.01 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -97.05 179.54 33.88 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-O 122.528 1.071 . . . . 0.0 114.735 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . 0.488 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -62.82 137.91 96.9 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.74 -1.73 . . . . 0.0 111.666 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.064 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.3 Cg_endo -81.29 156.88 19.64 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.248 3.299 . . . . 0.0 113.405 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 22.4 mtt -149.75 134.68 17.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.743 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.0 OUTLIER -84.97 123.9 31.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.629 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.69 -51.61 0.04 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.733 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.903 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -65.36 69.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.98 0.39 . . . . 0.0 110.588 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.21 -49.56 0.85 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.258 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.19 -16.09 0.42 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.911 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.826 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.22 -153.63 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.768 0.795 . . . . 0.0 111.86 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.535 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.76 119.38 35.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.698 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.903 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 11.0 m95 -121.17 118.48 29.78 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.653 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.72 145.19 30.44 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.681 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.8 tt0 -79.64 102.32 8.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.274 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.906 HG22 HG12 ' 1' ' 91' ' ' VAL . 42.2 t -100.25 136.47 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.922 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 t-20 -86.73 101.38 13.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.502 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.689 ' CD1' ' HB ' ' 1' ' 114' ' ' VAL . 12.4 m-85 -101.44 167.6 10.05 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 123.008 1.385 . . . . 0.0 112.101 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.931 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.4 t -52.17 -66.12 0.44 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 111.871 -2.422 . . . . 0.0 116.67 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.931 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.5 -55.93 3.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.86 -7.41 61.87 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.008 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.87 -89.64 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -86.42 130.86 34.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.313 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.896 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.6 t -145.58 113.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.111 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 44.2 m95 -90.25 156.17 18.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.135 0.969 . . . . 0.0 113.465 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.606 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.57 142.95 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.731 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.705 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -64.91 100.32 0.4 Allowed 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 124.801 2.239 . . . . 0.0 107.282 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.064 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.7 t -76.32 16.3 0.48 Allowed 'General case' 0 C--N 1.28 -2.453 1 CA-C-N 107.962 -4.199 . . . . 0.0 113.45 -174.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.688 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 7.2 t -63.51 23.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.453 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 1.028 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.64 122.22 0.15 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.553 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 1.2 ptpt -71.14 -40.38 71.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.217 1.008 . . . . 0.0 108.401 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.844 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 68.2 m-20 -66.05 -4.66 7.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 1.028 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.0 -58.67 6.53 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.672 0.749 . . . . 0.0 110.401 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.049 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.15 -56.69 13.03 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 122.01 0.909 . . . . 0.0 109.325 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.618 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.7 mp -58.36 -46.03 87.07 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.212 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.36 -32.1 6.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.701 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.7 26.27 7.68 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.36 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.844 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.0 mttt . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.88 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.94 132.77 47.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.6 126.29 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.706 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.84 -30.67 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.42 -35.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 103.21 15.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.3 119.52 38.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.635 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.48 77.23 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.277 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.59 18.62 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -64.96 -82.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.487 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.38 129.41 6.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.364 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.09 -29.35 9.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . 0.557 ' H ' ' HD2' ' 1' ' 14' ' ' PRO . 3.0 mp0 -110.45 -62.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' H ' ' 1' ' 13' ' ' GLU . 74.1 Cg_endo -76.9 93.93 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.237 1.958 . . . . 0.0 112.445 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . 0.539 HG23 ' O ' ' 1' ' 14' ' ' PRO . 0.1 OUTLIER -172.72 174.99 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -111.41 121.29 40.63 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.41 -178.46 4.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.0 112.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -133.6 53.27 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.843 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 3.7 t -165.55 41.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 72.6 m-20 -82.05 127.73 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 0.6 OUTLIER -63.66 86.12 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 1.1 mmtm -52.38 168.54 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.765 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.631 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.78 154.11 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.904 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.3 m-85 -107.53 169.5 8.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 9.7 mttt -116.62 108.84 16.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.745 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.826 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.39 81.47 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.067 0.937 . . . . 0.0 109.791 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.752 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.8 m-20 -80.92 -25.94 37.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.91 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 12.6 t0 -175.83 116.69 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.788 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -130.17 134.8 47.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.08 0.467 . . . . 0.0 110.226 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.851 ' O ' HG13 ' 1' ' 32' ' ' ILE . 1.7 mp0 -130.44 160.83 32.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.805 -177.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.525 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.2 tptp -71.3 102.81 2.67 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 1.01 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.2 mt -124.53 122.89 64.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.22 35.73 18.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.131 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.75 3.64 68.25 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.205 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.96 140.21 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.77 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 92.7 m95 -59.54 129.78 43.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.951 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.77 146.73 42.63 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.432 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.826 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 19.0 t -114.36 150.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.907 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.45 140.55 29.03 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.441 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.752 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.02 153.32 49.39 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.914 0.864 . . . . 0.0 108.761 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.472 ' H ' ' CG ' ' 1' ' 27' ' ' ASP . 1.7 p30 -62.14 -16.72 54.66 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.435 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.585 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -83.15 -50.55 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.758 0.79 . . . . 0.0 110.829 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.752 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -101.7 -11.0 19.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.376 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.76 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.5 t -146.9 71.33 12.37 Favored Pre-proline 0 CA--C 1.505 -0.786 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.988 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.606 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 73.1 Cg_exo -48.29 -32.93 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.518 2.145 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 8.0 t 169.09 154.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.662 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . 0.522 ' CG ' HG23 ' 1' ' 46' ' ' THR . 0.4 OUTLIER 72.24 56.06 0.16 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.907 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.55 111.77 18.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.749 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.81 91.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.655 0.74 . . . . 0.0 110.524 -178.587 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 1.01 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 34.8 m0 -44.41 -28.28 0.54 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.742 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.749 HG12 HG22 ' 1' ' 49' ' ' THR . 7.8 p -53.27 -56.95 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.54 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.698 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.0 t0 -153.25 -11.67 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.893 -1.503 . . . . 0.0 113.063 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 0.946 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.6 m120 -86.43 -12.37 49.26 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.642 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.951 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -82.86 144.03 22.66 Favored Glycine 1 N--CA 1.387 -4.595 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 175.296 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 0.859 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.15 119.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.788 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.42 87.49 0.63 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 0.99 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -34.18 -34.49 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.01 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.24 -35.98 63.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.633 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.2 m-20 -67.57 -27.21 66.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.911 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 0.851 HG13 HD11 ' 1' ' 55' ' ' ILE . 28.7 m -99.51 -172.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.887 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -144.68 112.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.981 -176.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.07 123.72 19.3 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.84 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.806 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 0.8 OUTLIER -108.17 155.79 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.628 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.673 HG23 HG22 ' 1' ' 68' ' ' THR . 1.9 p -85.09 160.02 20.06 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 80.3 p -37.87 -34.28 0.11 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.806 0.691 . . . . 0.0 112.738 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.26 -6.99 57.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 111.078 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 93.14 23.23 25.37 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.568 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.768 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -72.1 116.29 12.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.964 0.411 . . . . 0.0 110.668 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.806 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 0.0 OUTLIER -73.48 142.18 46.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 34.9 p 42.7 75.32 0.09 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.085 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -93.45 -49.12 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.34 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' 1' ' 73' ' ' GLN . 7.3 m-20 -99.36 -25.34 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.104 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' 1' ' 72' ' ' ASP . 0.0 OUTLIER 80.85 -25.65 0.17 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.223 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . 0.505 ' O ' HG13 ' 1' ' 74' ' ' VAL . 8.8 p -109.52 115.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.972 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 0.99 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -66.9 147.64 52.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.639 0.733 . . . . 0.0 112.424 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -157.48 132.78 8.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.361 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -72.82 151.35 42.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.528 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.94 17.34 5.91 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.528 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.765 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.65 -109.16 0.39 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.559 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.826 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.2 OUTLIER -151.86 160.47 43.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.904 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.826 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -155.05 172.99 17.21 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.014 0.912 . . . . 0.0 110.563 177.33 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.818 HG12 HD12 ' 1' ' 61' ' ' ILE . 1.2 t -138.55 125.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.596 HG23 ' CE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -72.72 112.74 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.997 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 113.58 5.35 Favored Pre-proline 0 N--CA 1.436 -1.134 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.662 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 86.9 Cg_endo -71.84 -27.69 17.53 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.424 2.749 . . . . 0.0 110.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.64 -28.18 60.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.73 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.997 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.87 -3.34 56.74 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.816 HG23 ' O ' ' 1' ' 84' ' ' ASN . 27.0 t -98.77 135.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.502 0 CA-C-O 122.945 1.355 . . . . 0.0 111.51 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.89 ' HD2' ' O ' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.61 -48.43 9.52 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.871 -2.422 . . . . 0.0 107.791 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER 172.28 172.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.465 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.823 HG13 HG22 ' 1' ' 106' ' ' VAL . 67.8 t -89.94 162.56 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -130.09 179.68 16.67 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.175 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.35 133.77 90.91 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.984 -1.108 . . . . 0.0 110.75 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.072 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.9 Cg_endo -81.35 158.18 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.347 3.364 . . . . 0.0 113.534 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtt -149.7 138.01 20.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.981 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 2.1 mtpt -85.84 125.4 33.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.561 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.96 -53.35 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.791 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.896 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -66.07 69.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.398 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.62 -49.47 0.86 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.208 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.13 -14.43 0.48 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.185 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.81 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -76.92 -153.15 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.83 0.824 . . . . 0.0 112.108 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.1 m -116.86 116.74 28.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.988 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.896 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 9.9 m95 -118.63 117.39 28.83 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -105.0 150.18 25.14 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.667 ' HG3' ' NE1' ' 1' ' 115' ' ' TRP . 23.0 tt0 -82.31 102.18 11.03 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.816 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.823 HG22 HG13 ' 1' ' 91' ' ' VAL . 53.2 t -98.84 135.77 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.89 ' O ' ' HD2' ' 1' ' 89' ' ' LYS . 2.4 m-20 -89.14 102.69 15.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.384 -177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.81 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 0.9 OUTLIER -102.77 169.14 8.79 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.978 1.37 . . . . 0.0 111.544 178.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.901 HG23 ' H ' ' 1' ' 110' ' ' THR . 2.7 t -51.38 -66.08 0.45 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.196 -2.274 . . . . 0.0 116.913 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.901 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.55 -56.12 3.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.925 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.77 -7.15 61.07 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.593 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.01 -91.67 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.31 131.06 34.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 121.947 -0.737 . . . . 0.0 109.066 176.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.814 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 7.9 t -145.36 113.48 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 0.946 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -89.42 153.38 20.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.901 0.858 . . . . 0.0 113.101 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.856 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.55 144.92 23.11 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.032 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.783 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -65.33 100.36 0.47 Allowed 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 124.675 2.179 . . . . 0.0 107.076 178.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.072 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 3.1 t -75.89 14.62 0.64 Allowed 'General case' 0 C--N 1.281 -2.396 1 CA-C-N 107.981 -4.19 . . . . 0.0 113.495 -174.546 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.783 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 14.8 t -63.79 22.73 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.047 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 1.032 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -175.24 123.07 0.22 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 18.5 tttt -72.29 -39.47 68.27 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.926 0.87 . . . . 0.0 108.666 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.901 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 78.1 m-20 -66.61 -5.14 10.46 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 1.032 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 5.4 t30 -62.73 -58.48 7.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.818 0.818 . . . . 0.0 110.27 -179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.048 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.86 -57.02 11.13 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 122.025 0.917 . . . . 0.0 109.515 178.086 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.613 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.71 -45.04 93.36 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.739 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -113.58 -31.43 6.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.706 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.42 26.59 8.6 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.273 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.901 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 23.4 mttp . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.81 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.696 0.284 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' 1' ' 2' ' ' ARG . 0.0 OUTLIER -98.01 41.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.643 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.26 58.25 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.225 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -65.35 134.71 54.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.36 . . . . 0.0 111.189 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -108.42 112.37 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -103.17 87.44 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.113 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 101.45 4.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -89.79 102.97 15.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -147.45 -23.81 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.574 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -171.76 -158.29 0.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.05 132.09 10.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.144 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -15.66 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.618 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' 1' ' 14' ' ' PRO . 23.4 mt-10 -80.43 164.52 51.44 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' 1' ' 13' ' ' GLU . 11.9 Cg_endo -53.79 -81.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.5 2.133 . . . . 0.0 112.486 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m 53.03 30.65 9.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.77 0.319 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -59.92 126.97 84.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.95 138.99 17.01 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.603 2.202 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -139.8 24.2 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . 0.4 HG22 ' H ' ' 1' ' 19' ' ' THR . 1.7 t -72.82 112.67 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . 0.409 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 7.9 p-10 -177.51 133.93 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 111.359 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' 1' ' 21' ' ' LEU . 0.3 OUTLIER -64.97 85.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER -47.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 111.664 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.666 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.49 155.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.928 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.6 m-85 -108.48 169.88 8.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.865 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 15.3 mmmt -116.64 108.52 16.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.133 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.781 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.54 82.63 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.976 0.893 . . . . 0.0 109.905 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.768 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.7 m-20 -83.48 -27.38 29.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.275 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -174.64 119.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.759 HD11 ' HB3' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -133.13 138.28 46.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.233 0.54 . . . . 0.0 110.743 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.694 ' OE1' ' O ' ' 1' ' 29' ' ' LEU . 0.7 OUTLIER -129.28 160.57 32.56 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.399 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.535 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.0 OUTLIER -71.93 103.18 3.11 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 0.889 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 1.1 mm -123.88 117.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -171.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 4.5 m120 61.22 37.58 17.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.101 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.72 1.95 68.36 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.292 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.57 136.36 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.759 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 93.1 m95 -59.66 131.56 51.29 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.889 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.97 146.49 42.97 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.899 -179.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.824 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 19.4 t -114.07 150.0 16.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.829 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 6.4 mtp180 -144.11 144.08 31.43 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.042 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.26 152.94 51.11 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.521 ' H ' ' CG ' ' 1' ' 27' ' ' ASP . 1.2 p30 -61.28 -17.33 52.98 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.4 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.583 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.9 mp -84.27 -50.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-O 121.699 0.761 . . . . 0.0 110.673 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.79 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -100.43 -11.8 19.91 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.425 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.761 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.63 71.09 9.74 Favored Pre-proline 0 CA--C 1.505 -0.761 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.197 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.59 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.3 Cg_exo -49.76 -31.84 27.15 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.534 2.156 . . . . 0.0 109.343 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.835 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 13.7 t 169.51 155.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.052 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . 0.835 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.31 56.49 0.15 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.829 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.81 113.81 20.7 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.775 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.52 91.76 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.726 0.774 . . . . 0.0 109.849 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 0.878 ' CD1' HD12 ' 1' ' 32' ' ' ILE . 42.5 m0 -47.58 -27.47 1.86 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.798 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.775 HG12 HG22 ' 1' ' 49' ' ' THR . 9.8 p -54.03 -56.19 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.657 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.703 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.5 t0 -151.38 -14.09 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.518 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.133 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 5.3 m-20 -86.82 -11.6 50.45 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.377 0.608 . . . . 0.0 110.812 -178.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.804 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.88 140.03 21.22 Favored Glycine 1 N--CA 1.391 -4.302 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 1.052 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.03 117.81 29.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.379 -178.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.833 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -68.97 87.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.579 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 1.049 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -34.38 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.585 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -37.04 64.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.434 0.635 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.833 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.5 OUTLIER -68.0 -26.19 65.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.116 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 1.052 HG13 HD11 ' 1' ' 55' ' ' ILE . 23.5 m -98.26 -171.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.978 HG22 ' HB3' ' 1' ' 71' ' ' SER . 0.0 OUTLIER -145.95 107.61 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.183 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.7 pt-20 -65.81 122.93 18.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.291 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.925 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 15.6 m -115.0 160.65 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.433 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.672 HG23 HG22 ' 1' ' 68' ' ' THR . 3.1 p -83.72 164.76 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.5 -35.88 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.46 -5.88 57.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.185 0.516 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 91.19 23.56 29.2 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.672 HG22 HG23 ' 1' ' 64' ' ' THR . 0.9 OUTLIER -74.61 118.9 18.09 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.007 0.432 . . . . 0.0 111.138 -178.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.925 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 21.2 mtt180 -69.1 144.87 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.362 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . 0.544 HG22 ' O ' ' 1' ' 62' ' ' GLU . 8.9 t -161.61 57.39 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . 0.978 ' HB3' HG22 ' 1' ' 61' ' ' ILE . 8.3 p -76.87 -6.93 54.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.075 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.64 -6.04 3.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -122.15 -156.97 0.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.621 0.248 . . . . 0.0 111.002 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.5 141.36 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 1.049 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.1 OUTLIER -66.63 150.81 48.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 111.643 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 6.2 mt-30 -154.55 133.04 11.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.923 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.695 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -77.55 152.25 34.13 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.584 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.61 18.46 4.84 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.54 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.772 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.37 -109.38 0.44 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 118.742 -1.694 . . . . 0.0 114.309 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.781 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.4 OUTLIER -151.68 160.05 43.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.589 . . . . 0.0 109.642 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.812 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.72 173.43 16.42 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.95 0.881 . . . . 0.0 110.291 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.916 HG12 HD12 ' 1' ' 61' ' ' ILE . 1.2 t -137.58 125.32 31.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.678 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.39 115.65 14.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.309 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.915 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -56.29 114.53 7.85 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.67 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 74.1 Cg_endo -65.13 -26.85 57.25 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 C-N-CA 122.933 2.422 . . . . 0.0 109.834 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.35 -27.07 61.3 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 113.419 -1.718 . . . . 0.0 109.92 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.669 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.9 t-20 -82.29 -2.35 52.37 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.799 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 55.6 t -101.85 130.55 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 CA-C-O 123.165 1.46 . . . . 0.0 113.029 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.899 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -90.58 -42.33 10.86 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.445 -2.616 . . . . 0.0 107.876 177.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.51 ' O ' HG13 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 174.66 173.47 0.21 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.383 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.935 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -103.28 138.35 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.252 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.46 179.69 20.92 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-O 122.194 0.885 . . . . 0.0 114.067 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . 0.503 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.5 137.79 94.82 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.178 -1.511 . . . . 0.0 111.601 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.036 ' HB3' HG21 ' 1' ' 118' ' ' THR . 22.1 Cg_endo -81.46 157.56 19.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 124.435 3.424 . . . . 0.0 113.625 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.6 mtm -149.5 137.81 20.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.9 mtmm -85.18 124.98 32.46 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.657 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.55 -55.88 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.206 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.896 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -63.75 69.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.901 0.351 . . . . 0.0 110.791 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.08 -49.55 0.85 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.258 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.36 -15.17 0.48 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.04 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.823 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.76 -153.21 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.754 0.788 . . . . 0.0 111.928 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.563 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.74 119.3 35.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.661 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.896 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.64 118.03 28.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -104.91 148.52 26.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.2 tt0 -81.22 102.94 10.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.742 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.935 HG22 HG12 ' 1' ' 91' ' ' VAL . 32.7 t -98.33 138.42 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.899 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER -88.48 102.12 14.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.835 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.693 ' C ' ' HD3' ' 1' ' 89' ' ' LYS . 12.1 m-85 -100.22 157.93 16.23 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-O 122.104 0.954 . . . . 0.0 109.695 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.648 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.3 OUTLIER -58.64 -62.55 1.78 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.681 -1.599 . . . . 0.0 114.228 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.648 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.12 10.72 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.911 0.862 . . . . 0.0 109.804 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.514 ' HA3' ' OD2' ' 1' ' 59' ' ' ASP . . . -73.83 -2.39 61.13 Favored Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.159 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 46.88 -92.52 0.01 OUTLIER Glycine 0 C--O 1.212 -1.226 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.26 130.59 37.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.827 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.7 t -145.36 117.58 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.133 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 42.7 m95 -92.46 156.18 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.342 -0.943 . . . . 0.0 113.023 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.682 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.75 143.03 21.48 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.731 -1.577 . . . . 0.0 108.678 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.831 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -64.87 101.4 0.49 Allowed 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 124.595 2.141 . . . . 0.0 107.052 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.036 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 6.6 t -75.64 14.5 0.62 Allowed 'General case' 0 C--N 1.281 -2.374 1 CA-C-N 108.2 -4.091 . . . . 0.0 113.527 -174.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.831 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 12.6 t -62.37 21.51 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.715 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 1.012 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.6 OUTLIER -175.33 126.37 0.25 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.611 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 0.3 OUTLIER -74.51 -41.35 60.8 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 122.126 0.965 . . . . 0.0 108.893 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.888 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 1.3 m-20 -66.25 -4.41 7.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 1.012 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 4.8 t30 -62.23 -58.81 6.37 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.417 0.627 . . . . 0.0 110.453 -179.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.058 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.89 -55.08 21.53 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.789 0.805 . . . . 0.0 109.601 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.614 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -60.33 -43.73 96.14 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.037 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.595 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 2.1 m-85 -114.49 -32.14 6.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.92 26.04 7.7 Favored Glycine 0 CA--C 1.505 -0.575 0 C-N-CA 119.427 -1.368 . . . . 0.0 111.718 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.888 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 26.3 mttp . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.952 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' 1' ' 2' ' ' ARG . 8.9 mtp180 -75.39 162.15 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.91 7.03 36.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.747 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -69.4 135.29 50.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -116.77 -31.86 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.43 100.9 11.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -133.0 129.48 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.01 72.83 7.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -122.24 177.07 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.438 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.35 176.46 7.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.23 21.84 43.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.623 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -93.51 18.69 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.712 0.291 . . . . 0.0 111.111 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.51 58.6 17.44 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.79 140.73 51.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.686 2.257 . . . . 0.0 112.369 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.17 45.35 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.802 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . 0.583 HG22 ' HD2' ' 1' ' 17' ' ' PRO . 0.2 OUTLIER -97.47 142.12 24.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . 0.583 ' HD2' HG22 ' 1' ' 16' ' ' THR . 40.2 Cg_endo -66.69 135.02 37.12 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.398 2.065 . . . . 0.0 112.297 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 17.4 m -127.2 53.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 16.3 p -115.43 41.84 2.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . 0.45 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 3.0 m120 -72.12 129.63 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.32 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.53 HD13 ' HD3' ' 1' ' 85' ' ' PRO . 0.5 OUTLIER -63.51 87.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.952 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -50.62 166.93 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.199 0.523 . . . . 0.0 111.522 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.7 HG12 ' HB2' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -72.5 152.2 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.935 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -105.85 170.94 7.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.406 -1.725 . . . . 0.0 106.555 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.713 ' HD2' HD11 ' 1' ' 42' ' ' ILE . 70.7 mttt -117.41 109.5 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.98 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.834 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -80.19 81.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.138 0.971 . . . . 0.0 109.708 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.3 m-20 -79.04 -26.74 43.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.745 -2.025 . . . . 0.0 111.618 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 11.6 t0 -176.54 118.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -133.62 137.4 45.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.185 177.698 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.74 160.84 32.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.716 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.497 ' HG2' ' CE2' ' 1' ' 36' ' ' TRP . 0.1 OUTLIER -70.62 103.25 2.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 175.262 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 0.97 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -124.66 123.27 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . 0.405 ' O ' HG13 ' 1' ' 35' ' ' ILE . 4.3 m120 59.41 37.67 23.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.485 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.2 3.68 70.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.267 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -138.53 138.69 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.805 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 82.0 m95 -59.77 130.1 45.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.967 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.91 144.93 43.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.393 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.8 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 21.8 t -112.8 150.97 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.831 ' HG2' HG11 ' 1' ' 44' ' ' VAL . 75.8 mtm180 -144.65 135.44 24.81 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.513 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.785 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -124.76 153.03 43.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.083 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' 1' ' 41' ' ' ASN . 1.5 p30 -61.91 -17.75 57.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.057 -1.428 . . . . 0.0 112.451 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.713 HD11 ' HD2' ' 1' ' 25' ' ' LYS . 3.3 mp -81.97 -50.62 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.842 0.83 . . . . 0.0 110.968 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.739 HD12 HD21 ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.12 -12.23 18.96 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.593 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.831 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.4 t -148.42 70.84 10.78 Favored Pre-proline 0 CA--C 1.503 -0.851 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.998 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.574 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.6 Cg_exo -49.32 -31.89 24.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.815 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 14.0 t 170.24 154.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.994 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . 0.815 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.29 56.68 0.15 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.808 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -85.07 112.77 20.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.844 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.26 91.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.705 0.764 . . . . 0.0 110.301 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 0.97 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 37.2 m0 -45.37 -28.8 0.92 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.647 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.844 HG12 HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.28 -57.09 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.797 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.729 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.0 t0 -150.94 -13.28 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.609 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.046 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -87.58 -14.33 40.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.76 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.967 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.62 145.27 27.47 Favored Glycine 1 N--CA 1.386 -4.638 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 175.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 0.944 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.16 118.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.757 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.502 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.35 87.58 0.62 Allowed 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 0.8 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -36.27 -34.77 0.06 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.694 -176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -54.67 -33.59 60.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.704 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.3 m-20 -68.62 -29.63 68.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.551 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 0.936 HG23 HD11 ' 1' ' 75' ' ' LEU . 29.0 m -100.04 -175.03 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.13 0.491 . . . . 0.0 112.172 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.855 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -141.74 110.08 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.043 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.2 OUTLIER -64.98 122.98 18.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.632 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.929 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 7.2 m -104.95 159.45 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.951 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.646 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 2.5 p -84.08 161.55 20.63 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -37.85 -33.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.845 0.716 . . . . 0.0 112.749 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -79.8 -7.56 58.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 92.63 23.35 26.3 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.607 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.785 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -73.68 116.69 14.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.921 0.391 . . . . 0.0 110.788 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.929 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 6.7 mtm105 -73.23 140.01 46.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.082 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . 0.495 HG23 ' O ' ' 1' ' 70' ' ' THR . 9.5 t 39.71 78.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.275 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 13.7 t -92.18 -47.68 7.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.693 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' 1' ' 73' ' ' GLN . 29.8 p30 -96.24 -13.94 23.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.679 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' 1' ' 72' ' ' ASP . 0.9 OUTLIER 71.66 9.77 6.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.627 0.251 . . . . 0.0 111.148 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . 0.595 ' O ' HG13 ' 1' ' 74' ' ' VAL . 11.6 p -149.21 109.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.783 0.325 . . . . 0.0 110.724 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 0.936 HD11 HG23 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -58.82 144.06 45.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.55 0.691 . . . . 0.0 112.354 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.527 ' HG2' ' C ' ' 1' ' 75' ' ' LEU . 0.6 OUTLIER -151.95 133.16 14.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.843 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.929 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -79.15 151.65 31.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.642 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.15 18.86 4.91 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.072 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.763 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.75 -106.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 118.881 -1.628 . . . . 0.0 114.244 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.834 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.1 OUTLIER -151.87 160.64 43.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.177 -0.511 . . . . 0.0 110.134 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.794 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -154.36 173.07 16.7 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 122.139 0.971 . . . . 0.0 111.204 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.855 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.0 OUTLIER -136.68 125.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.624 HG23 HG12 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -74.45 112.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.896 0.379 . . . . 0.0 110.457 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.91 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 114.65 6.96 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.677 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 89.5 Cg_endo -69.76 -28.12 25.63 Favored 'Trans proline' 0 CA--C 1.5 -1.197 0 C-N-CA 123.05 2.5 . . . . 0.0 110.882 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -28.53 61.44 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.012 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.91 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.55 -3.26 55.7 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.79 HG23 ' O ' ' 1' ' 84' ' ' ASN . 38.4 t -96.51 132.75 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-O 123.08 1.419 . . . . 0.0 112.246 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.906 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -86.08 -43.74 12.84 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 108.167 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.552 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.55 173.36 0.29 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.953 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.905 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.31 117.33 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.35 179.63 45.01 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 122.408 1.004 . . . . 0.0 114.711 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.63 142.38 98.47 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 112.711 -1.745 . . . . 0.0 111.26 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.004 ' HB3' HG21 ' 1' ' 118' ' ' THR . 26.0 Cg_endo -81.34 157.99 19.74 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.482 3.455 . . . . 0.0 113.762 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 11.4 mtt -149.57 135.2 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.7 mttm -85.39 126.51 33.83 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.414 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.25 -52.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.794 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.893 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -64.91 69.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.637 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.07 -49.39 0.86 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.193 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.07 -16.05 0.43 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.05 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.839 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.13 -152.89 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.807 0.813 . . . . 0.0 112.136 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.553 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.3 m -116.74 118.6 32.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.737 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.893 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.84 117.52 26.72 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.25 147.38 27.12 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.692 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.3 tt0 -80.9 102.76 10.28 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.851 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.905 HG22 HG12 ' 1' ' 91' ' ' VAL . 41.8 t -101.62 136.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.906 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.3 m120 -90.31 101.64 14.37 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.367 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.769 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.8 m-85 -98.89 168.36 10.16 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 123.034 1.397 . . . . 0.0 111.877 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.925 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.2 -65.32 0.58 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 111.972 -2.376 . . . . 0.0 116.569 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.925 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.16 -55.91 3.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.82 -6.02 66.2 Favored Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.995 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.11 -91.37 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.79 129.19 34.9 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.944 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.5 t -145.4 119.0 2.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.046 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 45.4 m95 -93.55 156.07 16.94 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.006 0.907 . . . . 0.0 113.17 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.607 HD23 ' HG ' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -153.43 143.2 21.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.1 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.739 HD21 HD12 ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -65.07 100.01 0.4 Allowed 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 124.965 2.317 . . . . 0.0 107.182 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.004 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 5.1 t -77.12 14.69 0.84 Allowed 'General case' 0 C--N 1.281 -2.387 1 CA-C-N 107.622 -4.354 . . . . 0.0 113.975 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.624 ' OG1' ' ND2' ' 1' ' 117' ' ' ASN . 0.9 OUTLIER -63.2 22.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.991 178.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 1.042 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 3.6 m -175.19 121.28 0.21 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -69.57 -40.34 76.81 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.944 0.878 . . . . 0.0 109.125 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.867 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 98.5 m-20 -65.2 -4.69 5.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 1.042 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.98 -58.59 6.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.703 0.763 . . . . 0.0 110.483 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.051 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.5 -56.81 11.66 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.02 0.914 . . . . 0.0 109.534 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.608 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.86 -44.62 94.03 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.696 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.607 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.52 -31.51 6.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.64 26.42 7.63 Favored Glycine 0 CA--C 1.504 -0.642 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.728 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.867 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 70.8 mttt . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.957 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 60.6 mtp . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.02 165.23 7.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.73 130.16 9.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.414 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.58 27.42 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 0.0 111.129 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.62 -55.69 3.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -137.56 120.25 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.206 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -100.22 135.58 41.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.484 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.16 84.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.277 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -142.91 -67.79 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.18 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.5 -14.83 59.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.465 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 44.9 3.35 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.148 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 10.5 p -113.7 -2.43 13.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 111.099 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -110.45 82.85 2.95 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.77 165.45 32.19 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.7 2.266 . . . . 0.0 112.404 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -96.83 -7.14 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.388 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -108.32 106.88 59.51 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.681 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.85 119.3 3.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.526 2.151 . . . . 0.0 112.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -146.84 30.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.829 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 19' ' ' THR . . . . . 0.572 ' O ' HG23 ' 1' ' 19' ' ' THR . 8.3 t -178.28 99.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.045 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 20' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' 1' ' 21' ' ' LEU . 1.3 t-20 -166.94 127.47 1.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.438 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 21' ' ' LEU . . . . . 0.623 HD11 ' HG3' ' 1' ' 85' ' ' PRO . 1.8 mt 6.69 96.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 22' ' ' LYS . . . . . 0.478 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 0.5 OUTLIER -60.75 168.72 2.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.195 0.522 . . . . 0.0 111.068 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 23' ' ' ILE . . . . . 0.608 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -73.26 154.3 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 24' ' ' TYR . . . . . 0.928 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.0 m-85 -105.96 169.54 8.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 25' ' ' LYS . . . . . 0.66 ' HG3' HD11 ' 1' ' 42' ' ' ILE . 0.2 OUTLIER -116.85 108.69 16.15 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.1 177.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 26' ' ' VAL . . . . . 0.809 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.42 82.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.888 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 27' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.9 m-20 -81.03 -27.34 35.83 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 112.82 -1.991 . . . . 0.0 111.81 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 28' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 2.5 t70 -175.84 118.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.227 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 29' ' ' LEU . . . . . 0.813 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -131.97 136.39 47.28 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.271 0.558 . . . . 0.0 110.344 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 30' ' ' GLN . . . . . 0.866 ' O ' HG13 ' 1' ' 32' ' ' ILE . 0.7 OUTLIER -129.82 160.5 33.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.701 -178.227 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' CZ2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.33 103.6 2.91 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 32' ' ' ILE . . . . . 0.988 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -123.94 118.93 55.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -171.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 33' ' ' ASN . . . . . 0.407 ' O ' HG13 ' 1' ' 35' ' ' ILE . 2.6 m120 61.08 39.27 16.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.534 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.15 4.85 69.41 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.6 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 35' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -137.9 136.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 36' ' ' TRP . . . . . 0.782 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 78.4 m95 -59.81 130.2 45.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 37' ' ' GLN . . . . . 0.945 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.8 146.71 42.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.411 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 38' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 21.5 t -114.18 150.97 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 39' ' ' ARG . . . . . 0.914 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 7.6 mtp180 -144.45 138.52 27.72 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.368 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 40' ' ' ASN . . . . . 0.773 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -128.56 153.04 47.62 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 121.989 0.9 . . . . 0.0 108.689 175.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 41' ' ' ASN . . . . . 0.553 HD22 ' CE ' ' 1' ' 25' ' ' LYS . 4.4 p30 -61.01 -18.46 57.81 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.47 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 42' ' ' ILE . . . . . 0.66 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.6 mp -82.25 -50.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.729 0.776 . . . . 0.0 110.853 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.684 ' HG ' HD22 ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -100.56 -11.92 19.69 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.529 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 44' ' ' VAL . . . . . 0.792 HG11 ' HB2' ' 1' ' 48' ' ' PHE . 2.2 t -148.43 71.6 10.83 Favored Pre-proline 0 CA--C 1.504 -0.798 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.086 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 45' ' ' PRO . . . . . 0.592 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.2 Cg_exo -49.47 -31.68 24.58 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.503 2.135 . . . . 0.0 109.113 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 46' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 14.2 t 169.87 152.79 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.005 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.7 56.91 0.13 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 48' ' ' PHE . . . . . 0.914 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.16 112.75 20.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 49' ' ' THR . . . . . 0.773 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.83 91.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.442 -178.479 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 50' ' ' TRP . . . . . 0.988 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.2 m0 -45.51 -27.97 0.84 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.555 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.773 HG12 HG22 ' 1' ' 49' ' ' THR . 8.9 p -53.73 -57.15 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.674 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 52' ' ' ASP . . . . . 0.708 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.9 t0 -152.29 -12.61 0.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.349 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 53' ' ' ASN . . . . . 1.068 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -86.75 -13.74 44.38 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.624 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 54' ' ' GLY . . . . . 0.945 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.89 144.5 27.64 Favored Glycine 1 N--CA 1.386 -4.635 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 175.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 55' ' ' ILE . . . . . 0.869 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.41 118.76 31.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.557 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.14 87.64 0.59 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 57' ' ' ALA . . . . . 0.994 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -35.1 -35.6 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.3 -1.318 . . . . 0.0 113.895 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -54.07 -34.43 60.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.349 0.595 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 59' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.1 m-20 -68.55 -27.54 66.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.848 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 60' ' ' VAL . . . . . 0.869 HG13 HD11 ' 1' ' 55' ' ' ILE . 30.1 m -99.75 -173.36 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 61' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -143.48 110.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.01 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 62' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.51 124.64 21.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.987 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 63' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 2.5 m -109.47 160.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.026 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 64' ' ' THR . . . . . 0.69 HG23 HG22 ' 1' ' 68' ' ' THR . 2.6 p -84.8 159.84 20.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 73.7 p -37.56 -33.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.929 0.768 . . . . 0.0 112.859 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -79.34 -8.37 59.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.267 0.556 . . . . 0.0 111.259 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 67' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.15 22.84 23.99 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.428 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 68' ' ' THR . . . . . 0.69 HG22 HG23 ' 1' ' 64' ' ' THR . 0.9 OUTLIER -75.12 117.27 16.77 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.067 0.461 . . . . 0.0 111.287 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 69' ' ' ARG . . . . . 0.835 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 7.8 mtp180 -71.46 141.0 50.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.93 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 21.2 p -154.22 93.83 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.575 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.28 -29.15 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.44 -27.54 56.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.187 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -86.15 -177.52 6.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.38 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -108.93 139.92 29.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 75' ' ' LEU . . . . . 0.994 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -66.73 145.12 55.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.329 0.585 . . . . 0.0 111.724 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' 1' ' 75' ' ' LEU . 4.0 mt-30 -152.84 132.93 13.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.814 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 77' ' ' LYS . . . . . 0.813 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.85 151.73 37.38 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 78' ' ' GLY . . . . . 0.582 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.03 17.31 5.46 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.357 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 79' ' ' GLY . . . . . 0.759 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.25 -108.02 0.33 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.54 -1.79 . . . . 0.0 114.6 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 80' ' ' TYR . . . . . 0.809 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.92 160.36 43.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.144 -0.528 . . . . 0.0 109.89 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.809 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.6 OUTLIER -154.19 172.83 16.97 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 121.916 0.865 . . . . 0.0 110.467 177.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 82' ' ' VAL . . . . . 0.798 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -137.27 124.8 31.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 83' ' ' ILE . . . . . 0.609 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.41 112.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 84' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -52.6 114.52 5.79 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.674 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.0 Cg_endo -71.24 -27.56 19.63 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 123.164 2.576 . . . . 0.0 110.845 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -74.89 -27.92 60.43 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.842 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 87' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.47 -4.08 56.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 88' ' ' VAL . . . . . 0.769 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.8 t -96.63 131.71 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-O 122.991 1.377 . . . . 0.0 111.84 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.864 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.43 -46.94 12.84 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 111.718 -2.492 . . . . 0.0 107.693 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 90' ' ' SER . . . . . 0.452 ' O ' HG13 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 173.76 172.88 0.17 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.787 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 91' ' ' VAL . . . . . 0.948 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.69 138.81 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 92' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.99 179.83 20.66 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 122.104 0.836 . . . . 0.0 114.021 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 93' ' ' THR . . . . . 0.411 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -60.6 136.18 92.38 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.286 -1.457 . . . . 0.0 111.684 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 94' ' ' PRO . . . . . 1.037 ' HB3' HG21 ' 1' ' 118' ' ' THR . 21.7 Cg_endo -81.21 157.16 19.92 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.42 3.413 . . . . 0.0 113.563 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 95' ' ' MET . . . . . 0.512 ' HG3' ' CH2' ' 1' ' 115' ' ' TRP . 0.3 OUTLIER -148.8 137.03 20.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.427 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 96' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -86.3 126.87 34.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.546 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 97' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.29 -53.66 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.51 -1.328 . . . . 0.0 113.803 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 98' ' ' SER . . . . . 0.899 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -64.96 69.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.655 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 99' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.0 -49.4 0.86 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.213 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.55 -15.67 0.47 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.008 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 101' ' ' LEU . . . . . 0.819 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.43 -153.68 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.797 0.808 . . . . 0.0 111.955 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.79 118.26 32.03 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.811 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 103' ' ' TRP . . . . . 0.899 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.2 m95 -120.11 117.2 27.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 104' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.73 148.19 26.36 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -175.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 105' ' ' GLN . . . . . 0.686 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 28.4 tt0 -82.21 102.31 11.05 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.395 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 106' ' ' VAL . . . . . 0.948 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 42.6 t -101.03 137.93 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 107' ' ' ASN . . . . . 0.864 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.0 OUTLIER -89.95 101.72 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.309 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 108' ' ' PHE . . . . . 0.736 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.7 m-85 -99.52 168.58 9.88 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.046 1.403 . . . . 0.0 111.79 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 109' ' ' THR . . . . . 0.917 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -52.29 -65.6 0.53 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.057 -2.338 . . . . 0.0 116.637 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 110' ' ' THR . . . . . 0.917 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.35 -56.06 3.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 111' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -71.77 -7.37 65.41 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.938 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 112' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.99 -90.6 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 113' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -84.7 130.5 34.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 114' ' ' VAL . . . . . 0.803 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.3 t -145.33 116.28 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 115' ' ' TRP . . . . . 1.068 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 50.0 m95 -92.08 154.14 18.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.853 0.835 . . . . 0.0 112.777 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 116' ' ' LEU . . . . . 0.908 HD23 HD22 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.58 143.5 22.01 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.045 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 117' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -64.9 100.39 0.41 Allowed 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 124.856 2.265 . . . . 0.0 107.103 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 118' ' ' THR . . . . . 1.037 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 3.4 t -75.82 15.02 0.57 Allowed 'General case' 0 C--N 1.279 -2.467 1 CA-C-N 107.858 -4.246 . . . . 0.0 113.348 -174.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 119' ' ' THR . . . . . 0.777 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 13.0 t -64.58 24.0 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.916 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 120' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -175.27 126.08 0.25 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 121' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 3.2 tttt -74.38 -40.78 61.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 122' ' ' ASP . . . . . 0.856 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 77.7 m-20 -65.83 -4.61 7.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 123' ' ' ASN . . . . . 1.001 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 4.5 t30 -62.9 -58.57 6.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.674 0.749 . . . . 0.0 110.457 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 124' ' ' LEU . . . . . 1.069 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -65.09 -55.62 17.73 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.131 0.967 . . . . 0.0 109.418 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 125' ' ' LEU . . . . . 0.598 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.7 mp -59.57 -45.15 92.7 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.261 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 126' ' ' TYR . . . . . 0.611 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -115.05 -31.51 6.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 127' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 102.45 26.77 7.12 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 119.233 -1.461 . . . . 0.0 111.829 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 128' ' ' LYS . . . . . 0.856 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 39.8 mttt . . . . . 0 N--CA 1.433 -1.285 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.814 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.55 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.5 154.53 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.867 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.6 m-85 -108.42 169.34 8.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.648 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.6 OUTLIER -116.93 110.75 18.7 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.823 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -80.55 81.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.977 0.894 . . . . 0.0 110.018 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 2.6 m-20 -82.48 -25.91 33.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 112.935 -1.939 . . . . 0.0 111.955 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.1 t70 -174.18 114.63 0.19 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.273 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.866 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.77 136.0 48.31 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.006 177.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.866 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -128.9 160.82 31.44 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.919 -177.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.538 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -72.01 103.35 3.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 1.025 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -123.8 119.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.839 -171.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . 0.408 ' O ' HG13 ' 1' ' 35' ' ' ILE . 43.6 m-20 61.66 36.65 16.47 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.355 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.56 2.93 65.17 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.307 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.852 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 94.2 m95 -60.24 131.04 49.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.975 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.62 146.69 42.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.721 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.835 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 21.1 t -115.14 151.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.931 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 30.5 mtp180 -144.3 142.94 30.75 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.126 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.808 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.86 150.07 52.26 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.631 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -59.69 -18.18 40.29 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.595 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.589 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -83.23 -50.5 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.64 0.733 . . . . 0.0 110.906 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.02 -11.21 20.78 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.249 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.771 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.3 t -148.84 71.33 10.41 Favored Pre-proline 0 CA--C 1.505 -0.781 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.996 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.593 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 76.3 Cg_exo -48.96 -32.32 22.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.573 2.182 . . . . 0.0 109.231 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.889 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 11.1 t 169.47 155.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.978 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . 0.889 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.33 56.96 0.15 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 177.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.931 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -84.19 111.45 19.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.747 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.75 91.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.54 0.686 . . . . 0.0 110.583 -178.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 1.025 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.1 m0 -44.31 -28.58 0.55 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.506 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.747 HG12 HG22 ' 1' ' 49' ' ' THR . 5.9 p -52.96 -56.2 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.682 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.2 t0 -153.68 -13.05 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.259 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.012 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -86.31 -13.01 47.85 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.461 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.975 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.53 142.29 22.7 Favored Glycine 1 N--CA 1.388 -4.525 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 175.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 0.94 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.42 119.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.729 -178.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.67 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.53 87.72 0.66 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.744 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.3 -35.16 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.767 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -54.46 -35.74 63.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.252 0.549 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.67 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 1.0 OUTLIER -66.19 -29.08 69.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.685 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 0.849 HG13 HD11 ' 1' ' 55' ' ' ILE . 26.5 m -100.17 -173.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.267 0.556 . . . . 0.0 112.407 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.835 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -142.66 112.34 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.817 -177.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -62.8 121.33 13.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.015 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.726 HG21 HG23 ' 1' ' 82' ' ' VAL . 1.8 m -105.22 153.71 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.896 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.55 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.6 p -83.97 161.3 20.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t . . . . . 0 N--CA 1.468 0.452 0 O-C-N 123.882 0.739 . . . . 0.0 112.593 -178.528 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -74.83 151.54 39.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.552 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 114.42 18.33 6.69 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.189 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.74 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.71 -109.54 0.43 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.766 -1.683 . . . . 0.0 114.675 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.823 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.1 OUTLIER -151.94 160.37 43.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.912 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.835 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.9 OUTLIER -154.98 173.25 16.83 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 122.013 0.911 . . . . 0.0 111.121 177.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.835 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.09 125.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.682 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.622 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.62 111.65 10.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.302 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.902 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.2 t-20 -54.03 115.05 7.42 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.683 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 95.0 Cg_endo -68.94 -28.21 29.58 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.133 2.555 . . . . 0.0 110.925 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -28.85 61.78 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.065 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.902 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.43 -3.56 55.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.788 HG23 ' O ' ' 1' ' 84' ' ' ASN . 39.2 t -96.53 132.77 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.362 0 CA-C-O 123.085 1.421 . . . . 0.0 112.134 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.97 -44.78 12.79 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 111.615 -2.539 . . . . 0.0 107.979 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.52 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.09 173.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.599 -1.637 . . . . 0.0 112.766 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.911 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -107.09 117.06 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.73 179.64 44.47 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-O 122.518 1.065 . . . . 0.0 115.028 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . 0.524 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.97 138.96 95.8 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.609 -1.796 . . . . 0.0 111.934 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.045 ' HB3' HG21 ' 1' ' 118' ' ' THR . 25.1 Cg_endo -81.18 158.3 20.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.477 3.451 . . . . 0.0 113.925 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.2 mtt -149.22 135.84 19.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 15.0 mttt -86.36 123.68 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.346 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.41 -52.64 0.04 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.915 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.9 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.99 69.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.009 0.405 . . . . 0.0 110.585 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.27 -49.58 0.85 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.149 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.02 -16.15 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.999 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.842 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.08 -153.53 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.769 0.795 . . . . 0.0 112.038 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.547 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.59 118.28 32.19 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.737 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.9 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.7 m95 -120.77 117.22 26.88 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.66 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.33 147.4 27.13 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.707 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 26.8 tt0 -80.86 102.62 10.16 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.611 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.911 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 43.8 t -100.92 135.79 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.878 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 m120 -89.85 101.94 14.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.389 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.746 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.9 m-85 -99.23 168.21 10.18 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-O 122.92 1.343 . . . . 0.0 111.927 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.929 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.13 -65.48 0.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.624 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.929 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.31 -56.01 3.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.32 -7.4 67.79 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.974 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.45 -91.63 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.67 130.11 34.75 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.009 -0.701 . . . . 0.0 109.298 176.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.94 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.5 t -145.63 117.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.012 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.4 m95 -92.96 155.36 17.61 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.887 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.556 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.36 144.43 22.94 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.975 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.792 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.3 OUTLIER -65.14 101.92 0.58 Allowed 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 124.64 2.162 . . . . 0.0 107.362 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.045 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.2 t -78.03 15.76 0.85 Allowed 'General case' 0 C--N 1.277 -2.56 1 CA-C-N 108.246 -4.07 . . . . 0.0 113.245 -174.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.792 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 6.8 t -63.34 21.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.845 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 0.999 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.5 m -175.13 125.26 0.25 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.559 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 4.9 ttmt -74.09 -40.63 62.6 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.991 0.901 . . . . 0.0 108.745 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.818 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 85.8 m-20 -65.69 -4.64 6.68 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 0.999 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.52 -58.73 6.53 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.77 0.795 . . . . 0.0 110.509 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.026 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.94 -55.62 18.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 122.021 0.915 . . . . 0.0 109.452 178.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.6 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.24 -45.81 90.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.147 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.3 m-85 -113.97 -31.74 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.739 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.0 26.21 8.02 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.389 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.818 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 80.0 mttt . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.005 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttm . . . . . 0 N--CA 1.45 -0.459 0 CA-C-O 120.91 0.386 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.598 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.17 156.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.803 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 5.4 m-85 -109.76 169.71 8.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.395 -1.729 . . . . 0.0 106.798 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.674 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 5.0 mmtt -116.4 108.99 16.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.089 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.854 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -80.0 80.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.138 0.97 . . . . 0.0 109.634 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 5.5 m-20 -80.45 -26.9 38.07 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.645 -2.071 . . . . 0.0 111.966 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . 0.443 ' HA ' ' CD ' ' 1' ' 77' ' ' LYS . 5.3 t0 -175.04 114.98 0.15 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.931 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -131.09 138.48 49.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.214 177.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.931 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -132.92 161.63 33.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.212 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.0 103.01 2.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 174.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 0.989 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -124.2 120.84 60.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.72 35.24 19.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.71 4.6 76.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.76 136.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.663 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 97.1 m95 -60.22 128.41 36.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.955 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.85 143.87 45.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.423 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.791 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 22.8 t -112.38 151.25 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.91 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 28.7 mtp180 -144.19 143.98 31.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.047 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.777 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.77 152.56 51.74 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.582 HD22 HD12 ' 1' ' 42' ' ' ILE . 0.1 OUTLIER -62.21 -15.4 46.43 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.374 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.643 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.9 mp -85.43 -50.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.498 0.666 . . . . 0.0 110.673 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.558 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.4 OUTLIER -99.71 -11.43 20.88 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.212 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.751 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.2 t -147.86 71.0 11.38 Favored Pre-proline 0 CA--C 1.505 -0.787 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.228 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.559 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.3 Cg_exo -49.5 -32.22 26.47 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.574 2.182 . . . . 0.0 109.078 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.608 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 13.3 t 170.1 154.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.045 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . 0.608 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.5 OUTLIER 72.47 56.35 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.91 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.1 112.03 19.44 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.812 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.95 92.31 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.643 0.735 . . . . 0.0 110.532 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 0.989 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 30.5 m0 -45.22 -28.6 0.81 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.594 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.812 HG12 HG22 ' 1' ' 49' ' ' THR . 9.9 p -54.06 -57.48 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.713 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.722 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.9 t0 -152.72 -11.91 0.17 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.631 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.062 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.9 m120 -87.4 -14.36 40.81 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.876 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.955 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.11 145.97 27.47 Favored Glycine 1 N--CA 1.388 -4.56 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 175.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 0.904 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.16 120.19 33.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.949 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.638 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.62 88.14 0.69 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.791 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.65 -34.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.005 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.66 -36.57 64.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.357 0.598 . . . . 0.0 110.572 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.638 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 1.4 m-20 -65.57 -29.07 69.63 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.552 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 0.904 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.9 m -99.37 -176.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.412 0.625 . . . . 0.0 112.626 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.826 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -140.27 107.82 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.668 -178.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.92 125.25 24.82 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.195 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.581 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 6.9 m -112.02 161.19 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.345 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.598 ' O ' HD11 ' 1' ' 23' ' ' ILE . 3.3 p -83.76 162.79 20.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.469 0.48 0 O-C-N 123.953 0.783 . . . . 0.0 112.988 -178.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 . . . . . 0 N--CA 1.451 -0.38 0 CA-C-O 121.098 0.475 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.913 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -80.02 152.27 29.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.631 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.16 19.99 4.55 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.754 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.751 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.39 -108.32 0.39 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.155 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.854 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -152.06 160.83 43.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.798 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.5 OUTLIER -153.67 172.67 16.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.145 0.974 . . . . 0.0 110.807 177.168 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.826 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.76 124.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.739 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.35 114.13 13.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.468 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.955 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.7 t-20 -55.33 114.93 8.03 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.674 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.6 Cg_endo -72.3 -27.24 16.6 Favored 'Trans proline' 0 CA--C 1.502 -1.088 0 C-N-CA 123.059 2.506 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -27.45 60.31 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.069 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.955 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -83.43 -3.51 57.63 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.781 HG23 ' O ' ' 1' ' 84' ' ' ASN . 25.1 t -96.54 133.17 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.484 0 CA-C-O 123.002 1.382 . . . . 0.0 111.821 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.84 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.91 -48.69 10.44 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.333 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.5 OUTLIER 172.3 172.68 0.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.518 179.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.76 HG13 HG22 ' 1' ' 106' ' ' VAL . 89.5 t -92.15 165.87 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -137.05 179.66 17.77 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.244 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.18 133.71 87.81 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 113.991 -1.105 . . . . 0.0 111.184 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.066 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.1 Cg_endo -80.88 158.55 21.13 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.284 3.322 . . . . 0.0 113.557 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 25.9 mtt -149.3 134.67 18.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.9 pttt -85.12 124.12 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.508 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.11 -53.11 0.05 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.881 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.78 69.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.862 0.331 . . . . 0.0 110.683 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.53 -49.4 0.87 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.105 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.23 -14.25 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.036 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.811 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -77.86 -153.32 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.688 0.756 . . . . 0.0 111.777 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.515 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.2 m -116.9 118.82 33.5 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.911 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.881 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.1 m95 -119.57 117.39 28.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.669 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -103.41 149.75 24.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.669 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.9 tt0 -82.96 102.76 11.92 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.163 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.76 HG22 HG13 ' 1' ' 91' ' ' VAL . 69.2 t -101.28 133.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.84 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -87.65 102.56 14.75 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.13 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.633 ' CE2' HG23 ' 1' ' 83' ' ' ILE . 5.5 m-85 -100.64 168.6 9.59 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.91 1.338 . . . . 0.0 111.98 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.929 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.6 t -52.21 -65.63 0.52 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.716 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.929 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.29 -55.93 3.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.07 -7.49 66.98 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.111 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 61.12 -90.44 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.18 132.09 34.34 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.76 HG13 ' HA ' ' 1' ' 55' ' ' ILE . 9.3 t -145.18 113.99 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.062 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -91.96 152.42 20.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.896 0.855 . . . . 0.0 112.848 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.561 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.66 145.38 23.4 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.727 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -65.24 99.26 0.37 Allowed 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 124.765 2.222 . . . . 0.0 107.68 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.066 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 1.6 t -76.11 14.66 0.67 Allowed 'General case' 0 C--N 1.28 -2.434 1 CA-C-N 108.047 -4.161 . . . . 0.0 113.399 -174.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.689 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 9.0 t -63.71 24.4 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.029 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 1.024 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.63 120.39 0.14 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 5.1 ttmm -68.77 -38.33 79.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.916 0.865 . . . . 0.0 108.893 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.805 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 13.1 m-20 -66.91 -5.0 10.82 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 1.024 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.24 -58.6 6.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.598 0.713 . . . . 0.0 110.309 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.075 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.94 -57.4 9.87 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.816 0.817 . . . . 0.0 109.662 178.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.622 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.4 mp -60.14 -46.23 90.37 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.528 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.0 OUTLIER -109.32 -31.04 7.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 98.39 26.09 9.62 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.336 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.805 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 58.6 mttt . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.963 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.2 OUTLIER . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.278 0.561 . . . . 0.0 112.089 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.566 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.48 154.85 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -177.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.998 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.9 m-85 -110.68 170.17 8.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.956 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.675 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 0.0 OUTLIER -117.12 109.63 17.18 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.501 178.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.805 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -79.28 80.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.951 0.882 . . . . 0.0 109.782 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.4 m-20 -81.84 -25.96 34.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.881 -1.963 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -174.87 116.54 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.977 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.93 137.14 49.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.948 177.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.977 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -133.32 161.26 34.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.845 -1.071 . . . . 0.0 113.167 -177.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' 1' ' 31' ' ' LYS . 0.2 OUTLIER -70.91 102.7 2.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 0.964 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.8 OUTLIER -124.84 129.35 73.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' 1' ' 32' ' ' ILE . 6.5 p30 52.55 35.16 17.19 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.207 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . 0.708 ' C ' HD13 ' 1' ' 35' ' ' ILE . . . 81.13 2.26 90.38 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.925 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.708 HD13 ' C ' ' 1' ' 34' ' ' GLY . 0.0 OUTLIER -140.23 145.08 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.771 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 94.7 m95 -60.96 131.22 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.93 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.7 146.63 42.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.279 -178.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.774 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 22.0 t -114.6 150.62 16.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.877 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 22.1 mtp180 -144.64 144.08 31.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.278 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.758 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.45 152.9 51.33 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.575 HD22 HD12 ' 1' ' 42' ' ' ILE . 0.1 OUTLIER -62.0 -16.05 48.62 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.373 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.576 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.8 mp -85.66 -50.91 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.535 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -99.86 -10.72 21.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.211 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.724 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.2 t -148.59 71.31 10.66 Favored Pre-proline 0 CA--C 1.505 -0.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.988 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.595 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.8 Cg_exo -49.37 -32.33 25.84 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.555 2.17 . . . . 0.0 109.307 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.744 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 9.6 t 169.69 153.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.152 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.8 OUTLIER 72.41 56.33 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.877 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -81.45 113.05 19.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.74 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.18 91.88 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.679 0.752 . . . . 0.0 110.335 -178.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 0.964 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.6 m0 -46.16 -27.38 0.97 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.591 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.74 HG12 HG22 ' 1' ' 49' ' ' THR . 4.0 p -53.63 -55.57 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.851 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.655 ' N ' HG13 ' 1' ' 51' ' ' VAL . 48.3 t0 -154.89 -11.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.358 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.104 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -88.28 -14.72 37.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.936 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.93 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.04 144.26 28.42 Favored Glycine 1 N--CA 1.387 -4.604 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 175.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 0.994 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.07 119.27 32.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.819 -178.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.879 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -69.78 87.62 0.52 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.774 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -33.35 -35.77 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.484 -1.234 . . . . 0.0 114.007 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -54.52 -35.89 63.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.116 0.484 . . . . 0.0 110.522 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.879 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.4 OUTLIER -66.76 -27.16 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.522 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 0.994 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.6 m -99.48 -171.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.932 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -146.05 109.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.148 -176.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.23 125.12 24.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.884 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.702 HG13 ' HB ' ' 1' ' 82' ' ' VAL . 6.9 m -107.85 167.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.566 ' O ' HD11 ' 1' ' 23' ' ' ILE . 2.4 p -85.36 160.16 19.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.678 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.2 OUTLIER -78.43 151.85 32.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.61 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.87 20.36 4.95 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.822 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.686 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.81 -107.93 0.32 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.515 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.805 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.99 160.6 43.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.936 -178.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.803 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.09 173.46 16.02 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.107 0.956 . . . . 0.0 110.888 177.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.912 HG12 HD12 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.94 124.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.68 HG23 ' HE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -74.13 113.58 12.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.943 -178.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.932 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 1.3 t-20 -55.4 115.85 10.3 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.009 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.698 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 82.5 Cg_endo -67.49 -27.09 39.86 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 123.106 2.537 . . . . 0.0 110.106 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.11 -25.14 60.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.68 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.4 t-20 -82.9 -2.16 54.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.817 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 57.2 t -101.26 129.82 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.323 0 CA-C-O 123.245 1.498 . . . . 0.0 113.092 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.923 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.25 -39.53 10.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 111.518 -2.583 . . . . 0.0 108.415 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.461 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.2 173.26 0.36 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.174 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.877 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.18 128.74 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -101.43 179.86 28.24 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 122.173 0.874 . . . . 0.0 114.181 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . 0.536 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.27 138.9 94.66 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.162 -1.519 . . . . 0.0 111.249 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.043 ' HB3' HG21 ' 1' ' 118' ' ' THR . 24.0 Cg_endo -81.03 158.04 20.56 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.201 3.267 . . . . 0.0 113.328 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mtt -149.58 136.12 19.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 12.3 mttt -85.47 126.06 33.52 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.497 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.56 -54.27 0.05 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.726 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.892 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -64.47 69.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.858 0.329 . . . . 0.0 110.471 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.42 -49.44 0.86 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.135 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.7 -14.62 0.52 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.155 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.822 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.92 -153.07 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.952 0.882 . . . . 0.0 111.997 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.542 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.3 m -116.56 117.31 29.5 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.567 -1.652 . . . . 0.0 109.795 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.892 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -120.18 117.78 28.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.646 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -104.76 147.32 27.83 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.727 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 29.0 tt0 -79.57 103.04 9.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.708 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.877 HG22 HG12 ' 1' ' 91' ' ' VAL . 17.8 t -99.01 138.34 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.923 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.1 OUTLIER -89.1 101.46 14.11 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.098 -177.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.68 ' HE2' HG23 ' 1' ' 83' ' ' ILE . 37.0 m-85 -100.31 157.89 16.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 122.025 0.917 . . . . 0.0 109.384 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.642 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.62 -62.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.039 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.642 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.08 10.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.929 0.871 . . . . 0.0 109.725 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.9 -1.99 56.55 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.03 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.45 -95.13 0.01 OUTLIER Glycine 0 C--O 1.212 -1.26 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.9 129.02 38.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.916 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 6.5 t -144.83 120.02 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.104 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.6 m95 -93.89 155.49 17.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.909 0.861 . . . . 0.0 112.784 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.543 HD21 ' HE2' ' 1' ' 24' ' ' TYR . 0.2 OUTLIER -153.93 146.19 23.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.126 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.834 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.4 OUTLIER -65.31 101.55 0.57 Allowed 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 124.847 2.261 . . . . 0.0 107.212 178.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.043 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.1 t -77.99 14.79 1.03 Allowed 'General case' 0 C--N 1.279 -2.494 1 CA-C-N 107.894 -4.23 . . . . 0.0 113.285 -174.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.834 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 8.1 t -62.96 22.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.849 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 1.018 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.3 m -175.81 125.18 0.22 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 7.3 tptm -73.8 -41.03 62.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.129 0.966 . . . . 0.0 108.699 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.801 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 11.8 m-20 -65.01 -4.41 4.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 1.018 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.05 -58.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.766 0.793 . . . . 0.0 110.239 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.02 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.16 -56.57 15.66 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 121.88 0.848 . . . . 0.0 109.581 178.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.632 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.4 mp -59.73 -43.62 94.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.185 -1.37 . . . . 0.0 112.736 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.632 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -119.96 -30.65 4.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' 1' ' 123' ' ' ASN . . . 100.21 27.96 7.48 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.732 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.801 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.435 -1.213 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.973 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . 0.444 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.6 mmtm . . . . . 0 CA--C 1.531 0.234 0 CA-C-O 120.71 0.291 . . . . 0.0 110.343 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.629 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.53 154.6 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -177.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.987 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.8 m-85 -111.65 171.53 7.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.867 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.662 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 14.5 mptt -116.91 109.67 17.35 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.279 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.807 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -79.85 80.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.9 0.857 . . . . 0.0 109.447 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.86 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 1.0 OUTLIER -81.59 -25.87 35.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.891 -178.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.59 116.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.149 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.907 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.27 136.92 49.69 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.112 0.482 . . . . 0.0 110.264 177.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.907 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -130.35 160.86 32.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.065 -177.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' 1' ' 31' ' ' LYS . 0.0 OUTLIER -71.99 102.49 2.97 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 0.98 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -124.9 122.22 62.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -171.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 60.96 35.51 19.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.253 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.13 4.27 72.3 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -136.19 139.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.771 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 87.4 m95 -60.42 129.85 43.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.921 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.76 145.14 43.69 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.34 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' 1' ' 57' ' ' ALA . 22.0 t -113.1 151.24 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.845 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 33.3 mtp180 -144.56 141.46 29.48 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.185 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.86 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -129.74 152.62 49.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.575 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.9 -15.98 47.14 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.608 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.572 HD12 HD22 ' 1' ' 41' ' ' ASN . 3.7 mp -84.34 -50.54 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.715 0.769 . . . . 0.0 110.76 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.612 ' HG ' HD23 ' 1' ' 116' ' ' LEU . 0.3 OUTLIER -101.72 -10.08 20.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.386 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.734 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.1 t -148.12 70.26 10.94 Favored Pre-proline 0 CA--C 1.505 -0.77 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.048 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.597 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 94.3 Cg_exo -50.86 -30.7 30.96 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.505 2.137 . . . . 0.0 109.323 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.0 t 169.22 151.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.259 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 56.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.845 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.64 112.39 18.79 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.868 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.11 91.84 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.662 0.744 . . . . 0.0 110.35 -178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 0.98 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 35.8 m0 -44.92 -28.19 0.63 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.653 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.868 HG12 HG22 ' 1' ' 49' ' ' THR . 7.3 p -53.5 -57.07 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.369 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.732 ' N ' HG13 ' 1' ' 51' ' ' VAL . 52.1 t0 -151.94 -11.79 0.19 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.498 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.015 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.8 m120 -87.23 -10.97 51.12 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.886 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.921 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.98 142.32 22.33 Favored Glycine 1 N--CA 1.388 -4.563 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 175.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 0.907 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.39 117.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.417 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.46 87.51 0.46 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.801 ' HB2' HG23 ' 1' ' 38' ' ' VAL . . . -34.88 -34.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.707 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -53.99 -33.97 58.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.07 0.462 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.5 m-20 -70.16 -27.6 64.67 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.852 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 0.907 HG13 HD11 ' 1' ' 55' ' ' ILE . 32.0 m -98.78 -173.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.424 0.63 . . . . 0.0 112.126 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.95 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -142.72 105.33 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.538 -177.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -65.81 126.46 28.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.744 -178.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.602 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 15.8 m -116.48 161.76 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.746 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.629 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.6 p -83.7 163.92 19.96 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.468 0.433 0 O-C-N 123.901 0.75 . . . . 0.0 112.926 -178.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 121.088 0.47 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.56 151.57 37.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.578 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 117.82 18.15 5.27 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.758 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -150.81 -109.47 0.46 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 118.655 -1.736 . . . . 0.0 114.579 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.807 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.86 160.19 43.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.927 -0.637 . . . . 0.0 109.523 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.772 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.9 OUTLIER -153.19 173.11 15.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.057 0.932 . . . . 0.0 110.946 177.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.802 HG12 HD12 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.28 124.54 35.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.615 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.19 112.22 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.439 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.95 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 1.4 t-20 -52.39 114.0 5.04 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.669 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 87.4 Cg_endo -70.61 -27.23 22.67 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.065 2.51 . . . . 0.0 110.532 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . 0.607 HD22 ' HG2' ' 1' ' 85' ' ' PRO . 6.7 m-80 -74.53 -28.62 61.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.999 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.946 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.71 -2.09 53.2 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.708 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.9 t -96.54 130.25 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.425 0 CA-C-O 123.002 1.382 . . . . 0.0 111.84 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.3 -46.28 13.85 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 111.782 -2.463 . . . . 0.0 107.856 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.451 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 173.99 172.72 0.18 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.815 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.932 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.96 145.93 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -118.19 179.44 17.06 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-O 122.072 0.818 . . . . 0.0 113.676 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . 0.489 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -60.05 137.85 91.03 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.48 -1.36 . . . . 0.0 111.443 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.022 ' HB3' HG21 ' 1' ' 118' ' ' THR . 25.4 Cg_endo -81.54 158.31 19.3 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.274 3.316 . . . . 0.0 113.574 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtm -149.53 130.89 14.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.509 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.4 mttp -85.17 124.97 32.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.857 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.77 -48.63 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.584 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.906 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -66.63 69.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.396 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.96 -49.39 0.86 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.152 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.81 -17.07 0.39 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.039 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.823 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -75.73 -153.45 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.849 0.833 . . . . 0.0 112.394 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.505 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.1 m -116.72 118.29 32.13 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.773 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.906 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.5 m95 -120.44 117.12 26.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.36 149.68 24.54 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.728 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.0 tt0 -83.52 103.07 12.57 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 112.576 -2.102 . . . . 0.0 111.897 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.932 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 44.1 t -102.88 138.69 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.878 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.9 OUTLIER -89.99 101.51 14.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 3.4 m-85 -98.35 167.27 10.95 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.953 1.359 . . . . 0.0 111.287 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.922 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -50.84 -65.88 0.48 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.299 -2.228 . . . . 0.0 116.55 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.922 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.5 OUTLIER -86.46 -56.6 3.36 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' 1' ' 59' ' ' ASP . . . -70.76 -7.32 61.41 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.587 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.73 -92.11 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' 1' ' 52' ' ' ASP . 0.4 OUTLIER -83.61 129.51 34.97 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.901 -0.764 . . . . 0.0 109.129 176.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.86 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 2.8 t -145.09 120.07 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.015 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.3 m95 -94.7 154.85 17.12 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.103 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -153.23 143.63 22.48 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.077 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.707 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -65.27 100.0 0.43 Allowed 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 124.704 2.193 . . . . 0.0 107.329 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.022 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 2.5 t -76.84 14.88 0.74 Allowed 'General case' 0 C--N 1.279 -2.47 1 CA-C-N 107.957 -4.201 . . . . 0.0 114.041 -174.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.482 ' OG1' ' OD1' ' 1' ' 117' ' ' ASN . 1.1 p -64.0 25.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.928 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 0.998 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.0 OUTLIER -175.15 126.01 0.26 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.53 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 21.3 tttm -74.26 -41.16 61.73 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.923 0.868 . . . . 0.0 108.676 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.9 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 6.4 m-20 -65.8 -4.54 6.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 0.998 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.76 -58.7 6.53 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.73 0.776 . . . . 0.0 110.526 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.053 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.81 -56.1 15.58 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.887 0.851 . . . . 0.0 109.353 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.604 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.5 mp -58.99 -45.17 91.26 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.355 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -115.35 -31.69 5.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.173 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.728 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.14 27.71 7.2 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.569 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.9 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 38.5 mttp . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.019 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . 0.45 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.8 mmtt . . . . . 0 N--CA 1.455 -0.176 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.652 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.43 153.21 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -177.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.908 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.9 m-85 -109.11 170.28 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.66 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 2.5 mttt -117.2 109.44 16.9 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.853 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.816 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -79.62 81.66 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.074 0.94 . . . . 0.0 109.756 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.768 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 4.0 m-20 -81.31 -27.23 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.898 -1.955 . . . . 0.0 111.983 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.3 t0 -175.72 118.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.852 HD11 ' HB3' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -132.06 137.87 47.95 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.277 0.56 . . . . 0.0 110.108 177.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.831 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.01 160.83 31.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.581 -177.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.544 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.4 OUTLIER -71.45 102.64 2.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 0.892 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 0.9 OUTLIER -120.69 120.72 63.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -171.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' 1' ' 32' ' ' ILE . 2.9 p-10 49.55 47.47 22.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . 0.87 ' O ' HD13 ' 1' ' 35' ' ' ILE . . . 72.89 3.2 59.28 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.294 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.87 HD13 ' O ' ' 1' ' 34' ' ' GLY . 1.6 mm -138.2 135.94 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.645 0.26 . . . . 0.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.852 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 87.5 m95 -59.75 131.55 51.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.892 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.7 146.48 42.74 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.806 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.827 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 19.9 t -113.33 150.96 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.924 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.61 141.97 29.8 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.412 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.78 ' O ' ' N ' ' 1' ' 44' ' ' VAL . 0.0 OUTLIER -131.24 150.32 52.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.699 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -59.74 -17.46 35.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.326 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.586 HD12 ' ND2' ' 1' ' 41' ' ' ASN . 3.7 mp -82.85 -50.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 121.54 0.686 . . . . 0.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.616 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.6 -11.93 19.64 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.162 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.78 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.49 71.82 9.87 Favored Pre-proline 0 CA--C 1.504 -0.822 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.274 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.594 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.5 Cg_exo -49.3 -32.3 25.25 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.548 2.165 . . . . 0.0 109.306 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 12.8 t 169.56 155.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.47 -1.696 . . . . 0.0 110.879 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . 0.487 ' CG ' HG23 ' 1' ' 46' ' ' THR . 0.3 OUTLIER 72.1 56.45 0.16 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.924 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.87 113.11 20.72 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.81 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.33 91.7 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.677 0.751 . . . . 0.0 110.082 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 0.839 ' HB3' HG23 ' 1' ' 32' ' ' ILE . 42.1 m0 -46.05 -28.47 1.19 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.887 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.81 HG12 HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.46 -56.86 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.794 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.724 ' N ' HG13 ' 1' ' 51' ' ' VAL . 48.2 t0 -149.33 -14.34 0.29 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.956 -1.475 . . . . 0.0 113.502 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.124 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 0.9 OUTLIER -87.02 -12.86 46.13 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.53 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.853 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.31 140.42 22.06 Favored Glycine 1 N--CA 1.387 -4.572 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 1.008 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.05 119.07 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.304 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.898 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -69.53 87.57 0.47 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.804 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.25 -35.3 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.859 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -54.58 -35.87 63.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.419 0.628 . . . . 0.0 110.216 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.898 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.5 OUTLIER -66.89 -27.64 67.67 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.722 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 1.008 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.1 m -99.05 -173.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.888 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -144.98 112.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.11 -176.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.9 mt-10 -63.83 128.28 35.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.56 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.622 HG13 ' HB ' ' 1' ' 82' ' ' VAL . 0.9 OUTLIER -109.07 161.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.876 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.652 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.4 p -85.41 159.08 20.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.469 0.492 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 . . . . . 0 N--CA 1.455 -0.212 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.04 151.8 38.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.613 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.1 18.05 5.19 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.293 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.752 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.78 -107.96 0.34 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 118.833 -1.651 . . . . 0.0 114.277 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.816 ' N ' HG23 ' 1' ' 26' ' ' VAL . 1.4 m-85 -151.7 160.38 43.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.827 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -154.5 173.57 16.11 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.128 0.966 . . . . 0.0 110.728 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.888 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.37 125.7 33.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.697 HG23 ' HE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -73.1 113.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.994 -178.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.884 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -55.67 114.65 7.75 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.663 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 70.0 Cg_endo -64.2 -26.69 64.56 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 122.95 2.434 . . . . 0.0 109.717 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.79 -27.52 62.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.953 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.8 t-20 -82.82 -1.75 52.69 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.82 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 53.8 t -102.6 129.77 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.319 0 CA-C-O 122.94 1.352 . . . . 0.0 112.786 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.879 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.83 -37.73 11.6 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 111.78 -2.464 . . . . 0.0 108.194 178.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.538 ' O ' HG13 ' 1' ' 106' ' ' VAL . 6.0 p 177.21 172.84 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.37 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.84 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -110.35 122.16 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -93.28 179.67 39.28 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-O 122.45 1.028 . . . . 0.0 114.873 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.91 139.66 97.86 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 112.723 -1.738 . . . . 0.0 111.182 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.027 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.7 Cg_endo -81.67 157.68 18.83 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.476 3.451 . . . . 0.0 113.869 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -149.68 137.6 20.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.49 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 1.7 mttt -84.53 124.26 31.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.617 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.56 -60.21 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.5 -1.334 . . . . 0.0 114.012 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.914 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -59.57 72.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.893 0.346 . . . . 0.0 111.108 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 105.08 -49.52 0.89 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.393 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.88 -16.0 0.45 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.828 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.42 -153.33 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.68 0.752 . . . . 0.0 112.107 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.537 ' C ' HG22 ' 1' ' 118' ' ' THR . 0.7 OUTLIER -116.54 119.21 34.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.593 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.914 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -121.44 119.31 31.69 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.561 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -106.84 147.02 30.24 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.699 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.1 tt0 -78.91 102.86 8.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.78 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.84 HG22 HG12 ' 1' ' 91' ' ' VAL . 19.7 t -97.7 137.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.879 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -86.79 102.09 13.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.951 -177.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.697 ' HE2' HG23 ' 1' ' 83' ' ' ILE . 35.8 m-85 -103.21 157.15 17.21 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.244 1.021 . . . . 0.0 110.062 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.65 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.61 -62.25 1.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.416 -1.72 . . . . 0.0 114.238 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.65 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.1 OUTLIER -85.91 -42.69 13.86 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.941 -177.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -78.55 -0.34 79.05 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.147 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.13 -91.49 0.01 OUTLIER Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -93.15 130.67 38.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.885 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.9 t -145.52 115.93 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.124 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.9 m95 -91.84 155.9 17.88 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.065 0.936 . . . . 0.0 113.152 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.68 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.85 144.56 22.53 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.094 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.793 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -65.19 100.81 0.48 Allowed 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 124.68 2.181 . . . . 0.0 107.126 178.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.027 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 5.7 t -75.94 15.4 0.54 Allowed 'General case' 0 C--N 1.279 -2.484 1 CA-C-N 108.273 -4.058 . . . . 0.0 113.401 -174.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.793 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 9.6 t -62.62 22.08 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.669 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.5 OUTLIER -175.68 125.86 0.23 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' 1' ' 122' ' ' ASP . 0.8 OUTLIER -74.24 -39.83 62.79 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.246 1.022 . . . . 0.0 108.354 -179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.851 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 75.2 m-20 -65.91 -5.04 8.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 1.001 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.86 -58.38 7.61 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.642 0.734 . . . . 0.0 110.299 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.04 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.3 -57.01 10.63 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 122.014 0.911 . . . . 0.0 109.605 178.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.614 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.08 -45.62 90.35 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.612 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.7 m-85 -112.58 -31.61 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.132 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.79 25.88 8.86 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 119.364 -1.398 . . . . 0.0 111.273 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.851 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' 1' ' 126' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 121.201 0.524 . . . . 0.0 111.414 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.628 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.45 154.18 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -176.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.875 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -107.65 170.42 7.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.4 OUTLIER -117.31 111.36 19.27 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.027 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.818 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -80.83 80.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 122.132 0.968 . . . . 0.0 109.676 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.788 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.8 m-20 -80.35 -26.37 38.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.946 -1.934 . . . . 0.0 111.686 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' 1' ' 39' ' ' ARG . 4.2 t0 -174.94 119.01 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.341 -0.543 . . . . 0.0 112.285 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.894 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.43 136.41 45.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.185 0.517 . . . . 0.0 110.255 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.894 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.86 160.95 31.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.093 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.536 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -70.87 102.42 2.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 174.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 1.002 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.1 mt -124.35 121.53 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.09 35.16 18.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.148 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.08 4.49 72.77 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.075 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.73 137.79 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.792 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 92.0 m95 -59.7 129.43 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.989 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.87 145.53 43.51 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.489 -177.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.795 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 22.6 t -114.07 151.39 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.926 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 4.3 mtp180 -144.36 144.25 31.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.986 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.788 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.72 151.54 51.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.578 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.88 -16.13 48.11 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.703 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.8 mp -83.93 -50.24 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-O 121.771 0.796 . . . . 0.0 110.581 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.631 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.5 -11.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.235 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.846 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.6 t -148.01 70.22 11.05 Favored Pre-proline 0 CA--C 1.504 -0.797 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.083 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.587 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.1 Cg_exo -49.88 -31.98 28.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.477 2.118 . . . . 0.0 109.265 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.587 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.1 t 169.87 154.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.255 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.18 55.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.926 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.86 112.21 19.46 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.719 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.07 92.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.646 0.736 . . . . 0.0 110.743 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 1.002 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 31.2 m0 -44.33 -29.43 0.67 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.814 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.719 HG12 HG22 ' 1' ' 49' ' ' THR . 6.5 p -53.78 -56.44 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.809 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.694 ' N ' HG13 ' 1' ' 51' ' ' VAL . 52.6 t0 -152.79 -13.1 0.16 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.405 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.111 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.0 OUTLIER -85.71 -14.92 43.89 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.394 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.989 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.96 144.32 26.14 Favored Glycine 1 N--CA 1.386 -4.689 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 0.896 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.25 119.75 33.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.488 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.704 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.48 87.87 0.66 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.753 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.58 -35.76 0.06 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.67 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -55.31 -32.87 62.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.305 0.574 . . . . 0.0 110.432 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.704 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.7 OUTLIER -69.42 -28.92 66.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.429 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 0.866 HG13 HD11 ' 1' ' 55' ' ' ILE . 31.7 m -100.49 -175.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.919 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.1 OUTLIER -141.53 113.63 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.127 -177.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' 1' ' 80' ' ' TYR . 1.8 mt-10 -64.89 128.98 38.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.115 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.639 HG21 HG23 ' 1' ' 82' ' ' VAL . 1.9 m -113.05 157.89 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.792 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.628 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.7 p -85.36 159.8 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 0.0 112.889 -178.312 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -73.48 151.71 40.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.545 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.2 17.26 5.4 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.35 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.759 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.57 -109.29 0.4 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 118.68 -1.724 . . . . 0.0 114.439 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.818 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.8 OUTLIER -152.01 160.4 43.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.372 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.797 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.8 OUTLIER -153.52 173.25 15.97 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.056 0.931 . . . . 0.0 110.582 177.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.919 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.04 125.41 39.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.339 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.741 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.46 114.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.941 0.4 . . . . 0.0 110.597 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.9 t-20 -56.79 114.82 8.65 Favored Pre-proline 0 N--CA 1.436 -1.167 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.657 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 84.4 Cg_endo -70.47 -26.95 23.67 Favored 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 123.088 2.526 . . . . 0.0 110.58 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.69 -29.42 61.21 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.039 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.99 -2.43 55.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.824 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.2 t -96.92 130.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.924 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.922 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 112.122 -2.308 . . . . 0.0 107.985 178.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.504 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.4 172.7 0.4 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.777 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.906 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -106.55 124.01 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -97.05 179.54 33.88 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-O 122.528 1.071 . . . . 0.0 114.735 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . 0.488 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -62.82 137.91 96.9 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.74 -1.73 . . . . 0.0 111.666 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.064 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.3 Cg_endo -81.29 156.88 19.64 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.248 3.299 . . . . 0.0 113.405 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 22.4 mtt -149.75 134.68 17.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.743 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.0 OUTLIER -84.97 123.9 31.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.629 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.69 -51.61 0.04 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.733 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.903 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -65.36 69.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.98 0.39 . . . . 0.0 110.588 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.21 -49.56 0.85 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.258 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.19 -16.09 0.42 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.911 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.826 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.22 -153.63 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.768 0.795 . . . . 0.0 111.86 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.535 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.76 119.38 35.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.698 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.903 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 11.0 m95 -121.17 118.48 29.78 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.653 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.72 145.19 30.44 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.681 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.8 tt0 -79.64 102.32 8.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.274 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.906 HG22 HG12 ' 1' ' 91' ' ' VAL . 42.2 t -100.25 136.47 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.922 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 t-20 -86.73 101.38 13.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.502 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.689 ' CD1' ' HB ' ' 1' ' 114' ' ' VAL . 12.4 m-85 -101.44 167.6 10.05 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 123.008 1.385 . . . . 0.0 112.101 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.931 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.4 t -52.17 -66.12 0.44 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 111.871 -2.422 . . . . 0.0 116.67 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.931 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.5 -55.93 3.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.86 -7.41 61.87 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.008 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.87 -89.64 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -86.42 130.86 34.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.896 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.6 t -145.58 113.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.111 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 44.2 m95 -90.25 156.17 18.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.135 0.969 . . . . 0.0 113.465 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.606 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.57 142.95 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.731 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.705 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -64.91 100.32 0.4 Allowed 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 124.801 2.239 . . . . 0.0 107.282 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.064 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.7 t -76.32 16.3 0.48 Allowed 'General case' 0 C--N 1.28 -2.453 1 CA-C-N 107.962 -4.199 . . . . 0.0 113.45 -174.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.688 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 7.2 t -63.51 23.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.453 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 1.028 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.64 122.22 0.15 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.553 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 1.2 ptpt -71.14 -40.38 71.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.217 1.008 . . . . 0.0 108.401 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.844 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 68.2 m-20 -66.05 -4.66 7.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 1.028 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.0 -58.67 6.53 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.672 0.749 . . . . 0.0 110.401 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.049 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.15 -56.69 13.03 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 122.01 0.909 . . . . 0.0 109.325 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.618 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.7 mp -58.36 -46.03 87.07 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.212 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.36 -32.1 6.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.701 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.7 26.27 7.68 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.36 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.844 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.0 mttt . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.88 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 1.1 mmtm . . . . . 0 N--CA 1.453 -0.31 0 CA-C-O 121.247 0.546 . . . . 0.0 111.765 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.631 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.78 154.11 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.904 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.3 m-85 -107.53 169.5 8.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 9.7 mttt -116.62 108.84 16.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.745 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.826 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.39 81.47 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.067 0.937 . . . . 0.0 109.791 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.752 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.8 m-20 -80.92 -25.94 37.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.91 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 12.6 t0 -175.83 116.69 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.928 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.17 134.8 47.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.08 0.467 . . . . 0.0 110.226 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.928 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -130.44 160.83 32.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.805 -177.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.525 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.2 tptp -71.3 102.81 2.67 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 1.01 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.2 mt -124.53 122.89 64.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.22 35.73 18.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.131 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.75 3.64 68.25 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.205 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.96 140.21 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.77 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 92.7 m95 -59.54 129.78 43.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.951 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.77 146.73 42.63 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.432 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.826 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 19.0 t -114.36 150.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.907 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.45 140.55 29.03 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.441 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.752 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.02 153.32 49.39 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.914 0.864 . . . . 0.0 108.761 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.556 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -62.14 -16.72 54.66 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.435 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.585 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -83.15 -50.55 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.758 0.79 . . . . 0.0 110.829 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.611 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.7 -11.0 19.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.376 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.76 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.5 t -146.9 71.33 12.37 Favored Pre-proline 0 CA--C 1.505 -0.786 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.988 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.606 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 73.1 Cg_exo -48.29 -32.93 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.518 2.145 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 8.0 t 169.09 154.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.662 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . 0.522 ' CG ' HG23 ' 1' ' 46' ' ' THR . 0.4 OUTLIER 72.24 56.06 0.16 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.907 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.55 111.77 18.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.749 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.81 91.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.655 0.74 . . . . 0.0 110.524 -178.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 1.01 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 34.8 m0 -44.41 -28.28 0.54 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.742 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.749 HG12 HG22 ' 1' ' 49' ' ' THR . 7.8 p -53.27 -56.95 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.54 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.698 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.0 t0 -153.25 -11.67 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.893 -1.503 . . . . 0.0 113.063 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 0.946 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.6 m120 -86.43 -12.37 49.26 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.642 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.951 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -82.86 144.03 22.66 Favored Glycine 1 N--CA 1.387 -4.595 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 175.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 0.859 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.15 119.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.788 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.42 87.49 0.63 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.741 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -34.18 -34.49 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.01 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.24 -35.98 63.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.633 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.2 m-20 -67.57 -27.21 66.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.911 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 0.851 HG13 HD11 ' 1' ' 55' ' ' ILE . 28.7 m -99.51 -172.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.887 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -144.68 112.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.981 -176.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.07 123.72 19.3 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.84 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.608 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 0.8 OUTLIER -108.17 155.79 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.628 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.631 ' O ' HD11 ' 1' ' 23' ' ' ILE . 1.9 p -85.09 160.02 20.06 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 80.3 p . . . . . 0 N--CA 1.468 0.456 0 O-C-N 123.806 0.691 . . . . 0.0 112.738 -178.615 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -72.82 151.35 42.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.528 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.94 17.34 5.91 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.528 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.765 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.65 -109.16 0.39 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.559 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.826 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.2 OUTLIER -151.86 160.47 43.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.904 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.826 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -155.05 172.99 17.21 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.014 0.912 . . . . 0.0 110.563 177.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.818 HG12 HD12 ' 1' ' 61' ' ' ILE . 1.2 t -138.55 125.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.596 HG23 ' CE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -72.72 112.74 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.997 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 113.58 5.35 Favored Pre-proline 0 N--CA 1.436 -1.134 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.662 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 86.9 Cg_endo -71.84 -27.69 17.53 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.424 2.749 . . . . 0.0 110.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.64 -28.18 60.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.73 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.997 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.87 -3.34 56.74 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.816 HG23 ' O ' ' 1' ' 84' ' ' ASN . 27.0 t -98.77 135.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.502 0 CA-C-O 122.945 1.355 . . . . 0.0 111.51 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.89 ' HD2' ' O ' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.61 -48.43 9.52 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.871 -2.422 . . . . 0.0 107.791 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER 172.28 172.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.465 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.823 HG13 HG22 ' 1' ' 106' ' ' VAL . 67.8 t -89.94 162.56 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -130.09 179.68 16.67 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.175 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.35 133.77 90.91 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.984 -1.108 . . . . 0.0 110.75 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.072 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.9 Cg_endo -81.35 158.18 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.347 3.364 . . . . 0.0 113.534 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtt -149.7 138.01 20.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.981 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 2.1 mtpt -85.84 125.4 33.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.561 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.96 -53.35 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.791 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.896 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -66.07 69.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.398 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.62 -49.47 0.86 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.208 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.13 -14.43 0.48 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.185 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.81 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -76.92 -153.15 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.83 0.824 . . . . 0.0 112.108 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.1 m -116.86 116.74 28.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.988 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.896 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 9.9 m95 -118.63 117.39 28.83 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -105.0 150.18 25.14 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.667 ' HG3' ' NE1' ' 1' ' 115' ' ' TRP . 23.0 tt0 -82.31 102.18 11.03 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.816 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.823 HG22 HG13 ' 1' ' 91' ' ' VAL . 53.2 t -98.84 135.77 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.89 ' O ' ' HD2' ' 1' ' 89' ' ' LYS . 0.2 OUTLIER -89.14 102.69 15.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.384 -177.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.81 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 0.9 OUTLIER -102.77 169.14 8.79 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.978 1.37 . . . . 0.0 111.544 178.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.901 HG23 ' H ' ' 1' ' 110' ' ' THR . 2.7 t -51.38 -66.08 0.45 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.196 -2.274 . . . . 0.0 116.913 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.901 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.55 -56.12 3.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.77 -7.15 61.07 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.593 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.01 -91.67 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.31 131.06 34.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 121.947 -0.737 . . . . 0.0 109.066 176.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.814 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 7.9 t -145.36 113.48 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 0.946 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -89.42 153.38 20.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.901 0.858 . . . . 0.0 113.101 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.639 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.55 144.92 23.11 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.032 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.783 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -65.33 100.36 0.47 Allowed 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 124.675 2.179 . . . . 0.0 107.076 178.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.072 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 3.1 t -75.89 14.62 0.64 Allowed 'General case' 0 C--N 1.281 -2.396 1 CA-C-N 107.981 -4.19 . . . . 0.0 113.495 -174.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.783 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 14.8 t -63.79 22.73 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.047 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 1.032 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -175.24 123.07 0.22 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 18.5 tttt -72.29 -39.47 68.27 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.926 0.87 . . . . 0.0 108.666 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.901 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 78.1 m-20 -66.61 -5.14 10.46 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 1.032 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.73 -58.48 7.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.818 0.818 . . . . 0.0 110.27 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.048 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.86 -57.02 11.13 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 122.025 0.917 . . . . 0.0 109.515 178.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.613 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.71 -45.04 93.36 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.739 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -113.58 -31.43 6.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.706 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.42 26.59 8.6 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.273 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.901 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 23.4 mttp . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.81 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.191 0 CA-C-O 121.186 0.517 . . . . 0.0 111.664 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.666 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.49 155.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.928 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.6 m-85 -108.48 169.88 8.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.865 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 15.3 mmmt -116.64 108.52 16.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.133 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.781 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.54 82.63 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.976 0.893 . . . . 0.0 109.905 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.768 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.7 m-20 -83.48 -27.38 29.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.275 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -174.64 119.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.849 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.13 138.28 46.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.233 0.54 . . . . 0.0 110.743 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.849 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.28 160.57 32.56 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.399 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.535 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.0 OUTLIER -71.93 103.18 3.11 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 0.889 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 1.1 mm -123.88 117.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -171.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 61.22 37.58 17.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.101 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.72 1.95 68.36 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.292 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.57 136.36 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.759 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 93.1 m95 -59.66 131.56 51.29 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.889 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.97 146.49 42.97 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.899 -179.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.824 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 19.4 t -114.07 150.0 16.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.829 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 6.4 mtp180 -144.11 144.08 31.43 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.042 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.26 152.94 51.11 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.613 HD22 HD12 ' 1' ' 42' ' ' ILE . 0.1 OUTLIER -61.28 -17.33 52.98 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.4 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.613 HD12 HD22 ' 1' ' 41' ' ' ASN . 3.9 mp -84.27 -50.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-O 121.699 0.761 . . . . 0.0 110.673 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.581 ' CD2' HD21 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -100.43 -11.8 19.91 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.425 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.761 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.63 71.09 9.74 Favored Pre-proline 0 CA--C 1.505 -0.761 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.197 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.59 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.3 Cg_exo -49.76 -31.84 27.15 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.534 2.156 . . . . 0.0 109.343 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.835 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 13.7 t 169.51 155.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.052 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . 0.835 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.31 56.49 0.15 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.829 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.81 113.81 20.7 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.775 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.52 91.76 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.726 0.774 . . . . 0.0 109.849 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 0.878 ' CD1' HD12 ' 1' ' 32' ' ' ILE . 42.5 m0 -47.58 -27.47 1.86 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.798 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.775 HG12 HG22 ' 1' ' 49' ' ' THR . 9.8 p -54.03 -56.19 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.657 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.703 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.5 t0 -151.38 -14.09 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.518 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.133 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 0.8 OUTLIER -86.82 -11.6 50.45 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.377 0.608 . . . . 0.0 110.812 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.804 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.88 140.03 21.22 Favored Glycine 1 N--CA 1.391 -4.302 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 1.052 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.03 117.81 29.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.379 -178.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.833 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -68.97 87.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.579 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.824 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -34.38 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.585 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -37.04 64.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.434 0.635 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.833 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.5 OUTLIER -68.0 -26.19 65.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.116 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 1.052 HG13 HD11 ' 1' ' 55' ' ' ILE . 23.5 m -98.26 -171.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.916 HD12 HG12 ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -145.95 107.61 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.183 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.7 pt-20 -65.81 122.93 18.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.291 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.524 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 15.6 m -115.0 160.65 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.433 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.666 ' O ' HD11 ' 1' ' 23' ' ' ILE . 3.1 p -83.72 164.76 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.47 0.541 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 . . . . . 0 N--CA 1.452 -0.347 0 CA-C-O 121.006 0.432 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.695 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -77.55 152.25 34.13 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.584 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.61 18.46 4.84 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.54 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.772 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.37 -109.38 0.44 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 118.742 -1.694 . . . . 0.0 114.309 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.781 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.4 OUTLIER -151.68 160.05 43.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.589 . . . . 0.0 109.642 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.812 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.72 173.43 16.42 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.95 0.881 . . . . 0.0 110.291 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.916 HG12 HD12 ' 1' ' 61' ' ' ILE . 1.2 t -137.58 125.32 31.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.678 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.39 115.65 14.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.309 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.915 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -56.29 114.53 7.85 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.67 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 74.1 Cg_endo -65.13 -26.85 57.25 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 C-N-CA 122.933 2.422 . . . . 0.0 109.834 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.35 -27.07 61.3 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 113.419 -1.718 . . . . 0.0 109.92 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.669 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.9 t-20 -82.29 -2.35 52.37 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.799 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 55.6 t -101.85 130.55 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 CA-C-O 123.165 1.46 . . . . 0.0 113.029 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.899 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -90.58 -42.33 10.86 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.445 -2.616 . . . . 0.0 107.876 177.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.51 ' O ' HG13 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 174.66 173.47 0.21 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.383 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.935 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -103.28 138.35 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.46 179.69 20.92 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-O 122.194 0.885 . . . . 0.0 114.067 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . 0.503 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.5 137.79 94.82 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.178 -1.511 . . . . 0.0 111.601 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.036 ' HB3' HG21 ' 1' ' 118' ' ' THR . 22.1 Cg_endo -81.46 157.56 19.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 124.435 3.424 . . . . 0.0 113.625 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.6 mtm -149.5 137.81 20.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.9 mtmm -85.18 124.98 32.46 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.657 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.55 -55.88 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.206 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.896 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -63.75 69.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.901 0.351 . . . . 0.0 110.791 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.08 -49.55 0.85 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.258 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.36 -15.17 0.48 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.04 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.823 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.76 -153.21 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.754 0.788 . . . . 0.0 111.928 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.563 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.74 119.3 35.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.661 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.896 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.64 118.03 28.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -104.91 148.52 26.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.2 tt0 -81.22 102.94 10.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.742 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.935 HG22 HG12 ' 1' ' 91' ' ' VAL . 32.7 t -98.33 138.42 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.899 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER -88.48 102.12 14.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.835 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.693 ' C ' ' HD3' ' 1' ' 89' ' ' LYS . 12.1 m-85 -100.22 157.93 16.23 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-O 122.104 0.954 . . . . 0.0 109.695 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.648 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.3 OUTLIER -58.64 -62.55 1.78 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.681 -1.599 . . . . 0.0 114.228 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.648 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.12 10.72 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.911 0.862 . . . . 0.0 109.804 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.514 ' HA3' ' OD2' ' 1' ' 59' ' ' ASP . . . -73.83 -2.39 61.13 Favored Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.159 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 46.88 -92.52 0.01 OUTLIER Glycine 0 C--O 1.212 -1.226 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.26 130.59 37.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.827 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.7 t -145.36 117.58 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.133 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 42.7 m95 -92.46 156.18 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.342 -0.943 . . . . 0.0 113.023 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.524 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.75 143.03 21.48 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.731 -1.577 . . . . 0.0 108.678 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.831 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -64.87 101.4 0.49 Allowed 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 124.595 2.141 . . . . 0.0 107.052 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.036 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 6.6 t -75.64 14.5 0.62 Allowed 'General case' 0 C--N 1.281 -2.374 1 CA-C-N 108.2 -4.091 . . . . 0.0 113.527 -174.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.831 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 12.6 t -62.37 21.51 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.715 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 1.012 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.6 OUTLIER -175.33 126.37 0.25 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.611 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 0.3 OUTLIER -74.51 -41.35 60.8 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 122.126 0.965 . . . . 0.0 108.893 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.888 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 1.3 m-20 -66.25 -4.41 7.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 1.012 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.23 -58.81 6.37 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.417 0.627 . . . . 0.0 110.453 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.058 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.89 -55.08 21.53 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.789 0.805 . . . . 0.0 109.601 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.614 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -60.33 -43.73 96.14 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.037 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.595 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 2.1 m-85 -114.49 -32.14 6.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.92 26.04 7.7 Favored Glycine 0 CA--C 1.505 -0.575 0 C-N-CA 119.427 -1.368 . . . . 0.0 111.718 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.888 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 26.3 mttp . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.952 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 CA--C 1.531 0.22 0 CA-C-O 121.199 0.523 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.7 HG12 ' HB2' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -72.5 152.2 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.935 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -105.85 170.94 7.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.406 -1.725 . . . . 0.0 106.555 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.713 ' HD2' HD11 ' 1' ' 42' ' ' ILE . 70.7 mttt -117.41 109.5 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.98 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.834 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -80.19 81.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.138 0.971 . . . . 0.0 109.708 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.3 m-20 -79.04 -26.74 43.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.745 -2.025 . . . . 0.0 111.618 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 11.6 t0 -176.54 118.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -133.62 137.4 45.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.185 177.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.74 160.84 32.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.716 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.497 ' HG2' ' CE2' ' 1' ' 36' ' ' TRP . 0.1 OUTLIER -70.62 103.25 2.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 175.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 0.97 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -124.66 123.27 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . 0.405 ' O ' HG13 ' 1' ' 35' ' ' ILE . 2.2 m-80 59.41 37.67 23.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.485 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.2 3.68 70.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.267 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -138.53 138.69 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.805 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 82.0 m95 -59.77 130.1 45.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.967 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.91 144.93 43.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.393 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.8 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 21.8 t -112.8 150.97 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.831 ' HG2' HG11 ' 1' ' 44' ' ' VAL . 75.8 mtm180 -144.65 135.44 24.81 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.513 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.785 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -124.76 153.03 43.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.91 -17.75 57.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.057 -1.428 . . . . 0.0 112.451 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.713 HD11 ' HD2' ' 1' ' 25' ' ' LYS . 3.3 mp -81.97 -50.62 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.842 0.83 . . . . 0.0 110.968 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.617 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.12 -12.23 18.96 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.593 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.831 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.4 t -148.42 70.84 10.78 Favored Pre-proline 0 CA--C 1.503 -0.851 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.998 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.574 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.6 Cg_exo -49.32 -31.89 24.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.815 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 14.0 t 170.24 154.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.994 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . 0.815 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.29 56.68 0.15 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.808 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -85.07 112.77 20.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.844 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.26 91.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.705 0.764 . . . . 0.0 110.301 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 0.97 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 37.2 m0 -45.37 -28.8 0.92 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.647 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.844 HG12 HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.28 -57.09 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.797 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.729 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.0 t0 -150.94 -13.28 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.609 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.046 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -87.58 -14.33 40.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.76 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.967 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.62 145.27 27.47 Favored Glycine 1 N--CA 1.386 -4.638 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 175.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 0.944 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.16 118.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.757 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.502 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.35 87.58 0.62 Allowed 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.8 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -36.27 -34.77 0.06 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.694 -176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -54.67 -33.59 60.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.704 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.3 m-20 -68.62 -29.63 68.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.551 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 0.84 HG13 HD11 ' 1' ' 55' ' ' ILE . 29.0 m -100.04 -175.03 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.13 0.491 . . . . 0.0 112.172 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.855 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -141.74 110.08 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.043 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.2 OUTLIER -64.98 122.98 18.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.632 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.625 HG13 ' HB ' ' 1' ' 82' ' ' VAL . 7.2 m -104.95 159.45 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.951 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.413 ' O ' HD11 ' 1' ' 23' ' ' ILE . 2.5 p -84.08 161.55 20.63 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t . . . . . 0 N--CA 1.467 0.389 0 O-C-N 123.845 0.716 . . . . 0.0 112.749 -178.563 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.929 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -79.15 151.65 31.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.642 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.15 18.86 4.91 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.072 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.763 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.75 -106.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 118.881 -1.628 . . . . 0.0 114.244 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.834 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.1 OUTLIER -151.87 160.64 43.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.177 -0.511 . . . . 0.0 110.134 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.794 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -154.36 173.07 16.7 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 122.139 0.971 . . . . 0.0 111.204 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.855 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.0 OUTLIER -136.68 125.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.624 HG23 HG12 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -74.45 112.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.896 0.379 . . . . 0.0 110.457 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.91 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 114.65 6.96 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.677 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 89.5 Cg_endo -69.76 -28.12 25.63 Favored 'Trans proline' 0 CA--C 1.5 -1.197 0 C-N-CA 123.05 2.5 . . . . 0.0 110.882 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -28.53 61.44 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.012 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.91 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.55 -3.26 55.7 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.79 HG23 ' O ' ' 1' ' 84' ' ' ASN . 38.4 t -96.51 132.75 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-O 123.08 1.419 . . . . 0.0 112.246 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.906 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -86.08 -43.74 12.84 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 108.167 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.552 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.55 173.36 0.29 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.953 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.905 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.31 117.33 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.35 179.63 45.01 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 122.408 1.004 . . . . 0.0 114.711 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.63 142.38 98.47 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 112.711 -1.745 . . . . 0.0 111.26 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.004 ' HB3' HG21 ' 1' ' 118' ' ' THR . 26.0 Cg_endo -81.34 157.99 19.74 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.482 3.455 . . . . 0.0 113.762 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 11.4 mtt -149.57 135.2 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.7 mttm -85.39 126.51 33.83 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.414 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.25 -52.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.794 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.893 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -64.91 69.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.637 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.07 -49.39 0.86 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.193 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.07 -16.05 0.43 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.05 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.839 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.13 -152.89 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.807 0.813 . . . . 0.0 112.136 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.553 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.3 m -116.74 118.6 32.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.737 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.893 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.84 117.52 26.72 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.25 147.38 27.12 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.692 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.3 tt0 -80.9 102.76 10.28 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.851 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.905 HG22 HG12 ' 1' ' 91' ' ' VAL . 41.8 t -101.62 136.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.906 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.3 m120 -90.31 101.64 14.37 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.367 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.769 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.8 m-85 -98.89 168.36 10.16 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 123.034 1.397 . . . . 0.0 111.877 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.925 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.2 -65.32 0.58 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 111.972 -2.376 . . . . 0.0 116.569 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.925 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.16 -55.91 3.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.82 -6.02 66.2 Favored Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.995 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.11 -91.37 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.79 129.19 34.9 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.944 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.5 t -145.4 119.0 2.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.046 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 45.4 m95 -93.55 156.07 16.94 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.006 0.907 . . . . 0.0 113.17 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.607 HD23 ' HG ' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -153.43 143.2 21.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.1 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.692 ' HB2' ' CE2' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.07 100.01 0.4 Allowed 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 124.965 2.317 . . . . 0.0 107.182 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.004 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 5.1 t -77.12 14.69 0.84 Allowed 'General case' 0 C--N 1.281 -2.387 1 CA-C-N 107.622 -4.354 . . . . 0.0 113.975 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.474 ' OG1' ' OD1' ' 1' ' 117' ' ' ASN . 0.9 OUTLIER -63.2 22.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.991 178.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 1.042 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 3.6 m -175.19 121.28 0.21 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -69.57 -40.34 76.81 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.944 0.878 . . . . 0.0 109.125 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.867 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 98.5 m-20 -65.2 -4.69 5.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 1.042 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.98 -58.59 6.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.703 0.763 . . . . 0.0 110.483 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.051 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.5 -56.81 11.66 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.02 0.914 . . . . 0.0 109.534 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.608 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.86 -44.62 94.03 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.696 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.607 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.52 -31.51 6.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.64 26.42 7.63 Favored Glycine 0 CA--C 1.504 -0.642 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.728 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.867 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 70.8 mttt . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.957 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 22' ' ' LYS . . . . . 0.478 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.195 0.522 . . . . 0.0 111.068 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 23' ' ' ILE . . . . . 0.608 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -73.26 154.3 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 24' ' ' TYR . . . . . 0.928 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.0 m-85 -105.96 169.54 8.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 25' ' ' LYS . . . . . 0.66 ' HG3' HD11 ' 1' ' 42' ' ' ILE . 0.2 OUTLIER -116.85 108.69 16.15 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.1 177.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 26' ' ' VAL . . . . . 0.809 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.42 82.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.888 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 27' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.9 m-20 -81.03 -27.34 35.83 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 112.82 -1.991 . . . . 0.0 111.81 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 28' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 2.5 t70 -175.84 118.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.227 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 29' ' ' LEU . . . . . 0.863 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -131.97 136.39 47.28 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.271 0.558 . . . . 0.0 110.344 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 30' ' ' GLN . . . . . 0.866 ' O ' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -129.82 160.5 33.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.701 -178.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' CZ2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.33 103.6 2.91 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 32' ' ' ILE . . . . . 0.988 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -123.94 118.93 55.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -171.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 33' ' ' ASN . . . . . 0.407 ' O ' HG13 ' 1' ' 35' ' ' ILE . 2.1 m-80 61.08 39.27 16.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.534 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.15 4.85 69.41 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.6 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 35' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -137.9 136.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 36' ' ' TRP . . . . . 0.782 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 78.4 m95 -59.81 130.2 45.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 37' ' ' GLN . . . . . 0.945 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.8 146.71 42.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.411 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 38' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 21.5 t -114.18 150.97 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 39' ' ' ARG . . . . . 0.914 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 7.6 mtp180 -144.45 138.52 27.72 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.368 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 40' ' ' ASN . . . . . 0.773 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -128.56 153.04 47.62 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 121.989 0.9 . . . . 0.0 108.689 175.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 41' ' ' ASN . . . . . 0.596 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -61.01 -18.46 57.81 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.47 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 42' ' ' ILE . . . . . 0.66 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.6 mp -82.25 -50.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.729 0.776 . . . . 0.0 110.853 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.597 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.4 OUTLIER -100.56 -11.92 19.69 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.529 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 44' ' ' VAL . . . . . 0.792 HG11 ' HB2' ' 1' ' 48' ' ' PHE . 2.2 t -148.43 71.6 10.83 Favored Pre-proline 0 CA--C 1.504 -0.798 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.086 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 45' ' ' PRO . . . . . 0.592 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.2 Cg_exo -49.47 -31.68 24.58 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.503 2.135 . . . . 0.0 109.113 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 46' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 14.2 t 169.87 152.79 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.005 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.7 56.91 0.13 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 48' ' ' PHE . . . . . 0.914 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.16 112.75 20.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 49' ' ' THR . . . . . 0.773 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.83 91.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.442 -178.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 50' ' ' TRP . . . . . 0.988 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.2 m0 -45.51 -27.97 0.84 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.555 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.773 HG12 HG22 ' 1' ' 49' ' ' THR . 8.9 p -53.73 -57.15 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.674 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 52' ' ' ASP . . . . . 0.708 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.9 t0 -152.29 -12.61 0.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.349 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 53' ' ' ASN . . . . . 1.068 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -86.75 -13.74 44.38 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.624 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 54' ' ' GLY . . . . . 0.945 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.89 144.5 27.64 Favored Glycine 1 N--CA 1.386 -4.635 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 175.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 55' ' ' ILE . . . . . 0.869 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.41 118.76 31.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.557 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.14 87.64 0.59 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 57' ' ' ALA . . . . . 0.773 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.1 -35.6 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.3 -1.318 . . . . 0.0 113.895 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -54.07 -34.43 60.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.349 0.595 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 59' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.1 m-20 -68.55 -27.54 66.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.848 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 60' ' ' VAL . . . . . 0.869 HG13 HD11 ' 1' ' 55' ' ' ILE . 30.1 m -99.75 -173.36 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 61' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -143.48 110.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.01 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 62' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.51 124.64 21.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.987 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 63' ' ' VAL . . . . . 0.578 ' H ' ' HA ' ' 1' ' 81' ' ' PHE . 2.5 m -109.47 160.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.026 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 64' ' ' THR . . . . . 0.608 ' O ' HD11 ' 1' ' 23' ' ' ILE . 2.6 p -84.8 159.84 20.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 73.7 p . . . . . 0 N--CA 1.469 0.509 0 O-C-N 123.929 0.768 . . . . 0.0 112.859 -178.532 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 . . . . . 0 N--CA 1.453 -0.28 0 CA-C-O 121.024 0.44 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' 1' 1 ' 77' ' ' LYS . . . . . 0.813 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.85 151.73 37.38 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 78' ' ' GLY . . . . . 0.582 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.03 17.31 5.46 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.357 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 79' ' ' GLY . . . . . 0.759 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.25 -108.02 0.33 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.54 -1.79 . . . . 0.0 114.6 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 80' ' ' TYR . . . . . 0.809 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.92 160.36 43.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.144 -0.528 . . . . 0.0 109.89 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.809 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.6 OUTLIER -154.19 172.83 16.97 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 121.916 0.865 . . . . 0.0 110.467 177.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 82' ' ' VAL . . . . . 0.798 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -137.27 124.8 31.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 83' ' ' ILE . . . . . 0.609 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.41 112.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 84' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -52.6 114.52 5.79 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.674 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.0 Cg_endo -71.24 -27.56 19.63 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 123.164 2.576 . . . . 0.0 110.845 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -74.89 -27.92 60.43 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.842 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 87' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.47 -4.08 56.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 88' ' ' VAL . . . . . 0.769 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.8 t -96.63 131.71 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-O 122.991 1.377 . . . . 0.0 111.84 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.864 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.43 -46.94 12.84 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 111.718 -2.492 . . . . 0.0 107.693 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 90' ' ' SER . . . . . 0.452 ' O ' HG13 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 173.76 172.88 0.17 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.787 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 91' ' ' VAL . . . . . 0.948 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.69 138.81 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 92' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.99 179.83 20.66 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 122.104 0.836 . . . . 0.0 114.021 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 93' ' ' THR . . . . . 0.411 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -60.6 136.18 92.38 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.286 -1.457 . . . . 0.0 111.684 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 94' ' ' PRO . . . . . 1.037 ' HB3' HG21 ' 1' ' 118' ' ' THR . 21.7 Cg_endo -81.21 157.16 19.92 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.42 3.413 . . . . 0.0 113.563 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 95' ' ' MET . . . . . 0.512 ' HG3' ' CH2' ' 1' ' 115' ' ' TRP . 0.3 OUTLIER -148.8 137.03 20.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.427 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 96' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -86.3 126.87 34.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.546 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 97' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.29 -53.66 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.51 -1.328 . . . . 0.0 113.803 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 98' ' ' SER . . . . . 0.899 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -64.96 69.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.655 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 99' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.0 -49.4 0.86 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.213 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.55 -15.67 0.47 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.008 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 101' ' ' LEU . . . . . 0.819 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.43 -153.68 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.797 0.808 . . . . 0.0 111.955 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.79 118.26 32.03 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.811 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 103' ' ' TRP . . . . . 0.899 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.2 m95 -120.11 117.2 27.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 104' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.73 148.19 26.36 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -175.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 105' ' ' GLN . . . . . 0.686 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 28.4 tt0 -82.21 102.31 11.05 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.395 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 106' ' ' VAL . . . . . 0.948 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 42.6 t -101.03 137.93 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 107' ' ' ASN . . . . . 0.864 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.0 OUTLIER -89.95 101.72 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.309 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 108' ' ' PHE . . . . . 0.736 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.7 m-85 -99.52 168.58 9.88 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.046 1.403 . . . . 0.0 111.79 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 109' ' ' THR . . . . . 0.917 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -52.29 -65.6 0.53 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.057 -2.338 . . . . 0.0 116.637 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 110' ' ' THR . . . . . 0.917 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.35 -56.06 3.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 111' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -71.77 -7.37 65.41 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.938 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 112' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.99 -90.6 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 113' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -84.7 130.5 34.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 114' ' ' VAL . . . . . 0.803 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.3 t -145.33 116.28 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 115' ' ' TRP . . . . . 1.068 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 50.0 m95 -92.08 154.14 18.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.853 0.835 . . . . 0.0 112.777 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 116' ' ' LEU . . . . . 0.638 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.58 143.5 22.01 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.045 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 117' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -64.9 100.39 0.41 Allowed 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 124.856 2.265 . . . . 0.0 107.103 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 118' ' ' THR . . . . . 1.037 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 3.4 t -75.82 15.02 0.57 Allowed 'General case' 0 C--N 1.279 -2.467 1 CA-C-N 107.858 -4.246 . . . . 0.0 113.348 -174.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 119' ' ' THR . . . . . 0.777 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 13.0 t -64.58 24.0 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.916 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 120' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -175.27 126.08 0.25 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 121' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 3.2 tttt -74.38 -40.78 61.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 122' ' ' ASP . . . . . 0.856 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 77.7 m-20 -65.83 -4.61 7.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 123' ' ' ASN . . . . . 1.001 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.7 OUTLIER -62.9 -58.57 6.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.674 0.749 . . . . 0.0 110.457 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 124' ' ' LEU . . . . . 1.069 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -65.09 -55.62 17.73 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.131 0.967 . . . . 0.0 109.418 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 125' ' ' LEU . . . . . 0.598 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.7 mp -59.57 -45.15 92.7 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.261 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 126' ' ' TYR . . . . . 0.611 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -115.05 -31.51 6.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 127' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 102.45 26.77 7.12 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 119.233 -1.461 . . . . 0.0 111.829 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 128' ' ' LYS . . . . . 0.856 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 39.8 mttt . . . . . 0 N--CA 1.433 -1.285 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.814 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 121.008 0.432 . . . . 0.0 110.896 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -89.83 111.48 22.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.19 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 52.98 33.99 45.23 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.978 -0.63 . . . . 0.0 112.996 179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 46.8 t -99.6 2.78 44.91 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.601 0.239 . . . . 0.0 111.351 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -102.42 112.01 24.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.698 0.285 . . . . 0.0 110.944 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -168.09 113.58 0.67 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.225 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -108.1 142.37 38.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -149.75 150.46 32.08 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.11 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -114.91 159.23 20.94 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.162 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 9.2 m80 -83.61 -172.28 4.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.282 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -109.16 138.69 14.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.289 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -96.04 10.22 38.21 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 111.7 0.259 . . . . 0.0 111.7 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -128.71 69.27 79.72 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.763 0.316 . . . . 0.0 110.949 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -74.49 130.0 13.4 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.546 2.164 . . . . 0.0 112.283 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.03 -169.32 0.26 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.399 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -97.38 103.16 14.79 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.788 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.27 165.71 30.36 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.591 2.194 . . . . 0.0 112.482 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 9.2 t -109.67 -2.89 17.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.426 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 3.1 t -113.3 58.27 0.66 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.739 0.304 . . . . 0.0 111.274 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . 0.421 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 29.8 m120 -67.22 127.54 33.0 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.084 0.468 . . . . 0.0 111.039 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.525 HD13 ' HD3' ' 1' ' 85' ' ' PRO . 0.3 OUTLIER -67.01 94.3 0.32 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.882 179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.454 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER -53.11 169.22 0.11 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.099 179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.55 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.5 154.53 7.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -176.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.867 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.6 m-85 -108.42 169.34 8.7 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 176.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.648 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.6 OUTLIER -116.93 110.75 18.7 Favored 'General case' 0 C--N 1.314 -0.951 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.104 178.045 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.823 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -80.55 81.63 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 CA-C-O 121.977 0.894 . . . . 0.0 110.018 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.808 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 2.6 m-20 -82.48 -25.91 33.09 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 112.935 -1.939 . . . . 0.0 111.955 -178.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.1 t70 -174.18 114.63 0.19 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.373 -0.531 . . . . 0.0 112.273 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.866 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.77 136.0 48.31 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.006 177.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.866 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -128.9 160.82 31.44 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.919 -177.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.538 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -72.01 103.35 3.21 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 174.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 1.025 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -123.8 119.55 57.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.431 -0.804 . . . . 0.0 112.839 -171.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . 0.408 ' O ' HG13 ' 1' ' 35' ' ' ILE . 43.6 m-20 61.66 36.65 16.47 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.355 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.56 2.93 65.17 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.307 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.43 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.24 138.16 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.693 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.852 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 94.2 m95 -60.24 131.04 49.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.975 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.62 146.69 42.52 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.721 -178.564 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.835 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 21.1 t -115.14 151.13 16.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -177.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.931 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 30.5 mtp180 -144.3 142.94 30.75 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 114.23 -1.35 . . . . 0.0 111.126 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.808 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.86 150.07 52.26 Favored 'General case' 0 CA--C 1.494 -1.204 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 175.056 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.631 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -59.69 -18.18 40.29 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.5 -1.227 . . . . 0.0 112.595 -179.854 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.589 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -83.23 -50.5 15.52 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.64 0.733 . . . . 0.0 110.906 -179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.574 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.02 -11.21 20.78 Favored 'General case' 0 N--CA 1.436 -1.155 0 CA-C-N 114.7 -1.136 . . . . 0.0 110.249 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.771 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.3 t -148.84 71.33 10.41 Favored Pre-proline 0 CA--C 1.505 -0.781 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.996 -178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.593 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 76.3 Cg_exo -48.96 -32.32 22.8 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 C-N-CA 122.573 2.182 . . . . 0.0 109.231 177.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.889 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 11.1 t 169.47 155.4 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 113.462 -1.699 . . . . 0.0 110.978 178.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . 0.889 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.33 56.96 0.15 Allowed 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 177.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.931 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -84.19 111.45 19.37 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 176.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.747 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.75 91.98 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.54 0.686 . . . . 0.0 110.583 -178.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 1.025 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.1 m0 -44.31 -28.58 0.55 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.506 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.747 HG12 HG22 ' 1' ' 49' ' ' THR . 5.9 p -52.96 -56.2 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.898 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.717 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.682 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.2 t0 -153.68 -13.05 0.14 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 114.045 -1.434 . . . . 0.0 113.259 -177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.012 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -86.31 -13.01 47.85 Favored 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.461 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.975 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.53 142.29 22.7 Favored Glycine 1 N--CA 1.388 -4.525 0 N-CA-C 108.878 -1.689 . . . . 0.0 108.878 175.442 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 0.94 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.42 119.2 32.33 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.729 -178.815 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.67 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.53 87.72 0.66 Allowed 'General case' 0 N--CA 1.438 -1.025 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 1.048 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -35.3 -35.16 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 114.316 -1.311 . . . . 0.0 113.767 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -54.46 -35.74 63.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.252 0.549 . . . . 0.0 110.464 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.67 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 1.0 OUTLIER -66.19 -29.08 69.28 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.685 179.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 0.849 HG13 HD11 ' 1' ' 55' ' ' ILE . 26.5 m -100.17 -173.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.014 0 CA-C-O 121.267 0.556 . . . . 0.0 112.407 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.835 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -142.66 112.34 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.817 -177.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.492 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -62.8 121.33 13.18 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.015 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.85 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 1.8 m -105.22 153.71 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.896 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.653 HG23 HG22 ' 1' ' 68' ' ' THR . 1.6 p -83.97 161.3 20.82 Favored 'General case' 0 CA--C 1.518 -0.266 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 16.1 t -37.81 -35.66 0.15 Allowed 'General case' 0 N--CA 1.468 0.452 0 O-C-N 123.882 0.739 . . . . 0.0 112.593 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -77.01 -7.43 55.62 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.182 0.515 . . . . 0.0 111.085 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.639 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 92.05 23.33 27.76 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.734 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.816 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.8 OUTLIER -72.32 116.34 12.64 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.862 0.363 . . . . 0.0 110.415 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.85 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 5.5 mtt85 -72.85 137.56 45.77 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 1.8 t 42.05 74.15 0.12 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.94 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 4.2 t -86.02 -49.17 8.02 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.616 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . 0.463 ' O ' ' CB ' ' 1' ' 73' ' ' GLN . 1.0 OUTLIER -96.87 -27.11 14.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.953 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' 1' ' 72' ' ' ASP . 7.8 tt0 86.9 -24.72 0.11 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.057 -179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 21.8 t -109.53 105.99 19.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.199 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 1.048 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -57.24 147.22 25.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.591 0.71 . . . . 0.0 111.811 -179.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.553 ' HG3' ' C ' ' 1' ' 75' ' ' LEU . 6.9 mt-30 -154.27 132.81 12.08 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.487 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -74.83 151.54 39.03 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.552 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 114.42 18.33 6.69 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.975 -1.011 . . . . 0.0 111.189 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.74 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.71 -109.54 0.43 Allowed Glycine 0 N--CA 1.441 -0.995 0 C-N-CA 118.766 -1.683 . . . . 0.0 114.675 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.823 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.1 OUTLIER -151.94 160.37 43.52 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.999 -0.6 . . . . 0.0 109.912 -178.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.835 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.9 OUTLIER -154.98 173.25 16.83 Favored 'General case' 0 CA--C 1.495 -1.167 0 CA-C-O 122.013 0.911 . . . . 0.0 111.121 177.483 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.835 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.09 125.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-N 115.134 -0.939 . . . . 0.0 108.682 179.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.622 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.62 111.65 10.76 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.302 -179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.902 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.2 t-20 -54.03 115.05 7.42 Favored Pre-proline 0 N--CA 1.438 -1.042 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.683 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 95.0 Cg_endo -68.94 -28.21 29.58 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.133 2.555 . . . . 0.0 110.925 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.87 -28.85 61.78 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.065 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.902 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.43 -3.56 55.86 Favored 'General case' 0 N--CA 1.431 -1.385 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 175.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.788 HG23 ' O ' ' 1' ' 84' ' ' ASN . 39.2 t -96.53 132.77 40.07 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.362 0 CA-C-O 123.085 1.421 . . . . 0.0 112.134 -177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.97 -44.78 12.79 Favored 'General case' 0 C--N 1.283 -2.304 0 CA-C-N 111.615 -2.539 . . . . 0.0 107.979 178.666 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.52 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.09 173.08 0.25 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.599 -1.637 . . . . 0.0 112.766 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.911 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -107.09 117.06 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.799 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 176.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.73 179.64 44.47 Favored Glycine 0 N--CA 1.434 -1.465 0 CA-C-O 122.518 1.065 . . . . 0.0 115.028 -176.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . 0.524 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.97 138.96 95.8 Favored Pre-proline 0 C--N 1.311 -1.079 0 CA-C-N 112.609 -1.796 . . . . 0.0 111.934 -179.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.045 ' HB3' HG21 ' 1' ' 118' ' ' THR . 25.1 Cg_endo -81.18 158.3 20.21 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 124.477 3.451 . . . . 0.0 113.925 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.2 mtt -149.22 135.84 19.48 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.599 -1.182 . . . . 0.0 110.744 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 15.0 mttt -86.36 123.68 31.87 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.346 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.479 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.41 -52.64 0.04 OUTLIER Glycine 0 C--N 1.334 0.424 0 C-N-CA 119.52 -1.324 . . . . 0.0 113.915 -179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.9 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.99 69.3 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.009 0.405 . . . . 0.0 110.585 -179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.27 -49.58 0.85 Allowed Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.935 -0.65 . . . . 0.0 113.149 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.02 -16.15 0.44 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.999 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.842 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.08 -153.53 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.128 0 CA-C-O 121.769 0.795 . . . . 0.0 112.038 -179.684 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.547 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.59 118.28 32.19 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 113.624 -1.626 . . . . 0.0 109.737 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.9 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.7 m95 -120.77 117.22 26.88 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.66 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.33 147.4 27.13 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -175.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.707 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 26.8 tt0 -80.86 102.62 10.16 Favored 'General case' 0 N--CA 1.427 -1.61 0 CA-C-N 112.74 -2.027 . . . . 0.0 111.611 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.911 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 43.8 t -100.92 135.79 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.878 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 m120 -89.85 101.94 14.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.389 -176.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.746 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.9 m-85 -99.23 168.21 10.18 Favored 'General case' 0 N--CA 1.412 -2.329 0 CA-C-O 122.92 1.343 . . . . 0.0 111.927 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.929 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.13 -65.48 0.55 Allowed 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 112.092 -2.322 . . . . 0.0 116.624 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.929 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.31 -56.01 3.64 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -176.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.32 -7.4 67.79 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.974 -178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.513 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.45 -91.63 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.67 130.11 34.75 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.009 -0.701 . . . . 0.0 109.298 176.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.94 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.5 t -145.63 117.26 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.958 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.012 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.4 m95 -92.96 155.36 17.61 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.477 -0.889 . . . . 0.0 112.887 -177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.556 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.36 144.43 22.94 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 114.143 -1.389 . . . . 0.0 108.975 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.792 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.3 OUTLIER -65.14 101.92 0.58 Allowed 'General case' 0 CA--C 1.483 -1.604 0 CA-C-O 124.64 2.162 . . . . 0.0 107.362 178.214 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.045 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.2 t -78.03 15.76 0.85 Allowed 'General case' 0 C--N 1.277 -2.56 1 CA-C-N 108.246 -4.07 . . . . 0.0 113.245 -174.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.792 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 6.8 t -63.34 21.74 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 119.681 -0.808 . . . . 0.0 110.845 178.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 0.999 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.5 m -175.13 125.26 0.25 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.559 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 4.9 ttmt -74.09 -40.63 62.6 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.991 0.901 . . . . 0.0 108.745 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.818 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 85.8 m-20 -65.69 -4.64 6.68 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 174.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 0.999 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.52 -58.73 6.53 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.77 0.795 . . . . 0.0 110.509 -179.276 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.026 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.94 -55.62 18.11 Favored 'General case' 0 C--N 1.284 -2.277 0 CA-C-O 122.021 0.915 . . . . 0.0 109.452 178.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.6 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.24 -45.81 90.18 Favored 'General case' 0 N--CA 1.434 -1.235 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.147 -179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.608 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.3 m-85 -113.97 -31.74 6.29 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.739 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.0 26.21 8.02 Favored Glycine 0 CA--C 1.507 -0.452 0 C-N-CA 119.319 -1.42 . . . . 0.0 111.389 -178.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.818 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 80.0 mttt . . . . . 0 N--CA 1.435 -1.212 0 CA-C-O 118.26 -0.876 . . . . 0.0 111.005 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' 1' ' 2' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . 0.405 ' HB2' ' O ' ' 1' ' 1' ' ' MET . 6.6 mmt85 66.13 96.18 0.05 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.908 0.385 . . . . 0.0 110.773 -179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 122.54 150.74 8.21 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.23 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -169.39 -175.78 2.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.949 0.404 . . . . 0.0 111.102 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 73.58 -76.99 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.104 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -122.96 132.73 54.28 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.708 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -139.41 127.74 22.74 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.847 0.356 . . . . 0.0 111.077 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 m-70 -90.01 170.02 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.151 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -122.87 -45.54 2.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.703 179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -121.64 25.85 9.07 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.507 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 67.42 -158.79 50.77 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.308 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.55 -25.6 9.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.723 0.297 . . . . 0.0 111.046 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 120.94 34.67 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.036 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -68.63 -167.59 0.19 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.314 2.01 . . . . 0.0 111.954 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -87.73 97.8 11.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.883 0.373 . . . . 0.0 111.054 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -116.12 128.54 25.91 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.778 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.32 153.2 35.48 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.415 2.076 . . . . 0.0 112.177 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 8.8 t -89.75 -2.0 58.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.224 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . 0.579 ' HB ' ' HE1' ' 1' ' 126' ' ' TYR . 44.5 p -77.74 134.65 38.03 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.134 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . 0.601 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 1.1 m-80 -93.05 127.82 38.72 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-O 121.041 0.448 . . . . 0.0 111.252 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.515 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 0.9 OUTLIER -62.49 89.82 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.114 0.483 . . . . 0.0 111.45 -179.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -58.15 168.69 0.96 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.547 178.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.598 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.17 156.67 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -177.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.803 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 5.4 m-85 -109.76 169.71 8.54 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 113.395 -1.729 . . . . 0.0 106.798 177.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.674 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 5.0 mmtt -116.4 108.99 16.73 Favored 'General case' 0 C--N 1.313 -1.022 0 C-N-CA 119.799 -0.761 . . . . 0.0 111.089 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.854 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -80.0 80.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-O 122.138 0.97 . . . . 0.0 109.634 179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 5.5 m-20 -80.45 -26.9 38.07 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 112.645 -2.071 . . . . 0.0 111.966 -178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . 0.443 ' HA ' ' CD ' ' 1' ' 77' ' ' LYS . 5.3 t0 -175.04 114.98 0.15 Allowed 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.931 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -131.09 138.48 49.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.214 177.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.931 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -132.92 161.63 33.75 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.674 -1.148 . . . . 0.0 113.212 -177.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.0 103.01 2.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 103.549 -2.76 . . . . 0.0 103.549 174.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 0.989 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -124.2 120.84 60.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -171.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 60.72 35.24 19.74 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.215 179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.71 4.6 76.55 Favored Glycine 0 N--CA 1.442 -0.918 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.923 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.438 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.76 136.6 50.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 -179.424 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.663 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 97.1 m95 -60.22 128.41 36.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.955 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.85 143.87 45.18 Favored 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.423 -177.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.791 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 22.8 t -112.38 151.25 14.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 -177.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.91 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 28.7 mtp180 -144.19 143.98 31.33 Favored 'General case' 0 C--N 1.343 0.283 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.047 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.777 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.77 152.56 51.74 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 175.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.582 HD22 HD12 ' 1' ' 42' ' ' ILE . 0.1 OUTLIER -62.21 -15.4 46.43 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 114.232 -1.349 . . . . 0.0 112.374 -179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.643 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.9 mp -85.43 -50.7 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.158 0 CA-C-O 121.498 0.666 . . . . 0.0 110.673 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.558 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.4 OUTLIER -99.71 -11.43 20.88 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.212 178.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.751 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.2 t -147.86 71.0 11.38 Favored Pre-proline 0 CA--C 1.505 -0.787 0 C-N-CA 119.932 -0.707 . . . . 0.0 112.228 -178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.559 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.3 Cg_exo -49.5 -32.22 26.47 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.574 2.182 . . . . 0.0 109.078 177.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.608 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 13.3 t 170.1 154.31 0.05 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 113.416 -1.72 . . . . 0.0 111.045 178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . 0.608 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.5 OUTLIER 72.47 56.35 0.15 Allowed 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.787 1.402 . . . . 0.0 114.787 177.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.91 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.1 112.03 19.44 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 176.774 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.812 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.95 92.31 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.643 0.735 . . . . 0.0 110.532 -178.428 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 0.989 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 30.5 m0 -45.22 -28.6 0.81 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.512 -1.222 . . . . 0.0 110.594 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.812 HG12 HG22 ' 1' ' 49' ' ' THR . 9.9 p -54.06 -57.48 5.71 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.713 -178.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.722 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.9 t0 -152.72 -11.91 0.17 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.046 -1.434 . . . . 0.0 113.631 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.062 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.9 m120 -87.4 -14.36 40.81 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.876 -178.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.955 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.11 145.97 27.47 Favored Glycine 1 N--CA 1.388 -4.56 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 175.123 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 0.904 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.16 120.19 33.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.949 -178.529 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.638 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.62 88.14 0.69 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 176.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 0.89 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -35.65 -34.47 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.354 -1.294 . . . . 0.0 114.005 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -54.66 -36.57 64.74 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.357 0.598 . . . . 0.0 110.572 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.638 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 1.4 m-20 -65.57 -29.07 69.63 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.552 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 0.904 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.9 m -99.37 -176.41 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 CA-C-O 121.412 0.625 . . . . 0.0 112.626 -178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.826 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -140.27 107.82 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.708 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.668 -178.039 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.92 125.25 24.82 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.0 -1.0 . . . . 0.0 113.195 -178.199 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.914 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 6.9 m -112.02 161.19 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 CA-C-N 115.239 -0.892 . . . . 0.0 110.345 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.664 HG23 HG22 ' 1' ' 68' ' ' THR . 3.3 p -83.76 162.79 20.53 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 178.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.52 -35.48 0.13 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.953 0.783 . . . . 0.0 112.988 -178.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -79.6 -8.05 58.92 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.191 0.519 . . . . 0.0 111.44 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.55 23.26 21.89 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.696 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -74.69 117.88 17.03 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 120.994 0.426 . . . . 0.0 111.241 -178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.914 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 6.7 mtp180 -71.42 145.9 49.03 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.738 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . 0.509 HG22 ' O ' ' 1' ' 62' ' ' GLU . 4.3 t -160.56 79.64 0.65 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.953 0.406 . . . . 0.0 111.168 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -85.02 -21.97 29.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.375 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -55.23 -47.32 75.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.969 0.414 . . . . 0.0 110.753 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 16.4 mt-30 -71.53 -172.28 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.718 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 10.5 p -108.49 129.95 62.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.407 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 0.89 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -53.94 149.45 9.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.41 0.624 . . . . 0.0 111.727 -179.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -155.33 133.27 11.43 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.882 -1.053 . . . . 0.0 109.834 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.913 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -80.02 152.27 29.52 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -179.254 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.631 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.16 19.99 4.55 Favored Glycine 0 N--CA 1.438 -1.207 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.754 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.751 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.39 -108.32 0.39 Allowed Glycine 0 N--CA 1.44 -1.043 0 C-N-CA 119.297 -1.43 . . . . 0.0 114.155 -179.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.854 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -152.06 160.83 43.35 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.089 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.798 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.5 OUTLIER -153.67 172.67 16.9 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 122.145 0.974 . . . . 0.0 110.807 177.168 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.826 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.76 124.71 39.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.675 -1.232 . . . . 0.0 107.675 178.73 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.739 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.35 114.13 13.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 C-N-CA 120.441 -0.504 . . . . 0.0 110.468 -178.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.955 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.7 t-20 -55.33 114.93 8.03 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.674 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.6 Cg_endo -72.3 -27.24 16.6 Favored 'Trans proline' 0 CA--C 1.502 -1.088 0 C-N-CA 123.059 2.506 . . . . 0.0 110.911 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.8 -27.45 60.31 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.948 -1.478 . . . . 0.0 110.069 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.955 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -83.43 -3.51 57.63 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.781 HG23 ' O ' ' 1' ' 84' ' ' ASN . 25.1 t -96.54 133.17 38.92 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.484 0 CA-C-O 123.002 1.382 . . . . 0.0 111.821 -178.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.84 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.91 -48.69 10.44 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 111.839 -2.437 . . . . 0.0 107.333 178.18 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.5 OUTLIER 172.3 172.68 0.11 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.451 -1.704 . . . . 0.0 111.518 179.672 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.76 HG13 HG22 ' 1' ' 106' ' ' VAL . 89.5 t -92.15 165.87 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.559 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -137.05 179.66 17.77 Favored Glycine 0 N--CA 1.436 -1.318 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.244 -177.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.18 133.71 87.81 Favored Pre-proline 0 C--N 1.311 -1.076 0 CA-C-N 113.991 -1.105 . . . . 0.0 111.184 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.066 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.1 Cg_endo -80.88 158.55 21.13 Favored 'Trans proline' 0 C--N 1.322 -0.825 0 C-N-CA 124.284 3.322 . . . . 0.0 113.557 -178.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 25.9 mtt -149.3 134.67 18.39 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.149 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.9 pttt -85.12 124.12 31.42 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 121.116 -0.234 . . . . 0.0 110.508 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.11 -53.11 0.05 OUTLIER Glycine 0 C--N 1.333 0.403 0 C-N-CA 119.707 -1.235 . . . . 0.0 113.651 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.881 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.0 OUTLIER -64.78 69.61 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.862 0.331 . . . . 0.0 110.683 -179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.53 -49.4 0.87 Allowed Glycine 0 CA--C 1.521 0.465 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.105 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.23 -14.25 0.55 Allowed Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.749 -0.738 . . . . 0.0 113.036 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.811 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -77.86 -153.32 0.06 Allowed 'General case' 0 N--CA 1.434 -1.266 0 CA-C-O 121.688 0.756 . . . . 0.0 111.777 -179.872 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.515 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.2 m -116.9 118.82 33.5 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.748 -1.569 . . . . 0.0 109.911 178.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.881 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.1 m95 -119.57 117.39 28.24 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.669 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -103.41 149.75 24.49 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 -175.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.669 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.9 tt0 -82.96 102.76 11.92 Favored 'General case' 0 N--CA 1.428 -1.528 0 CA-C-N 113.009 -1.905 . . . . 0.0 112.163 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.76 HG22 HG13 ' 1' ' 91' ' ' VAL . 69.2 t -101.28 133.75 43.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.84 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -87.65 102.56 14.75 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.13 -177.705 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.633 ' CE2' HG23 ' 1' ' 83' ' ' ILE . 5.5 m-85 -100.64 168.6 9.59 Favored 'General case' 0 N--CA 1.415 -2.195 0 CA-C-O 122.91 1.338 . . . . 0.0 111.98 179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.929 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.6 t -52.21 -65.63 0.52 Allowed 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 112.196 -2.275 . . . . 0.0 116.716 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.929 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.29 -55.93 3.68 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.829 0.677 . . . . 0.0 112.829 -176.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.07 -7.49 66.98 Favored Glycine 0 N--CA 1.434 -1.476 0 CA-C-N 115.652 -0.703 . . . . 0.0 113.111 -178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.523 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 61.12 -90.44 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.443 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.419 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.18 132.09 34.34 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 176.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.76 HG13 ' HA ' ' 1' ' 55' ' ' ILE . 9.3 t -145.18 113.99 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.062 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -91.96 152.42 20.03 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-O 121.896 0.855 . . . . 0.0 112.848 -177.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.561 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.66 145.38 23.4 Favored 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.409 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.727 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -65.24 99.26 0.37 Allowed 'General case' 0 CA--C 1.483 -1.601 0 CA-C-O 124.765 2.222 . . . . 0.0 107.68 178.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.066 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 1.6 t -76.11 14.66 0.67 Allowed 'General case' 0 C--N 1.28 -2.434 1 CA-C-N 108.047 -4.161 . . . . 0.0 113.399 -174.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.689 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 9.0 t -63.71 24.4 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.029 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 1.024 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.63 120.39 0.14 Allowed 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 5.1 ttmm -68.77 -38.33 79.97 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.916 0.865 . . . . 0.0 108.893 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.805 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 13.1 m-20 -66.91 -5.0 10.82 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 174.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 1.024 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.24 -58.6 6.64 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-O 121.598 0.713 . . . . 0.0 110.309 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.075 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.94 -57.4 9.87 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-O 121.816 0.817 . . . . 0.0 109.662 178.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.622 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.4 mp -60.14 -46.23 90.37 Favored 'General case' 0 N--CA 1.432 -1.371 0 CA-C-N 114.349 -1.296 . . . . 0.0 112.528 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.0 OUTLIER -109.32 -31.04 7.7 Favored 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -176.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.703 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 98.39 26.09 9.62 Favored Glycine 0 CA--C 1.505 -0.57 0 C-N-CA 119.155 -1.498 . . . . 0.0 111.336 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.805 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 58.6 mttt . . . . . 0 N--CA 1.437 -1.106 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.963 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.742 0.306 . . . . 0.0 111.107 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 21.8 mtm180 -113.55 -30.95 6.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 170.88 57.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.542 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.47 -21.7 12.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.634 0.254 . . . . 0.0 111.168 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -130.38 112.15 13.0 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.874 0.369 . . . . 0.0 111.039 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.88 99.89 12.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.722 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.76 121.96 15.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.12 -179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 22.4 m80 -90.69 139.89 30.29 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.105 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -169.81 22.29 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.388 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 8.6 m170 -90.91 -66.17 0.95 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.789 0.328 . . . . 0.0 111.223 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 111.65 -170.31 13.63 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.187 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 28.2 p -112.64 -35.49 5.5 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.767 0.318 . . . . 0.0 110.959 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . 0.46 ' HG3' ' HD2' ' 1' ' 14' ' ' PRO . 0.4 OUTLIER -108.43 131.45 21.75 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.475 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . 0.46 ' HD2' ' HG3' ' 1' ' 13' ' ' GLU . 85.4 Cg_endo -83.01 42.79 1.35 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.402 2.068 . . . . 0.0 112.643 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . 0.455 HG22 ' N ' ' 1' ' 16' ' ' THR . 91.5 m -83.8 163.69 20.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.589 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . 0.455 ' N ' HG22 ' 1' ' 15' ' ' THR . 0.2 OUTLIER -87.57 141.35 32.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.829 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.0 156.74 43.02 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.566 2.177 . . . . 0.0 112.645 -179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.84 36.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.568 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . 0.465 ' HA ' ' OH ' ' 1' ' 126' ' ' TYR . 5.0 t -155.67 30.3 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.161 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -87.23 141.5 28.6 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.219 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.581 HD13 ' HD3' ' 1' ' 85' ' ' PRO . 0.3 OUTLIER -56.48 95.32 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.925 179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.426 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 0.2 OUTLIER -41.96 165.24 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.4 -0.818 . . . . 0.0 112.089 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.566 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.48 154.85 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 -177.418 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.998 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.9 m-85 -110.68 170.17 8.27 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 113.57 -1.65 . . . . 0.0 106.956 177.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.675 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 0.0 OUTLIER -117.12 109.63 17.18 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 119.923 -0.711 . . . . 0.0 111.501 178.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.805 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.1 OUTLIER -79.28 80.97 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 121.951 0.882 . . . . 0.0 109.782 179.126 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.758 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.4 m-20 -81.84 -25.96 34.68 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 112.881 -1.963 . . . . 0.0 111.88 -178.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -174.87 116.54 0.17 Allowed 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.977 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.93 137.14 49.16 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.165 -0.47 . . . . 0.0 109.948 177.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.977 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -133.32 161.26 34.97 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.845 -1.071 . . . . 0.0 113.167 -177.312 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.52 ' HD3' ' HA ' ' 1' ' 31' ' ' LYS . 0.2 OUTLIER -70.91 102.7 2.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 103.761 -2.681 . . . . 0.0 103.761 175.293 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 0.964 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.8 OUTLIER -124.84 129.35 73.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -171.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . 0.42 ' ND2' ' O ' ' 1' ' 32' ' ' ILE . 6.5 p30 52.55 35.16 17.19 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.207 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . 0.708 ' C ' HD13 ' 1' ' 35' ' ' ILE . . . 81.13 2.26 90.38 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.925 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.708 HD13 ' C ' ' 1' ' 34' ' ' GLY . 0.0 OUTLIER -140.23 145.08 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.771 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 94.7 m95 -60.96 131.22 49.97 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.93 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.7 146.63 42.63 Favored 'General case' 0 CA--C 1.505 -0.775 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.279 -178.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.774 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 22.0 t -114.6 150.62 16.52 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.877 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 22.1 mtp180 -144.64 144.08 31.07 Favored 'General case' 0 C--N 1.345 0.385 0 CA-C-N 114.448 -1.251 . . . . 0.0 111.278 178.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.758 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.45 152.9 51.33 Favored 'General case' 0 CA--C 1.493 -1.233 0 N-CA-C 108.401 -0.962 . . . . 0.0 108.401 175.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.575 HD22 HD12 ' 1' ' 42' ' ' ILE . 0.1 OUTLIER -62.0 -16.05 48.62 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.373 -179.862 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.576 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.8 mp -85.66 -50.91 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.249 0 CA-C-O 121.578 0.704 . . . . 0.0 110.944 -179.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.535 ' O ' ' CH2' ' 1' ' 103' ' ' TRP . 0.3 OUTLIER -99.86 -10.72 21.43 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.211 179.015 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.724 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.2 t -148.59 71.31 10.66 Favored Pre-proline 0 CA--C 1.505 -0.788 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.988 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.595 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.8 Cg_exo -49.37 -32.33 25.84 Favored 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.555 2.17 . . . . 0.0 109.307 178.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.744 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 9.6 t 169.69 153.8 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 113.571 -1.65 . . . . 0.0 111.152 178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . 0.744 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.8 OUTLIER 72.41 56.33 0.15 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 177.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.877 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -81.45 113.05 19.26 Favored 'General case' 0 N--CA 1.432 -1.372 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 176.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.74 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.18 91.88 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 121.679 0.752 . . . . 0.0 110.335 -178.304 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 0.964 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.6 m0 -46.16 -27.38 0.97 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.591 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.74 HG12 HG22 ' 1' ' 49' ' ' THR . 4.0 p -53.63 -55.57 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.877 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.851 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.655 ' N ' HG13 ' 1' ' 51' ' ' VAL . 48.3 t0 -154.89 -11.38 0.12 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.098 -1.41 . . . . 0.0 113.358 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.104 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.4 m120 -88.28 -14.72 37.63 Favored 'General case' 0 CA--C 1.49 -1.342 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.936 -178.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.93 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.04 144.26 28.42 Favored Glycine 1 N--CA 1.387 -4.604 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 175.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 0.994 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.07 119.27 32.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.819 -178.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.879 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -69.78 87.62 0.52 Allowed 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 176.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 1.036 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -33.35 -35.77 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 114.484 -1.234 . . . . 0.0 114.007 -176.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -54.52 -35.89 63.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.116 0.484 . . . . 0.0 110.522 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.879 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.4 OUTLIER -66.76 -27.16 67.37 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.522 179.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 0.994 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.6 m -99.48 -171.48 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.012 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.932 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -146.05 109.05 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.148 -176.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -65.23 125.12 24.02 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.884 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.949 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 6.9 m -107.85 167.9 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.668 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.703 HG23 HG22 ' 1' ' 68' ' ' THR . 2.4 p -85.36 160.16 19.84 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 58.3 p -38.04 -30.67 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -83.46 -7.47 59.54 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.158 0.504 . . . . 0.0 111.485 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 95.16 22.91 21.37 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.37 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.703 HG22 HG23 ' 1' ' 64' ' ' THR . 0.9 OUTLIER -75.35 116.94 16.62 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 -178.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.949 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 15.9 mtm180 -74.11 143.02 45.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.233 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 66.0 p -159.04 86.47 0.83 Allowed 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.017 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 2.0 p -76.5 -27.41 56.05 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.576 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -56.99 -33.28 66.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.127 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -77.81 179.5 6.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.025 0.441 . . . . 0.0 111.57 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 13.3 p -109.07 129.27 64.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.652 179.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 1.036 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.3 OUTLIER -58.5 148.4 28.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.504 0.669 . . . . 0.0 111.934 -179.336 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.525 ' HG3' ' C ' ' 1' ' 75' ' ' LEU . 15.1 mt-30 -155.06 132.54 11.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.415 179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.793 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.2 OUTLIER -78.43 151.85 32.49 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 113.026 0.751 . . . . 0.0 113.026 -179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.61 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.87 20.36 4.95 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.822 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.686 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.81 -107.93 0.32 Allowed Glycine 0 N--CA 1.442 -0.934 0 C-N-CA 118.873 -1.632 . . . . 0.0 114.515 -179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.805 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.99 160.6 43.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.219 -0.491 . . . . 0.0 109.936 -178.642 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.803 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.09 173.46 16.02 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 122.107 0.956 . . . . 0.0 110.888 177.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.912 HG12 HD12 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -135.94 124.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 179.201 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.68 HG23 ' HE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -74.13 113.58 12.65 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.943 -178.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.932 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 1.3 t-20 -55.4 115.85 10.3 Favored Pre-proline 0 N--CA 1.438 -1.052 0 C-N-CA 119.764 -0.774 . . . . 0.0 109.009 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.698 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 82.5 Cg_endo -67.49 -27.09 39.86 Favored 'Trans proline' 0 CA--C 1.498 -1.298 0 C-N-CA 123.106 2.537 . . . . 0.0 110.106 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -73.11 -25.14 60.76 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 113.576 -1.647 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.68 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.4 t-20 -82.9 -2.16 54.13 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.817 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 57.2 t -101.26 129.82 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.323 0 CA-C-O 123.245 1.498 . . . . 0.0 113.092 -177.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.923 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.25 -39.53 10.94 Favored 'General case' 0 C--N 1.283 -2.298 0 CA-C-N 111.518 -2.583 . . . . 0.0 108.415 178.093 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.461 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.2 173.26 0.36 Allowed 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.024 -1.444 . . . . 0.0 113.174 -179.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.877 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.18 128.74 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.687 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -101.43 179.86 28.24 Favored Glycine 0 N--CA 1.433 -1.566 0 CA-C-O 122.173 0.874 . . . . 0.0 114.181 -176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . 0.536 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.27 138.9 94.66 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 113.162 -1.519 . . . . 0.0 111.249 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.043 ' HB3' HG21 ' 1' ' 118' ' ' THR . 24.0 Cg_endo -81.03 158.04 20.56 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 124.201 3.267 . . . . 0.0 113.328 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 3.3 mtt -149.58 136.12 19.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.879 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 12.3 mttt -85.47 126.06 33.52 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.947 -0.301 . . . . 0.0 110.497 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.56 -54.27 0.05 OUTLIER Glycine 0 C--N 1.334 0.426 0 C-N-CA 119.428 -1.368 . . . . 0.0 113.726 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.892 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -64.47 69.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.858 0.329 . . . . 0.0 110.471 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.42 -49.44 0.86 Allowed Glycine 0 CA--C 1.521 0.452 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.135 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 154.7 -14.62 0.52 Allowed Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.155 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.822 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.92 -153.07 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.952 0.882 . . . . 0.0 111.997 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.542 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.3 m -116.56 117.31 29.5 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 113.567 -1.652 . . . . 0.0 109.795 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.892 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -120.18 117.78 28.79 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 -179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.646 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -104.76 147.32 27.83 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -175.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.727 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 29.0 tt0 -79.57 103.04 9.21 Favored 'General case' 0 N--CA 1.429 -1.493 0 CA-C-N 112.668 -2.06 . . . . 0.0 111.708 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.877 HG22 HG12 ' 1' ' 91' ' ' VAL . 17.8 t -99.01 138.34 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.923 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.1 OUTLIER -89.1 101.46 14.11 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.098 -177.612 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.68 ' HE2' HG23 ' 1' ' 83' ' ' ILE . 37.0 m-85 -100.31 157.89 16.28 Favored 'General case' 0 N--CA 1.41 -2.446 0 CA-C-O 122.025 0.917 . . . . 0.0 109.384 178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.642 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.62 -62.46 1.84 Allowed 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 113.862 -1.517 . . . . 0.0 114.039 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.642 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.08 10.76 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.929 0.871 . . . . 0.0 109.725 -178.193 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.9 -1.99 56.55 Favored Glycine 0 N--CA 1.429 -1.77 0 CA-C-N 113.973 -1.467 . . . . 0.0 112.03 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.45 -95.13 0.01 OUTLIER Glycine 0 C--O 1.212 -1.26 0 N-CA-C 110.171 -1.171 . . . . 0.0 110.171 -178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.9 129.02 38.95 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.916 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 6.5 t -144.83 120.02 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.104 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.6 m95 -93.89 155.49 17.15 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.909 0.861 . . . . 0.0 112.784 -177.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.543 HD21 ' HE2' ' 1' ' 24' ' ' TYR . 0.2 OUTLIER -153.93 146.19 23.84 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.126 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.834 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.4 OUTLIER -65.31 101.55 0.57 Allowed 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 124.847 2.261 . . . . 0.0 107.212 178.082 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.043 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.1 t -77.99 14.79 1.03 Allowed 'General case' 0 C--N 1.279 -2.494 1 CA-C-N 107.894 -4.23 . . . . 0.0 113.285 -174.587 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.834 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 8.1 t -62.96 22.47 0.01 OUTLIER 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.849 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 1.018 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.3 m -175.81 125.18 0.22 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.607 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 7.3 tptm -73.8 -41.03 62.95 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-O 122.129 0.966 . . . . 0.0 108.699 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.801 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 11.8 m-20 -65.01 -4.41 4.61 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 174.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 1.018 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.05 -58.56 7.39 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.766 0.793 . . . . 0.0 110.239 -179.381 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.02 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.16 -56.57 15.66 Favored 'General case' 0 C--N 1.287 -2.139 0 CA-C-O 121.88 0.848 . . . . 0.0 109.581 178.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.632 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.4 mp -59.73 -43.62 94.13 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.185 -1.37 . . . . 0.0 112.736 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.632 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -119.96 -30.65 4.66 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' 1' ' 123' ' ' ASN . . . 100.21 27.96 7.48 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 119.288 -1.434 . . . . 0.0 111.732 -178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.801 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.435 -1.213 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.973 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 35.9 mtm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.815 0.34 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 9.6 mtt180 -67.54 138.69 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.897 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.55 -31.45 4.26 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.39 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 10.9 t -74.38 129.22 37.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.747 0.308 . . . . 0.0 110.939 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -160.5 39.88 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.982 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -140.04 124.33 17.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.962 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -140.03 109.96 6.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 5.4 m80 -89.86 107.63 19.22 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 13.1 m80 -122.59 157.86 31.2 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.003 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 63.71 84.82 0.14 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.938 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -147.29 -28.33 0.07 OUTLIER Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.381 -0.914 . . . . 0.0 113.662 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 2.8 p -103.66 -24.1 13.4 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 117.091 0.445 . . . . 0.0 111.868 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.99 93.71 4.14 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.674 0.273 . . . . 0.0 111.284 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.27 83.07 0.62 Allowed 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.513 2.142 . . . . 0.0 112.608 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . 0.401 ' HB ' ' H ' ' 1' ' 16' ' ' THR . 21.5 p -81.19 -164.19 0.72 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.542 179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . 0.401 ' H ' ' HB ' ' 1' ' 15' ' ' THR . 13.7 m -70.49 129.28 90.35 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.756 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -77.93 147.65 24.32 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.435 2.09 . . . . 0.0 112.309 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.26 -10.78 29.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.127 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 15.7 p -72.01 99.8 2.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.379 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -178.64 140.45 0.19 Allowed 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 120.985 0.421 . . . . 0.0 111.811 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.6 HD13 ' O ' ' 1' ' 125' ' ' LEU . 4.4 mm? 25.14 73.6 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.444 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.6 mmtm -60.17 168.83 1.79 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.71 0.291 . . . . 0.0 110.343 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.629 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.53 154.6 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 -177.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.987 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.8 m-85 -111.65 171.53 7.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.867 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.662 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 14.5 mptt -116.91 109.67 17.35 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.279 177.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.807 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -79.85 80.39 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-O 121.9 0.857 . . . . 0.0 109.447 178.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.86 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 1.0 OUTLIER -81.59 -25.87 35.39 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.891 -178.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -174.59 116.55 0.19 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.149 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.907 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.27 136.92 49.69 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.112 0.482 . . . . 0.0 110.264 177.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.907 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -130.35 160.86 32.69 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.065 -177.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' 1' ' 31' ' ' LYS . 0.0 OUTLIER -71.99 102.49 2.97 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 0.98 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 0.9 OUTLIER -124.9 122.22 62.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -171.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 60.96 35.51 19.05 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.253 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.13 4.27 72.3 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.138 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.445 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -136.19 139.53 45.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.521 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.771 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 87.4 m95 -60.42 129.85 43.66 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.921 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.76 145.14 43.69 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 120.744 -0.383 . . . . 0.0 111.34 -178.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.801 HG23 ' HB2' ' 1' ' 57' ' ' ALA . 22.0 t -113.1 151.24 15.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 114.557 1.317 . . . . 0.0 114.557 -177.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.845 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 33.3 mtp180 -144.56 141.46 29.48 Favored 'General case' 0 C--N 1.345 0.381 0 CA-C-N 114.368 -1.287 . . . . 0.0 111.185 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.86 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -129.74 152.62 49.03 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.575 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.9 -15.98 47.14 Favored 'General case' 0 C--N 1.285 -2.207 0 CA-C-N 114.27 -1.332 . . . . 0.0 112.608 179.999 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.572 HD12 HD22 ' 1' ' 41' ' ' ASN . 3.7 mp -84.34 -50.54 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 121.715 0.769 . . . . 0.0 110.76 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.612 ' HG ' HD23 ' 1' ' 116' ' ' LEU . 0.3 OUTLIER -101.72 -10.08 20.29 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 114.396 -1.275 . . . . 0.0 110.386 179.322 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.734 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.1 t -148.12 70.26 10.94 Favored Pre-proline 0 CA--C 1.505 -0.77 0 C-N-CA 119.925 -0.71 . . . . 0.0 112.048 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.597 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 94.3 Cg_exo -50.86 -30.7 30.96 Favored 'Trans proline' 0 N--CA 1.447 -1.225 0 C-N-CA 122.505 2.137 . . . . 0.0 109.323 178.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.0 t 169.22 151.92 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 113.668 -1.606 . . . . 0.0 111.259 179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.72 56.71 0.13 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.845 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.64 112.39 18.79 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 176.61 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.868 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.11 91.84 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.662 0.744 . . . . 0.0 110.35 -178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 0.98 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 35.8 m0 -44.92 -28.19 0.63 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.653 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.868 HG12 HG22 ' 1' ' 49' ' ' THR . 7.3 p -53.5 -57.07 5.85 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.961 0 CA-C-N 114.949 -1.023 . . . . 0.0 111.369 -179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.732 ' N ' HG13 ' 1' ' 51' ' ' VAL . 52.1 t0 -151.94 -11.79 0.19 Allowed 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 113.902 -1.499 . . . . 0.0 113.498 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.015 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.8 m120 -87.23 -10.97 51.12 Favored 'General case' 0 CA--C 1.491 -1.325 0 C-N-CA 120.082 -0.647 . . . . 0.0 110.886 -179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.921 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -81.98 142.32 22.33 Favored Glycine 1 N--CA 1.388 -4.563 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 175.694 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 0.907 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.39 117.2 28.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.417 -178.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -69.46 87.51 0.46 Allowed 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.129 -1.064 . . . . 0.0 108.129 176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 0.959 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -34.88 -34.62 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.233 -1.349 . . . . 0.0 113.707 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -53.99 -33.97 58.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.07 0.462 . . . . 0.0 110.7 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.5 m-20 -70.16 -27.6 64.67 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.852 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 0.907 HG13 HD11 ' 1' ' 55' ' ' ILE . 32.0 m -98.78 -173.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-O 121.424 0.63 . . . . 0.0 112.126 -178.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.95 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -142.72 105.33 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.865 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.538 -177.33 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -65.81 126.46 28.54 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.744 -178.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.954 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 15.8 m -116.48 161.76 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.829 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.746 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.714 HG23 HG22 ' 1' ' 68' ' ' THR . 1.6 p -83.7 163.92 19.96 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -37.86 -35.28 0.14 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.901 0.75 . . . . 0.0 112.926 -178.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -80.18 -4.99 55.29 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-O 121.174 0.512 . . . . 0.0 111.318 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.636 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 89.91 23.33 33.13 Favored Glycine 0 CA--C 1.505 -0.583 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.212 -178.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.714 HG22 HG23 ' 1' ' 64' ' ' THR . 0.8 OUTLIER -75.49 116.96 16.76 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 120.883 0.373 . . . . 0.0 111.129 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.954 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 3.4 mtp180 -68.45 115.82 8.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.568 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . 0.491 ' OG1' ' HG2' ' 1' ' 62' ' ' GLU . 68.2 p -79.95 89.29 5.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 30.4 m -61.31 -11.72 10.92 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.806 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . 0.604 ' HB3' HG12 ' 1' ' 74' ' ' VAL . 8.2 m-20 -49.03 -26.47 2.61 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 120.67 0.271 . . . . 0.0 111.429 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 74.76 7.87 4.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.631 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . 0.629 ' O ' HG13 ' 1' ' 74' ' ' VAL . 10.3 p -109.16 101.67 12.9 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-O 120.734 0.302 . . . . 0.0 111.176 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 0.959 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -83.8 151.12 25.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.226 0.536 . . . . 0.0 111.366 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 35.8 mt-30 -156.92 133.23 9.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.007 178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.56 151.57 37.87 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.578 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 117.82 18.15 5.27 Favored Glycine 0 N--CA 1.436 -1.324 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.758 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -150.81 -109.47 0.46 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 118.655 -1.736 . . . . 0.0 114.579 -179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.807 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.86 160.19 43.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.927 -0.637 . . . . 0.0 109.523 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.772 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.9 OUTLIER -153.19 173.11 15.95 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.057 0.932 . . . . 0.0 110.946 177.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.802 HG12 HD12 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.28 124.54 35.91 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.475 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.615 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.19 112.22 10.8 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 C-N-CA 120.425 -0.51 . . . . 0.0 110.439 -178.74 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.95 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 1.4 t-20 -52.39 114.0 5.04 Favored Pre-proline 0 N--CA 1.436 -1.137 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.669 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 87.4 Cg_endo -70.61 -27.23 22.67 Favored 'Trans proline' 0 CA--C 1.498 -1.289 0 C-N-CA 123.065 2.51 . . . . 0.0 110.532 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . 0.607 HD22 ' HG2' ' 1' ' 85' ' ' PRO . 6.7 m-80 -74.53 -28.62 61.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 113.485 -1.689 . . . . 0.0 109.999 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.946 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.71 -2.09 53.2 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 176.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.708 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.9 t -96.54 130.25 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.39 -3.425 0 CA-C-O 123.002 1.382 . . . . 0.0 111.84 -178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.878 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.3 -46.28 13.85 Favored 'General case' 0 C--N 1.28 -2.432 0 CA-C-N 111.782 -2.463 . . . . 0.0 107.856 178.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.451 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 173.99 172.72 0.18 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.815 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.932 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.96 145.93 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 175.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -118.19 179.44 17.06 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-O 122.072 0.818 . . . . 0.0 113.676 -177.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . 0.489 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -60.05 137.85 91.03 Favored Pre-proline 0 C--N 1.309 -1.166 0 CA-C-N 113.48 -1.36 . . . . 0.0 111.443 179.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.022 ' HB3' HG21 ' 1' ' 118' ' ' THR . 25.4 Cg_endo -81.54 158.31 19.3 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 124.274 3.316 . . . . 0.0 113.574 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtm -149.53 130.89 14.68 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.509 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 6.4 mttp -85.17 124.97 32.44 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.857 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.446 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.77 -48.63 0.05 OUTLIER Glycine 0 C--N 1.334 0.445 0 C-N-CA 119.829 -1.177 . . . . 0.0 113.584 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.906 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -66.63 69.36 0.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 110.396 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.96 -49.39 0.86 Allowed Glycine 0 CA--C 1.522 0.481 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.152 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.81 -17.07 0.39 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.916 -0.659 . . . . 0.0 113.039 -179.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.823 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -75.73 -153.45 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 121.849 0.833 . . . . 0.0 112.394 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.505 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.1 m -116.72 118.29 32.13 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 113.463 -1.699 . . . . 0.0 109.773 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.906 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.5 m95 -120.44 117.12 26.87 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.63 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.36 149.68 24.54 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -175.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.728 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.0 tt0 -83.52 103.07 12.57 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 112.576 -2.102 . . . . 0.0 111.897 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.932 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 44.1 t -102.88 138.69 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.44 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.878 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.9 OUTLIER -89.99 101.51 14.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.333 -177.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.647 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 3.4 m-85 -98.35 167.27 10.95 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-O 122.953 1.359 . . . . 0.0 111.287 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.922 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -50.84 -65.88 0.48 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 112.299 -2.228 . . . . 0.0 116.55 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.922 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.5 OUTLIER -86.46 -56.6 3.36 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -176.923 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.452 ' H ' ' CG ' ' 1' ' 59' ' ' ASP . . . -70.76 -7.32 61.41 Favored Glycine 0 N--CA 1.437 -1.297 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.587 -179.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.73 -92.11 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -178.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.435 ' ND2' ' OD1' ' 1' ' 52' ' ' ASP . 0.4 OUTLIER -83.61 129.51 34.97 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.901 -0.764 . . . . 0.0 109.129 176.758 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.86 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 2.8 t -145.09 120.07 3.3 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.982 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.015 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 47.3 m95 -94.7 154.85 17.12 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 119.445 -0.902 . . . . 0.0 113.103 -177.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.612 HD23 ' HG ' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -153.23 143.63 22.48 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.142 -1.39 . . . . 0.0 109.077 -179.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.707 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -65.27 100.0 0.43 Allowed 'General case' 0 CA--C 1.485 -1.535 0 CA-C-O 124.704 2.193 . . . . 0.0 107.329 178.445 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.022 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 2.5 t -76.84 14.88 0.74 Allowed 'General case' 0 C--N 1.279 -2.47 1 CA-C-N 107.957 -4.201 . . . . 0.0 114.041 -174.39 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.482 ' OG1' ' OD1' ' 1' ' 117' ' ' ASN . 1.1 p -64.0 25.01 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 120.004 -0.678 . . . . 0.0 110.928 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 0.998 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 1.0 OUTLIER -175.15 126.01 0.26 Allowed 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 178.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.53 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 21.3 tttm -74.26 -41.16 61.73 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.923 0.868 . . . . 0.0 108.676 -178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.9 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 6.4 m-20 -65.8 -4.54 6.8 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 174.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 0.998 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.76 -58.7 6.53 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.73 0.776 . . . . 0.0 110.526 -179.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.053 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.81 -56.1 15.58 Favored 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.887 0.851 . . . . 0.0 109.353 178.283 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.604 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.5 mp -58.99 -45.17 91.26 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 114.079 -1.419 . . . . 0.0 112.355 -179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.594 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -115.35 -31.69 5.87 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 120.359 -0.536 . . . . 0.0 112.173 -177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.728 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.14 27.71 7.2 Favored Glycine 0 CA--C 1.506 -0.482 0 C-N-CA 119.35 -1.405 . . . . 0.0 111.569 -178.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.9 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 38.5 mttp . . . . . 0 N--CA 1.435 -1.221 0 CA-C-O 118.236 -0.888 . . . . 0.0 111.019 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 5.9 mtm . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.772 0.32 . . . . 0.0 111.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -85.76 117.06 24.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.798 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 117.32 -103.49 1.09 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.604 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 27.4 t -64.8 121.55 14.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.0 111.018 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -84.13 -28.22 27.61 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.023 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -161.22 114.87 1.98 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.742 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -99.73 123.89 44.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.0 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -152.25 140.95 20.9 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.584 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -172.37 98.14 0.15 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.811 0.339 . . . . 0.0 111.82 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -81.51 130.52 35.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -80.32 104.5 2.26 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.26 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 66.3 p -103.77 11.58 35.66 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.714 0.264 . . . . 0.0 111.714 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -107.71 127.24 28.13 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.562 0.22 . . . . 0.0 111.043 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -72.99 178.94 5.86 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.526 2.15 . . . . 0.0 112.268 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 2.7 m -99.78 2.37 44.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.468 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.62 106.91 59.14 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-O 120.552 0.215 . . . . 0.0 110.929 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.99 121.75 6.78 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.476 2.117 . . . . 0.0 112.293 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.98 52.68 0.5 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.122 0.487 . . . . 0.0 110.56 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 14.5 t -152.1 23.6 0.65 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.605 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . 0.491 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 0.4 OUTLIER -75.07 127.36 33.03 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.987 0.422 . . . . 0.0 110.817 -179.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 1.4 mt -66.59 84.04 0.1 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.559 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.45 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 1.8 mmtt -55.6 169.43 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.186 0.517 . . . . 0.0 111.113 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.652 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.43 153.21 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 -177.162 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.908 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.9 m-85 -109.11 170.28 8.15 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.66 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 2.5 mttt -117.2 109.44 16.9 Favored 'General case' 0 C--N 1.314 -0.97 0 C-N-CA 119.924 -0.711 . . . . 0.0 110.853 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.816 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -79.62 81.66 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 CA-C-O 122.074 0.94 . . . . 0.0 109.756 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.768 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 4.0 m-20 -81.31 -27.23 35.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 112.898 -1.955 . . . . 0.0 111.983 -178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . 0.413 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 4.3 t0 -175.72 118.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.852 HD11 ' HB3' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -132.06 137.87 47.95 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-O 121.277 0.56 . . . . 0.0 110.108 177.918 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.831 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.01 160.83 31.5 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.581 -177.255 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.544 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.4 OUTLIER -71.45 102.64 2.71 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 174.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 0.892 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 0.9 OUTLIER -120.69 120.72 63.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -171.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . 0.525 ' OD1' HG22 ' 1' ' 32' ' ' ILE . 2.9 p-10 49.55 47.47 22.59 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.982 -1.008 . . . . 0.0 110.861 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . 0.87 ' O ' HD13 ' 1' ' 35' ' ' ILE . . . 72.89 3.2 59.28 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.598 -0.728 . . . . 0.0 113.294 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.87 HD13 ' O ' ' 1' ' 34' ' ' GLY . 1.6 mm -138.2 135.94 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.645 0.26 . . . . 0.0 110.582 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.852 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 87.5 m95 -59.75 131.55 51.23 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.892 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.7 146.48 42.74 Favored 'General case' 0 CA--C 1.504 -0.798 0 C-N-CA 120.674 -0.411 . . . . 0.0 110.806 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.827 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 19.9 t -113.33 150.96 15.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.703 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -178.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.924 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.61 141.97 29.8 Favored 'General case' 0 C--N 1.346 0.445 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.412 178.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.78 ' O ' ' N ' ' 1' ' 44' ' ' VAL . 0.0 OUTLIER -131.24 150.32 52.2 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 175.192 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.699 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -59.74 -17.46 35.24 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.429 -1.26 . . . . 0.0 112.326 179.777 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.586 HD12 ' ND2' ' 1' ' 41' ' ' ASN . 3.7 mp -82.85 -50.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 121.54 0.686 . . . . 0.0 110.726 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.616 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.5 OUTLIER -100.6 -11.93 19.64 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.162 178.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.78 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.49 71.82 9.87 Favored Pre-proline 0 CA--C 1.504 -0.822 0 C-N-CA 119.892 -0.723 . . . . 0.0 112.274 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.594 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.5 Cg_exo -49.3 -32.3 25.25 Favored 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.548 2.165 . . . . 0.0 109.306 177.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 12.8 t 169.56 155.66 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 113.47 -1.696 . . . . 0.0 110.879 179.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . 0.487 ' CG ' HG23 ' 1' ' 46' ' ' THR . 0.3 OUTLIER 72.1 56.45 0.16 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.924 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.87 113.11 20.72 Favored 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 177.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.81 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.33 91.7 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.677 0.751 . . . . 0.0 110.082 -179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 0.839 ' HB3' HG23 ' 1' ' 32' ' ' ILE . 42.1 m0 -46.05 -28.47 1.19 Allowed 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.887 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.81 HG12 HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.46 -56.86 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.836 -1.075 . . . . 0.0 111.794 -178.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.724 ' N ' HG13 ' 1' ' 51' ' ' VAL . 48.2 t0 -149.33 -14.34 0.29 Allowed 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 113.956 -1.475 . . . . 0.0 113.502 -177.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.124 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 0.9 OUTLIER -87.02 -12.86 46.13 Favored 'General case' 0 CA--C 1.491 -1.294 0 CA-C-O 121.376 0.608 . . . . 0.0 110.53 -178.972 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.853 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.31 140.42 22.06 Favored Glycine 1 N--CA 1.387 -4.572 0 N-CA-C 108.922 -1.671 . . . . 0.0 108.922 176.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 1.008 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.05 119.07 31.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.906 -0.718 . . . . 0.0 111.304 -178.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.898 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -69.53 87.57 0.47 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 0.909 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -35.25 -35.3 0.05 OUTLIER 'General case' 0 N--CA 1.443 -0.825 0 CA-C-N 114.553 -1.203 . . . . 0.0 113.859 -177.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -54.58 -35.87 63.79 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.419 0.628 . . . . 0.0 110.216 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.898 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.5 OUTLIER -66.89 -27.64 67.67 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.722 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 1.008 HG13 HD11 ' 1' ' 55' ' ' ILE . 25.1 m -99.05 -173.05 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.081 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.888 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -144.98 112.36 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.11 -176.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.9 mt-10 -63.83 128.28 35.12 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.56 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.855 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 0.9 OUTLIER -109.07 161.88 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.876 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.717 HG23 HG22 ' 1' ' 68' ' ' THR . 1.4 p -85.41 159.08 20.06 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -37.51 -33.77 0.08 Allowed 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.4 -8.1 58.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.552 . . . . 0.0 111.206 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.618 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.34 22.95 23.26 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.417 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.717 HG22 HG23 ' 1' ' 64' ' ' THR . 0.8 OUTLIER -74.27 116.54 15.05 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 121.044 0.45 . . . . 0.0 111.141 -179.119 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.855 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 8.8 mtp180 -73.51 138.42 45.03 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.001 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 1.4 t -162.12 100.49 1.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 6.0 t -88.8 -26.28 21.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.191 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 11.9 p30 -50.45 -29.82 11.22 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.601 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 3.7 pp0? -83.23 -179.26 7.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.914 0.388 . . . . 0.0 111.729 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 13.1 t -109.01 124.05 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.756 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 0.909 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.3 OUTLIER -56.98 147.4 24.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.452 0.644 . . . . 0.0 112.339 -179.236 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 12.1 mt-30 -156.99 133.24 9.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.578 -1.192 . . . . 0.0 109.747 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.76 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.04 151.8 38.7 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 -179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.613 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.1 18.05 5.19 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.293 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.752 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.78 -107.96 0.34 Allowed Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 118.833 -1.651 . . . . 0.0 114.277 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.816 ' N ' HG23 ' 1' ' 26' ' ' VAL . 1.4 m-85 -151.7 160.38 43.63 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.827 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -154.5 173.57 16.11 Favored 'General case' 0 CA--C 1.493 -1.221 0 CA-C-O 122.128 0.966 . . . . 0.0 110.728 177.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.888 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -137.37 125.7 33.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.921 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.275 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.697 HG23 ' HE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -73.1 113.62 11.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.994 -178.665 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.884 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -55.67 114.65 7.75 Favored Pre-proline 0 C--N 1.314 -0.967 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.663 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 70.0 Cg_endo -64.2 -26.69 64.56 Favored 'Trans proline' 0 CA--C 1.498 -1.312 0 C-N-CA 122.95 2.434 . . . . 0.0 109.717 178.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -72.79 -27.52 62.03 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 113.505 -1.68 . . . . 0.0 109.953 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.602 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.8 t-20 -82.82 -1.75 52.69 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 175.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.82 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 53.8 t -102.6 129.77 53.64 Favored 'Isoleucine or valine' 0 N--CA 1.393 -3.319 0 CA-C-O 122.94 1.352 . . . . 0.0 112.786 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.879 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -93.83 -37.73 11.6 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-N 111.78 -2.464 . . . . 0.0 108.194 178.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.538 ' O ' HG13 ' 1' ' 106' ' ' VAL . 6.0 p 177.21 172.84 0.5 Allowed 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.235 -1.348 . . . . 0.0 113.37 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.84 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -110.35 122.16 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -93.28 179.67 39.28 Favored Glycine 0 N--CA 1.433 -1.561 0 CA-C-O 122.45 1.028 . . . . 0.0 114.873 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.91 139.66 97.86 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 112.723 -1.738 . . . . 0.0 111.182 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.027 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.7 Cg_endo -81.67 157.68 18.83 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 124.476 3.451 . . . . 0.0 113.869 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 91.5 mtp -149.68 137.6 20.32 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.49 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 1.7 mttt -84.53 124.26 31.2 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.824 -0.351 . . . . 0.0 110.617 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.517 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.56 -60.21 0.04 OUTLIER Glycine 0 C--N 1.336 0.564 0 C-N-CA 119.5 -1.334 . . . . 0.0 114.012 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.914 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -59.57 72.42 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.893 0.346 . . . . 0.0 111.108 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 105.08 -49.52 0.89 Allowed Glycine 0 CA--C 1.521 0.44 0 C-N-CA 120.984 -0.627 . . . . 0.0 113.393 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.88 -16.0 0.45 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.123 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.828 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.42 -153.33 0.04 OUTLIER 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.68 0.752 . . . . 0.0 112.107 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.537 ' C ' HG22 ' 1' ' 118' ' ' THR . 0.7 OUTLIER -116.54 119.21 34.85 Favored 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.593 178.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.914 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.4 m95 -121.44 119.31 31.69 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.561 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -106.84 147.02 30.24 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 -176.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.699 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.1 tt0 -78.91 102.86 8.47 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 112.886 -1.961 . . . . 0.0 111.78 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.84 HG22 HG12 ' 1' ' 91' ' ' VAL . 19.7 t -97.7 137.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.879 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.7 OUTLIER -86.79 102.09 13.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.951 -177.224 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.697 ' HE2' HG23 ' 1' ' 83' ' ' ILE . 35.8 m-85 -103.21 157.15 17.21 Favored 'General case' 0 N--CA 1.41 -2.427 0 CA-C-O 122.244 1.021 . . . . 0.0 110.062 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.65 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.4 OUTLIER -58.61 -62.25 1.99 Allowed 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.416 -1.72 . . . . 0.0 114.238 -179.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.65 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.1 OUTLIER -85.91 -42.69 13.86 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.941 -177.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.555 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -78.55 -0.34 79.05 Favored Glycine 0 N--CA 1.427 -1.929 0 CA-C-N 114.112 -1.404 . . . . 0.0 112.147 179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 45.13 -91.49 0.01 OUTLIER Glycine 0 C--N 1.346 1.093 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.555 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -93.15 130.67 38.72 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.885 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.9 t -145.52 115.93 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.124 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 43.9 m95 -91.84 155.9 17.88 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 122.065 0.936 . . . . 0.0 113.152 -178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.68 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.85 144.56 22.53 Favored 'General case' 0 N--CA 1.424 -1.732 0 CA-C-N 113.681 -1.599 . . . . 0.0 109.094 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.793 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -65.19 100.81 0.48 Allowed 'General case' 0 CA--C 1.482 -1.641 0 CA-C-O 124.68 2.181 . . . . 0.0 107.126 178.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.027 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 5.7 t -75.94 15.4 0.54 Allowed 'General case' 0 C--N 1.279 -2.484 1 CA-C-N 108.273 -4.058 . . . . 0.0 113.401 -174.743 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.793 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 9.6 t -62.62 22.08 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.742 -0.783 . . . . 0.0 110.669 178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.5 OUTLIER -175.68 125.86 0.23 Allowed 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 178.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.515 ' HG3' ' N ' ' 1' ' 122' ' ' ASP . 0.8 OUTLIER -74.24 -39.83 62.79 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 122.246 1.022 . . . . 0.0 108.354 -179.221 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.851 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 75.2 m-20 -65.91 -5.04 8.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 174.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 1.001 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.86 -58.38 7.61 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.642 0.734 . . . . 0.0 110.299 -179.3 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.04 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.3 -57.01 10.63 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 122.014 0.911 . . . . 0.0 109.605 178.134 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.614 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.08 -45.62 90.35 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 114.11 -1.405 . . . . 0.0 112.612 -179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.621 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.7 m-85 -112.58 -31.61 6.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.132 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.729 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.79 25.88 8.86 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 119.364 -1.398 . . . . 0.0 111.273 -178.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.851 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.2 mttt . . . . . 0 N--CA 1.434 -1.238 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.92 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptm . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 120.773 0.32 . . . . 0.0 111.354 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 4.0 ttt-85 -74.93 136.68 41.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.903 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.26 -107.81 0.44 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.575 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 59.62 100.41 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.823 0.344 . . . . 0.0 111.098 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -87.58 -176.66 5.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.897 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -160.56 112.17 1.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.819 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 -137.12 114.36 10.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.586 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.9 80.04 6.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.091 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.08 -68.23 0.86 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.305 179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -82.42 36.42 0.48 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.573 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -79.6 4.83 62.92 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.065 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -102.01 -15.34 16.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.831 0.316 . . . . 0.0 111.292 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -168.55 95.28 0.57 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 120.616 0.246 . . . . 0.0 111.12 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.68 128.41 15.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.579 2.186 . . . . 0.0 112.239 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . 0.525 HG22 ' O ' ' 1' ' 15' ' ' THR . 83.5 m -95.11 54.27 1.65 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.659 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . 0.58 HG22 ' HD2' ' 1' ' 17' ' ' PRO . 0.2 OUTLIER -98.02 141.34 22.81 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.806 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . 0.58 ' HD2' HG22 ' 1' ' 16' ' ' THR . 57.2 Cg_endo -70.77 116.26 4.59 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.488 2.126 . . . . 0.0 112.539 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 2.6 t -124.37 -1.73 8.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.95 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . 0.446 ' HA ' ' OH ' ' 1' ' 126' ' ' TYR . 4.6 t -55.2 142.44 31.3 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.791 0.329 . . . . 0.0 111.26 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . 0.464 ' O ' ' CE1' ' 1' ' 126' ' ' TYR . 0.9 OUTLIER 179.47 128.7 0.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.617 179.927 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.54 HD13 ' HD3' ' 1' ' 85' ' ' PRO . 0.4 OUTLIER -62.39 86.84 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.18 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' 1' ' 126' ' ' TYR . 1.0 OUTLIER -50.09 169.47 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.414 179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.628 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.45 154.18 7.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 115.549 1.685 . . . . 0.0 115.549 -176.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.875 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -107.65 170.42 7.99 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 106.18 -1.785 . . . . 0.0 106.18 176.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.653 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 0.4 OUTLIER -117.31 111.36 19.27 Favored 'General case' 0 C--N 1.311 -1.085 0 C-N-CA 119.803 -0.759 . . . . 0.0 111.027 177.423 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.818 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -80.83 80.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-O 122.132 0.968 . . . . 0.0 109.676 179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.788 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.8 m-20 -80.35 -26.37 38.72 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 112.946 -1.934 . . . . 0.0 111.686 -178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . 0.526 ' O ' ' HD3' ' 1' ' 39' ' ' ARG . 4.2 t0 -174.94 119.01 0.19 Allowed 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.341 -0.543 . . . . 0.0 112.285 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.894 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.43 136.41 45.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 121.185 0.517 . . . . 0.0 110.255 177.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.894 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.86 160.95 31.96 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.747 -1.115 . . . . 0.0 113.093 -177.682 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.536 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 0.3 OUTLIER -70.87 102.42 2.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 103.381 -2.822 . . . . 0.0 103.381 174.759 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 1.002 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.1 mt -124.35 121.53 61.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -171.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 61.09 35.16 18.81 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.148 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.08 4.49 72.77 Favored Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.075 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.73 137.79 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 109.905 -0.406 . . . . 0.0 109.905 -179.523 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.792 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 92.0 m95 -59.7 129.43 41.85 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.989 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.87 145.53 43.51 Favored 'General case' 0 CA--C 1.505 -0.781 0 C-N-CA 120.91 -0.316 . . . . 0.0 111.489 -177.908 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.795 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 22.6 t -114.07 151.39 15.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.926 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 4.3 mtp180 -144.36 144.25 31.35 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.397 -1.274 . . . . 0.0 110.986 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.788 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.72 151.54 51.95 Favored 'General case' 0 CA--C 1.492 -1.275 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 174.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.578 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.88 -16.13 48.11 Favored 'General case' 0 C--N 1.282 -2.35 0 CA-C-N 114.235 -1.348 . . . . 0.0 112.703 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.648 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.8 mp -83.93 -50.24 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.096 0 CA-C-O 121.771 0.796 . . . . 0.0 110.581 -179.129 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.631 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.5 -11.85 18.98 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 114.368 -1.287 . . . . 0.0 110.235 179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.846 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.6 t -148.01 70.22 11.05 Favored Pre-proline 0 CA--C 1.504 -0.797 0 C-N-CA 120.066 -0.653 . . . . 0.0 112.083 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.587 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.1 Cg_exo -49.88 -31.98 28.51 Favored 'Trans proline' 0 N--CA 1.448 -1.185 0 C-N-CA 122.477 2.118 . . . . 0.0 109.265 177.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.587 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 15.1 t 169.87 154.97 0.05 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 113.583 -1.644 . . . . 0.0 111.255 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.18 55.46 0.17 Allowed 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 177.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.926 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.86 112.21 19.46 Favored 'General case' 0 N--CA 1.433 -1.318 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.007 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.719 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.07 92.2 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.646 0.736 . . . . 0.0 110.743 -178.618 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 1.002 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 31.2 m0 -44.33 -29.43 0.67 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.814 178.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.719 HG12 HG22 ' 1' ' 49' ' ' THR . 6.5 p -53.78 -56.44 9.0 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.976 0 CA-C-N 114.89 -1.05 . . . . 0.0 111.809 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.694 ' N ' HG13 ' 1' ' 51' ' ' VAL . 52.6 t0 -152.79 -13.1 0.16 Allowed 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.102 -1.408 . . . . 0.0 113.405 -177.459 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.111 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.0 OUTLIER -85.71 -14.92 43.89 Favored 'General case' 0 CA--C 1.488 -1.424 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.394 -178.888 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.989 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.96 144.32 26.14 Favored Glycine 1 N--CA 1.386 -4.689 0 N-CA-C 108.893 -1.683 . . . . 0.0 108.893 175.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 0.896 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.2 OUTLIER -83.25 119.75 33.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.488 -178.799 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.704 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.48 87.87 0.66 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 0.753 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -35.58 -35.76 0.06 Allowed 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 114.816 -1.083 . . . . 0.0 113.67 -177.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -55.31 -32.87 62.82 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.305 0.574 . . . . 0.0 110.432 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.704 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.7 OUTLIER -69.42 -28.92 66.57 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 115.26 -0.882 . . . . 0.0 111.429 179.738 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 0.866 HG13 HD11 ' 1' ' 55' ' ' ILE . 31.7 m -100.49 -175.27 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.919 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.1 OUTLIER -141.53 113.63 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.127 -177.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' 1' ' 80' ' ' TYR . 1.8 mt-10 -64.89 128.98 38.03 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.115 -178.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.817 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 1.9 m -113.05 157.89 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.792 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.634 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 1.7 p -85.36 159.8 19.92 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 1.4 m -37.29 -35.8 0.13 Allowed 'General case' 0 N--CA 1.467 0.417 0 O-C-N 123.886 0.741 . . . . 0.0 112.889 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -76.74 -9.87 58.98 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-O 121.253 0.549 . . . . 0.0 111.089 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 95.16 23.12 20.79 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.294 -0.866 . . . . 0.0 111.711 -179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.665 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.8 OUTLIER -74.46 116.93 15.7 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 120.942 0.401 . . . . 0.0 110.989 -179.339 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.817 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 22.0 mtm-85 -74.51 137.74 42.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.371 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 70.7 p -152.1 91.99 1.67 Allowed 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.217 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . 0.505 ' HB3' HG21 ' 1' ' 61' ' ' ILE . 93.3 p -88.26 -29.19 20.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.793 -179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.51 -35.66 63.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.455 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -77.42 -177.25 4.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.584 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 7.6 p -109.01 130.02 62.66 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.557 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 0.739 HD11 HG23 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -60.48 150.2 31.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.443 0.639 . . . . 0.0 112.21 -179.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -156.6 133.28 10.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.08 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.821 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -73.48 151.71 40.96 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.372 0.878 . . . . 0.0 113.372 -179.411 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.545 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.2 17.26 5.4 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 114.609 -1.178 . . . . 0.0 111.35 179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.759 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.57 -109.29 0.4 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 118.68 -1.724 . . . . 0.0 114.439 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.818 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.8 OUTLIER -152.01 160.4 43.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.869 -0.665 . . . . 0.0 109.372 -179.176 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.797 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.8 OUTLIER -153.52 173.25 15.97 Favored 'General case' 0 CA--C 1.494 -1.193 0 CA-C-O 122.056 0.931 . . . . 0.0 110.582 177.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.919 ' O ' HG13 ' 1' ' 61' ' ' ILE . 0.9 OUTLIER -136.04 125.41 39.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.339 179.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.741 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -74.46 114.35 14.16 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-O 120.941 0.4 . . . . 0.0 110.597 -178.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 1.9 t-20 -56.79 114.82 8.65 Favored Pre-proline 0 N--CA 1.436 -1.167 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 178.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.657 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 84.4 Cg_endo -70.47 -26.95 23.67 Favored 'Trans proline' 0 CA--C 1.5 -1.181 0 C-N-CA 123.088 2.526 . . . . 0.0 110.58 179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -74.69 -29.42 61.21 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.039 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.99 -2.43 55.21 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.824 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.2 t -96.92 130.08 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.245 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.924 -178.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.922 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -85.14 -42.48 14.72 Favored 'General case' 0 C--N 1.283 -2.321 0 CA-C-N 112.122 -2.308 . . . . 0.0 107.985 178.781 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.504 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 176.4 172.7 0.4 Allowed 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.777 179.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.906 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -106.55 124.01 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.569 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -97.05 179.54 33.88 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-O 122.528 1.071 . . . . 0.0 114.735 -176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . 0.488 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -62.82 137.91 96.9 Favored Pre-proline 0 C--N 1.312 -1.056 0 CA-C-N 112.74 -1.73 . . . . 0.0 111.666 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.064 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.3 Cg_endo -81.29 156.88 19.64 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 124.248 3.299 . . . . 0.0 113.405 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 22.4 mtt -149.75 134.68 17.87 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.743 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.0 OUTLIER -84.97 123.9 31.06 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.872 -0.331 . . . . 0.0 110.629 179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.467 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -171.69 -51.61 0.04 OUTLIER Glycine 0 C--N 1.335 0.476 0 C-N-CA 119.872 -1.156 . . . . 0.0 113.733 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.903 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -65.36 69.42 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.98 0.39 . . . . 0.0 110.588 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.21 -49.56 0.85 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.258 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.19 -16.09 0.42 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.955 -0.641 . . . . 0.0 112.911 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.826 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.22 -153.63 0.05 OUTLIER 'General case' 0 N--CA 1.434 -1.274 0 CA-C-O 121.768 0.795 . . . . 0.0 111.86 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.535 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.4 m -116.76 119.38 35.27 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 113.643 -1.617 . . . . 0.0 109.698 178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.903 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 11.0 m95 -121.17 118.48 29.78 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.653 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.72 145.19 30.44 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.681 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 25.8 tt0 -79.64 102.32 8.86 Favored 'General case' 0 N--CA 1.426 -1.649 0 CA-C-N 112.908 -1.951 . . . . 0.0 111.274 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.906 HG22 HG12 ' 1' ' 91' ' ' VAL . 42.2 t -100.25 136.47 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.922 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.2 t-20 -86.73 101.38 13.24 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.502 -176.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.689 ' CD1' ' HB ' ' 1' ' 114' ' ' VAL . 12.4 m-85 -101.44 167.6 10.05 Favored 'General case' 0 N--CA 1.413 -2.3 0 CA-C-O 123.008 1.385 . . . . 0.0 112.101 179.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.931 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.4 t -52.17 -66.12 0.44 Allowed 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 111.871 -2.422 . . . . 0.0 116.67 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.931 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.5 -55.93 3.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.86 -7.41 61.87 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.795 -0.717 . . . . 0.0 113.008 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 60.87 -89.64 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.388 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -86.42 130.86 34.35 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.313 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.896 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 4.6 t -145.58 113.86 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.02 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.111 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 44.2 m95 -90.25 156.17 18.48 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-O 122.135 0.969 . . . . 0.0 113.465 -177.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.606 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.2 OUTLIER -153.57 142.95 21.61 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-N 113.684 -1.598 . . . . 0.0 108.731 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.705 ' ND2' HD22 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -64.91 100.32 0.4 Allowed 'General case' 0 CA--C 1.484 -1.576 0 CA-C-O 124.801 2.239 . . . . 0.0 107.282 178.526 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.064 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 4.7 t -76.32 16.3 0.48 Allowed 'General case' 0 C--N 1.28 -2.453 1 CA-C-N 107.962 -4.199 . . . . 0.0 113.45 -174.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.688 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 7.2 t -63.51 23.79 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 119.595 -0.842 . . . . 0.0 110.453 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 1.028 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -176.64 122.22 0.15 Allowed 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.553 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 1.2 ptpt -71.14 -40.38 71.41 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 122.217 1.008 . . . . 0.0 108.401 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.844 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 68.2 m-20 -66.05 -4.66 7.67 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 1.028 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -63.0 -58.67 6.53 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-O 121.672 0.749 . . . . 0.0 110.401 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.049 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.15 -56.69 13.03 Favored 'General case' 0 C--N 1.285 -2.202 0 CA-C-O 122.01 0.909 . . . . 0.0 109.325 178.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.618 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.7 mp -58.36 -46.03 87.07 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.212 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.612 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.36 -32.1 6.05 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -176.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.701 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.7 26.27 7.68 Favored Glycine 0 CA--C 1.506 -0.471 0 C-N-CA 119.322 -1.418 . . . . 0.0 111.36 -178.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.844 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 76.0 mttt . . . . . 0 N--CA 1.434 -1.249 0 CA-C-O 118.128 -0.939 . . . . 0.0 110.88 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.797 0.332 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -67.94 132.77 47.93 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.842 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 130.6 126.29 2.78 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.706 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -126.84 -30.67 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.831 0.348 . . . . 0.0 110.873 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -170.42 -35.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.795 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.46 103.21 15.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -102.3 119.52 38.94 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.635 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -151.48 77.23 1.24 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.277 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -121.59 18.62 11.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.92 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -64.96 -82.21 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.487 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . 106.38 129.41 6.29 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.364 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.09 -29.35 9.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.751 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . 0.557 ' H ' ' HD2' ' 1' ' 14' ' ' PRO . 3.0 mp0 -110.45 -62.35 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.065 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . 0.557 ' HD2' ' H ' ' 1' ' 13' ' ' GLU . 74.1 Cg_endo -76.9 93.93 1.07 Allowed 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.237 1.958 . . . . 0.0 112.445 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . 0.539 HG23 ' O ' ' 1' ' 14' ' ' PRO . 0.1 OUTLIER -172.72 174.99 3.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.563 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 21.8 m -111.41 121.29 40.63 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.893 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.41 -178.46 4.47 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.472 2.115 . . . . 0.0 112.497 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 7.6 t -133.6 53.27 2.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.843 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 3.7 t -165.55 41.04 0.07 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.056 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . 0.477 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 72.6 m-20 -82.05 127.73 33.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.98 0.419 . . . . 0.0 110.878 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' 1' ' 125' ' ' LEU . 0.6 OUTLIER -63.66 86.12 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.191 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.428 ' CB ' ' O ' ' 1' ' 126' ' ' TYR . 1.1 mmtm -52.38 168.54 0.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.765 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.631 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.78 154.11 7.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 -177.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.904 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 2.3 m-85 -107.53 169.5 8.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 106.381 -1.711 . . . . 0.0 106.381 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.669 ' HB2' ' HB3' ' 1' ' 40' ' ' ASN . 9.7 mttt -116.62 108.84 16.43 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.745 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.826 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.39 81.47 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 CA-C-O 122.067 0.937 . . . . 0.0 109.791 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.752 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.8 m-20 -80.92 -25.94 37.11 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 112.925 -1.943 . . . . 0.0 111.91 -178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 12.6 t0 -175.83 116.69 0.14 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.928 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -130.17 134.8 47.56 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-O 121.08 0.467 . . . . 0.0 110.226 177.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.928 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -130.44 160.83 32.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.977 -1.011 . . . . 0.0 112.805 -177.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.525 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.2 tptp -71.3 102.81 2.67 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 103.529 -2.767 . . . . 0.0 103.529 175.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 1.01 HD13 ' CG ' ' 1' ' 50' ' ' TRP . 1.2 mt -124.53 122.89 64.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 -171.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.22 35.73 18.21 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.131 -179.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.75 3.64 68.25 Favored Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.205 -179.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.472 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -135.96 140.21 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 -179.496 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.77 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 92.7 m95 -59.54 129.78 43.64 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.951 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.77 146.73 42.63 Favored 'General case' 0 CA--C 1.506 -0.728 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.432 -178.094 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.826 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 19.0 t -114.36 150.96 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.907 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 5.7 mtp180 -144.45 140.55 29.03 Favored 'General case' 0 C--N 1.346 0.435 0 CA-C-N 114.512 -1.222 . . . . 0.0 111.441 178.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.752 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -131.02 153.32 49.39 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.914 0.864 . . . . 0.0 108.761 175.273 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.556 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -62.14 -16.72 54.66 Favored 'General case' 0 C--N 1.284 -2.267 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.435 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.585 HD12 ' H ' ' 1' ' 42' ' ' ILE . 3.7 mp -83.15 -50.55 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 CA-C-O 121.758 0.79 . . . . 0.0 110.829 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.611 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.7 -11.0 19.49 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-N 114.372 -1.285 . . . . 0.0 110.376 179.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.76 HG21 ' CE2' ' 1' ' 48' ' ' PHE . 2.5 t -146.9 71.33 12.37 Favored Pre-proline 0 CA--C 1.505 -0.786 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.988 -178.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.606 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 73.1 Cg_exo -48.29 -32.93 20.82 Favored 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.518 2.145 . . . . 0.0 109.235 177.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.606 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 8.0 t 169.09 154.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 113.36 -1.745 . . . . 0.0 110.662 179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . 0.522 ' CG ' HG23 ' 1' ' 46' ' ' THR . 0.4 OUTLIER 72.24 56.06 0.16 Allowed 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 177.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.907 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -81.55 111.77 18.16 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 106.973 -1.491 . . . . 0.0 106.973 176.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.749 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.81 91.97 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.655 0.74 . . . . 0.0 110.524 -178.587 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 1.01 ' CG ' HD13 ' 1' ' 32' ' ' ILE . 34.8 m0 -44.41 -28.28 0.54 Allowed 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.742 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.749 HG12 HG22 ' 1' ' 49' ' ' THR . 7.8 p -53.27 -56.95 5.9 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.968 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.54 -178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.698 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.0 t0 -153.25 -11.67 0.15 Allowed 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 113.893 -1.503 . . . . 0.0 113.063 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 0.946 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.6 m120 -86.43 -12.37 49.26 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.642 -179.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.951 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -82.86 144.03 22.66 Favored Glycine 1 N--CA 1.387 -4.595 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 175.296 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 0.859 ' O ' ' HA ' ' 1' ' 37' ' ' GLN . 0.1 OUTLIER -83.15 119.53 32.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 C-N-CA 120.579 -0.448 . . . . 0.0 111.788 -178.425 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' 1' ' 36' ' ' TRP . . . -70.42 87.49 0.63 Allowed 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 0.99 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -34.18 -34.49 0.03 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.111 -1.404 . . . . 0.0 114.01 -176.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.24 -35.98 63.06 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.208 0.528 . . . . 0.0 110.633 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.657 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.2 m-20 -67.57 -27.21 66.74 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.911 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 0.851 HG13 HD11 ' 1' ' 55' ' ' ILE . 28.7 m -99.51 -172.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.105 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.887 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -144.68 112.96 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.981 -176.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.483 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.07 123.72 19.3 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.285 -0.871 . . . . 0.0 112.84 -178.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.806 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 0.8 OUTLIER -108.17 155.79 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.628 178.359 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.673 HG23 HG22 ' 1' ' 68' ' ' THR . 1.9 p -85.09 160.02 20.06 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 80.3 p -37.87 -34.28 0.11 Allowed 'General case' 0 N--CA 1.468 0.456 0 O-C-N 123.806 0.691 . . . . 0.0 112.738 -178.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -79.26 -6.99 57.92 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.269 0.557 . . . . 0.0 111.078 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 93.14 23.23 25.37 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.568 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.768 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -72.1 116.29 12.33 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.964 0.411 . . . . 0.0 110.668 -179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.806 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 0.0 OUTLIER -73.48 142.18 46.81 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.246 0.546 . . . . 0.0 112.086 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 34.9 p 42.7 75.32 0.09 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.085 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 3.6 t -93.45 -49.12 6.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.34 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' 1' ' 73' ' ' GLN . 7.3 m-20 -99.36 -25.34 14.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.104 179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . 0.478 ' HB2' ' O ' ' 1' ' 72' ' ' ASP . 0.0 OUTLIER 80.85 -25.65 0.17 Allowed 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.223 -179.194 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . 0.505 ' O ' HG13 ' 1' ' 74' ' ' VAL . 8.8 p -109.52 115.39 49.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.972 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 0.99 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -66.9 147.64 52.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.639 0.733 . . . . 0.0 112.424 -178.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -157.48 132.78 8.97 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.359 -1.291 . . . . 0.0 109.361 178.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.788 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -72.82 151.35 42.07 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -179.362 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.528 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 116.94 17.34 5.91 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.528 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.765 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -152.65 -109.16 0.39 Allowed Glycine 0 N--CA 1.442 -0.918 0 C-N-CA 118.672 -1.728 . . . . 0.0 114.559 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.826 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.2 OUTLIER -151.86 160.47 43.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 114.952 -0.624 . . . . 0.0 109.904 -179.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.826 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -155.05 172.99 17.21 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-O 122.014 0.912 . . . . 0.0 110.563 177.33 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.818 HG12 HD12 ' 1' ' 61' ' ' ILE . 1.2 t -138.55 125.2 25.81 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.596 HG23 ' CE2' ' 1' ' 108' ' ' PHE . 0.3 OUTLIER -72.72 112.74 9.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.82 -178.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.997 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 113.58 5.35 Favored Pre-proline 0 N--CA 1.436 -1.134 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.662 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 86.9 Cg_endo -71.84 -27.69 17.53 Favored 'Trans proline' 0 CA--C 1.499 -1.245 0 C-N-CA 123.424 2.749 . . . . 0.0 110.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.64 -28.18 60.75 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 113.911 -1.495 . . . . 0.0 109.73 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.997 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.87 -3.34 56.74 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 175.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.816 HG23 ' O ' ' 1' ' 84' ' ' ASN . 27.0 t -98.77 135.36 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.502 0 CA-C-O 122.945 1.355 . . . . 0.0 111.51 -177.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.89 ' HD2' ' O ' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -84.61 -48.43 9.52 Favored 'General case' 0 C--N 1.276 -2.619 0 CA-C-N 111.871 -2.422 . . . . 0.0 107.791 177.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER 172.28 172.67 0.1 Allowed 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.465 179.333 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.823 HG13 HG22 ' 1' ' 106' ' ' VAL . 67.8 t -89.94 162.56 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.615 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -130.09 179.68 16.67 Favored Glycine 0 N--CA 1.436 -1.324 0 C-N-CA 120.851 -0.69 . . . . 0.0 113.175 -177.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -60.35 133.77 90.91 Favored Pre-proline 0 C--N 1.31 -1.123 0 CA-C-N 113.984 -1.108 . . . . 0.0 110.75 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.072 ' HB3' HG21 ' 1' ' 118' ' ' THR . 23.9 Cg_endo -81.35 158.18 19.76 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 124.347 3.364 . . . . 0.0 113.534 -179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 28.9 mtt -149.7 138.01 20.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.981 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.606 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 2.1 mtpt -85.84 125.4 33.26 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.109 -0.236 . . . . 0.0 110.561 178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -172.96 -53.35 0.05 OUTLIER Glycine 0 C--N 1.334 0.447 0 C-N-CA 119.649 -1.262 . . . . 0.0 113.791 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.896 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.2 m -66.07 69.25 0.05 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.937 0.399 . . . . 0.0 110.398 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 107.62 -49.47 0.86 Allowed Glycine 0 CA--C 1.522 0.476 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.208 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.13 -14.43 0.48 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.829 -0.701 . . . . 0.0 113.185 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.81 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.2 OUTLIER -76.92 -153.15 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 121.83 0.824 . . . . 0.0 112.108 -179.618 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' O ' ' N ' ' 1' ' 118' ' ' THR . 1.1 m -116.86 116.74 28.03 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 113.697 -1.592 . . . . 0.0 109.988 178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.896 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 9.9 m95 -118.63 117.39 28.83 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.609 ' HB2' HG21 ' 1' ' 118' ' ' THR . . . -105.0 150.18 25.14 Favored 'General case' 0 C--N 1.312 -1.047 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 -175.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.667 ' HG3' ' NE1' ' 1' ' 115' ' ' TRP . 23.0 tt0 -82.31 102.18 11.03 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-N 112.919 -1.946 . . . . 0.0 111.816 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.823 HG22 HG13 ' 1' ' 91' ' ' VAL . 53.2 t -98.84 135.77 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.421 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.89 ' O ' ' HD2' ' 1' ' 89' ' ' LYS . 0.2 OUTLIER -89.14 102.69 15.34 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.384 -177.509 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.81 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 0.9 OUTLIER -102.77 169.14 8.79 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.978 1.37 . . . . 0.0 111.544 178.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.901 HG23 ' H ' ' 1' ' 110' ' ' THR . 2.7 t -51.38 -66.08 0.45 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 112.196 -2.274 . . . . 0.0 116.913 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.901 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.55 -56.12 3.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -176.925 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -70.77 -7.15 61.07 Favored Glycine 0 N--CA 1.433 -1.516 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.593 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.01 -91.67 0.04 OUTLIER Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.43 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.4 OUTLIER -84.31 131.06 34.75 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 121.947 -0.737 . . . . 0.0 109.066 176.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.814 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 7.9 t -145.36 113.48 1.4 Allowed 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 0.946 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 53.3 m95 -89.42 153.38 20.88 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.901 0.858 . . . . 0.0 113.101 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.639 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -153.55 144.92 23.11 Favored 'General case' 0 N--CA 1.433 -1.275 0 CA-C-N 114.106 -1.406 . . . . 0.0 109.032 -179.596 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.783 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -65.33 100.36 0.47 Allowed 'General case' 0 CA--C 1.485 -1.526 0 CA-C-O 124.675 2.179 . . . . 0.0 107.076 178.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.072 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 3.1 t -75.89 14.62 0.64 Allowed 'General case' 0 C--N 1.281 -2.396 1 CA-C-N 107.981 -4.19 . . . . 0.0 113.495 -174.546 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.783 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 14.8 t -63.79 22.73 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.963 -0.695 . . . . 0.0 111.047 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 1.032 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.0 OUTLIER -175.24 123.07 0.22 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 178.859 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 18.5 tttt -72.29 -39.47 68.27 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.926 0.87 . . . . 0.0 108.666 -179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.901 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 78.1 m-20 -66.61 -5.14 10.46 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 107.923 -1.139 . . . . 0.0 107.923 174.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 1.032 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.73 -58.48 7.32 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-O 121.818 0.818 . . . . 0.0 110.27 -179.244 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.048 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -63.86 -57.02 11.13 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 122.025 0.917 . . . . 0.0 109.515 178.086 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.613 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.71 -45.04 93.36 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.739 -179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.624 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -113.58 -31.43 6.51 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.271 0.471 . . . . 0.0 112.271 -176.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.706 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 99.42 26.59 8.6 Favored Glycine 0 CA--C 1.505 -0.561 0 C-N-CA 119.226 -1.464 . . . . 0.0 111.273 -178.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.901 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 23.4 mttp . . . . . 0 N--CA 1.435 -1.188 0 CA-C-O 118.147 -0.93 . . . . 0.0 110.81 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.696 0.284 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' 1' ' 2' ' ' ARG . 0.0 OUTLIER -98.01 41.49 1.13 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.062 0.458 . . . . 0.0 110.643 179.92 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 168.26 58.25 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.225 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.4 p -65.35 134.71 54.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.36 . . . . 0.0 111.189 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 53.6 m-70 -108.42 112.37 24.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.628 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 3.9 m80 -103.17 87.44 2.9 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.113 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -140.24 101.45 4.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.66 179.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -89.79 102.97 15.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -147.45 -23.81 0.38 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.574 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -171.76 -158.29 0.13 Allowed 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -115.05 132.09 10.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.144 -179.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.5 -15.66 15.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.618 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . 0.547 ' HB3' ' HD2' ' 1' ' 14' ' ' PRO . 23.4 mt-10 -80.43 164.52 51.44 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.569 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' 1' ' 13' ' ' GLU . 11.9 Cg_endo -53.79 -81.01 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.5 2.133 . . . . 0.0 112.486 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 1.9 m 53.03 30.65 9.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.77 0.319 . . . . 0.0 111.097 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -59.92 126.97 84.84 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -77.95 138.99 17.01 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.603 2.202 . . . . 0.0 112.448 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 76.9 p -139.8 24.2 2.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.84 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . 0.4 HG22 ' H ' ' 1' ' 19' ' ' THR . 1.7 t -72.82 112.67 9.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . 0.409 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 4.1 p30 -177.51 133.93 0.17 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.062 0.458 . . . . 0.0 111.359 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.411 ' H ' ' HG ' ' 1' ' 21' ' ' LEU . 0.3 OUTLIER -64.97 85.13 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.697 179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.438 ' HD2' ' CD2' ' 1' ' 126' ' ' TYR . 0.0 OUTLIER -47.29 164.98 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.186 0.517 . . . . 0.0 111.664 -179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.666 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -72.49 155.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -177.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.928 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.6 m-85 -108.48 169.88 8.37 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.536 -1.665 . . . . 0.0 106.865 177.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.605 ' O ' ' HB3' ' 1' ' 40' ' ' ASN . 15.3 mmmt -116.64 108.52 16.03 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.133 177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.781 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.54 82.63 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.976 0.893 . . . . 0.0 109.905 179.568 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.768 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 6.7 m-20 -83.48 -27.38 29.49 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.085 -1.87 . . . . 0.0 112.275 -178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -174.64 119.23 0.22 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.849 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -133.13 138.28 46.59 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.233 0.54 . . . . 0.0 110.743 178.135 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.849 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.28 160.57 32.56 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.399 -177.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.535 ' HD3' ' CD2' ' 1' ' 36' ' ' TRP . 1.0 OUTLIER -71.93 103.18 3.11 Favored 'General case' 0 N--CA 1.439 -0.981 0 N-CA-C 103.015 -2.957 . . . . 0.0 103.015 174.219 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 0.889 HG13 ' HB3' ' 1' ' 37' ' ' GLN . 1.1 mm -123.88 117.98 52.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -171.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 61.22 37.58 17.29 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.049 -0.978 . . . . 0.0 110.101 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.72 1.95 68.36 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.292 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.432 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -134.57 136.36 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.554 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.759 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 93.1 m95 -59.66 131.56 51.29 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.889 ' HB3' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -116.97 146.49 42.97 Favored 'General case' 0 CA--C 1.504 -0.812 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.899 -179.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.824 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 19.4 t -114.07 150.0 16.23 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.829 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 6.4 mtp180 -144.11 144.08 31.43 Favored 'General case' 0 C--N 1.346 0.43 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.042 178.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.768 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -132.26 152.94 51.11 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 175.148 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.613 HD22 HD12 ' 1' ' 42' ' ' ILE . 0.1 OUTLIER -61.28 -17.33 52.98 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.05 -1.432 . . . . 0.0 112.4 -179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.613 HD12 HD22 ' 1' ' 41' ' ' ASN . 3.9 mp -84.27 -50.58 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 CA-C-O 121.699 0.761 . . . . 0.0 110.673 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.581 ' CD2' HD21 ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -100.43 -11.8 19.91 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 114.55 -1.204 . . . . 0.0 110.425 179.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.761 ' N ' ' O ' ' 1' ' 40' ' ' ASN . 2.3 t -149.63 71.09 9.74 Favored Pre-proline 0 CA--C 1.505 -0.761 0 C-N-CA 119.878 -0.729 . . . . 0.0 112.197 -178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.59 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 89.3 Cg_exo -49.76 -31.84 27.15 Favored 'Trans proline' 0 N--CA 1.447 -1.229 0 C-N-CA 122.534 2.156 . . . . 0.0 109.343 178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.835 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 13.7 t 169.51 155.07 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 113.586 -1.643 . . . . 0.0 111.052 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . 0.835 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.31 56.49 0.15 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 177.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.829 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.0 OUTLIER -82.81 113.81 20.7 Favored 'General case' 0 N--CA 1.434 -1.244 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.343 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.775 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.52 91.76 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.111 0 CA-C-O 121.726 0.774 . . . . 0.0 109.849 -179.332 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 0.878 ' CD1' HD12 ' 1' ' 32' ' ' ILE . 42.5 m0 -47.58 -27.47 1.86 Allowed 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.798 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.775 HG12 HG22 ' 1' ' 49' ' ' THR . 9.8 p -54.03 -56.19 10.59 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.979 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.657 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.703 ' N ' HG13 ' 1' ' 51' ' ' VAL . 50.5 t0 -151.38 -14.09 0.21 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.088 -1.415 . . . . 0.0 113.518 -177.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.133 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 0.8 OUTLIER -86.82 -11.6 50.45 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 121.377 0.608 . . . . 0.0 110.812 -178.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.804 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -80.88 140.03 21.22 Favored Glycine 1 N--CA 1.391 -4.302 0 N-CA-C 108.883 -1.687 . . . . 0.0 108.883 176.152 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 1.052 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.03 117.81 29.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.379 -178.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.833 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -68.97 87.72 0.38 Allowed 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.579 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 1.049 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -34.38 -34.34 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 114.395 -1.275 . . . . 0.0 113.585 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -54.34 -37.04 64.44 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.434 0.635 . . . . 0.0 110.191 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.833 ' OD2' ' HB3' ' 1' ' 56' ' ' ALA . 0.5 OUTLIER -68.0 -26.19 65.78 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.116 179.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 1.052 HG13 HD11 ' 1' ' 55' ' ' ILE . 23.5 m -98.26 -171.3 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.978 HG22 ' HB3' ' 1' ' 71' ' ' SER . 0.0 OUTLIER -145.95 107.61 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.845 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.183 -176.704 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 1.7 pt-20 -65.81 122.93 18.44 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 114.847 -1.069 . . . . 0.0 113.291 -178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.925 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 15.6 m -115.0 160.65 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.433 178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.672 HG23 HG22 ' 1' ' 68' ' ' THR . 3.1 p -83.72 164.76 19.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -37.5 -35.88 0.14 Allowed 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -178.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -80.46 -5.88 57.27 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.185 0.516 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.626 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 91.19 23.56 29.2 Favored Glycine 0 CA--C 1.503 -0.685 0 N-CA-C 110.956 -0.858 . . . . 0.0 110.956 -178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.672 HG22 HG23 ' 1' ' 64' ' ' THR . 0.9 OUTLIER -74.61 118.9 18.09 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-O 121.007 0.432 . . . . 0.0 111.138 -178.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.925 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 21.2 mtt180 -69.1 144.87 53.81 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.362 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . 0.544 HG22 ' O ' ' 1' ' 62' ' ' GLU . 8.9 t -161.61 57.39 0.27 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.066 0.46 . . . . 0.0 111.361 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . 0.978 ' HB3' HG22 ' 1' ' 61' ' ' ILE . 8.3 p -76.87 -6.93 54.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.075 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -62.64 -6.04 3.19 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -122.15 -156.97 0.72 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.621 0.248 . . . . 0.0 111.002 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 7.5 p -108.5 141.36 23.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.791 0.329 . . . . 0.0 110.851 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 1.049 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.1 OUTLIER -66.63 150.81 48.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.261 0.553 . . . . 0.0 111.643 -179.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.5 ' HG2' ' O ' ' 1' ' 75' ' ' LEU . 6.2 mt-30 -154.55 133.04 11.99 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.923 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.695 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -77.55 152.25 34.13 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -179.77 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.584 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.61 18.46 4.84 Favored Glycine 0 N--CA 1.437 -1.265 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.54 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.772 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -151.37 -109.38 0.44 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 118.742 -1.694 . . . . 0.0 114.309 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.781 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.4 OUTLIER -151.68 160.05 43.77 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.589 . . . . 0.0 109.642 -179.578 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.812 ' CE1' ' HB3' ' 1' ' 24' ' ' TYR . 0.6 OUTLIER -154.72 173.43 16.42 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-O 121.95 0.881 . . . . 0.0 110.291 177.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.916 HG12 HD12 ' 1' ' 61' ' ' ILE . 1.2 t -137.58 125.32 31.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.084 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.678 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.39 115.65 14.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.309 -178.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.915 ' HA ' HD11 ' 1' ' 61' ' ' ILE . 0.1 OUTLIER -56.29 114.53 7.85 Favored Pre-proline 0 N--CA 1.439 -1.018 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.67 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 74.1 Cg_endo -65.13 -26.85 57.25 Favored 'Trans proline' 0 CA--C 1.498 -1.275 0 C-N-CA 122.933 2.422 . . . . 0.0 109.834 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -73.35 -27.07 61.3 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 113.419 -1.718 . . . . 0.0 109.92 179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.669 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.9 t-20 -82.29 -2.35 52.37 Favored 'General case' 0 CA--C 1.503 -0.827 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 175.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.799 ' C ' ' HE2' ' 1' ' 89' ' ' LYS . 55.6 t -101.85 130.55 51.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.41 0 CA-C-O 123.165 1.46 . . . . 0.0 113.029 -177.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.899 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -90.58 -42.33 10.86 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 111.445 -2.616 . . . . 0.0 107.876 177.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.51 ' O ' HG13 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 174.66 173.47 0.21 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 113.735 -1.575 . . . . 0.0 112.383 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.935 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -103.28 138.35 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.834 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 176.252 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.46 179.69 20.92 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-O 122.194 0.885 . . . . 0.0 114.067 -176.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . 0.503 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -61.5 137.79 94.82 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.178 -1.511 . . . . 0.0 111.601 179.993 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.036 ' HB3' HG21 ' 1' ' 118' ' ' THR . 22.1 Cg_endo -81.46 157.56 19.35 Favored 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 124.435 3.424 . . . . 0.0 113.625 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 10.6 mtm -149.5 137.81 20.69 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.696 -1.138 . . . . 0.0 110.882 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.9 mtmm -85.18 124.98 32.46 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.103 -0.239 . . . . 0.0 110.657 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -173.55 -55.88 0.05 OUTLIER Glycine 0 C--N 1.336 0.568 0 C-N-CA 119.456 -1.354 . . . . 0.0 114.206 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.896 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -63.75 69.27 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.901 0.351 . . . . 0.0 110.791 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.08 -49.55 0.85 Allowed Glycine 0 CA--C 1.522 0.495 0 C-N-CA 120.882 -0.675 . . . . 0.0 113.258 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.36 -15.17 0.48 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.04 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.823 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.76 -153.21 0.05 OUTLIER 'General case' 0 N--CA 1.433 -1.284 0 CA-C-O 121.754 0.788 . . . . 0.0 111.928 -179.833 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.563 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.74 119.3 35.02 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 113.624 -1.625 . . . . 0.0 109.661 178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.896 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.64 118.03 28.17 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -104.91 148.52 26.6 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -175.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.693 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.2 tt0 -81.22 102.94 10.67 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 112.842 -1.981 . . . . 0.0 111.742 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.935 HG22 HG12 ' 1' ' 91' ' ' VAL . 32.7 t -98.33 138.42 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.899 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 0.6 OUTLIER -88.48 102.12 14.59 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.835 -177.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.693 ' C ' ' HD3' ' 1' ' 89' ' ' LYS . 12.1 m-85 -100.22 157.93 16.23 Favored 'General case' 0 N--CA 1.407 -2.612 0 CA-C-O 122.104 0.954 . . . . 0.0 109.695 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.648 ' CG2' ' N ' ' 1' ' 110' ' ' THR . 0.3 OUTLIER -58.64 -62.55 1.78 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 113.681 -1.599 . . . . 0.0 114.228 -179.231 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.648 ' N ' ' CG2' ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.14 -46.12 10.72 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 121.911 0.862 . . . . 0.0 109.804 -177.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.514 ' HA3' ' OD2' ' 1' ' 59' ' ' ASP . . . -73.83 -2.39 61.13 Favored Glycine 0 N--CA 1.429 -1.8 0 CA-C-N 113.883 -1.508 . . . . 0.0 112.159 179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.441 ' HA2' ' O ' ' 1' ' 108' ' ' PHE . . . 46.88 -92.52 0.01 OUTLIER Glycine 0 C--O 1.212 -1.226 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 -179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -92.26 130.59 37.93 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.827 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 3.7 t -145.36 117.58 2.23 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.06 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.133 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 42.7 m95 -92.46 156.18 17.35 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 119.342 -0.943 . . . . 0.0 113.023 -178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.524 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.75 143.03 21.48 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.731 -1.577 . . . . 0.0 108.678 -179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.831 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -64.87 101.4 0.49 Allowed 'General case' 0 CA--C 1.486 -1.517 0 CA-C-O 124.595 2.141 . . . . 0.0 107.052 178.399 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.036 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 6.6 t -75.64 14.5 0.62 Allowed 'General case' 0 C--N 1.281 -2.374 1 CA-C-N 108.2 -4.091 . . . . 0.0 113.527 -174.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.831 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 12.6 t -62.37 21.51 0.01 OUTLIER 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.715 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 1.012 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.6 OUTLIER -175.33 126.37 0.25 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.438 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.611 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 0.3 OUTLIER -74.51 -41.35 60.8 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 122.126 0.965 . . . . 0.0 108.893 -178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.888 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 1.3 m-20 -66.25 -4.41 7.71 Favored 'General case' 0 N--CA 1.427 -1.593 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 1.012 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.23 -58.81 6.37 Favored 'General case' 0 N--CA 1.439 -0.999 0 CA-C-O 121.417 0.627 . . . . 0.0 110.453 -179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.058 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.89 -55.08 21.53 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-O 121.789 0.805 . . . . 0.0 109.601 178.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.614 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -60.33 -43.73 96.14 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.446 -1.252 . . . . 0.0 113.037 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.595 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 2.1 m-85 -114.49 -32.14 6.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.899 -176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.92 26.04 7.7 Favored Glycine 0 CA--C 1.505 -0.575 0 C-N-CA 119.427 -1.368 . . . . 0.0 111.718 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.888 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 26.3 mttp . . . . . 0 N--CA 1.435 -1.19 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.952 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 120.715 0.293 . . . . 0.0 111.109 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' 1' ' 2' ' ' ARG . 8.9 mtp180 -75.39 162.15 28.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.98 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . 105.91 7.03 36.68 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.747 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -69.4 135.29 50.09 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.887 0.375 . . . . 0.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -116.77 -31.86 5.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.959 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . 0.438 ' O ' ' CD2' ' 1' ' 6' ' ' HIS . 0.4 OUTLIER -83.43 100.9 11.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.334 -179.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -133.0 129.48 38.22 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.709 179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -90.01 72.83 7.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.006 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -122.24 177.07 5.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.438 179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.35 176.46 7.1 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.507 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -99.23 21.84 43.7 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.623 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -93.51 18.69 9.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.712 0.291 . . . . 0.0 111.111 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -124.51 58.6 17.44 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 120.911 0.386 . . . . 0.0 110.605 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -67.79 140.73 51.87 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.686 2.257 . . . . 0.0 112.369 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.17 45.35 1.76 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.802 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . 0.583 HG22 ' HD2' ' 1' ' 17' ' ' PRO . 0.2 OUTLIER -97.47 142.12 24.07 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.75 179.981 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . 0.583 ' HD2' HG22 ' 1' ' 16' ' ' THR . 40.2 Cg_endo -66.69 135.02 37.12 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.398 2.065 . . . . 0.0 112.297 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 17.4 m -127.2 53.98 1.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.028 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . . . . . . . . . 16.3 p -115.43 41.84 2.39 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.638 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . 0.45 ' O ' ' CZ ' ' 1' ' 126' ' ' TYR . 3.0 m120 -72.12 129.63 38.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.32 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.53 HD13 ' HD3' ' 1' ' 85' ' ' PRO . 0.5 OUTLIER -63.51 87.56 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.952 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -50.62 166.93 0.07 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.199 0.523 . . . . 0.0 111.522 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.7 HG12 ' HB2' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -72.5 152.2 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 -176.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.935 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.5 m-85 -105.85 170.94 7.61 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.406 -1.725 . . . . 0.0 106.555 177.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.713 ' HD2' HD11 ' 1' ' 42' ' ' ILE . 70.7 mttt -117.41 109.5 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 120.05 -0.66 . . . . 0.0 110.98 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.834 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -80.19 81.19 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.015 0 CA-C-O 122.138 0.971 . . . . 0.0 109.708 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.785 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.3 m-20 -79.04 -26.74 43.12 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 112.745 -2.025 . . . . 0.0 111.618 -178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 11.6 t0 -176.54 118.86 0.13 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.929 ' HB3' ' HB3' ' 1' ' 77' ' ' LYS . 0.0 OUTLIER -133.62 137.4 45.41 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.185 177.698 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.902 ' NE2' ' O ' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -129.74 160.84 32.19 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.682 -1.144 . . . . 0.0 112.716 -177.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.497 ' HG2' ' CE2' ' 1' ' 36' ' ' TRP . 0.1 OUTLIER -70.62 103.25 2.47 Favored 'General case' 0 N--CA 1.427 -1.58 0 N-CA-C 104.074 -2.565 . . . . 0.0 104.074 175.262 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 0.97 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -124.66 123.27 65.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -171.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . 0.405 ' O ' HG13 ' 1' ' 35' ' ' ILE . 2.2 m-80 59.41 37.67 23.08 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.485 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.2 3.68 70.65 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.267 -179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.496 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -138.53 138.69 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -179.295 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.805 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 82.0 m95 -59.77 130.1 45.15 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.967 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.91 144.93 43.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.393 -178.255 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.8 ' CG2' ' HB2' ' 1' ' 57' ' ' ALA . 21.8 t -112.8 150.97 14.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 -177.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.831 ' HG2' HG11 ' 1' ' 44' ' ' VAL . 75.8 mtm180 -144.65 135.44 24.81 Favored 'General case' 0 C--N 1.346 0.419 0 CA-C-N 114.32 -1.309 . . . . 0.0 111.513 178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.785 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -124.76 153.03 43.06 Favored 'General case' 0 CA--C 1.49 -1.331 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 175.083 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.561 ' ND2' ' N ' ' 1' ' 41' ' ' ASN . 0.1 OUTLIER -61.91 -17.75 57.82 Favored 'General case' 0 C--N 1.281 -2.379 0 CA-C-N 114.057 -1.428 . . . . 0.0 112.451 -179.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.713 HD11 ' HD2' ' 1' ' 25' ' ' LYS . 3.3 mp -81.97 -50.62 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-O 121.842 0.83 . . . . 0.0 110.968 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.617 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.3 OUTLIER -101.12 -12.23 18.96 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.26 -1.336 . . . . 0.0 110.593 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.831 HG11 ' HG2' ' 1' ' 39' ' ' ARG . 2.4 t -148.42 70.84 10.78 Favored Pre-proline 0 CA--C 1.503 -0.851 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.998 -179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.574 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 84.6 Cg_exo -49.32 -31.89 24.09 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.529 2.153 . . . . 0.0 109.316 177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.815 HG23 ' OD2' ' 1' ' 47' ' ' ASP . 14.0 t 170.24 154.51 0.05 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.994 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . 0.815 ' OD2' HG23 ' 1' ' 46' ' ' THR . 0.7 OUTLIER 72.29 56.68 0.15 Allowed 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 114.929 1.455 . . . . 0.0 114.929 177.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.808 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -85.07 112.77 20.95 Favored 'General case' 0 N--CA 1.433 -1.323 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 176.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.844 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -47.26 91.84 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.705 0.764 . . . . 0.0 110.301 -178.749 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 0.97 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 37.2 m0 -45.37 -28.8 0.92 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 114.486 -1.233 . . . . 0.0 110.647 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.844 HG12 HG22 ' 1' ' 49' ' ' THR . 7.5 p -54.28 -57.09 6.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.797 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.729 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.0 t0 -150.94 -13.28 0.22 Allowed 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.124 -1.398 . . . . 0.0 113.609 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.046 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -87.58 -14.33 40.43 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 120.02 -0.672 . . . . 0.0 110.76 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.967 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -79.62 145.27 27.47 Favored Glycine 1 N--CA 1.386 -4.638 0 N-CA-C 108.757 -1.737 . . . . 0.0 108.757 175.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 0.944 ' HA ' ' CG1' ' 1' ' 114' ' ' VAL . 0.1 OUTLIER -83.16 118.55 30.99 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 C-N-CA 120.217 -0.593 . . . . 0.0 111.757 -178.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.502 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.35 87.58 0.62 Allowed 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 0.8 ' HB2' ' CG2' ' 1' ' 38' ' ' VAL . . . -36.27 -34.77 0.06 Allowed 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 114.371 -1.286 . . . . 0.0 113.694 -176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -54.67 -33.59 60.99 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.322 0.582 . . . . 0.0 110.343 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.704 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.3 m-20 -68.62 -29.63 68.18 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.551 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 0.936 HG23 HD11 ' 1' ' 75' ' ' LEU . 29.0 m -100.04 -175.03 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 121.13 0.491 . . . . 0.0 112.172 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.855 HG13 ' O ' ' 1' ' 82' ' ' VAL . 0.0 OUTLIER -141.74 110.08 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-N 115.41 -0.813 . . . . 0.0 112.043 -177.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.601 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.2 OUTLIER -64.98 122.98 18.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.632 -178.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.929 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 7.2 m -104.95 159.45 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.951 178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.646 ' O ' ' N ' ' 1' ' 67' ' ' GLY . 2.5 p -84.08 161.55 20.63 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -37.85 -33.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 123.845 0.716 . . . . 0.0 112.749 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -79.8 -7.56 58.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.291 0.567 . . . . 0.0 111.097 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.646 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 92.63 23.35 26.3 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.331 -0.85 . . . . 0.0 111.607 -179.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.785 ' O ' ' HA ' ' 1' ' 63' ' ' VAL . 0.9 OUTLIER -73.68 116.69 14.56 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 120.921 0.391 . . . . 0.0 110.788 -179.263 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.929 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 6.7 mtm105 -73.23 140.01 46.6 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.113 -0.494 . . . . 0.0 112.082 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . 0.495 HG23 ' O ' ' 1' ' 70' ' ' THR . 9.5 t 39.71 78.91 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.275 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 13.7 t -92.18 -47.68 7.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.693 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' 1' ' 73' ' ' GLN . 29.8 p30 -96.24 -13.94 23.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.679 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' 1' ' 72' ' ' ASP . 0.9 OUTLIER 71.66 9.77 6.33 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.627 0.251 . . . . 0.0 111.148 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . 0.595 ' O ' HG13 ' 1' ' 74' ' ' VAL . 11.6 p -149.21 109.35 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.097 0 CA-C-O 120.783 0.325 . . . . 0.0 110.724 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 0.936 HD11 HG23 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -58.82 144.06 45.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.55 0.691 . . . . 0.0 112.354 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.527 ' HG2' ' C ' ' 1' ' 75' ' ' LEU . 0.6 OUTLIER -151.95 133.16 14.42 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.367 -1.288 . . . . 0.0 108.843 179.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.929 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -79.15 151.65 31.2 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -179.177 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.642 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.15 18.86 4.91 Favored Glycine 0 N--CA 1.436 -1.346 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.072 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.763 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.75 -106.63 0.29 Allowed Glycine 0 N--CA 1.443 -0.863 0 C-N-CA 118.881 -1.628 . . . . 0.0 114.244 -179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.834 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.1 OUTLIER -151.87 160.64 43.47 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.177 -0.511 . . . . 0.0 110.134 -178.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.794 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.7 OUTLIER -154.36 173.07 16.7 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 122.139 0.971 . . . . 0.0 111.204 177.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.855 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.0 OUTLIER -136.68 125.14 35.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.624 HG23 HG12 ' 1' ' 60' ' ' VAL . 0.2 OUTLIER -74.45 112.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.896 0.379 . . . . 0.0 110.457 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.91 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -54.28 114.65 6.96 Favored Pre-proline 0 N--CA 1.438 -1.067 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.006 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.677 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 89.5 Cg_endo -69.76 -28.12 25.63 Favored 'Trans proline' 0 CA--C 1.5 -1.197 0 C-N-CA 123.05 2.5 . . . . 0.0 110.882 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -74.06 -28.53 61.44 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.867 -1.515 . . . . 0.0 110.012 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.91 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.55 -3.26 55.7 Favored 'General case' 0 N--CA 1.431 -1.381 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 176.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.79 HG23 ' O ' ' 1' ' 84' ' ' ASN . 38.4 t -96.51 132.75 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.271 0 CA-C-O 123.08 1.419 . . . . 0.0 112.246 -177.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.906 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -86.08 -43.74 12.84 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 108.167 178.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.552 ' O ' HG13 ' 1' ' 106' ' ' VAL . 1.0 OUTLIER 175.55 173.36 0.29 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.751 -1.568 . . . . 0.0 112.953 -179.355 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.905 HG12 HG22 ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -109.31 117.33 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.791 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -89.35 179.63 45.01 Favored Glycine 0 N--CA 1.433 -1.503 0 CA-C-O 122.408 1.004 . . . . 0.0 114.711 -176.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -64.63 142.38 98.47 Favored Pre-proline 0 C--N 1.31 -1.131 0 CA-C-N 112.711 -1.745 . . . . 0.0 111.26 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.004 ' HB3' HG21 ' 1' ' 118' ' ' THR . 26.0 Cg_endo -81.34 157.99 19.74 Favored 'Trans proline' 0 N--CA 1.451 -0.99 0 C-N-CA 124.482 3.455 . . . . 0.0 113.762 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . . . . . . . . . 11.4 mtt -149.57 135.2 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 114.637 -1.165 . . . . 0.0 110.672 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.611 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 3.7 mttm -85.39 126.51 33.83 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.414 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.472 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.25 -52.98 0.05 OUTLIER Glycine 0 C--N 1.335 0.506 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.794 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.893 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 0.9 OUTLIER -64.91 69.36 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.927 0.394 . . . . 0.0 110.637 -179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.07 -49.39 0.86 Allowed Glycine 0 CA--C 1.523 0.553 0 C-N-CA 120.924 -0.655 . . . . 0.0 113.193 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 156.07 -16.05 0.43 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.05 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.839 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.13 -152.89 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 121.807 0.813 . . . . 0.0 112.136 -179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.553 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.3 m -116.74 118.6 32.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 113.464 -1.698 . . . . 0.0 109.737 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.893 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.6 m95 -121.84 117.52 26.72 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.644 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.25 147.38 27.12 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 115.262 1.578 . . . . 0.0 115.262 -175.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.692 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 27.3 tt0 -80.9 102.76 10.28 Favored 'General case' 0 N--CA 1.428 -1.557 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.851 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.905 HG22 HG12 ' 1' ' 91' ' ' VAL . 41.8 t -101.62 136.66 32.49 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.906 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.3 m120 -90.31 101.64 14.37 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.367 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.769 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.8 m-85 -98.89 168.36 10.16 Favored 'General case' 0 N--CA 1.412 -2.346 0 CA-C-O 123.034 1.397 . . . . 0.0 111.877 179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.925 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.3 t -52.2 -65.32 0.58 Allowed 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 111.972 -2.376 . . . . 0.0 116.569 -179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.925 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.3 OUTLIER -86.16 -55.91 3.7 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -72.82 -6.02 66.2 Favored Glycine 0 N--CA 1.435 -1.418 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.995 -178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.54 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.11 -91.37 0.04 OUTLIER Glycine 0 N--CA 1.435 -1.411 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -85.79 129.19 34.9 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.944 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.5 t -145.4 119.0 2.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.046 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 45.4 m95 -93.55 156.07 16.94 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.006 0.907 . . . . 0.0 113.17 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.607 HD23 ' HG ' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -153.43 143.2 21.96 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 114.032 -1.44 . . . . 0.0 109.1 -179.76 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.692 ' HB2' ' CE2' ' 1' ' 103' ' ' TRP . 0.2 OUTLIER -65.07 100.01 0.4 Allowed 'General case' 0 CA--C 1.485 -1.544 0 CA-C-O 124.965 2.317 . . . . 0.0 107.182 178.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.004 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 5.1 t -77.12 14.69 0.84 Allowed 'General case' 0 C--N 1.281 -2.387 1 CA-C-N 107.622 -4.354 . . . . 0.0 113.975 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.474 ' OG1' ' OD1' ' 1' ' 117' ' ' ASN . 0.9 OUTLIER -63.2 22.98 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.991 178.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 1.042 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 3.6 m -175.19 121.28 0.21 Allowed 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.541 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -69.57 -40.34 76.81 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.944 0.878 . . . . 0.0 109.125 -178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.867 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 98.5 m-20 -65.2 -4.69 5.44 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 1.042 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.8 OUTLIER -62.98 -58.59 6.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.703 0.763 . . . . 0.0 110.483 -179.247 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.051 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -64.5 -56.81 11.66 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-O 122.02 0.914 . . . . 0.0 109.534 178.368 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.608 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.6 mp -59.86 -44.62 94.03 Favored 'General case' 0 N--CA 1.435 -1.202 0 CA-C-N 114.1 -1.409 . . . . 0.0 112.696 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.607 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.6 m-85 -114.52 -31.51 6.19 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -176.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.689 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 101.64 26.42 7.63 Favored Glycine 0 CA--C 1.504 -0.642 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.728 -178.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.867 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 70.8 mttt . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 118.311 -0.852 . . . . 0.0 110.957 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 1' ' ' MET . . . . . . . . . . . . . 60.6 mtp . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.9 0.381 . . . . 0.0 111.264 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' 1' 1 ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.02 165.23 7.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.957 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 3' ' ' GLY . . . . . . . . . . . . . . . -114.73 130.16 9.07 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.414 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.58 27.42 7.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.698 0.285 . . . . 0.0 111.129 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 5' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -90.62 -55.69 3.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.082 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 6' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -137.56 120.25 16.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.206 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 7' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -100.22 135.58 41.43 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.484 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 8' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -150.16 84.32 1.38 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.076 0.465 . . . . 0.0 111.277 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 9' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -142.91 -67.79 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.18 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 10' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -77.5 -14.83 59.58 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.465 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 11' ' ' GLY . . . . . . . . . . . . . . . -87.11 44.9 3.35 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.735 -0.745 . . . . 0.0 113.148 -179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 12' ' ' SER . . . . . . . . . . . . . 10.5 p -113.7 -2.43 13.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.677 0.275 . . . . 0.0 111.099 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -110.45 82.85 2.95 Favored Pre-proline 0 C--N 1.333 -0.135 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.846 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 14' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.77 165.45 32.19 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.7 2.266 . . . . 0.0 112.404 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 15' ' ' THR . . . . . . . . . . . . . 2.8 m -96.83 -7.14 34.34 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.388 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 16' ' ' THR . . . . . . . . . . . . . 5.0 m -108.32 106.88 59.51 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.681 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 17' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -80.85 119.3 3.58 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.526 2.151 . . . . 0.0 112.535 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 18' ' ' THR . . . . . . . . . . . . . 1.8 p -146.84 30.73 0.97 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.829 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 19' ' ' THR . . . . . 0.572 ' O ' HG23 ' 1' ' 19' ' ' THR . 8.3 t -178.28 99.29 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.045 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 20' ' ' ASN . . . . . 0.451 ' O ' ' C ' ' 1' ' 21' ' ' LEU . 1.3 t-20 -166.94 127.47 1.55 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.931 0.396 . . . . 0.0 111.438 179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 21' ' ' LEU . . . . . 0.623 HD11 ' HG3' ' 1' ' 85' ' ' PRO . 1.8 mt 6.69 96.29 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 22' ' ' LYS . . . . . 0.478 ' HB2' ' CD2' ' 1' ' 126' ' ' TYR . 0.5 OUTLIER -60.75 168.72 2.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.195 0.522 . . . . 0.0 111.068 178.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 23' ' ' ILE . . . . . 0.608 HD11 ' O ' ' 1' ' 64' ' ' THR . 0.0 OUTLIER -73.26 154.3 7.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 -177.698 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 24' ' ' TYR . . . . . 0.928 ' OH ' ' HA ' ' 1' ' 124' ' ' LEU . 3.0 m-85 -105.96 169.54 8.43 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.148 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 25' ' ' LYS . . . . . 0.66 ' HG3' HD11 ' 1' ' 42' ' ' ILE . 0.2 OUTLIER -116.85 108.69 16.15 Favored 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.1 177.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 26' ' ' VAL . . . . . 0.809 HG23 ' N ' ' 1' ' 80' ' ' TYR . 0.0 OUTLIER -78.42 82.15 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 CA-C-O 122.013 0.911 . . . . 0.0 109.888 179.598 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 27' ' ' ASP . . . . . 0.773 ' HB2' ' HA ' ' 1' ' 40' ' ' ASN . 3.9 m-20 -81.03 -27.34 35.83 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 112.82 -1.991 . . . . 0.0 111.81 -178.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 28' ' ' ASP . . . . . 0.438 ' O ' ' HB2' ' 1' ' 39' ' ' ARG . 2.5 t70 -175.84 118.8 0.15 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.5 -0.48 . . . . 0.0 112.227 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 29' ' ' LEU . . . . . 0.863 ' O ' ' NE2' ' 1' ' 30' ' ' GLN . 0.0 OUTLIER -131.97 136.39 47.28 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.271 0.558 . . . . 0.0 110.344 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 30' ' ' GLN . . . . . 0.866 ' O ' HG13 ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -129.82 160.5 33.28 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.701 -178.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' CZ2' ' 1' ' 36' ' ' TRP . 0.0 OUTLIER -71.33 103.6 2.91 Favored 'General case' 0 N--CA 1.426 -1.634 0 N-CA-C 103.649 -2.723 . . . . 0.0 103.649 174.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 32' ' ' ILE . . . . . 0.988 HD13 ' CD2' ' 1' ' 50' ' ' TRP . 1.1 mt -123.94 118.93 55.52 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 113.908 1.077 . . . . 0.0 113.908 -171.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 33' ' ' ASN . . . . . 0.407 ' O ' HG13 ' 1' ' 35' ' ' ILE . 2.1 m-80 61.08 39.27 16.38 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.534 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 34' ' ' GLY . . . . . . . . . . . . . . . 74.15 4.85 69.41 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.6 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 35' ' ' ILE . . . . . 0.417 ' O ' ' O ' ' 1' ' 32' ' ' ILE . 0.0 OUTLIER -137.9 136.54 45.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.614 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 -179.43 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 36' ' ' TRP . . . . . 0.782 ' HB3' HD11 ' 1' ' 29' ' ' LEU . 78.4 m95 -59.81 130.2 45.61 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 37' ' ' GLN . . . . . 0.945 ' OE1' ' HA3' ' 1' ' 54' ' ' GLY . 0.0 OUTLIER -116.8 146.71 42.68 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.411 -178.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 38' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' 1' ' 81' ' ' PHE . 21.5 t -114.18 150.97 16.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 -177.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 39' ' ' ARG . . . . . 0.914 ' HG2' ' HB2' ' 1' ' 48' ' ' PHE . 7.6 mtp180 -144.45 138.52 27.72 Favored 'General case' 0 C--N 1.345 0.397 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.368 178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 40' ' ' ASN . . . . . 0.773 ' HA ' ' HB2' ' 1' ' 27' ' ' ASP . 0.0 OUTLIER -128.56 153.04 47.62 Favored 'General case' 0 CA--C 1.491 -1.302 0 CA-C-O 121.989 0.9 . . . . 0.0 108.689 175.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 41' ' ' ASN . . . . . 0.596 HD22 ' N ' ' 1' ' 41' ' ' ASN . 0.0 OUTLIER -61.01 -18.46 57.81 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.903 -1.498 . . . . 0.0 112.47 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 42' ' ' ILE . . . . . 0.66 HD11 ' HG3' ' 1' ' 25' ' ' LYS . 3.6 mp -82.25 -50.4 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 CA-C-O 121.729 0.776 . . . . 0.0 110.853 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.597 ' O ' ' HB3' ' 1' ' 117' ' ' ASN . 0.4 OUTLIER -100.56 -11.92 19.69 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 114.413 -1.267 . . . . 0.0 110.529 179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 44' ' ' VAL . . . . . 0.792 HG11 ' HB2' ' 1' ' 48' ' ' PHE . 2.2 t -148.43 71.6 10.83 Favored Pre-proline 0 CA--C 1.504 -0.798 0 C-N-CA 119.86 -0.736 . . . . 0.0 112.086 -178.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 45' ' ' PRO . . . . . 0.592 ' O ' ' HB ' ' 1' ' 46' ' ' THR . 83.2 Cg_exo -49.47 -31.68 24.58 Favored 'Trans proline' 0 N--CA 1.448 -1.178 0 C-N-CA 122.503 2.135 . . . . 0.0 109.113 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 46' ' ' THR . . . . . 0.592 ' HB ' ' O ' ' 1' ' 45' ' ' PRO . 14.2 t 169.87 152.79 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 113.544 -1.662 . . . . 0.0 111.005 178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 72.7 56.91 0.13 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 48' ' ' PHE . . . . . 0.914 ' HB2' ' HG2' ' 1' ' 39' ' ' ARG . 0.1 OUTLIER -83.16 112.75 20.11 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 176.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 49' ' ' THR . . . . . 0.773 HG22 HG12 ' 1' ' 51' ' ' VAL . 0.2 OUTLIER -46.83 91.95 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.265 0 CA-C-O 121.672 0.749 . . . . 0.0 110.442 -178.479 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 50' ' ' TRP . . . . . 0.988 ' CD2' HD13 ' 1' ' 32' ' ' ILE . 33.2 m0 -45.51 -27.97 0.84 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.555 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.773 HG12 HG22 ' 1' ' 49' ' ' THR . 8.9 p -53.73 -57.15 6.02 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.674 -178.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 52' ' ' ASP . . . . . 0.708 ' N ' HG13 ' 1' ' 51' ' ' VAL . 51.9 t0 -152.29 -12.61 0.18 Allowed 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 113.994 -1.457 . . . . 0.0 113.349 -177.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 53' ' ' ASN . . . . . 1.068 ' HA ' ' HB2' ' 1' ' 115' ' ' TRP . 1.5 m120 -86.75 -13.74 44.38 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.624 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 54' ' ' GLY . . . . . 0.945 ' HA3' ' OE1' ' 1' ' 37' ' ' GLN . . . -78.89 144.5 27.64 Favored Glycine 1 N--CA 1.386 -4.635 0 N-CA-C 108.607 -1.797 . . . . 0.0 108.607 175.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 55' ' ' ILE . . . . . 0.869 HD11 HG13 ' 1' ' 60' ' ' VAL . 0.1 OUTLIER -83.41 118.76 31.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 120.345 -0.542 . . . . 0.0 111.557 -178.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 56' ' ' ALA . . . . . 0.476 ' HB3' ' OD2' ' 1' ' 59' ' ' ASP . . . -70.14 87.64 0.59 Allowed 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 57' ' ' ALA . . . . . 0.994 ' HB1' HD13 ' 1' ' 75' ' ' LEU . . . -35.1 -35.6 0.05 OUTLIER 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 114.3 -1.318 . . . . 0.0 113.895 -176.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 58' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -54.07 -34.43 60.09 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.349 0.595 . . . . 0.0 110.475 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 59' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' 1' ' 108' ' ' PHE . 1.1 m-20 -68.55 -27.54 66.18 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.848 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 60' ' ' VAL . . . . . 0.869 HG13 HD11 ' 1' ' 55' ' ' ILE . 30.1 m -99.75 -173.36 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.055 0 N-CA-C 112.635 0.606 . . . . 0.0 112.635 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 61' ' ' ILE . . . . . 0.863 HD11 ' HA ' ' 1' ' 84' ' ' ASN . 0.0 OUTLIER -143.48 110.52 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.53 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.01 -177.385 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 62' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -63.51 124.64 21.87 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.987 -178.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 63' ' ' VAL . . . . . 0.835 HG12 ' HA ' ' 1' ' 69' ' ' ARG . 2.5 m -109.47 160.0 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.715 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.026 178.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 64' ' ' THR . . . . . 0.69 HG23 HG22 ' 1' ' 68' ' ' THR . 2.6 p -84.8 159.84 20.35 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 65' ' ' SER . . . . . . . . . . . . . 73.7 p -37.56 -33.8 0.08 Allowed 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.929 0.768 . . . . 0.0 112.859 -178.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 66' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -79.34 -8.37 59.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.267 0.556 . . . . 0.0 111.259 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 67' ' ' GLY . . . . . 0.637 ' N ' ' O ' ' 1' ' 64' ' ' THR . . . 94.15 22.84 23.99 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.428 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 68' ' ' THR . . . . . 0.69 HG22 HG23 ' 1' ' 64' ' ' THR . 0.9 OUTLIER -75.12 117.27 16.77 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.067 0.461 . . . . 0.0 111.287 -178.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 69' ' ' ARG . . . . . 0.835 ' HA ' HG12 ' 1' ' 63' ' ' VAL . 7.8 mtp180 -71.46 141.0 50.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.93 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 70' ' ' THR . . . . . . . . . . . . . 21.2 p -154.22 93.83 1.66 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.575 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.28 -29.15 18.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.293 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 72' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.44 -27.54 56.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.187 -179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -86.15 -177.52 6.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.38 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 74' ' ' VAL . . . . . . . . . . . . . 18.1 t -108.93 139.92 29.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.432 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 75' ' ' LEU . . . . . 0.994 HD13 ' HB1' ' 1' ' 57' ' ' ALA . 0.2 OUTLIER -66.73 145.12 55.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.329 0.585 . . . . 0.0 111.724 -179.462 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' 1' ' 75' ' ' LEU . 4.0 mt-30 -152.84 132.93 13.43 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.833 -1.076 . . . . 0.0 109.814 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 77' ' ' LYS . . . . . 0.813 ' HB3' ' HB3' ' 1' ' 29' ' ' LEU . 0.0 OUTLIER -75.85 151.73 37.38 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 78' ' ' GLY . . . . . 0.582 ' H ' ' HB ' ' 1' ' 26' ' ' VAL . . . 118.03 17.31 5.46 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.357 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 79' ' ' GLY . . . . . 0.759 ' C ' HG23 ' 1' ' 26' ' ' VAL . . . -153.25 -108.02 0.33 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 118.54 -1.79 . . . . 0.0 114.6 -179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 80' ' ' TYR . . . . . 0.809 ' N ' HG23 ' 1' ' 26' ' ' VAL . 0.0 OUTLIER -151.92 160.36 43.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.144 -0.528 . . . . 0.0 109.89 -179.122 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.809 ' CZ ' HG11 ' 1' ' 38' ' ' VAL . 0.6 OUTLIER -154.19 172.83 16.97 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 121.916 0.865 . . . . 0.0 110.467 177.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 82' ' ' VAL . . . . . 0.798 ' O ' HG13 ' 1' ' 61' ' ' ILE . 1.2 t -137.27 124.8 31.13 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 83' ' ' ILE . . . . . 0.609 HD13 ' CE1' ' 1' ' 24' ' ' TYR . 0.3 OUTLIER -73.41 112.06 9.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.544 -178.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 84' ' ' ASN . . . . . 0.944 ' HB3' ' HB2' ' 1' ' 87' ' ' ASN . 0.1 OUTLIER -52.6 114.52 5.79 Favored Pre-proline 0 N--CA 1.437 -1.089 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.674 ' O ' ' HB ' ' 1' ' 88' ' ' VAL . 93.0 Cg_endo -71.24 -27.56 19.63 Favored 'Trans proline' 0 CA--C 1.499 -1.242 0 C-N-CA 123.164 2.576 . . . . 0.0 110.845 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 86' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -74.89 -27.92 60.43 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-N 113.781 -1.554 . . . . 0.0 109.842 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 87' ' ' ASN . . . . . 0.944 ' HB2' ' HB3' ' 1' ' 84' ' ' ASN . 1.2 t-20 -82.47 -4.08 56.87 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 175.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 88' ' ' VAL . . . . . 0.769 HG23 ' O ' ' 1' ' 84' ' ' ASN . 37.8 t -96.63 131.71 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.328 0 CA-C-O 122.991 1.377 . . . . 0.0 111.84 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.864 ' HB2' ' HB3' ' 1' ' 107' ' ' ASN . 0.0 OUTLIER -82.43 -46.94 12.84 Favored 'General case' 0 C--N 1.28 -2.452 0 CA-C-N 111.718 -2.492 . . . . 0.0 107.693 178.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 90' ' ' SER . . . . . 0.452 ' O ' HG13 ' 1' ' 106' ' ' VAL . 0.9 OUTLIER 173.76 172.88 0.17 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 113.442 -1.708 . . . . 0.0 111.787 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 91' ' ' VAL . . . . . 0.948 HG12 ' CG2' ' 1' ' 106' ' ' VAL . 0.0 OUTLIER -99.69 138.81 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 175.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 92' ' ' GLY . . . . . 0.583 ' HA3' ' O ' ' 1' ' 105' ' ' GLN . . . -109.99 179.83 20.66 Favored Glycine 0 N--CA 1.435 -1.431 0 CA-C-O 122.104 0.836 . . . . 0.0 114.021 -176.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 93' ' ' THR . . . . . 0.411 HG22 ' HD2' ' 1' ' 94' ' ' PRO . 0.2 OUTLIER -60.6 136.18 92.38 Favored Pre-proline 0 C--N 1.31 -1.111 0 CA-C-N 113.286 -1.457 . . . . 0.0 111.684 -179.843 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 94' ' ' PRO . . . . . 1.037 ' HB3' HG21 ' 1' ' 118' ' ' THR . 21.7 Cg_endo -81.21 157.16 19.92 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 124.42 3.413 . . . . 0.0 113.563 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 95' ' ' MET . . . . . 0.512 ' HG3' ' CH2' ' 1' ' 115' ' ' TRP . 0.3 OUTLIER -148.8 137.03 20.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.427 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 96' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -86.3 126.87 34.62 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.546 178.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 97' ' ' GLY . . . . . 0.471 ' O ' ' N ' ' 1' ' 99' ' ' GLY . . . -174.29 -53.66 0.05 OUTLIER Glycine 0 C--N 1.333 0.386 0 C-N-CA 119.51 -1.328 . . . . 0.0 113.803 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 98' ' ' SER . . . . . 0.899 ' HB2' ' CD2' ' 1' ' 103' ' ' TRP . 1.1 m -64.96 69.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.849 0.357 . . . . 0.0 110.655 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 99' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' 1' ' 97' ' ' GLY . . . 108.0 -49.4 0.86 Allowed Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.213 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 100' ' ' GLY . . . . . . . . . . . . . . . 155.55 -15.67 0.47 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.9 -0.667 . . . . 0.0 113.008 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 101' ' ' LEU . . . . . 0.819 ' H ' HD12 ' 1' ' 101' ' ' LEU . 0.1 OUTLIER -76.43 -153.68 0.05 OUTLIER 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 121.797 0.808 . . . . 0.0 111.955 -179.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 102' ' ' SER . . . . . 0.549 ' C ' HG22 ' 1' ' 118' ' ' THR . 1.1 m -116.79 118.26 32.03 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.811 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 103' ' ' TRP . . . . . 0.899 ' CD2' ' HB2' ' 1' ' 98' ' ' SER . 10.2 m95 -120.11 117.2 27.32 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 104' ' ' ALA . . . . . 0.624 ' HA ' ' HA ' ' 1' ' 94' ' ' PRO . . . -103.73 148.19 26.36 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -175.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 105' ' ' GLN . . . . . 0.686 ' HB2' ' CZ2' ' 1' ' 115' ' ' TRP . 28.4 tt0 -82.21 102.31 11.05 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.395 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 106' ' ' VAL . . . . . 0.948 ' CG2' HG12 ' 1' ' 91' ' ' VAL . 42.6 t -101.03 137.93 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.452 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 107' ' ' ASN . . . . . 0.864 ' HB3' ' HB2' ' 1' ' 89' ' ' LYS . 1.0 OUTLIER -89.95 101.72 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.309 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 108' ' ' PHE . . . . . 0.736 ' CE1' ' HB ' ' 1' ' 114' ' ' VAL . 1.7 m-85 -99.52 168.58 9.88 Favored 'General case' 0 N--CA 1.412 -2.365 0 CA-C-O 123.046 1.403 . . . . 0.0 111.79 178.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 109' ' ' THR . . . . . 0.917 HG23 ' H ' ' 1' ' 110' ' ' THR . 3.1 t -52.29 -65.6 0.53 Allowed 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 112.057 -2.338 . . . . 0.0 116.637 -179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 110' ' ' THR . . . . . 0.917 ' H ' HG23 ' 1' ' 109' ' ' THR . 0.2 OUTLIER -86.35 -56.06 3.61 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -176.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 111' ' ' GLY . . . . . 0.436 ' O ' ' N ' ' 1' ' 113' ' ' ASN . . . -71.77 -7.37 65.41 Favored Glycine 0 N--CA 1.434 -1.466 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.938 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 112' ' ' GLY . . . . . 0.509 ' O ' ' HA ' ' 1' ' 107' ' ' ASN . . . 59.99 -90.6 0.04 OUTLIER Glycine 0 N--CA 1.433 -1.521 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 113' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' 1' ' 111' ' ' GLY . 0.3 OUTLIER -84.7 130.5 34.69 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 114' ' ' VAL . . . . . 0.803 ' CG1' ' HA ' ' 1' ' 55' ' ' ILE . 5.3 t -145.33 116.28 1.91 Allowed 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 115' ' ' TRP . . . . . 1.068 ' HB2' ' HA ' ' 1' ' 53' ' ' ASN . 50.0 m95 -92.08 154.14 18.93 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.853 0.835 . . . . 0.0 112.777 -177.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 116' ' ' LEU . . . . . 0.638 HD23 ' OD1' ' 1' ' 123' ' ' ASN . 0.3 OUTLIER -153.58 143.5 22.01 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.045 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 117' ' ' ASN . . . . . 0.777 ' OD1' HG22 ' 1' ' 119' ' ' THR . 0.2 OUTLIER -64.9 100.39 0.41 Allowed 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 124.856 2.265 . . . . 0.0 107.103 178.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 118' ' ' THR . . . . . 1.037 HG21 ' HB3' ' 1' ' 94' ' ' PRO . 3.4 t -75.82 15.02 0.57 Allowed 'General case' 0 C--N 1.279 -2.467 1 CA-C-N 107.858 -4.246 . . . . 0.0 113.348 -174.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 119' ' ' THR . . . . . 0.777 HG22 ' OD1' ' 1' ' 117' ' ' ASN . 13.0 t -64.58 24.0 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.954 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.916 178.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 120' ' ' SER . . . . . 1.001 ' O ' ' HB3' ' 1' ' 123' ' ' ASN . 0.4 OUTLIER -175.27 126.08 0.25 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 107.376 -1.342 . . . . 0.0 107.376 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 121' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' 1' ' 124' ' ' LEU . 3.2 tttt -74.38 -40.78 61.86 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 122' ' ' ASP . . . . . 0.856 ' HB2' ' HD2' ' 1' ' 128' ' ' LYS . 77.7 m-20 -65.83 -4.61 7.0 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 174.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 123' ' ' ASN . . . . . 1.001 ' HB3' ' O ' ' 1' ' 120' ' ' SER . 0.7 OUTLIER -62.9 -58.57 6.92 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-O 121.674 0.749 . . . . 0.0 110.457 -179.192 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 124' ' ' LEU . . . . . 1.069 ' H ' HD22 ' 1' ' 124' ' ' LEU . 0.0 OUTLIER -65.09 -55.62 17.73 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-O 122.131 0.967 . . . . 0.0 109.418 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 125' ' ' LEU . . . . . 0.598 ' H ' HD12 ' 1' ' 125' ' ' LEU . 6.7 mp -59.57 -45.15 92.7 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.261 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 126' ' ' TYR . . . . . 0.611 ' N ' ' O ' ' 1' ' 122' ' ' ASP . 1.4 m-85 -115.05 -31.51 6.03 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -176.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 127' ' ' GLY . . . . . 0.694 ' HA2' ' O ' ' 1' ' 123' ' ' ASN . . . 102.45 26.77 7.12 Favored Glycine 0 CA--C 1.504 -0.601 0 C-N-CA 119.233 -1.461 . . . . 0.0 111.829 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 128' ' ' LYS . . . . . 0.856 ' HD2' ' HB2' ' 1' ' 122' ' ' ASP . 39.8 mttt . . . . . 0 N--CA 1.433 -1.285 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.814 179.603 . . . . . . . . 1 1 . 1 stop_ save_